Pathway ID	Description	Parent(s)	p-Value	Genes Involved	Variation IDs
R-HSA-1059683	Interleukin-6 signaling	Immune System	0.475135	PTPN11	chr12:112489105:A/T:1
R-HSA-109581	Apoptosis	Programmed Cell Death	0.069772	APAF1,ARHGAP10,CD14,CDH1,DAPK1,GSN,HIST1H1E,PKP1,PRKCD,PSMF1,RPS27A,STK26,TJP2,TNFRSF10A,UACA,UNC5B	chr10:71291226:C/T:1,chr12:98648251:A/T:1,chr15:70694991:A/T:1,chr16:68779429:G/T:1,chr1:201324373:G/T:1,chr20:1117130:G/T:1,chr2:55234745:A/T:1,chr3:53192052:T/G:1,chr4:147964990:A/T:1,chr4:147975614:C/A:1,chr5:140633030:C/A:1,chr6:26156427:G/C:1,chr8:23202515:G/T:1,chr9:121312182:C/T:1,chr9:69250885:T/G:1,chr9:87640616:C/T:1,chrX:132069471:A/T:1
R-HSA-109582	Hemostasis	Hemostasis	0.009969	CARMIL1,CD36,COL1A1,CSK,DAGLA,DGKI,DOCK1,DOCK4,F13A1,GNA12,GNAQ,GNAT3,GUCY1A2,GYPA,ITGA10,ITGAL,ITGAM,ITIH4,ITPR2,ITPR3,JMJD1C,KIF11,KIF25,KLC2,KLC4,L1CAM,LHFPL2,MPIG6B,NOS3,PAFAH2,PDE11A,PHACTR2,PIK3CB,PIK3R6,PLEK,PPP2R1A,PPP2R5C,PRKCB,PRKCD,PTPN1,PTPN11,PTPN6,SIN3A,SLC7A7,SLC8A1,SLC8A2,SLC8A3,TGFB2,TIMP3,TLN1,TNFRSF10A,TTN,TUBB2A,TUBB8	chr10:127257347:G/T:1,chr10:63215138:A/G:1,chr10:73757:T/G:1,chr10:92639648:G/T:1,chr11:106824788:A/T:1,chr11:61743387:T/A:1,chr11:66264919:G/A:1,chr12:112489105:A/T:1,chr12:26600531:C/A:1,chr12:6960084:C/T:1,chr14:101883867:G/T:1,chr14:22780250:C/A:1,chr14:70060534:G/T:1,chr15:74802540:C/T:1,chr15:75409706:G/A:1,chr16:23867049:C/T:1,chr16:30494137:C/A:1,chr16:31299762:C/T:1,chr17:50195100:C/A:1,chr17:8822843:A/G:1,chr19:47437640:G/T:1,chr19:52215622:C/T:1,chr1:145895756:C/T:1,chr1:145909820:C/A:1,chr1:218405442:G/T:1,chr1:25990859:G/T:1,chr20:50526505:C/A:1,chr22:32803374:G/T:1,chr2:177709965:T/C:1,chr2:178529881:A/T:1,chr2:40160677:G/T:1,chr2:68391550:T/C:1,chr3:138778223:G/A:1,chr3:52819352:G/A:1,chr3:53192052:T/G:1,chr4:144116771:A/T:1,chr5:78708953:G/A:1,chr6:143777479:C/A:1,chr6:168040119:C/A:1,chr6:25442364:C/A:1,chr6:3154999:A/G:1,chr6:31720741:T/A:1,chr6:33676739:C/A:1,chr6:43055804:A/T:1,chr6:6224619:A/T:1,chr7:111808804:C/T:1,chr7:137665038:C/A:1,chr7:151010230:G/T:1,chr7:2762539:T/C:1,chr7:80474080:T/G:1,chr8:23202515:G/T:1,chr9:35697963:G/T:1,chr9:77797745:T/A:1,chrX:153863598:G/T:1
R-HSA-109606	Intrinsic Pathway for Apoptosis	Programmed Cell Death	0.769127	APAF1,UACA	chr12:98648251:A/T:1,chr15:70694991:A/T:1
R-HSA-109704	PI3K Cascade	Signal Transduction;Immune System	0.738060	IRS1,PIK3CB,PTPN11	chr12:112489105:A/T:1,chr2:226796751:A/G:1,chr3:138778223:G/A:1
R-HSA-110056	MAPK3 (ERK1) activation	Signal Transduction	0.443443	PTPN11	chr12:112489105:A/T:1
R-HSA-110312	Translesion synthesis by REV1	DNA Repair	0.058990	RPA1,RPA2,RPS27A	chr17:1853255:C/A:1,chr1:27914481:C/T:1,chr2:55234745:A/T:1
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	DNA Repair	0.280796	POLE,RPA1,RPA2,RPS27A	chr12:132643245:T/C:1,chr17:1853255:C/A:1,chr1:27914481:C/T:1,chr2:55234745:A/T:1
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	DNA Repair	0.025613	POLE,RBX1,RPA1,RPA2,RPS27A	chr12:132643245:T/C:1,chr17:1853255:C/A:1,chr1:27914481:C/T:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1
R-HSA-110320	Translesion Synthesis by POLH	DNA Repair	0.090127	RPA1,RPA2,RPS27A	chr17:1853255:C/A:1,chr1:27914481:C/T:1,chr2:55234745:A/T:1
R-HSA-110328	Recognition and association of DNA glycosylase with site containing an affected pyrimidine	DNA Repair	0.262601	NEIL1	chr15:75355845:G/C:1
R-HSA-110329	Cleavage of the damaged pyrimidine 	DNA Repair	0.262601	NEIL1	chr15:75355845:G/C:1
R-HSA-110362	POLB-Dependent Long Patch Base Excision Repair	DNA Repair	0.374212	POLB	chr8:42369772:A/T:1
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	DNA Repair	0.050683	POLB,POLE,RPA1,RPA2	chr12:132643245:T/C:1,chr17:1853255:C/A:1,chr1:27914481:C/T:1,chr8:42369772:A/T:1
R-HSA-110381	Resolution of AP sites via the single-nucleotide replacement pathway	DNA Repair	0.208897	POLB	chr8:42369772:A/T:1
R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs	Metabolism of RNA	0.107415	NCBP1,SNRPE	chr1:203869988:C/G:1,chr9:97664178:C/A:1
R-HSA-111458	Formation of apoptosome	Programmed Cell Death	0.146339	APAF1,UACA	chr12:98648251:A/T:1,chr15:70694991:A/T:1
R-HSA-111459	Activation of caspases through apoptosome-mediated cleavage	Programmed Cell Death	0.296385	APAF1	chr12:98648251:A/T:1
R-HSA-111461	Cytochrome c-mediated apoptotic response	Programmed Cell Death	0.187575	APAF1,UACA	chr12:98648251:A/T:1,chr15:70694991:A/T:1
R-HSA-111463	SMAC (DIABLO) binds to IAPs 	Programmed Cell Death	0.374212	APAF1	chr12:98648251:A/T:1
R-HSA-111464	SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes 	Programmed Cell Death	0.374212	APAF1	chr12:98648251:A/T:1
R-HSA-111465	Apoptotic cleavage of cellular proteins	Programmed Cell Death	0.019271	CDH1,GSN,PKP1,PRKCD,STK26,TJP2	chr16:68779429:G/T:1,chr1:201324373:G/T:1,chr3:53192052:T/G:1,chr9:121312182:C/T:1,chr9:69250885:T/G:1,chrX:132069471:A/T:1
R-HSA-111469	SMAC, XIAP-regulated apoptotic response	Programmed Cell Death	0.409840	APAF1	chr12:98648251:A/T:1
R-HSA-111471	Apoptotic factor-mediated response	Programmed Cell Death	0.294775	APAF1,UACA	chr12:98648251:A/T:1,chr15:70694991:A/T:1
R-HSA-111885	Opioid Signalling	Signal Transduction	0.248186	GNAT3,ITPR2,ITPR3,PDE1C,PDE4D,PLCB4,PPP2R1A,PRKCD	chr12:26600531:C/A:1,chr19:52215622:C/T:1,chr20:9437223:T/G:1,chr3:53192052:T/G:1,chr5:59002058:C/A:1,chr6:33676739:C/A:1,chr7:32163293:C/T:1,chr7:80474080:T/G:1
R-HSA-111933	Calmodulin induced events	Signal Transduction	1.000000	PDE1C,PRKCD	chr3:53192052:T/G:1,chr7:32163293:C/T:1
R-HSA-111957	Cam-PDE 1 activation	Signal Transduction	0.208897	PDE1C	chr7:32163293:C/T:1
R-HSA-111996	Ca-dependent events	Signal Transduction	1.000000	PDE1C,PRKCD	chr3:53192052:T/G:1,chr7:32163293:C/T:1
R-HSA-111997	CaM pathway	Signal Transduction	1.000000	PDE1C,PRKCD	chr3:53192052:T/G:1,chr7:32163293:C/T:1
R-HSA-112040	G-protein mediated events	Signal Transduction	0.126800	GNAT3,ITPR2,ITPR3,PDE1C,PLCB4,PRKCD	chr12:26600531:C/A:1,chr20:9437223:T/G:1,chr3:53192052:T/G:1,chr6:33676739:C/A:1,chr7:32163293:C/T:1,chr7:80474080:T/G:1
R-HSA-112043	PLC beta mediated events	Signal Transduction	0.123512	GNAT3,ITPR2,ITPR3,PDE1C,PLCB4,PRKCD	chr12:26600531:C/A:1,chr20:9437223:T/G:1,chr3:53192052:T/G:1,chr6:33676739:C/A:1,chr7:32163293:C/T:1,chr7:80474080:T/G:1
R-HSA-112308	Presynaptic depolarization and calcium channel opening	Neuronal System	0.126518	CACNA2D3,CACNB2	chr10:18448206:G/A:1,chr3:54918338:T/C:1
R-HSA-112310	Neurotransmitter release cycle	Neuronal System	0.007626	CHAT,PPFIA4,SLC1A1,SLC6A11,SLC6A12,SYN1,SYN3,TSPOAP1	chr10:49662454:G/A:1,chr12:197114:C/T:1,chr17:58320561:C/A:1,chr1:203048066:G/T:1,chr22:32803374:G/T:1,chr3:10820021:T/A:1,chr3:10933011:G/T:1,chr9:4576050:G/A:1,chrX:47619193:G/T:1
R-HSA-112314	Neurotransmitter receptors and postsynaptic signal transmission	Neuronal System	0.878706	AP2B1,ERBB4,GABRA5,GNAT3,GRIK4,KCNJ6,PRKAA2,PRKAB2,PRKCB,RPS6KA1,TUBB2A,TUBB8	chr10:73757:T/G:1,chr11:120591708:G/A:1,chr11:120607427:G/T:1,chr15:26939977:C/A:1,chr16:23867049:C/T:1,chr17:35682607:A/G:1,chr1:147172001:G/A:1,chr1:26571817:C/A:1,chr1:56706008:C/A:1,chr21:37714489:C/T:1,chr2:211630704:C/G:1,chr6:3154999:A/G:1,chr7:80474080:T/G:1
R-HSA-112315	Transmission across Chemical Synapses	Neuronal System	0.081944	AP2B1,CACNA2D3,CACNB2,CHAT,ERBB4,GABRA5,GNAT3,GRIK4,KCNJ6,PPFIA4,PRKAA2,PRKAB2,PRKCB,RPS6KA1,SLC1A1,SLC6A11,SLC6A12,SYN1,SYN3,TSPOAP1,TUBB2A,TUBB8	chr10:18448206:G/A:1,chr10:49662454:G/A:1,chr10:73757:T/G:1,chr11:120591708:G/A:1,chr11:120607427:G/T:1,chr12:197114:C/T:1,chr15:26939977:C/A:1,chr16:23867049:C/T:1,chr17:35682607:A/G:1,chr17:58320561:C/A:1,chr1:147172001:G/A:1,chr1:203048066:G/T:1,chr1:26571817:C/A:1,chr1:56706008:C/A:1,chr21:37714489:C/T:1,chr22:32803374:G/T:1,chr2:211630704:C/G:1,chr3:10820021:T/A:1,chr3:10933011:G/T:1,chr3:54918338:T/C:1,chr6:3154999:A/G:1,chr7:80474080:T/G:1,chr9:4576050:G/A:1,chrX:47619193:G/T:1
R-HSA-112316	Neuronal System	Neuronal System	0.028759	AP2B1,CACNA2D3,CACNB2,CHAT,EPB41L5,ERBB4,GABRA5,GNAT3,GRIK4,IL1RAPL2,KCNH3,KCNJ6,KCNK1,KCNK16,KCNQ2,KCNQ3,LRFN3,NRXN1,NRXN3,PPFIA4,PRKAA2,PRKAB2,PRKCB,PTPRD,PTPRF,RPS6KA1,SLC1A1,SLC6A11,SLC6A12,SYN1,SYN3,TSPOAP1,TUBB2A,TUBB8	chr10:18448206:G/A:1,chr10:49662454:G/A:1,chr10:73757:T/G:1,chr11:120591708:G/A:1,chr11:120607427:G/T:1,chr12:197114:C/T:1,chr12:49557449:T/C:1,chr14:78220607:G/T:1,chr15:26939977:C/A:1,chr16:23867049:C/T:1,chr17:35682607:A/G:1,chr17:58320561:C/A:1,chr19:35939983:C/A:1,chr19:35944781:C/T:1,chr1:147172001:G/A:1,chr1:203048066:G/T:1,chr1:233647414:G/T:1,chr1:26571817:C/A:1,chr1:43591997:G/T:1,chr1:43617848:G/A:1,chr1:43619068:C/T:1,chr1:43620409:T/C:1,chr1:56706008:C/A:1,chr20:63439613:G/A:1,chr21:37714489:C/T:1,chr22:32803374:G/T:1,chr2:120161150:T/C:1,chr2:211630704:C/G:1,chr2:51201665:C/A:1,chr3:10820021:T/A:1,chr3:10933011:G/T:1,chr3:54918338:T/C:1,chr6:3154999:A/G:1,chr6:39314972:G/A:1,chr7:80474080:T/G:1,chr8:132175698:G/C:1,chr8:132192533:C/A:1,chr8:132421533:G/T:1,chr9:4576050:G/A:1,chr9:9208846:C/T:1,chrX:105219858:C/A:1,chrX:47619193:G/T:1
R-HSA-112382	Formation of RNA Pol II elongation complex 	Gene expression (Transcription)	0.583162	GTF2F1,NCBP1	chr19:6380036:G/T:1,chr9:97664178:C/A:1
R-HSA-112399	IRS-mediated signalling	Signal Transduction	0.752960	IRS1,PIK3CB,PTPN11	chr12:112489105:A/T:1,chr2:226796751:A/G:1,chr3:138778223:G/A:1
R-HSA-112409	RAF-independent MAPK1/3 activation	Signal Transduction	1.000000	PTPN11	chr12:112489105:A/T:1
R-HSA-112411	MAPK1 (ERK2) activation	Signal Transduction	0.409840	PTPN11	chr12:112489105:A/T:1
R-HSA-112412	SOS-mediated signalling	Signal Transduction	0.336437	IRS1	chr2:226796751:A/G:1
R-HSA-113418	Formation of the Early Elongation Complex	Gene expression (Transcription)	0.711848	GTF2F1,NCBP1	chr19:6380036:G/T:1,chr9:97664178:C/A:1
R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	Cell Cycle	0.533217	PPP2R1A	chr19:52215622:C/T:1
R-HSA-113510	E2F mediated regulation of DNA replication	Cell Cycle	1.000000	PPP2R1A	chr19:52215622:C/T:1
R-HSA-114508	Effects of PIP2 hydrolysis	Signal Transduction;Hemostasis	0.016681	DAGLA,DGKI,ITPR2,ITPR3,PRKCD	chr11:61743387:T/A:1,chr12:26600531:C/A:1,chr3:53192052:T/G:1,chr6:33676739:C/A:1,chr7:137665038:C/A:1
R-HSA-114516	Disinhibition of SNARE formation	Hemostasis	0.253920	PRKCB	chr16:23867049:C/T:1
R-HSA-114604	GPVI-mediated activation cascade	Hemostasis	0.013077	COL1A1,MPIG6B,PIK3CB,PIK3R6,PTPN11,PTPN6	chr12:112489105:A/T:1,chr12:6960084:C/T:1,chr17:50195100:C/A:1,chr17:8822843:A/G:1,chr3:138778223:G/A:1,chr6:31720741:T/A:1
R-HSA-114608	Platelet degranulation 	Hemostasis	0.250323	CD36,F13A1,ITIH4,LHFPL2,PHACTR2,PLEK,TGFB2,TIMP3,TLN1,TTN	chr1:218405442:G/T:1,chr22:32803374:G/T:1,chr2:178529881:A/T:1,chr2:68391550:T/C:1,chr3:52819352:G/A:1,chr5:78708953:G/A:1,chr6:143777479:C/A:1,chr6:6224619:A/T:1,chr7:80474080:T/G:1,chr9:35697963:G/T:1
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	Immune System	0.807771	CARD11,NFKBIA,PRKCB,PSMF1,RPS27A	chr14:35403479:G/T:1,chr16:23867049:C/T:1,chr20:1117130:G/T:1,chr2:55234745:A/T:1,chr7:2924035:T/C:1
R-HSA-1169091	Activation of NF-kappaB in B cells	Immune System	0.432005	CARD11,NFKBIA,PRKCB,PSMF1,RPS27A	chr14:35403479:G/T:1,chr16:23867049:C/T:1,chr20:1117130:G/T:1,chr2:55234745:A/T:1,chr7:2924035:T/C:1
R-HSA-1169408	ISG15 antiviral mechanism	Immune System	0.799622	NUP214,PIN1,RPS27A	chr19:9849326:C/A:1,chr2:55234745:A/T:1,chr9:131215059:A/G:1
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	Immune System	0.629890	NUP214,PIN1,RPS27A	chr19:9849326:C/A:1,chr2:55234745:A/T:1,chr9:131215059:A/G:1
R-HSA-1170546	Prolactin receptor signaling	Immune System	0.049974	CSH1,PTPN11,RBX1	chr12:112489105:A/T:1,chr17:63895212:T/C:1,chr22:40963988:A/T:1
R-HSA-1187000	Fertilization	Reproduction	0.657751	ADAM20,IZUMO1	chr14:70522598:A/T:1,chr19:48742399:A/G:1
R-HSA-1221632	Meiotic synapsis	Reproduction;Cell Cycle	0.458166	BRCA1,DIDO1,SMC1A,STAG2,STAG3,SYNE1	chr17:43049287:C/G:1,chr20:62896722:T/C:1,chr6:152391212:G/T:1,chr7:100180712:C/G:1,chrX:124057978:G/A:1,chrX:124422202:A/T:1,chrX:53380790:T/C:1
R-HSA-1222556	ROS and RNS production in phagocytes	Immune System	0.721233	NOS3	chr7:151010230:G/T:1
R-HSA-1226099	Signaling by FGFR in disease	Disease	1.000000	GTF2F1,MYO18A,NCBP1	chr17:29097561:C/T:1,chr19:6380036:G/T:1,chr9:97664178:C/A:1
R-HSA-1227986	Signaling by ERBB2	Signal Transduction	0.206495	ERBB4,NRG3,PRKCD,RPS27A,USP8	chr10:82985678:T/A:1,chr15:50441258:C/A:1,chr2:211630704:C/G:1,chr2:55234745:A/T:1,chr3:53192052:T/G:1
R-HSA-1227990	Signaling by ERBB2 in Cancer	Disease	0.657751	ERBB4,NRG3	chr10:82985678:T/A:1,chr2:211630704:C/G:1
R-HSA-1234174	Cellular response to hypoxia	Cellular responses to external stimuli	1.000000	LIMD1,PSMF1,RBX1,RPS27A	chr20:1117130:G/T:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1,chr3:45595947:T/C:1,chr3:45665554:A/T:1
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	Cellular responses to external stimuli	0.789194	LIMD1,PSMF1,RBX1,RPS27A	chr20:1117130:G/T:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1,chr3:45595947:T/C:1,chr3:45665554:A/T:1
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	Disease	1.000000	RPS27A	chr2:55234745:A/T:1
R-HSA-1236394	Signaling by ERBB4	Signal Transduction	0.571460	ERBB4,NCSTN,NRG3,RPS27A	chr10:82985678:T/A:1,chr1:160353563:A/G:1,chr2:211630704:C/G:1,chr2:55234745:A/T:1
R-HSA-1236973	Cross-presentation of particulate exogenous antigens (phagosomes)	Immune System	0.374212	CD36	chr7:80474080:T/G:1
R-HSA-1236974	ER-Phagosome pathway	Immune System	0.811175	CD14,CD36,HLA-B,PSMF1,RPS27A	chr20:1117130:G/T:1,chr2:55234745:A/T:1,chr5:140633030:C/A:1,chr6:31356312:G/A:1,chr7:80474080:T/G:1
R-HSA-1236975	Antigen processing-Cross presentation	Immune System	1.000000	CD14,CD36,HLA-B,PSMF1,RPS27A	chr20:1117130:G/T:1,chr2:55234745:A/T:1,chr5:140633030:C/A:1,chr6:31356312:G/A:1,chr7:80474080:T/G:1
R-HSA-1236977	Endosomal/Vacuolar pathway	Immune System	0.475135	HLA-B	chr6:31356312:G/A:1
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	Immune System	0.367433	PSMF1	chr20:1117130:G/T:1
R-HSA-1250196	SHC1 events in ERBB2 signaling	Signal Transduction	0.126639	ERBB4,NRG3,PRKCD	chr10:82985678:T/A:1,chr2:211630704:C/G:1,chr3:53192052:T/G:1
R-HSA-1250342	PI3K events in ERBB4 signaling	Signal Transduction	0.107415	ERBB4,NRG3	chr10:82985678:T/A:1,chr2:211630704:C/G:1
R-HSA-1250347	SHC1 events in ERBB4 signaling	Signal Transduction	0.187575	ERBB4,NRG3	chr10:82985678:T/A:1,chr2:211630704:C/G:1
R-HSA-1251985	Nuclear signaling by ERBB4	Signal Transduction	0.426293	ERBB4,NCSTN,NRG3	chr10:82985678:T/A:1,chr1:160353563:A/G:1,chr2:211630704:C/G:1
R-HSA-1253288	Downregulation of ERBB4 signaling	Signal Transduction	0.089187	ERBB4,RPS27A	chr2:211630704:C/G:1,chr2:55234745:A/T:1
R-HSA-1257604	PIP3 activates AKT signaling	Signal Transduction	0.418062	AGO4,ERBB4,HDAC3,HDAC5,IRS1,KITLG,NRG3,PIK3CB,PIP5K1C,PPP2R1A,PPP2R5C,PSMF1,PTPN11,RPS27A,RPTOR,SUZ12,TNKS,TNRC6B	chr10:82985678:T/A:1,chr12:112489105:A/T:1,chr12:88516155:G/T:1,chr14:101883867:G/T:1,chr17:31973320:T/G:1,chr17:44079338:G/T:1,chr17:80664395:C/A:1,chr19:3643094:C/A:1,chr19:52215622:C/T:1,chr1:35850806:C/A:1,chr20:1117130:G/T:1,chr22:40049003:G/T:1,chr2:211630704:C/G:1,chr2:226796751:A/G:1,chr2:55234745:A/T:1,chr3:138778223:G/A:1,chr5:141629409:G/A:1,chr8:9776590:C/A:1
R-HSA-1266695	Interleukin-7 signaling	Immune System	0.720030	IRS1,SMARCA4	chr19:11025539:C/G:1,chr2:226796751:A/G:1
R-HSA-1266738	Developmental Biology	Developmental Biology	0.024802	ABL2,ANK1,ANK3,AP2B1,ARPC1B,CACNA1G,CACNA1I,CACNB2,CD36,CHD9,CLASP2,CNOT9,COL2A1,COL5A1,COL5A2,DOCK1,EPHB1,EPHB2,EPHB6,EVL,FLI1,HDAC3,HNF1A,ITGA10,KALRN,KAT2B,KCNQ2,KCNQ3,KRT3,KRT6A,KRT75,KRT9,KRTAP10-4,L1CAM,LIMK2,MED13L,MED14,MED25,MYH9,MYOD1,NAB1,NCAM1,NCBP1,NCSTN,NRCAM,PDX1,PIK3CB,PIP5K1C,PITPNA,PKP1,PLXNB1,PLXND1,PSMF1,PTPN11,PTPRA,RBX1,ROBO3,RPL10,RPL23,RPL31,RPS27A,RPS6,RPS6KA1,RPS9,SALL1,SCN1A,SCN1B,SMARCA4,SPINK5,SPTBN4,ST8SIA2,SUZ12,THRAP3,TIAM1,TLN1,TUBB2A,TUBB8,UNC5B,VLDLR,WDR5,ZNF638	chr10:127257347:G/T:1,chr10:18448206:G/A:1,chr10:60685310:G/A:1,chr10:71291226:C/T:1,chr10:73757:T/G:1,chr11:113207596:G/T:1,chr11:124874968:C/A:1,chr11:128784861:G/A:1,chr11:17721453:C/G:1,chr12:112489105:A/T:1,chr12:115986913:T/C:1,chr12:120978908:G/T:1,chr12:47982418:C/T:1,chr12:52424307:T/C:1,chr12:52492434:T/C:1,chr12:52790990:A/G:1,chr13:27920403:C/A:1,chr14:100141166:C/A:1,chr15:92412994:G/T:1,chr16:51137759:C/T:1,chr16:53255530:C/A:1,chr17:1520665:A/G:1,chr17:31973320:T/G:1,chr17:35682607:A/G:1,chr17:38850552:C/A:1,chr17:41571796:C/A:1,chr17:50578132:A/G:1,chr17:50600626:G/T:1,chr19:11025539:C/G:1,chr19:35033920:T/C:1,chr19:3643094:C/A:1,chr19:40569803:G/A:1,chr19:49830773:C/A:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr1:145895756:C/T:1,chr1:145909820:C/A:1,chr1:160353563:A/G:1,chr1:179221566:G/A:1,chr1:201324373:G/T:1,chr1:22893268:A/C:1,chr1:26571817:C/A:1,chr1:36301559:C/T:1,chr20:1117130:G/T:1,chr20:2975202:A/T:1,chr20:2988197:T/A:1,chr20:63439613:G/A:1,chr21:31135807:A/G:1,chr21:44585730:C/A:1,chr22:31260099:C/A:1,chr22:36320146:C/A:1,chr22:39647807:A/G:1,chr22:40963988:A/T:1,chr2:101018980:G/T:1,chr2:166047534:C/T:1,chr2:166047536:A/T:1,chr2:189098495:C/A:1,chr2:190687195:C/T:1,chr2:190687196:A/T:1,chr2:218582908:A/T:1,chr2:55234745:A/T:1,chr2:71424636:A/T:1,chr3:124138871:G/T:1,chr3:124477465:C/A:1,chr3:129575694:T/G:1,chr3:134932373:A/G:1,chr3:138778223:G/A:1,chr3:20072202:A/T:1,chr3:33602979:G/T:1,chr3:48421052:G/A:1,chr5:141629409:G/A:1,chr5:148118167:C/T:1,chr6:3154999:A/G:1,chr7:108168322:C/T:1,chr7:142863808:C/A:1,chr7:80474080:T/G:1,chr7:99394321:C/T:1,chr8:132175698:G/C:1,chr8:132192533:C/A:1,chr8:132421533:G/T:1,chr8:41808044:G/T:1,chr9:134155272:C/G:1,chr9:134782781:A/G:1,chr9:19376102:T/C:1,chr9:2644144:G/T:1,chr9:35697963:G/T:1,chr9:97664178:C/A:1,chrX:153863598:G/T:1,chrX:154405329:C/A:1,chrX:40703435:G/C:1
R-HSA-1280215	Cytokine Signaling in Immune system	Immune System	0.247877	BLNK,CCL3L1,CD36,CNTFR,CSH1,CSK,DAB2IP,ERBB4,F13A1,FCER2,HCK,HLA-B,HLA-DRB1,HLA-DRB5,IFI6,IGHG1,IGHG4,IL16,IL2RB,IQGAP1,IRS1,ITGAM,KITLG,LIFR,MAP2K3,NCAM1,NFKBIA,NOD2,NRG3,NUP214,PIK3CB,PIN1,PITPNA,PPP2R1A,PPP2R5C,PRKCD,PSMF1,PTPN1,PTPN11,PTPN6,PTPRA,RAPGEF1,RASAL1,RASAL2,RBX1,RORA,RPS27A,RPS6KA1,SMARCA4,SNRPA1,SOD2,SPRED3,SPTBN4,STAT6,TLN1,TNFRSF1B	chr10:82985678:T/A:1,chr10:96227700:G/C:1,chr11:113207596:G/T:1,chr12:112489105:A/T:1,chr12:113100514:A/G:1,chr12:113118892:G/T:1,chr12:57102572:A/C:1,chr12:6960084:C/T:1,chr12:88516155:G/T:1,chr14:101883867:G/T:1,chr14:105624404:C/G:1,chr14:105741468:G/C:1,chr14:105741485:A/G:1,chr14:35403479:G/T:1,chr15:101281621:G/T:1,chr15:60556760:G/T:1,chr15:74802540:C/T:1,chr15:81169619:C/A:1,chr15:90390695:A/G:1,chr15:90485816:T/C:1,chr16:31299762:C/T:1,chr16:50711288:C/T:1,chr17:1520665:A/G:1,chr17:21303128:C/T:1,chr17:36195375:A/G:1,chr17:63895212:T/C:1,chr19:11025539:C/G:1,chr19:38392374:C/T:1,chr19:38394161:T/G:1,chr19:40569803:G/A:1,chr19:52215622:C/T:1,chr19:7699499:C/T:1,chr19:9849326:C/A:1,chr1:12188701:A/G:1,chr1:12203460:C/A:1,chr1:178470804:T/C:1,chr1:26571817:C/A:1,chr1:27668390:G/T:1,chr20:1117130:G/T:1,chr20:2975202:A/T:1,chr20:2988197:T/A:1,chr20:32098788:C/A:1,chr20:50526505:C/A:1,chr22:37132322:T/G:1,chr22:37142288:T/C:1,chr22:40963988:A/T:1,chr2:211630704:C/G:1,chr2:226796751:A/G:1,chr2:55234745:A/T:1,chr3:138778223:G/A:1,chr3:53192052:T/G:1,chr5:38482482:C/A:1,chr6:159684794:A/T:1,chr6:31356312:G/A:1,chr6:32530260:C/G:1,chr6:32584008:G/C:1,chr6:6224619:A/T:1,chr7:80474080:T/G:1,chr9:121578321:C/A:1,chr9:131215059:A/G:1,chr9:131592242:G/T:1,chr9:34582938:G/T:1,chr9:35697963:G/T:1
R-HSA-1280218	Adaptive Immune System	Immune System	0.343903	ANAPC1,ANAPC4,AP2B1,ASB3,BLNK,CARD11,CD14,CD274,CD36,CDH1,COL1A1,COL2A1,CSK,CTSB,EVL,FBXO21,FBXW7,GRAP2,HECW2,HLA-B,HLA-DRB1,HLA-DRB5,ITGAL,ITPR2,ITPR3,KIF11,KIR2DL3,KLC2,KLC4,KLRD1,LILRA5,LILRB3,NFKBIA,PIANP,PIK3CB,PPP2R1A,PPP2R5C,PRKCB,PRKN,PSMF1,PTPN11,PTPN6,RBX1,RPS27A,SEC23A,SEC24D,SEC31A,SFTPD,SMURF1,TUBB2A,TUBB8,ZBTB16	chr10:73757:T/G:1,chr10:79946379:C/A:1,chr10:92639648:G/T:1,chr10:96227700:G/C:1,chr11:114087490:T/C:1,chr11:66264919:G/A:1,chr12:10308110:T/A:1,chr12:112489105:A/T:1,chr12:117174552:T/C:1,chr12:26600531:C/A:1,chr12:47982418:C/T:1,chr12:6699412:G/T:1,chr12:6960084:C/T:1,chr14:100141166:C/A:1,chr14:101883867:G/T:1,chr14:35403479:G/T:1,chr14:39040609:C/A:1,chr15:74802540:C/T:1,chr16:23867049:C/T:1,chr16:30494137:C/A:1,chr16:68779429:G/T:1,chr17:35682607:A/G:1,chr17:50195100:C/A:1,chr19:52215622:C/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr19:54307267:G/A:1,chr19:54742741:T/A:1,chr20:1117130:G/T:1,chr22:39964624:C/A:1,chr22:40963988:A/T:1,chr2:111863902:T/A:1,chr2:196222438:A/C:1,chr2:53728873:T/A:1,chr2:55234745:A/T:1,chr3:138778223:G/A:1,chr4:118833895:C/A:1,chr4:152350128:T/A:1,chr4:25418042:G/T:1,chr4:82855072:T/A:1,chr5:140633030:C/A:1,chr6:161549199:T/A:1,chr6:31356312:G/A:1,chr6:3154999:A/G:1,chr6:32530260:C/G:1,chr6:32584008:G/C:1,chr6:33676739:C/A:1,chr6:43055804:A/T:1,chr7:2924035:T/C:1,chr7:80474080:T/G:1,chr7:99061975:G/T:1,chr8:11847933:G/T:1,chr9:5456056:A/T:1
R-HSA-1295596	Spry regulation of FGF signaling	Signal Transduction	0.058990	PPP2R1A,PTPN11,RPS27A	chr12:112489105:A/T:1,chr19:52215622:C/T:1,chr2:55234745:A/T:1
R-HSA-1296041	Activation of G protein gated Potassium channels	Neuronal System	1.000000	KCNJ6	chr21:37714489:C/T:1
R-HSA-1296059	G protein gated Potassium channels	Neuronal System	1.000000	KCNJ6	chr21:37714489:C/T:1
R-HSA-1296065	Inwardly rectifying K+ channels	Neuronal System	0.720838	KCNJ6	chr21:37714489:C/T:1
R-HSA-1296071	Potassium Channels	Neuronal System	0.831728	KCNH3,KCNJ6,KCNK1,KCNK16,KCNQ2,KCNQ3	chr12:49557449:T/C:1,chr1:233647414:G/T:1,chr20:63439613:G/A:1,chr21:37714489:C/T:1,chr6:39314972:G/A:1,chr8:132175698:G/C:1,chr8:132192533:C/A:1,chr8:132421533:G/T:1
R-HSA-1296072	Voltage gated Potassium channels	Neuronal System	0.734871	KCNH3,KCNQ2,KCNQ3	chr12:49557449:T/C:1,chr20:63439613:G/A:1,chr8:132175698:G/C:1,chr8:132192533:C/A:1,chr8:132421533:G/T:1
R-HSA-1296346	Tandem pore domain potassium channels	Neuronal System	0.146339	KCNK1,KCNK16	chr1:233647414:G/T:1,chr6:39314972:G/A:1
R-HSA-1299308	Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)	Neuronal System	0.161161	KCNK1	chr1:233647414:G/T:1
R-HSA-1299361	TWIK-related alkaline pH activated K+ channel (TALK)	Neuronal System	0.110550	KCNK16	chr6:39314972:G/A:1
R-HSA-1300645	Acrosome Reaction and Sperm:Oocyte Membrane Binding	Reproduction	0.296385	IZUMO1	chr19:48742399:A/G:1
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	Signal Transduction	0.166735	RPS27A,USP8	chr15:50441258:C/A:1,chr2:55234745:A/T:1
R-HSA-1368071	NR1D1 (REV-ERBA) represses gene expression	Circadian Clock	0.208897	HDAC3	chr5:141629409:G/A:1
R-HSA-1368082	RORA activates gene expression	Circadian Clock	0.273233	CHD9,RORA	chr15:60556760:G/T:1,chr16:53255530:C/A:1
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	Circadian Clock	1.000000	CHD9	chr16:53255530:C/A:1
R-HSA-1369062	ABC transporters in lipid homeostasis	Transport of small molecules	0.273233	ABCA3,ABCG1	chr16:2287934:C/A:1,chr21:42291695:T/G:1
R-HSA-139853	Elevation of cytosolic Ca2+ levels	Hemostasis	0.230138	ITPR2,ITPR3	chr12:26600531:C/A:1,chr6:33676739:C/A:1
R-HSA-140342	Apoptosis induced DNA fragmentation	Programmed Cell Death	0.533217	HIST1H1E	chr6:26156427:G/C:1
R-HSA-140534	Caspase activation via Death Receptors in the presence of ligand	Programmed Cell Death	0.230138	CD14,TNFRSF10A	chr5:140633030:C/A:1,chr8:23202515:G/T:1
R-HSA-140875	Common Pathway of Fibrin Clot Formation	Hemostasis	1.000000	F13A1	chr6:6224619:A/T:1
R-HSA-140877	Formation of Fibrin Clot (Clotting Cascade)	Hemostasis	0.724963	F13A1	chr6:6224619:A/T:1
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	Cell Cycle	0.316221	ANAPC1,ANAPC4	chr2:111863902:T/A:1,chr4:25418042:G/T:1
R-HSA-141424	Amplification of signal from the kinetochores	Cell Cycle	0.656822	CLASP2,CLIP1,KNL1,PPP2R1A,PPP2R5C,RCC2	chr12:122341757:C/T:1,chr14:101883867:G/T:1,chr15:40651961:A/T:1,chr19:52215622:C/T:1,chr1:17413265:G/T:1,chr3:33602979:G/T:1
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	Cell Cycle	0.316221	ANAPC1,ANAPC4	chr2:111863902:T/A:1,chr4:25418042:G/T:1
R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	Cell Cycle	0.656822	CLASP2,CLIP1,KNL1,PPP2R1A,PPP2R5C,RCC2	chr12:122341757:C/T:1,chr14:101883867:G/T:1,chr15:40651961:A/T:1,chr19:52215622:C/T:1,chr1:17413265:G/T:1,chr3:33602979:G/T:1
R-HSA-1428517	The citric acid (TCA) cycle and respiratory electron transport	Metabolism	0.607102	ACAD9,ETFA,LRPPRC,NDUFA10,NDUFB2,PDHA1,PPARD	chr15:76261301:A/T:1,chr2:239969825:G/A:1,chr2:43944068:C/A:1,chr3:128908910:T/C:1,chr6:35396106:C/T:1,chr7:140705050:A/G:1,chrX:19355267:G/T:1
R-HSA-1430728	Metabolism	Metabolism	0.792774	ABCD4,ACAD9,ACSBG2,ACSM3,AGXT,AK2,ALDH1L2,ALDH4A1,ALDH7A1,ALDH9A1,ARSA,ASMT,B3GALT5,BCAN,BCO1,CACNB2,CD36,CD38,CERS3,CES1,CHAT,CHD9,CHDH,COQ3,CRAT,CSPG4,CYP11A1,CYP2A7,CYP2B6,CYP2D6,CYP2S1,ENPP1,ETFA,EXT2,GALE,GALNS,GLP1R,GNAQ,GNPAT,GNS,GPAT2,HAL,HDAC3,HSPG2,IARS,IMPA2,IQGAP1,ITPR2,ITPR3,LPCAT1,LPCAT2,LPIN1,LPIN3,LRPPRC,LSS,MAN2C1,MAT1A,MED13L,MED14,MED25,MGST1,MMS19,MUT,NDUFA10,NDUFB2,NOS3,NR1H3,NUDT10,NUP214,PCCA,PDHA1,PHGDH,PHKA2,PIK3CB,PIK3R6,PIP5K1C,PLA2R1,PLB1,PLCB4,PNPLA2,PPARD,PPARGC1B,PPM1K,PPP2R1A,PPT1,PRKAA2,PRKAB2,PSMF1,PTGR1,RAB4A,RORA,RPL10,RPL23,RPL31,RPS27A,RPS6,RPS9,RTEL1,SARDH,SBF1,SEC23A,SEC24D,SIN3A,SLC27A1,SLC37A2,SLC52A2,SLC6A11,SLC6A12,SMPD4,SMS,STARD3,SULT1A2,SULT2B1,TBXAS1,THRAP3,TSPOAP1	chr10:18448206:G/A:1,chr10:49662454:G/A:1,chr10:80283820:G/A:1,chr10:97477794:A/G:1,chr11:125085266:C/T:1,chr11:44236478:G/T:1,chr11:47259936:C/A:1,chr11:822271:G/T:1,chr12:105038287:C/A:1,chr12:115986913:T/C:1,chr12:16605069:T/G:1,chr12:197114:C/T:1,chr12:26600531:C/A:1,chr12:64722884:C/A:1,chr12:95976434:G/T:1,chr13:100469233:C/A:1,chr14:39040609:C/A:1,chr14:74292598:G/T:1,chr14:74292774:C/T:1,chr15:100472812:G/T:1,chr15:60556760:G/T:1,chr15:74348128:C/T:1,chr15:75355845:G/C:1,chr15:75409706:G/A:1,chr15:75675473:A/G:1,chr15:76261301:A/T:1,chr15:90390695:A/G:1,chr15:90485816:T/C:1,chr16:20621896:G/T:1,chr16:28592021:A/G:1,chr16:28592334:T/G:1,chr16:53255530:C/A:1,chr16:55566632:C/A:1,chr16:55830823:C/A:1,chr16:81245335:G/T:1,chr16:88837557:G/T:1,chr17:38850552:C/A:1,chr17:39660742:G/T:1,chr17:58320561:C/A:1,chr17:8822843:A/G:1,chr18:12028250:G/A:1,chr19:17487596:C/T:1,chr19:3643094:C/A:1,chr19:40881190:A/T:1,chr19:41014829:G/T:1,chr19:41202176:C/T:1,chr19:48599142:C/T:1,chr19:49830773:C/A:1,chr19:52215622:C/T:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr19:6161586:G/A:1,chr1:119721477:C/G:1,chr1:147172001:G/A:1,chr1:156650224:G/T:1,chr1:156652083:T/G:1,chr1:165676357:A/G:1,chr1:18874401:C/T:1,chr1:21839609:G/T:1,chr1:21850169:G/T:1,chr1:229288550:C/A:1,chr1:231267458:C/A:1,chr1:23798309:A/C:1,chr1:33024644:G/C:1,chr1:36301559:C/T:1,chr1:40085102:C/T:1,chr1:56706008:C/A:1,chr20:1117130:G/T:1,chr20:41345676:A/G:1,chr20:63667624:C/A:1,chr20:9437223:T/G:1,chr21:39664662:C/T:1,chr21:46213081:T/C:1,chr22:42126548:G/A:1,chr22:50461719:C/T:1,chr22:50625611:G/C:1,chr2:101018980:G/T:1,chr2:11819407:C/G:1,chr2:130153274:G/A:1,chr2:160032712:C/A:1,chr2:239969825:G/A:1,chr2:240869136:A/G:1,chr2:28516675:G/T:1,chr2:43944068:C/A:1,chr2:55234745:A/T:1,chr2:96023639:T/A:1,chr3:10820021:T/A:1,chr3:10933011:G/T:1,chr3:128908910:T/C:1,chr3:138778223:G/A:1,chr3:53819484:G/T:1,chr4:118833895:C/A:1,chr4:15778700:C/A:1,chr4:88265238:T/C:1,chr5:126559182:C/A:1,chr5:141629409:G/A:1,chr5:149834580:G/T:1,chr5:1501675:T/C:1,chr6:131864504:A/T:1,chr6:33676739:C/A:1,chr6:35396106:C/T:1,chr6:39086149:G/A:1,chr6:49444826:C/A:1,chr6:99394018:G/T:1,chr7:139865711:G/A:1,chr7:140705050:A/G:1,chr7:151010230:G/T:1,chr7:80474080:T/G:1,chr8:144356365:C/A:1,chr8:144360013:C/A:1,chr9:111594402:T/A:1,chr9:129110977:A/C:1,chr9:131215059:A/G:1,chr9:133730014:G/T:1,chr9:19376102:T/C:1,chr9:77797745:T/A:1,chr9:92274385:C/A:1,chrX:154405329:C/A:1,chrX:1624068:G/T:1,chrX:18910786:G/T:1,chrX:19355267:G/T:1,chrX:21985061:A/T:1,chrX:40703435:G/C:1,chrX:51332989:A/G:1
R-HSA-1433557	Signaling by SCF-KIT	Signal Transduction	0.095399	CHEK1,GRAP2,KITLG,PTPN11,PTPN6	chr11:125637382:T/C:1,chr12:112489105:A/T:1,chr12:6960084:C/T:1,chr12:88516155:G/T:1,chr22:39964624:C/A:1
R-HSA-1433559	Regulation of KIT signaling	Signal Transduction	0.230138	KITLG,PTPN6	chr12:6960084:C/T:1,chr12:88516155:G/T:1
R-HSA-1442490	Collagen degradation	Extracellular matrix organization	0.003084	COL11A1,COL11A2,COL12A1,COL13A1,COL1A1,COL2A1,COL4A6,COL5A1,COL5A2,CTSB	chr10:69827305:G/T:1,chr12:47982418:C/T:1,chr17:50195100:C/A:1,chr1:102962717:G/T:1,chr2:189098495:C/A:1,chr6:33171551:C/T:1,chr6:75151273:C/A:1,chr8:11847933:G/T:1,chr9:134782781:A/G:1,chrX:108187727:G/A:1
R-HSA-1445148	Translocation of SLC2A4 (GLUT4) to the plasma membrane	Vesicle-mediated transport	0.128596	MYH9,PRKAA2,PRKAB2,RAB10,RAB4A,TUBB2A,TUBB8	chr10:73757:T/G:1,chr1:147172001:G/A:1,chr1:229288550:C/A:1,chr1:56706008:C/A:1,chr22:36320146:C/A:1,chr2:26109711:A/T:1,chr6:3154999:A/G:1
R-HSA-1474151	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	Metabolism	0.443443	NOS3	chr7:151010230:G/T:1
R-HSA-1474165	Reproduction	Reproduction	0.275125	ADAM20,BRCA1,DIDO1,IZUMO1,MSH5,RPA1,RPA2,SMC1A,STAG2,STAG3,SYNE1	chr14:70522598:A/T:1,chr17:1853255:C/A:1,chr17:43049287:C/G:1,chr19:48742399:A/G:1,chr1:27914481:C/T:1,chr20:62896722:T/C:1,chr6:152391212:G/T:1,chr6:31747193:C/A:1,chr7:100180712:C/G:1,chrX:124057978:G/A:1,chrX:124422202:A/T:1,chrX:53380790:T/C:1
R-HSA-1474228	Degradation of the extracellular matrix	Extracellular matrix organization	0.000004	ADAMTS1,BCAN,BMP1,CAPN5,CAPN7,CAPN9,CDH1,COL11A1,COL11A2,COL12A1,COL13A1,COL1A1,COL2A1,COL4A6,COL5A1,COL5A2,CTSB,FBN1,FBN3,HSPG2,LAMB3,LAMC2,NCSTN	chr10:69827305:G/T:1,chr11:77115237:G/T:1,chr12:47982418:C/T:1,chr15:48472836:A/C:1,chr16:68779429:G/T:1,chr17:50195100:C/A:1,chr19:8141511:C/A:1,chr1:102962717:G/T:1,chr1:156650224:G/T:1,chr1:156652083:T/G:1,chr1:160353563:A/G:1,chr1:183228170:A/G:1,chr1:209618498:C/T:1,chr1:21839609:G/T:1,chr1:21850169:G/T:1,chr1:230757027:A/T:1,chr21:26843749:G/A:1,chr2:189098495:C/A:1,chr3:15246713:A/C:1,chr6:33171551:C/T:1,chr6:75151273:C/A:1,chr8:11847933:G/T:1,chr8:22196292:A/C:1,chr9:134782781:A/G:1,chrX:108187727:G/A:1
R-HSA-1474244	Extracellular matrix organization	Extracellular matrix organization	0.000011	ADAMTS1,BCAN,BMP1,CAPN5,CAPN7,CAPN9,CDH1,COL11A1,COL11A2,COL12A1,COL13A1,COL1A1,COL22A1,COL2A1,COL4A6,COL5A1,COL5A2,CTSB,FBLN1,FBLN2,FBN1,FBN3,HSPG2,ITGA10,ITGAD,ITGAE,ITGAL,ITGAM,LAMB3,LAMC2,NCAM1,NCSTN,NRXN1,SH3PXD2A,TGFB2,TNR,TNXB	chr10:103661168:C/A:1,chr10:69827305:G/T:1,chr11:113207596:G/T:1,chr11:77115237:G/T:1,chr12:47982418:C/T:1,chr15:48472836:A/C:1,chr16:30494137:C/A:1,chr16:31299762:C/T:1,chr16:31426083:T/G:1,chr16:68779429:G/T:1,chr17:3732402:C/A:1,chr17:50195100:C/A:1,chr19:8141511:C/A:1,chr1:102962717:G/T:1,chr1:145895756:C/T:1,chr1:145909820:C/A:1,chr1:156650224:G/T:1,chr1:156652083:T/G:1,chr1:160353563:A/G:1,chr1:175403542:C/T:1,chr1:183228170:A/G:1,chr1:209618498:C/T:1,chr1:21839609:G/T:1,chr1:218405442:G/T:1,chr1:21850169:G/T:1,chr1:230757027:A/T:1,chr21:26843749:G/A:1,chr22:45577115:G/T:1,chr2:189098495:C/A:1,chr2:51201665:C/A:1,chr3:13636498:C/A:1,chr3:15246713:A/C:1,chr6:32043581:A/G:1,chr6:32067650:T/C:1,chr6:32067826:C/T:1,chr6:32073565:C/A:1,chr6:32081732:G/T:1,chr6:33171551:C/T:1,chr6:75151273:C/A:1,chr8:11847933:G/T:1,chr8:138852265:G/T:1,chr8:138870935:G/A:1,chr8:22196292:A/C:1,chr9:134782781:A/G:1,chrX:108187727:G/A:1
R-HSA-1474290	Collagen formation	Extracellular matrix organization	0.000523	BMP1,COL11A1,COL11A2,COL12A1,COL13A1,COL1A1,COL22A1,COL2A1,COL4A6,COL5A1,COL5A2,CTSB,LAMB3,LAMC2	chr10:69827305:G/T:1,chr12:47982418:C/T:1,chr17:50195100:C/A:1,chr1:102962717:G/T:1,chr1:183228170:A/G:1,chr1:209618498:C/T:1,chr2:189098495:C/A:1,chr6:33171551:C/T:1,chr6:75151273:C/A:1,chr8:11847933:G/T:1,chr8:138852265:G/T:1,chr8:138870935:G/A:1,chr8:22196292:A/C:1,chr9:134782781:A/G:1,chrX:108187727:G/A:1
R-HSA-1482788	Acyl chain remodelling of PC	Metabolism	0.064374	LPCAT1,LPCAT2,PLA2R1,PLB1	chr16:55566632:C/A:1,chr2:160032712:C/A:1,chr2:28516675:G/T:1,chr5:1501675:T/C:1
R-HSA-1482801	Acyl chain remodelling of PS	Metabolism	1.000000	PLA2R1	chr2:160032712:C/A:1
R-HSA-1482839	Acyl chain remodelling of PE	Metabolism	1.000000	PLA2R1	chr2:160032712:C/A:1
R-HSA-1482883	Acyl chain remodeling of DAG and TAG	Metabolism	0.336437	PNPLA2	chr11:822271:G/T:1
R-HSA-1482922	Acyl chain remodelling of PI	Metabolism	1.000000	PLA2R1	chr2:160032712:C/A:1
R-HSA-1482925	Acyl chain remodelling of PG	Metabolism	0.273233	LPCAT1,PLA2R1	chr2:160032712:C/A:1,chr5:1501675:T/C:1
R-HSA-1483166	Synthesis of PA	Metabolism	0.280796	GNPAT,GPAT2,LPCAT1,PLA2R1	chr1:231267458:C/A:1,chr2:160032712:C/A:1,chr2:96023639:T/A:1,chr5:1501675:T/C:1
R-HSA-1483191	Synthesis of PC	Metabolism	0.071873	CHAT,LPCAT1,LPIN1,LPIN3	chr10:49662454:G/A:1,chr20:41345676:A/G:1,chr2:11819407:C/G:1,chr5:1501675:T/C:1
R-HSA-1483206	Glycerophospholipid biosynthesis	Metabolism	0.332034	CHAT,GNPAT,GPAT2,LPCAT1,LPCAT2,LPIN1,LPIN3,PLA2R1,PLB1,PNPLA2	chr10:49662454:G/A:1,chr11:822271:G/T:1,chr16:55566632:C/A:1,chr1:231267458:C/A:1,chr20:41345676:A/G:1,chr2:11819407:C/G:1,chr2:160032712:C/A:1,chr2:28516675:G/T:1,chr2:96023639:T/A:1,chr5:1501675:T/C:1
R-HSA-1483213	Synthesis of PE	Metabolism	0.166735	LPIN1,LPIN3	chr20:41345676:A/G:1,chr2:11819407:C/G:1
R-HSA-1483248	Synthesis of PIPs at the ER membrane	Metabolism	0.253920	SBF1	chr22:50461719:C/T:1
R-HSA-1483249	Inositol phosphate metabolism	Metabolism	0.752960	IMPA2,NUDT10,PLCB4	chr18:12028250:G/A:1,chr20:9437223:T/G:1,chrX:51332989:A/G:1
R-HSA-1483255	PI Metabolism	Metabolism	0.813027	PIK3CB,PIK3R6,PIP5K1C,RAB4A,SBF1	chr17:8822843:A/G:1,chr19:3643094:C/A:1,chr1:229288550:C/A:1,chr22:50461719:C/T:1,chr3:138778223:G/A:1
R-HSA-1483257	Phospholipid metabolism	Metabolism	0.365697	CHAT,GNPAT,GPAT2,LPCAT1,LPCAT2,LPIN1,LPIN3,PIK3CB,PIK3R6,PIP5K1C,PLA2R1,PLB1,PNPLA2,RAB4A,SBF1	chr10:49662454:G/A:1,chr11:822271:G/T:1,chr16:55566632:C/A:1,chr17:8822843:A/G:1,chr19:3643094:C/A:1,chr1:229288550:C/A:1,chr1:231267458:C/A:1,chr20:41345676:A/G:1,chr22:50461719:C/T:1,chr2:11819407:C/G:1,chr2:160032712:C/A:1,chr2:28516675:G/T:1,chr2:96023639:T/A:1,chr3:138778223:G/A:1,chr5:1501675:T/C:1
R-HSA-1489509	DAG and IP3 signaling	Signal Transduction	0.293034	ITPR2,ITPR3,PDE1C,PRKCD	chr12:26600531:C/A:1,chr3:53192052:T/G:1,chr6:33676739:C/A:1,chr7:32163293:C/T:1
R-HSA-1500620	Meiosis	Cell Cycle;Reproduction	0.315103	BRCA1,DIDO1,MSH5,RPA1,RPA2,SMC1A,STAG2,STAG3,SYNE1	chr17:1853255:C/A:1,chr17:43049287:C/G:1,chr1:27914481:C/T:1,chr20:62896722:T/C:1,chr6:152391212:G/T:1,chr6:31747193:C/A:1,chr7:100180712:C/G:1,chrX:124057978:G/A:1,chrX:124422202:A/T:1,chrX:53380790:T/C:1
R-HSA-1500931	Cell-Cell communication	Cell-Cell communication	0.052459	CD2AP,CDH1,FLNC,IQGAP1,KIRREL2,LAMB3,LAMC2,LIMS2,NPHS1,PIK3CB,PTPN11,PTPN6,SFTPD	chr10:79946379:C/A:1,chr12:112489105:A/T:1,chr12:6960084:C/T:1,chr15:90390695:A/G:1,chr15:90485816:T/C:1,chr16:68779429:G/T:1,chr19:35849297:C/T:1,chr19:35861057:C/T:1,chr1:183228170:A/G:1,chr1:209618498:C/T:1,chr2:127640046:C/A:1,chr3:138778223:G/A:1,chr6:47503412:G/T:1,chr6:47573971:A/T:1,chr7:128850499:T/C:1
R-HSA-156580	Phase II - Conjugation of compounds	Metabolism	0.528678	MAT1A,MGST1,SULT1A2,SULT2B1	chr10:80283820:G/A:1,chr12:16605069:T/G:1,chr16:28592021:A/G:1,chr16:28592334:T/G:1,chr19:48599142:C/T:1
R-HSA-156581	Methylation	Metabolism	0.559805	MAT1A	chr10:80283820:G/A:1
R-HSA-156584	Cytosolic sulfonation of small molecules	Metabolism	0.644786	SULT1A2,SULT2B1	chr16:28592021:A/G:1,chr16:28592334:T/G:1,chr19:48599142:C/T:1
R-HSA-156590	Glutathione conjugation	Metabolism	0.720838	MGST1	chr12:16605069:T/G:1
R-HSA-1566948	Elastic fibre formation	Extracellular matrix organization	0.110639	FBLN1,FBLN2,FBN1,FBN3,TGFB2	chr15:48472836:A/C:1,chr19:8141511:C/A:1,chr1:218405442:G/T:1,chr22:45577115:G/T:1,chr3:13636498:C/A:1
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	Metabolism of proteins	1.000000	RPL10,RPL23,RPL31,RPS27A,RPS6,RPS9	chr17:38850552:C/A:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr2:101018980:G/T:1,chr2:55234745:A/T:1,chr9:19376102:T/C:1,chrX:154405329:C/A:1
R-HSA-156842	Eukaryotic Translation Elongation	Metabolism of proteins	0.656822	RPL10,RPL23,RPL31,RPS27A,RPS6,RPS9	chr17:38850552:C/A:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr2:101018980:G/T:1,chr2:55234745:A/T:1,chr9:19376102:T/C:1,chrX:154405329:C/A:1
R-HSA-156902	Peptide chain elongation	Metabolism of proteins	0.644852	RPL10,RPL23,RPL31,RPS27A,RPS6,RPS9	chr17:38850552:C/A:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr2:101018980:G/T:1,chr2:55234745:A/T:1,chr9:19376102:T/C:1,chrX:154405329:C/A:1
R-HSA-157118	Signaling by NOTCH	Signal Transduction	0.161579	ACTA2,AGO4,FBXW7,FCER2,HDAC11,HDAC3,HDAC5,HDAC8,HEY1,KAT2B,NCSTN,PLXND1,PSMF1,RBX1,RPS27A,SEL1L,TLE4,TNRC6B,WWC1	chr10:88947447:C/A:1,chr14:81490564:A/C:1,chr17:44079338:G/T:1,chr19:7699499:C/T:1,chr1:160353563:A/G:1,chr1:35850806:C/A:1,chr20:1117130:G/T:1,chr22:40049003:G/T:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1,chr3:129575694:T/G:1,chr3:13496579:C/G:1,chr3:20072202:A/T:1,chr4:152350128:T/A:1,chr5:141629409:G/A:1,chr5:168402535:G/T:1,chr8:79766933:C/A:1,chr9:79693752:C/G:1,chrX:72572139:G/A:1
R-HSA-157579	Telomere Maintenance	Cell Cycle	0.490148	RPA1,RPA2,RTEL1	chr17:1853255:C/A:1,chr1:27914481:C/T:1,chr20:63667624:C/A:1
R-HSA-157858	Gap junction trafficking and regulation	Vesicle-mediated transport	1.000000	TUBB2A,TUBB8	chr10:73757:T/G:1,chr6:3154999:A/G:1
R-HSA-15869	Metabolism of nucleotides	Metabolism	0.045442	AK2	chr1:33024644:G/C:1
R-HSA-1592230	Mitochondrial biogenesis	Organelle biogenesis and maintenance	0.650519	CHD9,HDAC3,PPARGC1B,PRKAA2,PRKAB2,SOD2	chr16:53255530:C/A:1,chr1:147172001:G/A:1,chr1:56706008:C/A:1,chr5:141629409:G/A:1,chr5:149834580:G/T:1,chr6:159684794:A/T:1
R-HSA-159227	Transport of the SLBP independent Mature mRNA	Metabolism of RNA	0.449056	NCBP1,NUP214,NXF1	chr11:62795754:C/G:1,chr9:131215059:A/G:1,chr9:97664178:C/A:1
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	Metabolism of RNA	0.457614	NCBP1,NUP214,NXF1	chr11:62795754:C/G:1,chr9:131215059:A/G:1,chr9:97664178:C/A:1
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	Metabolism of RNA	0.515678	NCBP1,NUP214,NXF1	chr11:62795754:C/G:1,chr9:131215059:A/G:1,chr9:97664178:C/A:1
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	Metabolism of RNA	0.734871	NCBP1,NUP214,NXF1	chr11:62795754:C/G:1,chr9:131215059:A/G:1,chr9:97664178:C/A:1
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	Metabolism of RNA	0.321362	DDX39B,NCBP1,NUP214,NXF1,SRSF11,THOC5	chr11:62795754:C/G:1,chr1:70228405:A/T:1,chr22:29527997:G/T:1,chr6:31536198:G/C:1,chr9:131215059:A/G:1,chr9:97664178:C/A:1
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	Immune System	1.000000	NFKBIA	chr14:35403479:G/T:1
R-HSA-1614635	Sulfur amino acid metabolism	Metabolism	1.000000	MAT1A	chr10:80283820:G/A:1
R-HSA-162582	Signal Transduction	Signal Transduction	0.704315	ABCA4,ABCG1,ACTA2,ADGRE5,AGO4,AP2B1,ARHGAP10,ARHGAP18,ARHGAP29,ARHGEF19,ARHGEF4,ARPC1B,AVPR1A,BCO1,C5,CASP2,CCL3L1,CDH1,CFTR,CHEK1,CIT,CLASP2,CLIP1,COL11A1,COL11A2,COL1A1,COL2A1,COL5A1,COL5A2,CRHR1,CSK,CTTN,CXCL11,DAB2IP,DAGLA,DGKI,DOCK1,EPS15,ERBB4,EVL,FBXW7,FCER2,GLP1R,GNA12,GNAQ,GNAT3,GRAP2,GTF2F1,HDAC11,HDAC3,HDAC5,HDAC8,HEY1,HSPG2,ID1,IL2RB,IQCE,IQGAP1,IQGAP2,IRS1,ITPR2,ITPR3,KALRN,KAT2B,KDM4C,KISS1,KITLG,KLC2,KLC4,KNL1,LAMB3,LAMC2,LGR5,LHCGR,LIMK2,MCF2L,MEN1,MYH9,MYO7A,NAB1,NCAM1,NCBP1,NCSTN,NFKBIA,NOS3,NPY,NR1H3,NRG3,OBSCN,OR13C5,OR2F1,OR4C11,OR4N2,OXTR,PDE11A,PDE1C,PDE4D,PDHA1,PIK3CB,PIK3R6,PIN1,PIP5K1C,PLB1,PLCB4,PLXNB1,PLXND1,PPARD,PPP1R12A,PPP2R1A,PPP2R5C,PRKAA2,PRKAB2,PRKCB,PRKCD,PSMF1,PTBP1,PTPN1,PTPN11,PTPN6,PTPRA,PYGO1,RAB4A,RAPGEF1,RASAL1,RASAL2,RBX1,RCC2,RGS9,RGSL1,ROR2,RPS27A,RPS6,RPS6KA1,RPTOR,RSPO1,SCRIB,SEL1L,SMARCA4,SMC1A,SMURF1,SPRED3,SPTBN4,STAG2,STAM,STAT6,SUZ12,TAX1BP1,TCF7L2,TIAM1,TJP2,TLE4,TLN1,TNFRSF10A,TNKS,TNRC6B,TUBB2A,TUBB8,USF2,USP8,VIPR2,WASF2,WNT7A,WWC1	chr10:112964742:G/A:1,chr10:127257347:G/T:1,chr10:17660650:A/C:1,chr10:73757:T/G:1,chr10:82985678:T/A:1,chr10:88947447:C/A:1,chr11:113207596:G/T:1,chr11:125637382:T/C:1,chr11:47259936:C/A:1,chr11:55603498:C/A:1,chr11:61743387:T/A:1,chr11:64807481:C/T:1,chr11:66264919:G/A:1,chr11:70431006:C/A:1,chr11:77157326:T/C:1,chr11:77160849:G/T:1,chr11:77205582:C/A:1,chr12:112489105:A/T:1,chr12:113100514:A/G:1,chr12:113118892:G/T:1,chr12:119796589:G/T:1,chr12:122341757:C/T:1,chr12:26600531:C/A:1,chr12:47982418:C/T:1,chr12:57102572:A/C:1,chr12:63149800:A/T:1,chr12:6960084:C/T:1,chr12:71578101:A/C:1,chr12:79822198:G/T:1,chr12:88516155:G/T:1,chr13:113046521:T/G:1,chr14:100141166:C/A:1,chr14:101883867:G/T:1,chr14:19760050:G/T:1,chr14:35403479:G/T:1,chr14:81490564:A/C:1,chr15:40651961:A/T:1,chr15:50441258:C/A:1,chr15:55588703:G/T:1,chr15:74802540:C/T:1,chr15:90390695:A/G:1,chr15:90485816:T/C:1,chr16:23867049:C/T:1,chr16:68779429:G/T:1,chr16:81245335:G/T:1,chr17:31973320:T/G:1,chr17:35682607:A/G:1,chr17:36195375:A/G:1,chr17:44079338:G/T:1,chr17:45831011:G/T:1,chr17:45833036:G/C:1,chr17:50195100:C/A:1,chr17:65217991:G/T:1,chr17:80664395:C/A:1,chr17:8822843:A/G:1,chr19:11025539:C/G:1,chr19:14404629:C/A:1,chr19:35270616:A/G:1,chr19:3643094:C/A:1,chr19:38392374:C/T:1,chr19:38394161:T/G:1,chr19:40569803:G/A:1,chr19:52215622:C/T:1,chr19:6380036:G/T:1,chr19:7699499:C/T:1,chr19:804704:T/A:1,chr19:9849326:C/A:1,chr1:102962717:G/T:1,chr1:147172001:G/A:1,chr1:160353563:A/G:1,chr1:16199915:C/A:1,chr1:17413265:G/T:1,chr1:178470804:T/C:1,chr1:182550726:A/G:1,chr1:183228170:A/G:1,chr1:204195297:C/T:1,chr1:209618498:C/T:1,chr1:21839609:G/T:1,chr1:21850169:G/T:1,chr1:228306995:G/A:1,chr1:229288550:C/A:1,chr1:26571817:C/A:1,chr1:27412951:A/T:1,chr1:35850806:C/A:1,chr1:37625400:G/T:1,chr1:51465474:T/A:1,chr1:56706008:C/A:1,chr1:94036566:G/A:1,chr1:94179658:C/A:1,chr20:1117130:G/T:1,chr20:2975202:A/T:1,chr20:2988197:T/A:1,chr20:31605444:G/T:1,chr20:50526505:C/A:1,chr20:9437223:T/G:1,chr21:31135807:A/G:1,chr21:42291695:T/G:1,chr22:31260099:C/A:1,chr22:36320146:C/A:1,chr22:37132322:T/G:1,chr22:37142288:T/C:1,chr22:39964624:C/A:1,chr22:40049003:G/T:1,chr22:40963988:A/T:1,chr2:130920920:C/A:1,chr2:177709965:T/C:1,chr2:189098495:C/A:1,chr2:190687195:C/T:1,chr2:190687196:A/T:1,chr2:211630704:C/G:1,chr2:226796751:A/G:1,chr2:28516675:G/T:1,chr2:48708797:C/G:1,chr2:55234745:A/T:1,chr3:124138871:G/T:1,chr3:124477465:C/A:1,chr3:129575694:T/G:1,chr3:13496579:C/G:1,chr3:13816735:G/A:1,chr3:13816744:T/C:1,chr3:138778223:G/A:1,chr3:20072202:A/T:1,chr3:33602979:G/T:1,chr3:48421052:G/A:1,chr3:53192052:T/G:1,chr3:8767870:G/A:1,chr4:147964990:A/T:1,chr4:147975614:C/A:1,chr4:152350128:T/A:1,chr4:76036090:T/C:1,chr5:141629409:G/A:1,chr5:168402535:G/T:1,chr5:59002058:C/A:1,chr5:76654711:T/C:1,chr6:129629283:A/T:1,chr6:3154999:A/G:1,chr6:33171551:C/T:1,chr6:33676739:C/A:1,chr6:35396106:C/T:1,chr6:39086149:G/A:1,chr6:43055804:A/T:1,chr7:117542008:A/T:1,chr7:137665038:C/A:1,chr7:143292189:T/C:1,chr7:143985449:C/T:1,chr7:151010230:G/T:1,chr7:159142629:C/A:1,chr7:24285140:T/G:1,chr7:2607089:A/G:1,chr7:2762539:T/C:1,chr7:27841060:C/A:1,chr7:32163293:C/T:1,chr7:80474080:T/G:1,chr7:99061975:G/T:1,chr7:99394321:C/T:1,chr8:143793785:G/A:1,chr8:23202515:G/T:1,chr8:79766933:C/A:1,chr8:9776590:C/A:1,chr9:104598758:G/A:1,chr9:120961515:C/A:1,chr9:121578321:C/A:1,chr9:131592242:G/T:1,chr9:134782781:A/G:1,chr9:19376102:T/C:1,chr9:35697963:G/T:1,chr9:6893015:A/T:1,chr9:69250885:T/G:1,chr9:77797745:T/A:1,chr9:79693752:C/G:1,chr9:91724340:G/A:1,chr9:97664178:C/A:1,chrX:124057978:G/A:1,chrX:124422202:A/T:1,chrX:19355267:G/T:1,chrX:53380790:T/C:1,chrX:72572139:G/A:1
R-HSA-162587	HIV Life Cycle	Disease	0.478393	GTF2F1,NCBP1,NUP214,RCC1,RPS27A,TAF5	chr10:103387074:A/C:1,chr19:6380036:G/T:1,chr1:28508571:C/A:1,chr2:55234745:A/T:1,chr9:131215059:A/G:1,chr9:97664178:C/A:1
R-HSA-162588	Budding and maturation of HIV virion	Disease	1.000000	RPS27A	chr2:55234745:A/T:1
R-HSA-162599	Late Phase of HIV Life Cycle	Disease	0.583281	GTF2F1,NCBP1,NUP214,RCC1,RPS27A,TAF5	chr10:103387074:A/C:1,chr19:6380036:G/T:1,chr1:28508571:C/A:1,chr2:55234745:A/T:1,chr9:131215059:A/G:1,chr9:97664178:C/A:1
R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	Metabolism of proteins	0.079100	PIGB,PIGG,PIGO	chr15:55340803:G/A:1,chr4:500224:G/A:1,chr9:35093530:T/C:1
R-HSA-162791	Attachment of GPI anchor to uPAR	Metabolism of proteins	0.336437	PIGS	chr17:28564087:A/G:1
R-HSA-162906	HIV Infection	Disease	0.473421	AP2B1,GTF2F1,HCK,NCBP1,NUP214,PSMF1,RBX1,RCC1,RPS27A,TAF5	chr10:103387074:A/C:1,chr17:35682607:A/G:1,chr19:6380036:G/T:1,chr1:28508571:C/A:1,chr20:1117130:G/T:1,chr20:32098788:C/A:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1,chr9:131215059:A/G:1,chr9:97664178:C/A:1
R-HSA-162909	Host Interactions of HIV factors	Disease	1.000000	AP2B1,HCK,NUP214,PSMF1,RBX1,RCC1,RPS27A	chr17:35682607:A/G:1,chr1:28508571:C/A:1,chr20:1117130:G/T:1,chr20:32098788:C/A:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1,chr9:131215059:A/G:1
R-HSA-1630316	Glycosaminoglycan metabolism	Metabolism	0.845762	BCAN,CSPG4,EXT2,GALNS,GNS,HSPG2	chr11:44236478:G/T:1,chr12:64722884:C/A:1,chr15:75675473:A/G:1,chr16:88837557:G/T:1,chr1:156650224:G/T:1,chr1:156652083:T/G:1,chr1:21839609:G/T:1,chr1:21850169:G/T:1
R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	Metabolism of proteins	0.010801	ART3,CNTN3,CNTN5,LSAMP,LY6G6C,MDGA1,NTM,OPCML,PIGB,PIGG,PIGO,PIGS	chr11:100308186:C/A:1,chr11:132146101:C/T:1,chr11:133140763:C/A:1,chr15:55340803:G/A:1,chr17:28564087:A/G:1,chr3:116602824:C/A:1,chr3:74521082:G/T:1,chr4:500224:G/A:1,chr4:76036090:T/C:1,chr6:31720741:T/A:1,chr6:37650494:G/C:1,chr9:35093530:T/C:1
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	Metabolism	0.836036	ACAD9,ETFA,LRPPRC,NDUFA10,NDUFB2	chr15:76261301:A/T:1,chr2:239969825:G/A:1,chr2:43944068:C/A:1,chr3:128908910:T/C:1,chr7:140705050:A/G:1
R-HSA-1632852	Macroautophagy	Autophagy	0.060087	ATG14,ATG16L1,CFTR,GABARAP,PCNT,PEX5,PRKAA2,PRKAB2,PRKN,RPS27A,RPTOR,TUBB2A,TUBB8	chr10:73757:T/G:1,chr12:7190218:T/G:1,chr14:55385868:G/A:1,chr17:7240852:C/A:1,chr17:80664395:C/A:1,chr1:147172001:G/A:1,chr1:56706008:C/A:1,chr21:46351357:C/A:1,chr2:233274667:A/T:1,chr2:55234745:A/T:1,chr6:161549199:T/A:1,chr6:3154999:A/G:1,chr7:117542008:A/T:1
R-HSA-163680	AMPK inhibits chREBP transcriptional activation activity	Metabolism	0.072010	PRKAA2,PRKAB2	chr1:147172001:G/A:1,chr1:56706008:C/A:1
R-HSA-163685	Integration of energy metabolism	Metabolism	0.137236	CACNB2,CD36,GLP1R,GNAQ,IQGAP1,ITPR2,ITPR3,PPP2R1A,PRKAA2,PRKAB2	chr10:18448206:G/A:1,chr12:26600531:C/A:1,chr15:90390695:A/G:1,chr15:90485816:T/C:1,chr19:52215622:C/T:1,chr1:147172001:G/A:1,chr1:56706008:C/A:1,chr6:33676739:C/A:1,chr6:39086149:G/A:1,chr7:80474080:T/G:1,chr9:77797745:T/A:1
R-HSA-163767	PP2A-mediated dephosphorylation of key metabolic factors	Metabolism	0.336437	PPP2R1A	chr19:52215622:C/T:1
R-HSA-1638074	Keratan sulfate/keratin metabolism	Metabolism	0.720030	GALNS,GNS	chr12:64722884:C/A:1,chr16:88837557:G/T:1
R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	Metabolism	0.554003	BCAN,CSPG4,EXT2,HSPG2	chr11:44236478:G/T:1,chr15:75675473:A/G:1,chr1:156650224:G/T:1,chr1:156652083:T/G:1,chr1:21839609:G/T:1,chr1:21850169:G/T:1
R-HSA-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	Metabolism of proteins	0.724963	ARSA	chr22:50625611:G/C:1
R-HSA-1640170	Cell Cycle	Cell Cycle	0.606136	ABRAXAS1,AKAP9,ANAPC1,ANAPC4,BABAM2,BRCA1,CDCA5,CEP78,CHEK1,CLASP2,CLIP1,COP1,DIDO1,HDAC8,KNL1,LPIN1,LPIN3,MSH5,NUP214,OIP5,PCNT,POLE,PPP1R12A,PPP2R1A,PPP2R5C,PRKCB,PSMF1,RBX1,RCC1,RCC2,RPA1,RPA2,RPS27A,RTEL1,SMC1A,STAG2,STAG3,SYNE1,TUBB2A,TUBB8,VRK2	chr10:73757:T/G:1,chr11:125637382:T/C:1,chr11:65083833:C/T:1,chr12:122341757:C/T:1,chr12:132643245:T/C:1,chr12:79822198:G/T:1,chr14:101883867:G/T:1,chr15:40651961:A/T:1,chr15:41319933:G/T:1,chr16:23867049:C/T:1,chr17:1853255:C/A:1,chr17:43049287:C/G:1,chr19:52215622:C/T:1,chr1:17413265:G/T:1,chr1:176136414:C/A:1,chr1:27914481:C/T:1,chr1:28508571:C/A:1,chr20:1117130:G/T:1,chr20:41345676:A/G:1,chr20:62896722:T/C:1,chr20:63667624:C/A:1,chr21:46351357:C/A:1,chr22:40963988:A/T:1,chr2:111863902:T/A:1,chr2:11819407:C/G:1,chr2:28274140:C/A:1,chr2:55234745:A/T:1,chr2:58084877:A/T:1,chr3:33602979:G/T:1,chr4:25418042:G/T:1,chr4:83460892:G/T:1,chr6:152391212:G/T:1,chr6:3154999:A/G:1,chr6:31747193:C/A:1,chr7:100180712:C/G:1,chr7:91974127:C/A:1,chr7:92040995:G/T:1,chr9:131215059:A/G:1,chr9:78246838:C/A:1,chrX:124057978:G/A:1,chrX:124422202:A/T:1,chrX:53380790:T/C:1,chrX:72572139:G/A:1
R-HSA-1643685	Disease	Disease	0.015163	ABCA3,ABCA4,ABCC6,ABCD4,ADAMTS1,ADAMTS13,AKAP9,ALG12,AP2B1,ARPC1B,AVPR1A,BCAN,BIN2,CD14,CD36,CDH1,CFTR,CRHR1,CSK,CSPG4,CYP11A1,DERL3,DOCK1,EPS15,ERBB4,EXT2,FBXW7,GALE,GALNS,GLP1R,GNAT3,GNS,GTF2F1,HCK,HDAC11,HDAC3,HDAC5,HDAC8,HEY1,HSPG2,IGHG1,IGHG2,IGHG4,IQGAP1,IRS1,ITPR2,ITPR3,KAT2B,KITLG,LHCGR,MAP2K3,MAT1A,MUC15,MUC17,MUC3A,MUC4,MUT,MYH9,MYO18A,NCBP1,NCSTN,NEIL1,NFKBIA,NRG3,NUP214,PCCA,PIK3CB,PLK2,PPP2R1A,PPP2R5C,PSMF1,PTPN11,RBX1,RCC1,RPL10,RPL23,RPL31,RPS27A,RPS6,RPS9,SEL1L,SFTPD,SIN3A,SLC12A3,SLC1A1,SLC27A4,SLC2A9,SLC4A4,SLC6A2,SLC7A7,SOD2,SPRED3,STAM,SUZ12,TAF5,TBXAS1,TCF7L2,TLN1,TNKS,TUBB2A,TUBB8,VIPR2,VPS33B,WASF2	chr10:103387074:A/C:1,chr10:112964742:G/A:1,chr10:127257347:G/T:1,chr10:17660650:A/C:1,chr10:73757:T/G:1,chr10:79946379:C/A:1,chr10:80283820:G/A:1,chr10:82985678:T/A:1,chr11:26561226:C/A:1,chr11:44236478:G/T:1,chr12:112489105:A/T:1,chr12:26600531:C/A:1,chr12:51297095:C/A:1,chr12:63149800:A/T:1,chr12:64722884:C/A:1,chr12:88516155:G/T:1,chr13:100469233:C/A:1,chr14:101883867:G/T:1,chr14:105624404:C/G:1,chr14:105641644:C/T:1,chr14:105741468:G/C:1,chr14:105741485:A/G:1,chr14:22780250:C/A:1,chr14:35403479:G/T:1,chr14:74292598:G/T:1,chr14:74292774:C/T:1,chr14:81490564:A/C:1,chr15:74348128:C/T:1,chr15:74802540:C/T:1,chr15:75355845:G/C:1,chr15:75409706:G/A:1,chr15:75675473:A/G:1,chr15:90390695:A/G:1,chr15:90485816:T/C:1,chr15:91014129:G/T:1,chr16:16203671:G/A:1,chr16:2287934:C/A:1,chr16:55656513:C/T:1,chr16:56879526:C/A:1,chr16:68779429:G/T:1,chr16:88837557:G/T:1,chr17:21303128:C/T:1,chr17:29097561:C/T:1,chr17:31973320:T/G:1,chr17:35682607:A/G:1,chr17:38850552:C/A:1,chr17:44079338:G/T:1,chr17:45831011:G/T:1,chr17:45833036:G/C:1,chr19:38392374:C/T:1,chr19:38394161:T/G:1,chr19:52215622:C/T:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr19:6380036:G/T:1,chr1:156650224:G/T:1,chr1:156652083:T/G:1,chr1:160353563:A/G:1,chr1:21839609:G/T:1,chr1:21850169:G/T:1,chr1:23798309:A/C:1,chr1:27412951:A/T:1,chr1:28508571:C/A:1,chr1:51465474:T/A:1,chr1:94036566:G/A:1,chr20:1117130:G/T:1,chr20:32098788:C/A:1,chr21:26843749:G/A:1,chr22:23838266:G/T:1,chr22:36320146:C/A:1,chr22:40963988:A/T:1,chr22:49903355:G/T:1,chr2:101018980:G/T:1,chr2:211630704:C/G:1,chr2:226796751:A/G:1,chr2:48708797:C/G:1,chr2:55234745:A/T:1,chr3:13496579:C/G:1,chr3:138778223:G/A:1,chr3:195752618:A/G:1,chr3:195752619:G/C:1,chr3:20072202:A/T:1,chr4:10005462:C/T:1,chr4:152350128:T/A:1,chr4:71544404:G/T:1,chr5:140633030:C/A:1,chr5:141629409:G/A:1,chr5:58454762:G/T:1,chr6:159684794:A/T:1,chr6:3154999:A/G:1,chr6:33676739:C/A:1,chr6:39086149:G/A:1,chr6:49444826:C/A:1,chr7:100958263:A/G:1,chr7:101035696:G/T:1,chr7:117542008:A/T:1,chr7:139865711:G/A:1,chr7:159142629:C/A:1,chr7:80474080:T/G:1,chr7:91974127:C/A:1,chr7:92040995:G/T:1,chr7:99394321:C/T:1,chr8:79766933:C/A:1,chr8:9776590:C/A:1,chr9:128360555:C/A:1,chr9:131215059:A/G:1,chr9:133439628:C/T:1,chr9:19376102:T/C:1,chr9:35697963:G/T:1,chr9:4576050:G/A:1,chr9:97664178:C/A:1,chrX:154405329:C/A:1,chrX:72572139:G/A:1
R-HSA-1643713	Signaling by EGFR in Cancer	Disease	1.000000	RPS27A	chr2:55234745:A/T:1
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	Disease	1.000000	AP2B1	chr17:35682607:A/G:1
R-HSA-164944	Nef and signal transduction	Disease	0.374212	HCK	chr20:32098788:C/A:1
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	Disease	0.672201	AP2B1,HCK	chr17:35682607:A/G:1,chr20:32098788:C/A:1
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	Disease	1.000000	NUP214,RCC1	chr1:28508571:C/A:1,chr9:131215059:A/G:1
R-HSA-1650814	Collagen biosynthesis and modifying enzymes	Extracellular matrix organization	0.001289	BMP1,COL11A1,COL11A2,COL12A1,COL13A1,COL1A1,COL22A1,COL2A1,COL4A6,COL5A1,COL5A2	chr10:69827305:G/T:1,chr12:47982418:C/T:1,chr17:50195100:C/A:1,chr1:102962717:G/T:1,chr2:189098495:C/A:1,chr6:33171551:C/T:1,chr6:75151273:C/A:1,chr8:138852265:G/T:1,chr8:138870935:G/A:1,chr8:22196292:A/C:1,chr9:134782781:A/G:1,chrX:108187727:G/A:1
R-HSA-165159	mTOR signalling	Signal Transduction	0.286635	PRKAA2,PRKAB2,RPS6,RPTOR	chr17:80664395:C/A:1,chr1:147172001:G/A:1,chr1:56706008:C/A:1,chr9:19376102:T/C:1
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	Metabolism	0.554003	CHD9,LSS,SEC23A,SEC24D	chr14:39040609:C/A:1,chr16:53255530:C/A:1,chr21:46213081:T/C:1,chr4:118833895:C/A:1
R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	Immune System	0.079146	CD14,CD36,IKBKE,ITGAM,MAP2K3,NFKBIA,NOD2,PPP2R1A,PTPN11,RPS27A,RPS6KA1,SFTPD	chr10:79946379:C/A:1,chr12:112489105:A/T:1,chr14:35403479:G/T:1,chr16:31299762:C/T:1,chr16:50711288:C/T:1,chr17:21303128:C/T:1,chr19:52215622:C/T:1,chr1:206479188:C/A:1,chr1:26571817:C/A:1,chr2:55234745:A/T:1,chr5:140633030:C/A:1,chr7:80474080:T/G:1
R-HSA-166020	Transfer of LPS from LBP carrier to CD14	Immune System	0.110550	CD14	chr5:140633030:C/A:1
R-HSA-1660499	Synthesis of PIPs at the plasma membrane	Metabolism	0.543720	PIK3CB,PIK3R6,PIP5K1C,RAB4A	chr17:8822843:A/G:1,chr19:3643094:C/A:1,chr1:229288550:C/A:1,chr3:138778223:G/A:1
R-HSA-166058	MyD88:MAL(TIRAP) cascade initiated on plasma membrane	Immune System	0.256178	CD14,CD36,MAP2K3,NFKBIA,NOD2,PPP2R1A,RPS27A,RPS6KA1	chr14:35403479:G/T:1,chr16:50711288:C/T:1,chr17:21303128:C/T:1,chr19:52215622:C/T:1,chr1:26571817:C/A:1,chr2:55234745:A/T:1,chr5:140633030:C/A:1,chr7:80474080:T/G:1
R-HSA-1660661	Sphingolipid de novo biosynthesis	Metabolism	0.516674	CERS3	chr15:100472812:G/T:1
R-HSA-1660662	Glycosphingolipid metabolism	Metabolism	1.000000	ARSA,SMPD4	chr22:50625611:G/C:1,chr2:130153274:G/A:1
R-HSA-166166	MyD88-independent TLR4 cascade 	Immune System	0.122923	CD14,IKBKE,MAP2K3,NFKBIA,NOD2,PPP2R1A,PTPN11,RPS27A,RPS6KA1	chr12:112489105:A/T:1,chr14:35403479:G/T:1,chr16:50711288:C/T:1,chr17:21303128:C/T:1,chr19:52215622:C/T:1,chr1:206479188:C/A:1,chr1:26571817:C/A:1,chr2:55234745:A/T:1,chr5:140633030:C/A:1
R-HSA-166208	mTORC1-mediated signalling	Signal Transduction	0.379439	RPS6,RPTOR	chr17:80664395:C/A:1,chr9:19376102:T/C:1
R-HSA-1663150	The activation of arylsulfatases	Metabolism of proteins	0.533217	ARSA	chr22:50625611:G/C:1
R-HSA-166520	Signaling by NTRKs	Signal Transduction	0.346599	AP2B1,ID1,IRS1,NAB1,PIK3CB,PPP2R1A,PTPN11,RAPGEF1,RPS6KA1,TIAM1	chr12:112489105:A/T:1,chr17:35682607:A/G:1,chr19:52215622:C/T:1,chr1:26571817:C/A:1,chr20:31605444:G/T:1,chr21:31135807:A/G:1,chr2:190687195:C/T:1,chr2:190687196:A/T:1,chr2:226796751:A/G:1,chr3:138778223:G/A:1,chr9:131592242:G/T:1
R-HSA-166658	Complement cascade	Immune System	0.538064	C5,C7,C9,CPN2,FCN1,IGHG1,IGHG2,IGHG4	chr14:105624404:C/G:1,chr14:105641644:C/T:1,chr14:105741468:G/C:1,chr14:105741485:A/G:1,chr3:194341790:C/T:1,chr5:39342273:C/A:1,chr5:40936518:G/A:1,chr9:120961515:C/A:1,chr9:134914627:C/T:1
R-HSA-166662	Lectin pathway of complement activation	Immune System	0.374212	FCN1	chr9:134914627:C/T:1
R-HSA-166663	Initial triggering of complement	Immune System	1.000000	FCN1,IGHG1,IGHG2,IGHG4	chr14:105624404:C/G:1,chr14:105641644:C/T:1,chr14:105741468:G/C:1,chr14:105741485:A/G:1,chr9:134914627:C/T:1
R-HSA-166665	Terminal pathway of complement	Immune System	0.008272	C5,C7,C9	chr5:39342273:C/A:1,chr5:40936518:G/A:1,chr9:120961515:C/A:1
R-HSA-166786	Creation of C4 and C2 activators	Immune System	1.000000	FCN1,IGHG1,IGHG2,IGHG4	chr14:105624404:C/G:1,chr14:105641644:C/T:1,chr14:105741468:G/C:1,chr14:105741485:A/G:1,chr9:134914627:C/T:1
R-HSA-167152	Formation of HIV elongation complex in the absence of HIV Tat	Disease	1.000000	GTF2F1,NCBP1	chr19:6380036:G/T:1,chr9:97664178:C/A:1
R-HSA-167158	Formation of the HIV-1 Early Elongation Complex	Disease	0.711848	GTF2F1,NCBP1	chr19:6380036:G/T:1,chr9:97664178:C/A:1
R-HSA-167160	RNA Pol II CTD phosphorylation and interaction with CE during HIV infection	Disease	1.000000	GTF2F1	chr19:6380036:G/T:1
R-HSA-167161	HIV Transcription Initiation	Disease	1.000000	GTF2F1,TAF5	chr10:103387074:A/C:1,chr19:6380036:G/T:1
R-HSA-167162	RNA Polymerase II HIV Promoter Escape	Disease	1.000000	GTF2F1,TAF5	chr10:103387074:A/C:1,chr19:6380036:G/T:1
R-HSA-167169	HIV Transcription Elongation	Disease	1.000000	GTF2F1,NCBP1	chr19:6380036:G/T:1,chr9:97664178:C/A:1
R-HSA-167172	Transcription of the HIV genome	Disease	0.799016	GTF2F1,NCBP1,TAF5	chr10:103387074:A/C:1,chr19:6380036:G/T:1,chr9:97664178:C/A:1
R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	Disease	1.000000	GTF2F1,NCBP1	chr19:6380036:G/T:1,chr9:97664178:C/A:1
R-HSA-167238	Pausing and recovery of Tat-mediated HIV elongation	Disease	1.000000	GTF2F1	chr19:6380036:G/T:1
R-HSA-167242	Abortive elongation of HIV-1 transcript in the absence of Tat	Disease	0.379439	GTF2F1,NCBP1	chr19:6380036:G/T:1,chr9:97664178:C/A:1
R-HSA-167243	Tat-mediated HIV elongation arrest and recovery	Disease	1.000000	GTF2F1	chr19:6380036:G/T:1
R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	Disease	1.000000	GTF2F1,NCBP1	chr19:6380036:G/T:1,chr9:97664178:C/A:1
R-HSA-167287	HIV elongation arrest and recovery	Disease	0.721233	GTF2F1	chr19:6380036:G/T:1
R-HSA-167290	Pausing and recovery of HIV elongation	Disease	0.721233	GTF2F1	chr19:6380036:G/T:1
R-HSA-167590	Nef Mediated CD4 Down-regulation	Disease	0.409840	AP2B1	chr17:35682607:A/G:1
R-HSA-1679131	Trafficking and processing of endosomal TLR	Immune System	0.533217	CTSB	chr8:11847933:G/T:1
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	Immune System	0.499003	CD14,MAP2K3,NFKBIA,NOD2,PPP2R1A,RPS27A,RPS6KA1	chr14:35403479:G/T:1,chr16:50711288:C/T:1,chr17:21303128:C/T:1,chr19:52215622:C/T:1,chr1:26571817:C/A:1,chr2:55234745:A/T:1,chr5:140633030:C/A:1
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	Immune System	0.479734	MAP2K3,NFKBIA,NOD2,PPP2R1A,RPS27A,RPS6KA1	chr14:35403479:G/T:1,chr16:50711288:C/T:1,chr17:21303128:C/T:1,chr19:52215622:C/T:1,chr1:26571817:C/A:1,chr2:55234745:A/T:1
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	Immune System	0.372219	IKBKE,MAP2K3,NFKBIA,NOD2,PPP2R1A,RPS27A,RPS6KA1	chr14:35403479:G/T:1,chr16:50711288:C/T:1,chr17:21303128:C/T:1,chr19:52215622:C/T:1,chr1:206479188:C/A:1,chr1:26571817:C/A:1,chr2:55234745:A/T:1
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	Immune System	0.479734	MAP2K3,NFKBIA,NOD2,PPP2R1A,RPS27A,RPS6KA1	chr14:35403479:G/T:1,chr16:50711288:C/T:1,chr17:21303128:C/T:1,chr19:52215622:C/T:1,chr1:26571817:C/A:1,chr2:55234745:A/T:1
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	Immune System	0.122923	CD14,CD36,MAP2K3,NFKBIA,NOD2,PPP2R1A,RPS27A,RPS6KA1,SFTPD	chr10:79946379:C/A:1,chr14:35403479:G/T:1,chr16:50711288:C/T:1,chr17:21303128:C/T:1,chr19:52215622:C/T:1,chr1:26571817:C/A:1,chr2:55234745:A/T:1,chr5:140633030:C/A:1,chr7:80474080:T/G:1
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	Immune System	0.362437	CD14,MAP2K3,NFKBIA,NOD2,PPP2R1A,RPS27A,RPS6KA1	chr14:35403479:G/T:1,chr16:50711288:C/T:1,chr17:21303128:C/T:1,chr19:52215622:C/T:1,chr1:26571817:C/A:1,chr2:55234745:A/T:1,chr5:140633030:C/A:1
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	Immune System	0.256178	CD14,CD36,MAP2K3,NFKBIA,NOD2,PPP2R1A,RPS27A,RPS6KA1	chr14:35403479:G/T:1,chr16:50711288:C/T:1,chr17:21303128:C/T:1,chr19:52215622:C/T:1,chr1:26571817:C/A:1,chr2:55234745:A/T:1,chr5:140633030:C/A:1,chr7:80474080:T/G:1
R-HSA-168249	Innate Immune System	Immune System	0.046522	ADGRE5,ANPEP,APAF1,ARPC1B,ARSA,BIN2,BPIFA1,C5,C7,C9,CAMP,CARD11,CASP2,CAT,CD14,CD36,CLEC4D,CPN2,CRACR2A,CTSB,DDX3X,DNASE1L1,DOCK1,FCN1,FRMPD3,GALNS,GNS,GRAP2,GSN,HCK,HLA-B,IFI16,IGHG1,IGHG2,IGHG4,IKBKE,IQGAP1,IQGAP2,ITGAL,ITGAM,ITPR2,ITPR3,KLRD1,LILRB3,LPCAT1,MAP2K3,MGAM,MGST1,MUC15,MUC17,MUC3A,MUC4,MYH9,NCSTN,NFKBIA,NOD2,NOS3,PADI2,PDAP1,PIK3CB,PIN1,PKP1,PPP2R1A,PRKCD,PSMF1,PTPN11,PTPN6,RAB10,RAB24,RAB3D,RPS27A,RPS6KA1,S100A7A,SFTPD,STAT6,TAX1BP1,TNFRSF1B,WASF2	chr10:127257347:G/T:1,chr10:79946379:C/A:1,chr11:26561226:C/A:1,chr11:34471141:A/C:1,chr12:10308110:T/A:1,chr12:112489105:A/T:1,chr12:16605069:T/G:1,chr12:26600531:C/A:1,chr12:3658138:G/T:1,chr12:51297095:C/A:1,chr12:57102572:A/C:1,chr12:64722884:C/A:1,chr12:6960084:C/T:1,chr12:8512275:G/T:1,chr12:98648251:A/T:1,chr14:105624404:C/G:1,chr14:105641644:C/T:1,chr14:105741468:G/C:1,chr14:105741485:A/G:1,chr14:35403479:G/T:1,chr15:89801121:T/C:1,chr15:90390695:A/G:1,chr15:90485816:T/C:1,chr16:30494137:C/A:1,chr16:31299762:C/T:1,chr16:50711288:C/T:1,chr16:88837557:G/T:1,chr17:21303128:C/T:1,chr19:11343264:G/A:1,chr19:14404629:C/A:1,chr19:52215622:C/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr19:9849326:C/A:1,chr1:12188701:A/G:1,chr1:12203460:C/A:1,chr1:153419515:C/A:1,chr1:159000259:G/T:1,chr1:160353563:A/G:1,chr1:17070003:T/C:1,chr1:201324373:G/T:1,chr1:206479188:C/A:1,chr1:26571817:C/A:1,chr1:27412951:A/T:1,chr20:1117130:G/T:1,chr20:32098788:C/A:1,chr20:33237991:G/A:1,chr22:36320146:C/A:1,chr22:39964624:C/A:1,chr22:50625611:G/C:1,chr2:26109711:A/T:1,chr2:55234745:A/T:1,chr3:138778223:G/A:1,chr3:194341790:C/T:1,chr3:195752618:A/G:1,chr3:195752619:G/C:1,chr3:48225051:G/T:1,chr3:53192052:T/G:1,chr5:140633030:C/A:1,chr5:1501675:T/C:1,chr5:177301877:T/C:1,chr5:39342273:C/A:1,chr5:40936518:G/A:1,chr5:76654711:T/C:1,chr6:31356312:G/A:1,chr6:33676739:C/A:1,chr7:100958263:A/G:1,chr7:101035696:G/T:1,chr7:142093478:C/A:1,chr7:143292189:T/C:1,chr7:151010230:G/T:1,chr7:27841060:C/A:1,chr7:2924035:T/C:1,chr7:80474080:T/G:1,chr7:99394321:C/T:1,chr8:11847933:G/T:1,chr9:120961515:C/A:1,chr9:121312182:C/T:1,chr9:134914627:C/T:1,chrX:107602813:C/A:1,chrX:154405329:C/A:1,chrX:41343158:A/T:1
R-HSA-168255	Influenza Infection	Disease	1.000000	GTF2F1,NUP214,RPL10,RPL23,RPL31,RPS27A,RPS6,RPS9	chr17:38850552:C/A:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr19:6380036:G/T:1,chr2:101018980:G/T:1,chr2:55234745:A/T:1,chr9:131215059:A/G:1,chr9:19376102:T/C:1,chrX:154405329:C/A:1
R-HSA-168256	Immune System	Immune System	0.097880	ADGRE5,ANAPC1,ANAPC4,ANPEP,AP2B1,APAF1,ARPC1B,ARSA,ASB3,BIN2,BLNK,BPIFA1,C5,C7,C9,CAMP,CARD11,CASP2,CAT,CCL3L1,CD14,CD274,CD36,CDH1,CLEC4D,CNTFR,COL1A1,COL2A1,CPN2,CRACR2A,CSH1,CSK,CTSB,DAB2IP,DDX3X,DNASE1L1,DOCK1,ERBB4,EVL,F13A1,FBXO21,FBXW7,FCER2,FCN1,FRMPD3,GALNS,GNS,GRAP2,GSN,HCK,HECW2,HLA-B,HLA-DRB1,HLA-DRB5,IFI16,IFI6,IGHG1,IGHG2,IGHG4,IKBKE,IL16,IL2RB,IQGAP1,IQGAP2,IRS1,ITGAL,ITGAM,ITPR2,ITPR3,KIF11,KIR2DL3,KITLG,KLC2,KLC4,KLRD1,LIFR,LILRA5,LILRB3,LPCAT1,MAP2K3,MGAM,MGST1,MUC15,MUC17,MUC3A,MUC4,MYH9,NCAM1,NCSTN,NFKBIA,NOD2,NOS3,NRG3,NUP214,PADI2,PDAP1,PIANP,PIK3CB,PIN1,PITPNA,PKP1,PPP2R1A,PPP2R5C,PRKCB,PRKCD,PRKN,PSMF1,PTPN1,PTPN11,PTPN6,PTPRA,RAB10,RAB24,RAB3D,RAPGEF1,RASAL1,RASAL2,RBX1,RORA,RPS27A,RPS6KA1,S100A7A,SEC23A,SEC24D,SEC31A,SFTPD,SMARCA4,SMURF1,SNRPA1,SOD2,SPRED3,SPTBN4,STAT6,TAX1BP1,TLN1,TNFRSF1B,TUBB2A,TUBB8,WASF2,ZBTB16	chr10:127257347:G/T:1,chr10:73757:T/G:1,chr10:79946379:C/A:1,chr10:82985678:T/A:1,chr10:92639648:G/T:1,chr10:96227700:G/C:1,chr11:113207596:G/T:1,chr11:114087490:T/C:1,chr11:26561226:C/A:1,chr11:34471141:A/C:1,chr11:66264919:G/A:1,chr12:10308110:T/A:1,chr12:112489105:A/T:1,chr12:113100514:A/G:1,chr12:113118892:G/T:1,chr12:117174552:T/C:1,chr12:16605069:T/G:1,chr12:26600531:C/A:1,chr12:3658138:G/T:1,chr12:47982418:C/T:1,chr12:51297095:C/A:1,chr12:57102572:A/C:1,chr12:64722884:C/A:1,chr12:6699412:G/T:1,chr12:6960084:C/T:1,chr12:8512275:G/T:1,chr12:88516155:G/T:1,chr12:98648251:A/T:1,chr14:100141166:C/A:1,chr14:101883867:G/T:1,chr14:105624404:C/G:1,chr14:105641644:C/T:1,chr14:105741468:G/C:1,chr14:105741485:A/G:1,chr14:35403479:G/T:1,chr14:39040609:C/A:1,chr15:101281621:G/T:1,chr15:60556760:G/T:1,chr15:74802540:C/T:1,chr15:81169619:C/A:1,chr15:89801121:T/C:1,chr15:90390695:A/G:1,chr15:90485816:T/C:1,chr16:23867049:C/T:1,chr16:30494137:C/A:1,chr16:31299762:C/T:1,chr16:50711288:C/T:1,chr16:68779429:G/T:1,chr16:88837557:G/T:1,chr17:1520665:A/G:1,chr17:21303128:C/T:1,chr17:35682607:A/G:1,chr17:36195375:A/G:1,chr17:50195100:C/A:1,chr17:63895212:T/C:1,chr19:11025539:C/G:1,chr19:11343264:G/A:1,chr19:14404629:C/A:1,chr19:38392374:C/T:1,chr19:38394161:T/G:1,chr19:40569803:G/A:1,chr19:52215622:C/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr19:54307267:G/A:1,chr19:54742741:T/A:1,chr19:7699499:C/T:1,chr19:9849326:C/A:1,chr1:12188701:A/G:1,chr1:12203460:C/A:1,chr1:153419515:C/A:1,chr1:159000259:G/T:1,chr1:160353563:A/G:1,chr1:17070003:T/C:1,chr1:178470804:T/C:1,chr1:201324373:G/T:1,chr1:206479188:C/A:1,chr1:26571817:C/A:1,chr1:27412951:A/T:1,chr1:27668390:G/T:1,chr20:1117130:G/T:1,chr20:2975202:A/T:1,chr20:2988197:T/A:1,chr20:32098788:C/A:1,chr20:33237991:G/A:1,chr20:50526505:C/A:1,chr22:36320146:C/A:1,chr22:37132322:T/G:1,chr22:37142288:T/C:1,chr22:39964624:C/A:1,chr22:40963988:A/T:1,chr22:50625611:G/C:1,chr2:111863902:T/A:1,chr2:196222438:A/C:1,chr2:211630704:C/G:1,chr2:226796751:A/G:1,chr2:26109711:A/T:1,chr2:53728873:T/A:1,chr2:55234745:A/T:1,chr3:138778223:G/A:1,chr3:194341790:C/T:1,chr3:195752618:A/G:1,chr3:195752619:G/C:1,chr3:48225051:G/T:1,chr3:53192052:T/G:1,chr4:118833895:C/A:1,chr4:152350128:T/A:1,chr4:25418042:G/T:1,chr4:82855072:T/A:1,chr5:140633030:C/A:1,chr5:1501675:T/C:1,chr5:177301877:T/C:1,chr5:38482482:C/A:1,chr5:39342273:C/A:1,chr5:40936518:G/A:1,chr5:76654711:T/C:1,chr6:159684794:A/T:1,chr6:161549199:T/A:1,chr6:31356312:G/A:1,chr6:3154999:A/G:1,chr6:32530260:C/G:1,chr6:32584008:G/C:1,chr6:33676739:C/A:1,chr6:43055804:A/T:1,chr6:6224619:A/T:1,chr7:100958263:A/G:1,chr7:101035696:G/T:1,chr7:142093478:C/A:1,chr7:143292189:T/C:1,chr7:151010230:G/T:1,chr7:27841060:C/A:1,chr7:2924035:T/C:1,chr7:80474080:T/G:1,chr7:99061975:G/T:1,chr7:99394321:C/T:1,chr8:11847933:G/T:1,chr9:120961515:C/A:1,chr9:121312182:C/T:1,chr9:121578321:C/A:1,chr9:131215059:A/G:1,chr9:131592242:G/T:1,chr9:134914627:C/T:1,chr9:34582938:G/T:1,chr9:35697963:G/T:1,chr9:5456056:A/T:1,chrX:107602813:C/A:1,chrX:154405329:C/A:1,chrX:41343158:A/T:1
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	Disease	1.000000	NUP214	chr9:131215059:A/G:1
R-HSA-168273	Influenza Viral RNA Transcription and Replication	Disease	0.851994	GTF2F1,NUP214,RPL10,RPL23,RPL31,RPS27A,RPS6,RPS9	chr17:38850552:C/A:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr19:6380036:G/T:1,chr2:101018980:G/T:1,chr2:55234745:A/T:1,chr9:131215059:A/G:1,chr9:19376102:T/C:1,chrX:154405329:C/A:1
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	Disease	1.000000	NUP214	chr9:131215059:A/G:1
R-HSA-168276	NS1 Mediated Effects on Host Pathways	Disease	0.729299	NUP214	chr9:131215059:A/G:1
R-HSA-168325	Viral Messenger RNA Synthesis	Disease	1.000000	GTF2F1,NUP214	chr19:6380036:G/T:1,chr9:131215059:A/G:1
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	Disease	1.000000	NUP214	chr9:131215059:A/G:1
R-HSA-168638	NOD1/2 Signaling Pathway	Immune System	0.457614	CASP2,NOD2,RPS27A	chr16:50711288:C/T:1,chr2:55234745:A/T:1,chr7:143292189:T/C:1
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	Immune System	1.000000	CASP2,NOD2,RPS27A	chr16:50711288:C/T:1,chr2:55234745:A/T:1,chr7:143292189:T/C:1
R-HSA-168898	Toll-like Receptor Cascades	Immune System	0.155113	CD14,CD36,CTSB,IKBKE,ITGAM,MAP2K3,NFKBIA,NOD2,PPP2R1A,PTPN11,RPS27A,RPS6KA1,SFTPD	chr10:79946379:C/A:1,chr12:112489105:A/T:1,chr14:35403479:G/T:1,chr16:31299762:C/T:1,chr16:50711288:C/T:1,chr17:21303128:C/T:1,chr19:52215622:C/T:1,chr1:206479188:C/A:1,chr1:26571817:C/A:1,chr2:55234745:A/T:1,chr5:140633030:C/A:1,chr7:80474080:T/G:1,chr8:11847933:G/T:1
R-HSA-168927	TICAM1, RIP1-mediated IKK complex recruitment	Immune System	1.000000	RPS27A	chr2:55234745:A/T:1
R-HSA-168928	DDX58/IFIH1-mediated induction of interferon-alpha/beta	Immune System	0.803501	IKBKE,NFKBIA,PIN1,RPS27A,TAX1BP1	chr14:35403479:G/T:1,chr19:9849326:C/A:1,chr1:206479188:C/A:1,chr2:55234745:A/T:1,chr7:27841060:C/A:1
R-HSA-169893	Prolonged ERK activation events	Signal Transduction	0.559805	RAPGEF1	chr9:131592242:G/T:1
R-HSA-169911	Regulation of Apoptosis	Programmed Cell Death	1.000000	ARHGAP10,PSMF1,RPS27A	chr20:1117130:G/T:1,chr2:55234745:A/T:1,chr4:147964990:A/T:1,chr4:147975614:C/A:1
R-HSA-170670	Adenylate cyclase inhibitory pathway	Signal Transduction;Neuronal System	0.559805	GNAT3	chr7:80474080:T/G:1
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	Metabolism	1.000000	NUP214	chr9:131215059:A/G:1
R-HSA-170834	Signaling by TGF-beta Receptor Complex	Signal Transduction	0.799016	MEN1,RPS27A,SMURF1	chr11:64807481:C/T:1,chr2:55234745:A/T:1,chr7:99061975:G/T:1
R-HSA-170968	Frs2-mediated activation	Signal Transduction	0.505026	RAPGEF1	chr9:131592242:G/T:1
R-HSA-171319	Telomere Extension By Telomerase	Cell Cycle	0.608530	RTEL1	chr20:63667624:C/A:1
R-HSA-173623	Classical antibody-mediated complement activation	Immune System	1.000000	IGHG1,IGHG2,IGHG4	chr14:105624404:C/G:1,chr14:105641644:C/T:1,chr14:105741468:G/C:1,chr14:105741485:A/G:1
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	Cell Cycle	0.139819	ANAPC1,ANAPC4,RPS27A	chr2:111863902:T/A:1,chr2:55234745:A/T:1,chr4:25418042:G/T:1
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	Cell Cycle	0.781876	ANAPC1,ANAPC4,PSMF1,RPS27A	chr20:1117130:G/T:1,chr2:111863902:T/A:1,chr2:55234745:A/T:1,chr4:25418042:G/T:1
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	Cell Cycle	0.769701	PSMF1,RPS27A	chr20:1117130:G/T:1,chr2:55234745:A/T:1
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	Cell Cycle	1.000000	ANAPC1,ANAPC4,PSMF1,RPS27A	chr20:1117130:G/T:1,chr2:111863902:T/A:1,chr2:55234745:A/T:1,chr4:25418042:G/T:1
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	Cell Cycle	0.791884	ANAPC1,ANAPC4,PSMF1,RPS27A	chr20:1117130:G/T:1,chr2:111863902:T/A:1,chr2:55234745:A/T:1,chr4:25418042:G/T:1
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	Cell Cycle	1.000000	ANAPC1,ANAPC4,PSMF1,RPS27A	chr20:1117130:G/T:1,chr2:111863902:T/A:1,chr2:55234745:A/T:1,chr4:25418042:G/T:1
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	Cell Cycle	1.000000	ANAPC1,ANAPC4,PSMF1,RPS27A	chr20:1117130:G/T:1,chr2:111863902:T/A:1,chr2:55234745:A/T:1,chr4:25418042:G/T:1
R-HSA-174414	Processive synthesis on the C-strand of the telomere	Cell Cycle	0.166735	RPA1,RPA2	chr17:1853255:C/A:1,chr1:27914481:C/T:1
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	Cell Cycle	0.672201	RPA1,RPA2	chr17:1853255:C/A:1,chr1:27914481:C/T:1
R-HSA-174437	Removal of the Flap Intermediate from the C-strand	Cell Cycle	0.126518	RPA1,RPA2	chr17:1853255:C/A:1,chr1:27914481:C/T:1
R-HSA-174490	Membrane binding and targetting of GAG proteins	Disease	0.559805	RPS27A	chr2:55234745:A/T:1
R-HSA-174495	Synthesis And Processing Of GAG, GAGPOL Polyproteins	Disease	0.559805	RPS27A	chr2:55234745:A/T:1
R-HSA-174577	Activation of C3 and C5	Immune System	0.336437	C5	chr9:120961515:C/A:1
R-HSA-174824	Plasma lipoprotein assembly, remodeling, and clearance	Transport of small molecules	0.297815	ABCG1,AP2B1,BMP1,LPA,NR1H3,VLDLR	chr11:47259936:C/A:1,chr17:35682607:A/G:1,chr21:42291695:T/G:1,chr6:160535531:T/C:1,chr8:22196292:A/C:1,chr9:2644144:G/T:1
R-HSA-175474	Assembly Of The HIV Virion	Disease	0.608530	RPS27A	chr2:55234745:A/T:1
R-HSA-176033	Interactions of Vpr with host cellular proteins	Disease	0.722070	NUP214	chr9:131215059:A/G:1
R-HSA-176187	Activation of ATR in response to replication stress	Cell Cycle	0.466570	CHEK1,RPA1,RPA2	chr11:125637382:T/C:1,chr17:1853255:C/A:1,chr1:27914481:C/T:1
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	Cell Cycle	0.294775	ANAPC1,ANAPC4	chr2:111863902:T/A:1,chr4:25418042:G/T:1
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	Cell Cycle	1.000000	ANAPC1,ANAPC4,PSMF1,RPS27A	chr20:1117130:G/T:1,chr2:111863902:T/A:1,chr2:55234745:A/T:1,chr4:25418042:G/T:1
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	Cell Cycle	1.000000	ANAPC1,ANAPC4,PSMF1,RPS27A	chr20:1117130:G/T:1,chr2:111863902:T/A:1,chr2:55234745:A/T:1,chr4:25418042:G/T:1
R-HSA-176412	Phosphorylation of the APC/C	Cell Cycle	0.294775	ANAPC1,ANAPC4	chr2:111863902:T/A:1,chr4:25418042:G/T:1
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	Cell Cycle	1.000000	ANAPC1,ANAPC4,PSMF1,RPS27A	chr20:1117130:G/T:1,chr2:111863902:T/A:1,chr2:55234745:A/T:1,chr4:25418042:G/T:1
R-HSA-177243	Interactions of Rev with host cellular proteins	Disease	1.000000	NUP214,RCC1	chr1:28508571:C/A:1,chr9:131215059:A/G:1
R-HSA-177504	Retrograde neurotrophin signalling	Signal Transduction	0.559805	AP2B1	chr17:35682607:A/G:1
R-HSA-177929	Signaling by EGFR	Signal Transduction	0.206495	CSK,EPS15,PTPN11,RPS27A,STAM	chr10:17660650:A/C:1,chr12:112489105:A/T:1,chr15:74802540:C/T:1,chr1:51465474:T/A:1,chr2:55234745:A/T:1
R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	Metabolism	0.761410	BCAN,CSPG4,HSPG2	chr15:75675473:A/G:1,chr1:156650224:G/T:1,chr1:156652083:T/G:1,chr1:21839609:G/T:1,chr1:21850169:G/T:1
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	Cell Cycle	0.167448	ANAPC1,ANAPC4,RPS27A	chr2:111863902:T/A:1,chr2:55234745:A/T:1,chr4:25418042:G/T:1
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	Cell Cycle	1.000000	ANAPC1,ANAPC4,PSMF1,RPS27A	chr20:1117130:G/T:1,chr2:111863902:T/A:1,chr2:55234745:A/T:1,chr4:25418042:G/T:1
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	Metabolism of proteins	0.836699	RPL10,RPL23,RPL31,RPS27A,RPS6,RPS9,SRP72	chr17:38850552:C/A:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr2:101018980:G/T:1,chr2:55234745:A/T:1,chr4:56478721:C/G:1,chr4:56502018:T/G:1,chr9:19376102:T/C:1,chrX:154405329:C/A:1
R-HSA-180024	DARPP-32 events	Signal Transduction	0.651048	PDE4D,PPP2R1A	chr19:52215622:C/T:1,chr5:59002058:C/A:1
R-HSA-180292	GAB1 signalosome	Signal Transduction	0.251662	CSK,PTPN11	chr12:112489105:A/T:1,chr15:74802540:C/T:1
R-HSA-180534	Vpu mediated degradation of CD4	Disease	0.768730	PSMF1,RPS27A	chr20:1117130:G/T:1,chr2:55234745:A/T:1
R-HSA-180585	Vif-mediated degradation of APOBEC3G	Disease	1.000000	PSMF1,RBX1,RPS27A	chr20:1117130:G/T:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1
R-HSA-180746	Nuclear import of Rev protein	Disease	0.720030	NUP214,RCC1	chr1:28508571:C/A:1,chr9:131215059:A/G:1
R-HSA-180786	Extension of Telomeres	Cell Cycle	0.738060	RPA1,RPA2,RTEL1	chr17:1853255:C/A:1,chr1:27914481:C/T:1,chr20:63667624:C/A:1
R-HSA-180910	Vpr-mediated nuclear import of PICs	Disease	1.000000	NUP214	chr9:131215059:A/G:1
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	Immune System	1.000000	NFKBIA	chr14:35403479:G/T:1
R-HSA-181429	Serotonin Neurotransmitter Release Cycle	Neuronal System	0.016755	PPFIA4,SYN1,SYN3,TSPOAP1	chr17:58320561:C/A:1,chr1:203048066:G/T:1,chr22:32803374:G/T:1,chrX:47619193:G/T:1
R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle	Neuronal System	0.273233	PPFIA4,TSPOAP1	chr17:58320561:C/A:1,chr1:203048066:G/T:1
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	Immune System	0.122923	CD14,CD36,MAP2K3,NFKBIA,NOD2,PPP2R1A,RPS27A,RPS6KA1,SFTPD	chr10:79946379:C/A:1,chr14:35403479:G/T:1,chr16:50711288:C/T:1,chr17:21303128:C/T:1,chr19:52215622:C/T:1,chr1:26571817:C/A:1,chr2:55234745:A/T:1,chr5:140633030:C/A:1,chr7:80474080:T/G:1
R-HSA-182218	Nef Mediated CD8 Down-regulation	Disease	0.336437	AP2B1	chr17:35682607:A/G:1
R-HSA-182971	EGFR downregulation	Signal Transduction	0.257582	EPS15,RPS27A,STAM	chr10:17660650:A/C:1,chr1:51465474:T/A:1,chr2:55234745:A/T:1
R-HSA-1834941	STING mediated induction of host immune responses	Immune System	0.230138	IFI16,STAT6	chr12:57102572:A/C:1,chr1:159000259:G/T:1
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA 	Immune System	0.781876	IFI16,NFKBIA,RPS27A,STAT6	chr12:57102572:A/C:1,chr14:35403479:G/T:1,chr1:159000259:G/T:1,chr2:55234745:A/T:1
R-HSA-1839117	Signaling by cytosolic FGFR1 fusion mutants	Disease	1.000000	MYO18A	chr17:29097561:C/T:1
R-HSA-1839124	FGFR1 mutant receptor activation	Disease	1.000000	MYO18A	chr17:29097561:C/T:1
R-HSA-1839126	FGFR2 mutant receptor activation	Disease	0.711848	GTF2F1,NCBP1	chr19:6380036:G/T:1,chr9:97664178:C/A:1
R-HSA-1852241	Organelle biogenesis and maintenance	Organelle biogenesis and maintenance	1.000000	AKAP9,B9D1,CEP78,CHD9,FBF1,HDAC3,MARK4,NPHP1,PCNT,PPARGC1B,PPP2R1A,PRKAA2,PRKAB2,SOD2,TUBB2A,TUBB8	chr10:73757:T/G:1,chr16:53255530:C/A:1,chr17:19343762:G/A:1,chr17:75926749:C/A:1,chr19:45103617:C/A:1,chr19:52215622:C/T:1,chr1:147172001:G/A:1,chr1:56706008:C/A:1,chr21:46351357:C/A:1,chr2:110144454:A/T:1,chr5:141629409:G/A:1,chr5:149834580:G/T:1,chr6:159684794:A/T:1,chr6:3154999:A/G:1,chr7:91974127:C/A:1,chr7:92040995:G/T:1,chr9:78246838:C/A:1
R-HSA-1855167	Synthesis of pyrophosphates in the cytosol	Metabolism	0.443443	NUDT10	chrX:51332989:A/G:1
R-HSA-1855183	Synthesis of IP2, IP, and Ins in the cytosol	Metabolism	0.559805	IMPA2	chr18:12028250:G/A:1
R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	Metabolism	1.000000	PLCB4	chr20:9437223:T/G:1
R-HSA-186712	Regulation of beta-cell development	Developmental Biology	0.515678	HNF1A,KAT2B,PDX1	chr12:120978908:G/T:1,chr13:27920403:C/A:1,chr3:20072202:A/T:1
R-HSA-186763	Downstream signal transduction	Signal Transduction	0.079795	PIK3CB,PTPN11,RAPGEF1,STAT6	chr12:112489105:A/T:1,chr12:57102572:A/C:1,chr3:138778223:G/A:1,chr9:131592242:G/T:1
R-HSA-186797	Signaling by PDGF	Signal Transduction	0.045294	COL2A1,COL5A1,COL5A2,PIK3CB,PTPN11,RAPGEF1,STAT6	chr12:112489105:A/T:1,chr12:47982418:C/T:1,chr12:57102572:A/C:1,chr2:189098495:C/A:1,chr3:138778223:G/A:1,chr9:131592242:G/T:1,chr9:134782781:A/G:1
R-HSA-187037	Signaling by NTRK1 (TRKA)	Signal Transduction	0.540328	AP2B1,ID1,IRS1,NAB1,PIK3CB,PPP2R1A,RAPGEF1,RPS6KA1	chr17:35682607:A/G:1,chr19:52215622:C/T:1,chr1:26571817:C/A:1,chr20:31605444:G/T:1,chr2:190687195:C/T:1,chr2:190687196:A/T:1,chr2:226796751:A/G:1,chr3:138778223:G/A:1,chr9:131592242:G/T:1
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	Cell Cycle	0.583138	PSMF1,RPS27A	chr20:1117130:G/T:1,chr2:55234745:A/T:1
R-HSA-187687	Signalling to ERKs	Signal Transduction	1.000000	RAPGEF1	chr9:131592242:G/T:1
R-HSA-189085	Digestion of dietary carbohydrate	Digestion and absorption	0.475135	MGAM	chr7:142093478:C/A:1
R-HSA-189200	Cellular hexose transport	Transport of small molecules	0.113936	SLC2A11,SLC2A6,SLC2A9	chr22:23875020:A/T:1,chr4:10005462:C/T:1,chr9:133472046:G/A:1
R-HSA-190236	Signaling by FGFR	Signal Transduction	0.637691	GTF2F1,NCBP1,PPP2R1A,PTBP1,PTPN11,RPS27A	chr12:112489105:A/T:1,chr19:52215622:C/T:1,chr19:6380036:G/T:1,chr19:804704:T/A:1,chr2:55234745:A/T:1,chr9:97664178:C/A:1
R-HSA-190828	Gap junction trafficking	Vesicle-mediated transport	1.000000	TUBB2A,TUBB8	chr10:73757:T/G:1,chr6:3154999:A/G:1
R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	Vesicle-mediated transport	0.316221	TUBB2A,TUBB8	chr10:73757:T/G:1,chr6:3154999:A/G:1
R-HSA-190861	Gap junction assembly	Vesicle-mediated transport	1.000000	TUBB2A,TUBB8	chr10:73757:T/G:1,chr6:3154999:A/G:1
R-HSA-190872	Transport of connexons to the plasma membrane	Vesicle-mediated transport	0.337515	TUBB2A,TUBB8	chr10:73757:T/G:1,chr6:3154999:A/G:1
R-HSA-1912408	Pre-NOTCH Transcription and Translation	Signal Transduction	0.286208	AGO4,KAT2B,TNRC6B	chr1:35850806:C/A:1,chr22:40049003:G/T:1,chr3:20072202:A/T:1
R-HSA-1912420	Pre-NOTCH Processing in Golgi	Signal Transduction	1.000000	SEL1L	chr14:81490564:A/C:1
R-HSA-1912422	Pre-NOTCH Expression and Processing	Signal Transduction	0.419795	AGO4,KAT2B,SEL1L,TNRC6B	chr14:81490564:A/C:1,chr1:35850806:C/A:1,chr22:40049003:G/T:1,chr3:20072202:A/T:1
R-HSA-191273	Cholesterol biosynthesis	Metabolism	1.000000	LSS	chr21:46213081:T/C:1
R-HSA-191859	snRNP Assembly	Metabolism of RNA	1.000000	NCBP1,NUP214,SNRPE	chr1:203869988:C/G:1,chr9:131215059:A/G:1,chr9:97664178:C/A:1
R-HSA-192823	Viral mRNA Translation	Disease	0.644852	RPL10,RPL23,RPL31,RPS27A,RPS6,RPS9	chr17:38850552:C/A:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr2:101018980:G/T:1,chr2:55234745:A/T:1,chr9:19376102:T/C:1,chrX:154405329:C/A:1
R-HSA-193639	p75NTR signals via NF-kB	Signal Transduction	0.230138	NFKBIA,RPS27A	chr14:35403479:G/T:1,chr2:55234745:A/T:1
R-HSA-193648	NRAGE signals death through JNK	Signal Transduction	0.148674	ARHGEF19,ARHGEF4,KALRN,MCF2L,OBSCN,TIAM1	chr13:113046521:T/G:1,chr1:16199915:C/A:1,chr1:228306995:G/A:1,chr21:31135807:A/G:1,chr2:130920920:C/A:1,chr3:124138871:G/T:1,chr3:124477465:C/A:1
R-HSA-193670	p75NTR negatively regulates cell cycle via SC1	Signal Transduction	0.296385	HDAC3	chr5:141629409:G/A:1
R-HSA-193692	Regulated proteolysis of p75NTR	Signal Transduction	0.475135	NCSTN	chr1:160353563:A/G:1
R-HSA-193704	p75 NTR receptor-mediated signalling	Signal Transduction	0.024889	ARHGEF19,ARHGEF4,CASP2,HDAC3,KALRN,MCF2L,NCSTN,NFKBIA,OBSCN,RPS27A,TIAM1	chr13:113046521:T/G:1,chr14:35403479:G/T:1,chr1:160353563:A/G:1,chr1:16199915:C/A:1,chr1:228306995:G/A:1,chr21:31135807:A/G:1,chr2:130920920:C/A:1,chr2:55234745:A/T:1,chr3:124138871:G/T:1,chr3:124477465:C/A:1,chr5:141629409:G/A:1,chr7:143292189:T/C:1
R-HSA-194138	Signaling by VEGF	Signal Transduction	0.394990	DOCK1,ITPR2,ITPR3,NOS3,PIK3CB,PRKCB,PRKCD,WASF2	chr10:127257347:G/T:1,chr12:26600531:C/A:1,chr16:23867049:C/T:1,chr1:27412951:A/T:1,chr3:138778223:G/A:1,chr3:53192052:T/G:1,chr6:33676739:C/A:1,chr7:151010230:G/T:1
R-HSA-194315	Signaling by Rho GTPases	Signal Transduction	0.037699	ARHGAP10,ARHGAP18,ARHGAP29,ARHGEF19,ARHGEF4,ARPC1B,CDH1,CFTR,CIT,CLASP2,CLIP1,CTTN,EVL,IQGAP1,IQGAP2,KALRN,KDM4C,KLC2,KLC4,KNL1,LIMK2,MCF2L,MEN1,MYH9,OBSCN,PIN1,PPP1R12A,PPP2R1A,PPP2R5C,PRKCB,PRKCD,RCC2,TIAM1,TUBB2A,TUBB8,WASF2	chr10:73757:T/G:1,chr11:64807481:C/T:1,chr11:66264919:G/A:1,chr11:70431006:C/A:1,chr12:119796589:G/T:1,chr12:122341757:C/T:1,chr12:79822198:G/T:1,chr13:113046521:T/G:1,chr14:100141166:C/A:1,chr14:101883867:G/T:1,chr15:40651961:A/T:1,chr15:90390695:A/G:1,chr15:90485816:T/C:1,chr16:23867049:C/T:1,chr16:68779429:G/T:1,chr19:52215622:C/T:1,chr19:9849326:C/A:1,chr1:16199915:C/A:1,chr1:17413265:G/T:1,chr1:228306995:G/A:1,chr1:27412951:A/T:1,chr1:94179658:C/A:1,chr21:31135807:A/G:1,chr22:31260099:C/A:1,chr22:36320146:C/A:1,chr2:130920920:C/A:1,chr3:124138871:G/T:1,chr3:124477465:C/A:1,chr3:33602979:G/T:1,chr3:53192052:T/G:1,chr4:147964990:A/T:1,chr4:147975614:C/A:1,chr5:76654711:T/C:1,chr6:129629283:A/T:1,chr6:3154999:A/G:1,chr6:43055804:A/T:1,chr7:117542008:A/T:1,chr7:99394321:C/T:1,chr9:6893015:A/T:1
R-HSA-194441	Metabolism of non-coding RNA	Metabolism of RNA	1.000000	NCBP1,NUP214,SNRPE	chr1:203869988:C/G:1,chr9:131215059:A/G:1,chr9:97664178:C/A:1
R-HSA-194840	Rho GTPase cycle	Signal Transduction	0.711275	ARHGAP10,ARHGAP18,ARHGAP29,ARHGEF19,ARHGEF4,KALRN,MCF2L,OBSCN,TIAM1	chr13:113046521:T/G:1,chr1:16199915:C/A:1,chr1:228306995:G/A:1,chr1:94179658:C/A:1,chr21:31135807:A/G:1,chr2:130920920:C/A:1,chr3:124138871:G/T:1,chr3:124477465:C/A:1,chr4:147964990:A/T:1,chr4:147975614:C/A:1,chr6:129629283:A/T:1
R-HSA-195253	Degradation of beta-catenin by the destruction complex	Signal Transduction	0.339173	PPP2R1A,PPP2R5C,PSMF1,RBX1,RPS27A,TCF7L2,TLE4	chr10:112964742:G/A:1,chr14:101883867:G/T:1,chr19:52215622:C/T:1,chr20:1117130:G/T:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1,chr9:79693752:C/G:1
R-HSA-195258	RHO GTPase Effectors	Signal Transduction	0.049138	ARPC1B,CDH1,CFTR,CIT,CLASP2,CLIP1,CTTN,EVL,IQGAP1,IQGAP2,KDM4C,KLC2,KLC4,KNL1,LIMK2,MEN1,MYH9,PIN1,PPP1R12A,PPP2R1A,PPP2R5C,PRKCB,PRKCD,RCC2,TUBB2A,TUBB8,WASF2	chr10:73757:T/G:1,chr11:64807481:C/T:1,chr11:66264919:G/A:1,chr11:70431006:C/A:1,chr12:119796589:G/T:1,chr12:122341757:C/T:1,chr12:79822198:G/T:1,chr14:100141166:C/A:1,chr14:101883867:G/T:1,chr15:40651961:A/T:1,chr15:90390695:A/G:1,chr15:90485816:T/C:1,chr16:23867049:C/T:1,chr16:68779429:G/T:1,chr19:52215622:C/T:1,chr19:9849326:C/A:1,chr1:17413265:G/T:1,chr1:27412951:A/T:1,chr22:31260099:C/A:1,chr22:36320146:C/A:1,chr3:33602979:G/T:1,chr3:53192052:T/G:1,chr5:76654711:T/C:1,chr6:3154999:A/G:1,chr6:43055804:A/T:1,chr7:117542008:A/T:1,chr7:99394321:C/T:1,chr9:6893015:A/T:1
R-HSA-195721	Signaling by WNT	Signal Transduction	0.224747	AGO4,AP2B1,ITPR2,ITPR3,LGR5,MEN1,PPP2R1A,PPP2R5C,PRKCB,PSMF1,PYGO1,RBX1,ROR2,RPS27A,RSPO1,SCRIB,SMARCA4,SMURF1,TCF7L2,TLE4,TNKS,TNRC6B,USP8,WNT7A	chr10:112964742:G/A:1,chr11:64807481:C/T:1,chr12:26600531:C/A:1,chr12:71578101:A/C:1,chr14:101883867:G/T:1,chr15:50441258:C/A:1,chr15:55588703:G/T:1,chr16:23867049:C/T:1,chr17:35682607:A/G:1,chr19:11025539:C/G:1,chr19:52215622:C/T:1,chr1:35850806:C/A:1,chr1:37625400:G/T:1,chr20:1117130:G/T:1,chr22:40049003:G/T:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1,chr3:13816735:G/A:1,chr3:13816744:T/C:1,chr6:33676739:C/A:1,chr7:99061975:G/T:1,chr8:143793785:G/A:1,chr8:9776590:C/A:1,chr9:79693752:C/G:1,chr9:91724340:G/A:1
R-HSA-196071	Metabolism of steroid hormones	Metabolism	0.449056	CYP11A1,STARD3,TSPOAP1	chr15:74348128:C/T:1,chr17:39660742:G/T:1,chr17:58320561:C/A:1
R-HSA-196108	Pregnenolone biosynthesis	Metabolism	0.027413	CYP11A1,STARD3,TSPOAP1	chr15:74348128:C/T:1,chr17:39660742:G/T:1,chr17:58320561:C/A:1
R-HSA-196299	Beta-catenin phosphorylation cascade	Signal Transduction	0.251662	PPP2R1A,PPP2R5C	chr14:101883867:G/T:1,chr19:52215622:C/T:1
R-HSA-1963640	GRB2 events in ERBB2 signaling	Signal Transduction	0.230138	ERBB4,NRG3	chr10:82985678:T/A:1,chr2:211630704:C/G:1
R-HSA-1963642	PI3K events in ERBB2 signaling	Signal Transduction	0.230138	ERBB4,NRG3	chr10:82985678:T/A:1,chr2:211630704:C/G:1
R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	Metabolism	0.337515	ABCD4,MUT	chr14:74292598:G/T:1,chr14:74292774:C/T:1,chr6:49444826:C/A:1
R-HSA-196757	Metabolism of folate and pterines	Metabolism	1.000000	ALDH1L2	chr12:105038287:C/A:1
R-HSA-196780	Biotin transport and metabolism	Metabolism	0.475135	PCCA	chr13:100469233:C/A:1
R-HSA-196807	Nicotinate metabolism	Metabolism	1.000000	CD38	chr4:15778700:C/A:1
R-HSA-196843	Vitamin B2 (riboflavin) metabolism	Metabolism	0.056075	ENPP1,SLC52A2	chr6:131864504:A/T:1,chr8:144356365:C/A:1,chr8:144360013:C/A:1
R-HSA-196849	Metabolism of water-soluble vitamins and cofactors	Metabolism	1.000000	ABCD4,ALDH1L2,CD38,ENPP1,MUT,PCCA,SLC52A2	chr12:105038287:C/A:1,chr13:100469233:C/A:1,chr14:74292598:G/T:1,chr14:74292774:C/T:1,chr4:15778700:C/A:1,chr6:131864504:A/T:1,chr6:49444826:C/A:1,chr8:144356365:C/A:1,chr8:144360013:C/A:1
R-HSA-196854	Metabolism of vitamins and cofactors	Metabolism	0.634730	ABCD4,ALDH1L2,BCO1,CD38,COQ3,ENPP1,HSPG2,MUT,NOS3,PCCA,PLB1,SLC52A2	chr12:105038287:C/A:1,chr13:100469233:C/A:1,chr14:74292598:G/T:1,chr14:74292774:C/T:1,chr16:81245335:G/T:1,chr1:21839609:G/T:1,chr1:21850169:G/T:1,chr2:28516675:G/T:1,chr4:15778700:C/A:1,chr6:131864504:A/T:1,chr6:49444826:C/A:1,chr6:99394018:G/T:1,chr7:151010230:G/T:1,chr8:144356365:C/A:1,chr8:144360013:C/A:1
R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	Metabolism	0.181814	BCAN,CSPG4,HSPG2	chr15:75675473:A/G:1,chr1:156650224:G/T:1,chr1:156652083:T/G:1,chr1:21839609:G/T:1,chr1:21850169:G/T:1
R-HSA-1980143	Signaling by NOTCH1	Signal Transduction	0.002925	FBXW7,HDAC11,HDAC3,HDAC5,HDAC8,HEY1,KAT2B,NCSTN,RBX1,RPS27A,TLE4	chr17:44079338:G/T:1,chr1:160353563:A/G:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1,chr3:13496579:C/G:1,chr3:20072202:A/T:1,chr4:152350128:T/A:1,chr5:141629409:G/A:1,chr8:79766933:C/A:1,chr9:79693752:C/G:1,chrX:72572139:G/A:1
R-HSA-1980145	Signaling by NOTCH2	Signal Transduction	0.433338	FCER2,NCSTN,RPS27A	chr19:7699499:C/T:1,chr1:160353563:A/G:1,chr2:55234745:A/T:1
R-HSA-198203	PI3K/AKT activation	Signal Transduction	0.089187	IRS1,PIK3CB	chr2:226796751:A/G:1,chr3:138778223:G/A:1
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	Signal Transduction	0.777723	ID1,NAB1,PPP2R1A,RPS6KA1	chr19:52215622:C/T:1,chr1:26571817:C/A:1,chr20:31605444:G/T:1,chr2:190687195:C/T:1,chr2:190687196:A/T:1
R-HSA-198753	ERK/MAPK targets	Signal Transduction;Immune System	0.358602	PPP2R1A,RPS6KA1	chr19:52215622:C/T:1,chr1:26571817:C/A:1
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	Immune System	0.872579	CDH1,COL1A1,COL2A1,HLA-B,ITGAL,KIR2DL3,KLRD1,LILRA5,LILRB3,PIANP,SFTPD	chr10:79946379:C/A:1,chr12:10308110:T/A:1,chr12:47982418:C/T:1,chr12:6699412:G/T:1,chr16:30494137:C/A:1,chr16:68779429:G/T:1,chr17:50195100:C/A:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr19:54307267:G/A:1,chr19:54742741:T/A:1,chr6:31356312:G/A:1
R-HSA-1989781	PPARA activates gene expression	Metabolism	0.101095	CD36,CHD9,HDAC3,MED13L,MED14,MED25,NR1H3,PPARGC1B,RORA,SLC27A1,THRAP3	chr11:47259936:C/A:1,chr12:115986913:T/C:1,chr15:60556760:G/T:1,chr16:53255530:C/A:1,chr19:17487596:C/T:1,chr19:49830773:C/A:1,chr1:36301559:C/T:1,chr5:141629409:G/A:1,chr5:149834580:G/T:1,chr7:80474080:T/G:1,chrX:40703435:G/C:1
R-HSA-199220	Vitamin B5 (pantothenate) metabolism	Metabolism	1.000000	ENPP1	chr6:131864504:A/T:1
R-HSA-199418	Negative regulation of the PI3K/AKT network	Signal Transduction	0.294676	ERBB4,IRS1,KITLG,NRG3,PIK3CB,PIP5K1C,PPP2R1A,PPP2R5C,PTPN11	chr10:82985678:T/A:1,chr12:112489105:A/T:1,chr12:88516155:G/T:1,chr14:101883867:G/T:1,chr19:3643094:C/A:1,chr19:52215622:C/T:1,chr2:211630704:C/G:1,chr2:226796751:A/G:1,chr3:138778223:G/A:1
R-HSA-199920	CREB phosphorylation	Signal Transduction;Immune System	0.336437	RPS6KA1	chr1:26571817:C/A:1
R-HSA-199977	ER to Golgi Anterograde Transport	Metabolism of proteins;Vesicle-mediated transport	0.601597	ANK1,ANK3,PPP6C,SEC16B,SEC23A,SEC24D,SEC31A,SPTBN4,TUBB2A,TUBB8	chr10:60685310:G/A:1,chr10:73757:T/G:1,chr14:39040609:C/A:1,chr19:40569803:G/A:1,chr1:177936177:G/T:1,chr4:118833895:C/A:1,chr4:82855072:T/A:1,chr6:3154999:A/G:1,chr8:41808044:G/T:1,chr9:125171223:T/A:1
R-HSA-199991	Membrane Trafficking	Vesicle-mediated transport	0.109707	ALPP,ALS2,ANK1,ANK3,AP2B1,BIN1,CFTR,CPD,CTTN,DENND3,EPS15,FCHO1,FCHO2,GABARAP,GGA2,GNS,GOLGA1,HPS4,ITSN2,KIF11,KIF25,KLC2,KLC4,MYH9,NBAS,PIP5K1C,PPP6C,PRKAA2,PRKAB2,RAB10,RAB3GAP1,RAB4A,RAB6B,RPS27A,SBF1,SCOC,SEC16B,SEC23A,SEC24D,SEC31A,SPTBN4,STAM,TBC1D14,TUBB2A,TUBB8	chr10:17660650:A/C:1,chr10:60685310:G/A:1,chr10:73757:T/G:1,chr10:92639648:G/T:1,chr11:66264919:G/A:1,chr11:70431006:C/A:1,chr12:64722884:C/A:1,chr14:39040609:C/A:1,chr16:23469223:G/T:1,chr17:30461111:A/T:1,chr17:35682607:A/G:1,chr17:7240852:C/A:1,chr19:17774499:G/A:1,chr19:17787746:T/C:1,chr19:3643094:C/A:1,chr19:40569803:G/A:1,chr1:147172001:G/A:1,chr1:177936177:G/T:1,chr1:229288550:C/A:1,chr1:51465474:T/A:1,chr1:56706008:C/A:1,chr22:26465716:C/T:1,chr22:36320146:C/A:1,chr22:50461719:C/T:1,chr2:127060445:C/T:1,chr2:135113016:C/T:1,chr2:15421926:C/A:1,chr2:201728707:T/A:1,chr2:232379271:A/T:1,chr2:24209639:T/G:1,chr2:26109711:A/T:1,chr2:55234745:A/T:1,chr3:133841152:G/A:1,chr4:118833895:C/A:1,chr4:140287063:A/C:1,chr4:7030472:G/C:1,chr4:82855072:T/A:1,chr5:73087969:C/A:1,chr6:168040119:C/A:1,chr6:3154999:A/G:1,chr6:43055804:A/T:1,chr7:117542008:A/T:1,chr8:141176474:A/G:1,chr8:41808044:G/T:1,chr9:124921607:C/T:1,chr9:125171223:T/A:1
R-HSA-199992	trans-Golgi Network Vesicle Budding	Vesicle-mediated transport	0.440074	CPD,GNS	chr12:64722884:C/A:1,chr17:30461111:A/T:1
R-HSA-200425	Carnitine metabolism	Metabolism	0.041691	PPARD,PRKAA2,PRKAB2	chr1:147172001:G/A:1,chr1:56706008:C/A:1,chr6:35396106:C/T:1
R-HSA-201451	Signaling by BMP	Signal Transduction	1.000000	SMURF1	chr7:99061975:G/T:1
R-HSA-201681	TCF dependent signaling in response to WNT	Signal Transduction	0.774182	LGR5,MEN1,PPP2R1A,PPP2R5C,PSMF1,PYGO1,RBX1,RPS27A,RSPO1,SMARCA4,TCF7L2,TLE4,TNKS,USP8	chr10:112964742:G/A:1,chr11:64807481:C/T:1,chr12:71578101:A/C:1,chr14:101883867:G/T:1,chr15:50441258:C/A:1,chr15:55588703:G/T:1,chr19:11025539:C/G:1,chr19:52215622:C/T:1,chr1:37625400:G/T:1,chr20:1117130:G/T:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1,chr8:9776590:C/A:1,chr9:79693752:C/G:1
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	Signal Transduction	1.000000	MEN1,PYGO1,SMARCA4,TCF7L2,TLE4	chr10:112964742:G/A:1,chr11:64807481:C/T:1,chr15:55588703:G/T:1,chr19:11025539:C/G:1,chr9:79693752:C/G:1
R-HSA-202040	G-protein activation	Signal Transduction	1.000000	GNAT3	chr7:80474080:T/G:1
R-HSA-202131	Metabolism of nitric oxide: eNOS activation and regulation	Metabolism	0.584880	NOS3	chr7:151010230:G/T:1
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	Extracellular matrix organization	0.000138	BMP1,COL11A1,COL11A2,COL12A1,COL1A1,COL2A1,COL4A6,COL5A1,COL5A2,CTSB,LAMB3,LAMC2	chr12:47982418:C/T:1,chr17:50195100:C/A:1,chr1:102962717:G/T:1,chr1:183228170:A/G:1,chr1:209618498:C/T:1,chr2:189098495:C/A:1,chr6:33171551:C/T:1,chr6:75151273:C/A:1,chr8:11847933:G/T:1,chr8:22196292:A/C:1,chr9:134782781:A/G:1,chrX:108187727:G/A:1
R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins	Metabolism of proteins	0.273233	ANPEP,CES1	chr15:89801121:T/C:1,chr16:55830823:C/A:1
R-HSA-2022857	Keratan sulfate degradation	Metabolism	0.166735	GALNS,GNS	chr12:64722884:C/A:1,chr16:88837557:G/T:1
R-HSA-2022870	Chondroitin sulfate biosynthesis	Metabolism	0.316221	BCAN,CSPG4	chr15:75675473:A/G:1,chr1:156650224:G/T:1,chr1:156652083:T/G:1
R-HSA-2022923	Dermatan sulfate biosynthesis	Metabolism	0.126518	BCAN,CSPG4	chr15:75675473:A/G:1,chr1:156650224:G/T:1,chr1:156652083:T/G:1
R-HSA-2022928	HS-GAG biosynthesis	Metabolism	0.695622	EXT2,HSPG2	chr11:44236478:G/T:1,chr1:21839609:G/T:1,chr1:21850169:G/T:1
R-HSA-202403	TCR signaling	Immune System	0.231221	CARD11,CSK,EVL,GRAP2,HLA-DRB1,HLA-DRB5,NFKBIA,PIK3CB,PSMF1,RPS27A	chr14:100141166:C/A:1,chr14:35403479:G/T:1,chr15:74802540:C/T:1,chr20:1117130:G/T:1,chr22:39964624:C/A:1,chr2:55234745:A/T:1,chr3:138778223:G/A:1,chr6:32530260:C/G:1,chr6:32584008:G/C:1,chr7:2924035:T/C:1
R-HSA-2024096	HS-GAG degradation	Metabolism	1.000000	HSPG2	chr1:21839609:G/T:1,chr1:21850169:G/T:1
R-HSA-2024101	CS/DS degradation	Metabolism	0.187575	BCAN,CSPG4	chr15:75675473:A/G:1,chr1:156650224:G/T:1,chr1:156652083:T/G:1
R-HSA-202424	Downstream TCR signaling	Immune System	0.510478	CARD11,HLA-DRB1,HLA-DRB5,NFKBIA,PIK3CB,PSMF1,RPS27A	chr14:35403479:G/T:1,chr20:1117130:G/T:1,chr2:55234745:A/T:1,chr3:138778223:G/A:1,chr6:32530260:C/G:1,chr6:32584008:G/C:1,chr7:2924035:T/C:1
R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	Immune System	0.153436	CSK,HLA-DRB1,HLA-DRB5	chr15:74802540:C/T:1,chr6:32530260:C/G:1,chr6:32584008:G/C:1
R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	Immune System	0.337515	HLA-DRB1,HLA-DRB5	chr6:32530260:C/G:1,chr6:32584008:G/C:1
R-HSA-202433	Generation of second messenger molecules	Immune System	0.146062	EVL,GRAP2,HLA-DRB1,HLA-DRB5	chr14:100141166:C/A:1,chr22:39964624:C/A:1,chr6:32530260:C/G:1,chr6:32584008:G/C:1
R-HSA-202670	ERKs are inactivated	Signal Transduction;Immune System	0.533217	PPP2R1A	chr19:52215622:C/T:1
R-HSA-202733	Cell surface interactions at the vascular wall	Hemostasis	0.875980	COL1A1,GYPA,ITGAL,ITGAM,L1CAM,PIK3CB,PTPN11,PTPN6,SLC7A7,TNFRSF10A	chr12:112489105:A/T:1,chr12:6960084:C/T:1,chr14:22780250:C/A:1,chr16:30494137:C/A:1,chr16:31299762:C/T:1,chr17:50195100:C/A:1,chr3:138778223:G/A:1,chr4:144116771:A/T:1,chr8:23202515:G/T:1,chrX:153863598:G/T:1
R-HSA-2028269	Signaling by Hippo	Signal Transduction	0.316221	TJP2,WWC1	chr5:168402535:G/T:1,chr9:69250885:T/G:1
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	Immune System	0.198451	ARPC1B,DOCK1,HCK,IGHG1,IGHG2,IGHG4,ITPR2,ITPR3,MYH9,PIK3CB,PRKCD,WASF2	chr10:127257347:G/T:1,chr12:26600531:C/A:1,chr14:105624404:C/G:1,chr14:105641644:C/T:1,chr14:105741468:G/C:1,chr14:105741485:A/G:1,chr1:27412951:A/T:1,chr20:32098788:C/A:1,chr22:36320146:C/A:1,chr3:138778223:G/A:1,chr3:53192052:T/G:1,chr6:33676739:C/A:1,chr7:99394321:C/T:1
R-HSA-2029481	FCGR activation	Immune System	0.797578	HCK,IGHG1,IGHG2,IGHG4	chr14:105624404:C/G:1,chr14:105641644:C/T:1,chr14:105741468:G/C:1,chr14:105741485:A/G:1,chr20:32098788:C/A:1
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	Immune System	0.841136	ARPC1B,DOCK1,IGHG1,IGHG2,IGHG4,MYH9,WASF2	chr10:127257347:G/T:1,chr14:105624404:C/G:1,chr14:105641644:C/T:1,chr14:105741468:G/C:1,chr14:105741485:A/G:1,chr1:27412951:A/T:1,chr22:36320146:C/A:1,chr7:99394321:C/T:1
R-HSA-2029485	Role of phospholipids in phagocytosis	Immune System	0.232766	IGHG1,IGHG2,IGHG4,ITPR2,ITPR3,PIK3CB,PRKCD	chr12:26600531:C/A:1,chr14:105624404:C/G:1,chr14:105641644:C/T:1,chr14:105741468:G/C:1,chr14:105741485:A/G:1,chr3:138778223:G/A:1,chr3:53192052:T/G:1,chr6:33676739:C/A:1
R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	Gene expression (Transcription)	0.584880	KAT2B	chr3:20072202:A/T:1
R-HSA-203615	eNOS activation	Metabolism	0.475135	NOS3	chr7:151010230:G/T:1
R-HSA-203641	NOSTRIN mediated eNOS trafficking	Metabolism	0.253920	NOS3	chr7:151010230:G/T:1
R-HSA-203754	NOSIP mediated eNOS trafficking	Metabolism	0.110550	NOS3	chr7:151010230:G/T:1
R-HSA-203927	MicroRNA (miRNA) biogenesis	Gene expression (Transcription)	1.000000	AGO4	chr1:35850806:C/A:1
R-HSA-204005	COPII-mediated vesicle transport	Metabolism of proteins;Vesicle-mediated transport	0.593134	PPP6C,SEC16B,SEC23A,SEC24D,SEC31A	chr14:39040609:C/A:1,chr1:177936177:G/T:1,chr4:118833895:C/A:1,chr4:82855072:T/A:1,chr9:125171223:T/A:1
R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex	Metabolism	0.230138	PDHA1,PPARD	chr6:35396106:C/T:1,chrX:19355267:G/T:1
R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	Signal Transduction	0.039412	ARHGEF19,ARHGEF4,CASP2,KALRN,MCF2L,NCSTN,OBSCN,RPS27A,TIAM1	chr13:113046521:T/G:1,chr1:160353563:A/G:1,chr1:16199915:C/A:1,chr1:228306995:G/A:1,chr21:31135807:A/G:1,chr2:130920920:C/A:1,chr2:55234745:A/T:1,chr3:124138871:G/T:1,chr3:124477465:C/A:1,chr7:143292189:T/C:1
R-HSA-205025	NADE modulates death signalling	Signal Transduction	0.296385	CASP2	chr7:143292189:T/C:1
R-HSA-205043	NRIF signals cell death from the nucleus	Signal Transduction	0.230138	NCSTN,RPS27A	chr1:160353563:A/G:1,chr2:55234745:A/T:1
R-HSA-209543	p75NTR recruits signalling complexes	Signal Transduction	0.533217	RPS27A	chr2:55234745:A/T:1
R-HSA-209560	NF-kB is activated and signals survival	Signal Transduction	0.166735	NFKBIA,RPS27A	chr14:35403479:G/T:1,chr2:55234745:A/T:1
R-HSA-209776	Metabolism of amine-derived hormones	Metabolism	1.000000	ASMT	chrX:1624068:G/T:1
R-HSA-209931	Serotonin and melatonin biosynthesis	Metabolism	0.253920	ASMT	chrX:1624068:G/T:1
R-HSA-210500	Glutamate Neurotransmitter Release Cycle	Neuronal System	0.153436	PPFIA4,SLC1A1,TSPOAP1	chr17:58320561:C/A:1,chr1:203048066:G/T:1,chr9:4576050:G/A:1
R-HSA-210744	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	Developmental Biology	0.608530	KAT2B	chr3:20072202:A/T:1
R-HSA-210745	Regulation of gene expression in beta cells	Developmental Biology	0.337515	HNF1A,PDX1	chr12:120978908:G/T:1,chr13:27920403:C/A:1
R-HSA-210747	Regulation of gene expression in early pancreatic precursor cells	Developmental Biology	0.374212	PDX1	chr13:27920403:C/A:1
R-HSA-210990	PECAM1 interactions	Hemostasis	0.146339	PTPN11,PTPN6	chr12:112489105:A/T:1,chr12:6960084:C/T:1
R-HSA-210991	Basigin interactions	Hemostasis	0.651048	L1CAM,SLC7A7	chr14:22780250:C/A:1,chrX:153863598:G/T:1
R-HSA-210993	Tie2 Signaling	Hemostasis	0.273233	PIK3CB,PTPN11	chr12:112489105:A/T:1,chr3:138778223:G/A:1
R-HSA-211000	Gene Silencing by RNA	Gene expression (Transcription)	0.090801	AGO4,NUP214,TNRC6B	chr1:35850806:C/A:1,chr22:40049003:G/T:1,chr9:131215059:A/G:1
R-HSA-211728	Regulation of PAK-2p34 activity by PS-GAP/RHG10	Programmed Cell Death	0.110550	ARHGAP10	chr4:147964990:A/T:1,chr4:147975614:C/A:1
R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation	Programmed Cell Death	1.000000	PSMF1,RPS27A	chr20:1117130:G/T:1,chr2:55234745:A/T:1
R-HSA-211859	Biological oxidations	Metabolism	0.769148	CES1,CYP11A1,CYP2A7,CYP2B6,CYP2D6,CYP2S1,MAT1A,MGST1,SULT1A2,SULT2B1,TBXAS1	chr10:80283820:G/A:1,chr12:16605069:T/G:1,chr15:74348128:C/T:1,chr16:28592021:A/G:1,chr16:28592334:T/G:1,chr16:55830823:C/A:1,chr19:40881190:A/T:1,chr19:41014829:G/T:1,chr19:41202176:C/T:1,chr19:48599142:C/T:1,chr22:42126548:G/A:1,chr7:139865711:G/A:1
R-HSA-211897	Cytochrome P450 - arranged by substrate type	Metabolism	0.178594	CYP11A1,CYP2A7,CYP2B6,CYP2D6,CYP2S1,TBXAS1	chr15:74348128:C/T:1,chr19:40881190:A/T:1,chr19:41014829:G/T:1,chr19:41202176:C/T:1,chr22:42126548:G/A:1,chr7:139865711:G/A:1
R-HSA-211935	Fatty acids	Metabolism	0.049974	CYP2A7,CYP2B6,CYP2D6	chr19:40881190:A/T:1,chr19:41014829:G/T:1,chr22:42126548:G/A:1
R-HSA-211945	Phase I - Functionalization of compounds	Metabolism	0.667130	CES1,CYP11A1,CYP2A7,CYP2B6,CYP2D6,CYP2S1,TBXAS1	chr15:74348128:C/T:1,chr16:55830823:C/A:1,chr19:40881190:A/T:1,chr19:41014829:G/T:1,chr19:41202176:C/T:1,chr22:42126548:G/A:1,chr7:139865711:G/A:1
R-HSA-211958	Miscellaneous substrates	Metabolism	0.146339	CYP2D6,CYP2S1	chr19:41202176:C/T:1,chr22:42126548:G/A:1
R-HSA-211976	Endogenous sterols	Metabolism	1.000000	CYP11A1	chr15:74348128:C/T:1
R-HSA-211979	Eicosanoids	Metabolism	0.505026	TBXAS1	chr7:139865711:G/A:1
R-HSA-211981	Xenobiotics	Metabolism	0.038769	CYP2A7,CYP2B6,CYP2D6,CYP2S1	chr19:40881190:A/T:1,chr19:41014829:G/T:1,chr19:41202176:C/T:1,chr22:42126548:G/A:1
R-HSA-211999	CYP2E1 reactions	Metabolism	0.002482	CYP2A7,CYP2B6,CYP2D6,CYP2S1	chr19:40881190:A/T:1,chr19:41014829:G/T:1,chr19:41202176:C/T:1,chr22:42126548:G/A:1
R-HSA-212165	Epigenetic regulation of gene expression	Gene expression (Transcription)	0.282550	DNMT1,KAT2B,MYBBP1A,SIN3A,SUZ12	chr15:75409706:G/A:1,chr17:31973320:T/G:1,chr17:4545528:G/A:1,chr19:10173083:G/A:1,chr3:20072202:A/T:1
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	Signal Transduction	0.000302	FBXW7,HDAC11,HDAC3,HDAC5,HDAC8,HEY1,KAT2B,RBX1,RPS27A,TLE4	chr17:44079338:G/T:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1,chr3:13496579:C/G:1,chr3:20072202:A/T:1,chr4:152350128:T/A:1,chr5:141629409:G/A:1,chr8:79766933:C/A:1,chr9:79693752:C/G:1,chrX:72572139:G/A:1
R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	Signal Transduction	0.695622	NCSTN,RPS27A	chr1:160353563:A/G:1,chr2:55234745:A/T:1
R-HSA-212300	PRC2 methylates histones and DNA	Gene expression (Transcription)	0.438864	DNMT1,SUZ12	chr17:31973320:T/G:1,chr19:10173083:G/A:1
R-HSA-212436	Generic Transcription Pathway	Gene expression (Transcription)	0.845173	AGO4,ANAPC1,ANAPC4,APAF1,ARID1B,BRCA1,CASP2,CAT,CHEK1,CNOT9,COL1A1,DDIT4,FANCI,FBXW7,GTF2F1,HDAC11,HDAC3,HDAC5,HDAC8,HEY1,ITGAL,JMY,KAT2B,KMT2B,LIFR,LRPPRC,MED14,MED25,MEN1,NPY,NR1H3,PIN1,PLK2,POU4F1,PPARD,PPARGC1B,PPP2R1A,PPP2R5C,PRKAA2,PRKAB2,PRKCB,PSMF1,PTPN1,PTPN11,RBFOX1,RBX1,RORA,RPA1,RPA2,RPS27A,RPTOR,SIN3A,SMARCA4,SMURF1,SOD2,SUZ12,TAF5,TCF7L2,TIGAR,TNFRSF10A,TNRC6B,WDR5,ZNF135,ZNF154,ZNF267,ZNF551,ZNF552,ZNF555,ZNF586,ZNF595,ZNF699,ZNF717	chr10:103387074:A/C:1,chr10:112964742:G/A:1,chr10:72275283:T/A:1,chr11:125637382:T/C:1,chr11:34471141:A/C:1,chr11:47259936:C/A:1,chr11:64807481:C/T:1,chr12:112489105:A/T:1,chr12:4321404:C/A:1,chr12:98648251:A/T:1,chr13:78601815:G/T:1,chr14:101883867:G/T:1,chr15:60556760:G/T:1,chr15:75409706:G/A:1,chr15:89263297:C/A:1,chr15:89304999:T/C:1,chr16:23867049:C/T:1,chr16:30494137:C/A:1,chr16:31895162:G/A:1,chr16:5366001:C/A:1,chr17:1853255:C/A:1,chr17:31973320:T/G:1,chr17:43049287:C/G:1,chr17:44079338:G/T:1,chr17:50195100:C/A:1,chr17:80664395:C/A:1,chr19:11025539:C/G:1,chr19:2852284:A/C:1,chr19:35731956:C/T:1,chr19:49830773:C/A:1,chr19:52215622:C/T:1,chr19:57704603:C/A:1,chr19:57814755:G/T:1,chr19:58063587:G/T:1,chr19:6380036:G/T:1,chr19:9305000:G/T:1,chr19:9849326:C/A:1,chr1:147172001:G/A:1,chr1:27914481:C/T:1,chr1:35850806:C/A:1,chr1:56706008:C/A:1,chr20:1117130:G/T:1,chr20:50526505:C/A:1,chr22:40049003:G/T:1,chr22:40963988:A/T:1,chr2:111863902:T/A:1,chr2:218582908:A/T:1,chr2:43944068:C/A:1,chr2:55234745:A/T:1,chr3:13496579:C/G:1,chr3:20072202:A/T:1,chr3:75741893:A/G:1,chr4:152350128:T/A:1,chr4:25418042:G/T:1,chr4:54908:G/A:1,chr5:141629409:G/A:1,chr5:149834580:G/T:1,chr5:38482482:C/A:1,chr5:58454762:G/T:1,chr5:79300647:C/A:1,chr6:156829096:A/G:1,chr6:157039620:T/A:1,chr6:159684794:A/T:1,chr6:35396106:C/T:1,chr7:143292189:T/C:1,chr7:24285140:T/G:1,chr7:99061975:G/T:1,chr8:23202515:G/T:1,chr8:79766933:C/A:1,chr9:134155272:C/G:1,chrX:40703435:G/C:1,chrX:72572139:G/A:1
R-HSA-212676	Dopamine Neurotransmitter Release Cycle	Neuronal System	0.038769	PPFIA4,SYN1,SYN3,TSPOAP1	chr17:58320561:C/A:1,chr1:203048066:G/T:1,chr22:32803374:G/T:1,chrX:47619193:G/T:1
R-HSA-2129379	Molecules associated with elastic fibres	Extracellular matrix organization	0.062432	FBLN1,FBLN2,FBN1,FBN3,TGFB2	chr15:48472836:A/C:1,chr19:8141511:C/A:1,chr1:218405442:G/T:1,chr22:45577115:G/T:1,chr3:13636498:C/A:1
R-HSA-2132295	MHC class II antigen presentation	Immune System	0.072987	AP2B1,CTSB,HLA-DRB1,HLA-DRB5,KIF11,KLC2,KLC4,SEC23A,SEC24D,SEC31A,TUBB2A,TUBB8	chr10:73757:T/G:1,chr10:92639648:G/T:1,chr11:66264919:G/A:1,chr14:39040609:C/A:1,chr17:35682607:A/G:1,chr4:118833895:C/A:1,chr4:82855072:T/A:1,chr6:3154999:A/G:1,chr6:32530260:C/G:1,chr6:32584008:G/C:1,chr6:43055804:A/T:1,chr8:11847933:G/T:1
R-HSA-2142691	Synthesis of Leukotrienes (LT) and Eoxins (EX)	Metabolism	1.000000	PTGR1	chr9:111594402:T/A:1
R-HSA-2142700	Synthesis of Lipoxins (LX)	Metabolism	0.296385	PTGR1	chr9:111594402:T/A:1
R-HSA-2142753	Arachidonic acid metabolism	Metabolism	0.774251	PTGR1,TBXAS1	chr7:139865711:G/A:1,chr9:111594402:T/A:1
R-HSA-2142789	Ubiquinol biosynthesis	Metabolism	0.374212	COQ3	chr6:99394018:G/T:1
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	Organelle biogenesis and maintenance	0.554003	CHD9,HDAC3,PPARGC1B,SOD2	chr16:53255530:C/A:1,chr5:141629409:G/A:1,chr5:149834580:G/T:1,chr6:159684794:A/T:1
R-HSA-2151209	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	Organelle biogenesis and maintenance	0.107415	PRKAA2,PRKAB2	chr1:147172001:G/A:1,chr1:56706008:C/A:1
R-HSA-216083	Integrin cell surface interactions	Extracellular matrix organization	0.000286	CDH1,COL13A1,COL1A1,COL2A1,COL4A6,COL5A1,COL5A2,FBN1,HSPG2,ITGA10,ITGAD,ITGAE,ITGAL,ITGAM	chr10:69827305:G/T:1,chr12:47982418:C/T:1,chr15:48472836:A/C:1,chr16:30494137:C/A:1,chr16:31299762:C/T:1,chr16:31426083:T/G:1,chr16:68779429:G/T:1,chr17:3732402:C/A:1,chr17:50195100:C/A:1,chr1:145895756:C/T:1,chr1:145909820:C/A:1,chr1:21839609:G/T:1,chr1:21850169:G/T:1,chr2:189098495:C/A:1,chr9:134782781:A/G:1,chrX:108187727:G/A:1
R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	Metabolism	0.584880	TBXAS1	chr7:139865711:G/A:1
R-HSA-2172127	DAP12 interactions	Immune System	0.280796	GRAP2,HLA-B,KLRD1,PIK3CB	chr12:10308110:T/A:1,chr22:39964624:C/A:1,chr3:138778223:G/A:1,chr6:31356312:G/A:1
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	Vesicle-mediated transport	0.181771	CD36,COL1A1	chr17:50195100:C/A:1,chr7:80474080:T/G:1
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	Signal Transduction	0.657751	RPS27A,SMURF1	chr2:55234745:A/T:1,chr7:99061975:G/T:1
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	Signal Transduction	0.703700	RPS27A,SMURF1	chr2:55234745:A/T:1,chr7:99061975:G/T:1
R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	Signal Transduction	0.230138	RPS27A,SMURF1	chr2:55234745:A/T:1,chr7:99061975:G/T:1
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	Signal Transduction;Gene expression (Transcription)	1.000000	MEN1,RPS27A	chr11:64807481:C/T:1,chr2:55234745:A/T:1
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	Signal Transduction;Gene expression (Transcription)	1.000000	RPS27A	chr2:55234745:A/T:1
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	Signal Transduction;Gene expression (Transcription)	0.703700	MEN1,RPS27A	chr11:64807481:C/T:1,chr2:55234745:A/T:1
R-HSA-2187338	Visual phototransduction	Signal Transduction	0.827443	ABCA4,BCO1,HSPG2,MYO7A,PLB1,RGS9	chr11:77157326:T/C:1,chr11:77160849:G/T:1,chr11:77205582:C/A:1,chr16:81245335:G/T:1,chr17:65217991:G/T:1,chr1:21839609:G/T:1,chr1:21850169:G/T:1,chr1:94036566:G/A:1,chr2:28516675:G/T:1
R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	Signal Transduction	0.505026	FCER2	chr19:7699499:C/T:1
R-HSA-2206281	Mucopolysaccharidoses	Disease	0.126518	GALNS,GNS	chr12:64722884:C/A:1,chr16:88837557:G/T:1
R-HSA-2206290	MPS IV - Morquio syndrome A	Disease	0.056891	GALNS	chr16:88837557:G/T:1
R-HSA-2206305	MPS IIID - Sanfilippo syndrome D	Disease	0.056891	GNS	chr12:64722884:C/A:1
R-HSA-2214320	Anchoring fibril formation	Extracellular matrix organization	0.001092	BMP1,COL1A1,COL4A6,LAMB3,LAMC2	chr17:50195100:C/A:1,chr1:183228170:A/G:1,chr1:209618498:C/T:1,chr8:22196292:A/C:1,chrX:108187727:G/A:1
R-HSA-2219528	PI3K/AKT Signaling in Cancer	Disease	0.830225	ERBB4,IRS1,KITLG,NRG3,PIK3CB,PTPN11	chr10:82985678:T/A:1,chr12:112489105:A/T:1,chr12:88516155:G/T:1,chr2:211630704:C/G:1,chr2:226796751:A/G:1,chr3:138778223:G/A:1
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	Disease	0.321362	ERBB4,IRS1,KITLG,NRG3,PIK3CB,PTPN11	chr10:82985678:T/A:1,chr12:112489105:A/T:1,chr12:88516155:G/T:1,chr2:211630704:C/G:1,chr2:226796751:A/G:1,chr3:138778223:G/A:1
R-HSA-2243919	Crosslinking of collagen fibrils	Extracellular matrix organization	0.079100	BMP1,COL1A1,COL4A6	chr17:50195100:C/A:1,chr8:22196292:A/C:1,chrX:108187727:G/A:1
R-HSA-2262752	Cellular responses to stress	Cellular responses to external stimuli	0.785399	AGO4,ANAPC1,ANAPC4,C12orf66,CAT,CCAR2,COL4A6,HIST1H1E,HSPA13,ID1,LIMD1,MAP2K3,NUP214,PSMF1,RBX1,RPA1,RPA2,RPL10,RPL23,RPL31,RPS27A,RPS6,RPS6KA1,RPS9,RPTOR,SOD2,SUZ12,SZT2,TNIK,TNRC6B,TUBB2A,TUBB8	chr10:73757:T/G:1,chr11:34471141:A/C:1,chr12:64216016:T/A:1,chr17:1853255:C/A:1,chr17:21303128:C/T:1,chr17:31973320:T/G:1,chr17:38850552:C/A:1,chr17:80664395:C/A:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr1:26571817:C/A:1,chr1:27914481:C/T:1,chr1:35850806:C/A:1,chr1:43426518:G/A:1,chr20:1117130:G/T:1,chr20:31605444:G/T:1,chr21:14373552:G/T:1,chr22:40049003:G/T:1,chr22:40963988:A/T:1,chr2:101018980:G/T:1,chr2:111863902:T/A:1,chr2:55234745:A/T:1,chr3:171373477:C/A:1,chr3:45595947:T/C:1,chr3:45665554:A/T:1,chr4:25418042:G/T:1,chr6:159684794:A/T:1,chr6:26156427:G/C:1,chr6:3154999:A/G:1,chr8:22615430:G/T:1,chr9:131215059:A/G:1,chr9:19376102:T/C:1,chrX:108187727:G/A:1,chrX:154405329:C/A:1
R-HSA-2404192	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	Signal Transduction	1.000000	IRS1,PIK3CB,PTPN11	chr12:112489105:A/T:1,chr2:226796751:A/G:1,chr3:138778223:G/A:1
R-HSA-2408508	Metabolism of ingested SeMet, Sec, MeSec into H2Se	Metabolism	0.374212	MAT1A	chr10:80283820:G/A:1
R-HSA-2408522	Selenoamino acid metabolism	Metabolism	0.548199	IARS,MAT1A,RPL10,RPL23,RPL31,RPS27A,RPS6,RPS9	chr10:80283820:G/A:1,chr17:38850552:C/A:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr2:101018980:G/T:1,chr2:55234745:A/T:1,chr9:19376102:T/C:1,chr9:92274385:C/A:1,chrX:154405329:C/A:1
R-HSA-2408557	Selenocysteine synthesis	Metabolism	0.656822	RPL10,RPL23,RPL31,RPS27A,RPS6,RPS9	chr17:38850552:C/A:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr2:101018980:G/T:1,chr2:55234745:A/T:1,chr9:19376102:T/C:1,chrX:154405329:C/A:1
R-HSA-2424491	DAP12 signaling	Immune System	0.226639	GRAP2,KLRD1,PIK3CB	chr12:10308110:T/A:1,chr22:39964624:C/A:1,chr3:138778223:G/A:1
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	Metabolism	1.000000	CHD9,LSS	chr16:53255530:C/A:1,chr21:46213081:T/C:1
R-HSA-2428924	IGF1R signaling cascade	Signal Transduction	1.000000	IRS1,PIK3CB,PTPN11	chr12:112489105:A/T:1,chr2:226796751:A/G:1,chr3:138778223:G/A:1
R-HSA-2428928	IRS-related events triggered by IGF1R	Signal Transduction	1.000000	IRS1,PIK3CB,PTPN11	chr12:112489105:A/T:1,chr2:226796751:A/G:1,chr3:138778223:G/A:1
R-HSA-2453864	Retinoid cycle disease events	Disease	0.533217	ABCA4	chr1:94036566:G/A:1
R-HSA-2453902	The canonical retinoid cycle in rods (twilight vision)	Signal Transduction	0.379439	ABCA4,MYO7A	chr11:77157326:T/C:1,chr11:77160849:G/T:1,chr11:77205582:C/A:1,chr1:94036566:G/A:1
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	Immune System	0.522264	CARD11,GRAP2,ITPR2,ITPR3,NFKBIA,PIK3CB,PSMF1,RPS27A	chr12:26600531:C/A:1,chr14:35403479:G/T:1,chr20:1117130:G/T:1,chr22:39964624:C/A:1,chr2:55234745:A/T:1,chr3:138778223:G/A:1,chr6:33676739:C/A:1,chr7:2924035:T/C:1
R-HSA-2465910	MASTL Facilitates Mitotic Progression	Cell Cycle	0.443443	PPP2R1A	chr19:52215622:C/T:1
R-HSA-2467813	Separation of Sister Chromatids	Cell Cycle	0.111641	ANAPC1,ANAPC4,CDCA5,CLASP2,CLIP1,HDAC8,KNL1,PPP2R1A,PPP2R5C,PSMF1,RCC2,RPS27A,SMC1A,STAG2,TUBB2A,TUBB8	chr10:73757:T/G:1,chr11:65083833:C/T:1,chr12:122341757:C/T:1,chr14:101883867:G/T:1,chr15:40651961:A/T:1,chr19:52215622:C/T:1,chr1:17413265:G/T:1,chr20:1117130:G/T:1,chr2:111863902:T/A:1,chr2:55234745:A/T:1,chr3:33602979:G/T:1,chr4:25418042:G/T:1,chr6:3154999:A/G:1,chrX:124057978:G/A:1,chrX:124422202:A/T:1,chrX:53380790:T/C:1,chrX:72572139:G/A:1
R-HSA-2468052	Establishment of Sister Chromatid Cohesion	Cell Cycle	0.021449	CDCA5,SMC1A,STAG2	chr11:65083833:C/T:1,chrX:124057978:G/A:1,chrX:124422202:A/T:1,chrX:53380790:T/C:1
R-HSA-2470946	Cohesin Loading onto Chromatin	Cell Cycle	0.107415	SMC1A,STAG2	chrX:124057978:G/A:1,chrX:124422202:A/T:1,chrX:53380790:T/C:1
R-HSA-2474795	Diseases associated with visual transduction	Disease	0.533217	ABCA4	chr1:94036566:G/A:1
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	Cell Cycle	0.077405	CDCA5,CLASP2,CLIP1,HDAC8,KNL1,PPP2R1A,PPP2R5C,RCC2,SMC1A,STAG2,TUBB2A,TUBB8	chr10:73757:T/G:1,chr11:65083833:C/T:1,chr12:122341757:C/T:1,chr14:101883867:G/T:1,chr15:40651961:A/T:1,chr19:52215622:C/T:1,chr1:17413265:G/T:1,chr3:33602979:G/T:1,chr6:3154999:A/G:1,chrX:124057978:G/A:1,chrX:124422202:A/T:1,chrX:53380790:T/C:1,chrX:72572139:G/A:1
R-HSA-2514856	The phototransduction cascade	Signal Transduction	1.000000	RGS9	chr17:65217991:G/T:1
R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade	Signal Transduction	1.000000	RGS9	chr17:65217991:G/T:1
R-HSA-2534343	Interaction With Cumulus Cells And The Zona Pellucida	Reproduction	0.475135	ADAM20	chr14:70522598:A/T:1
R-HSA-2555396	Mitotic Metaphase and Anaphase	Cell Cycle	0.197676	ANAPC1,ANAPC4,CDCA5,CLASP2,CLIP1,HDAC8,KNL1,PPP2R1A,PPP2R5C,PSMF1,RCC1,RCC2,RPS27A,SMC1A,STAG2,TUBB2A,TUBB8,VRK2	chr10:73757:T/G:1,chr11:65083833:C/T:1,chr12:122341757:C/T:1,chr14:101883867:G/T:1,chr15:40651961:A/T:1,chr19:52215622:C/T:1,chr1:17413265:G/T:1,chr1:28508571:C/A:1,chr20:1117130:G/T:1,chr2:111863902:T/A:1,chr2:55234745:A/T:1,chr2:58084877:A/T:1,chr3:33602979:G/T:1,chr4:25418042:G/T:1,chr6:3154999:A/G:1,chrX:124057978:G/A:1,chrX:124422202:A/T:1,chrX:53380790:T/C:1,chrX:72572139:G/A:1
R-HSA-2559580	Oxidative Stress Induced Senescence	Cellular responses to external stimuli	0.845762	AGO4,MAP2K3,RPS27A,SUZ12,TNIK,TNRC6B	chr17:21303128:C/T:1,chr17:31973320:T/G:1,chr1:35850806:C/A:1,chr22:40049003:G/T:1,chr2:55234745:A/T:1,chr3:171373477:C/A:1
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	Cellular responses to external stimuli	0.529713	ANAPC1,ANAPC4,RPS27A,RPS6KA1	chr1:26571817:C/A:1,chr2:111863902:T/A:1,chr2:55234745:A/T:1,chr4:25418042:G/T:1
R-HSA-2559583	Cellular Senescence	Cellular responses to external stimuli	1.000000	AGO4,ANAPC1,ANAPC4,HIST1H1E,ID1,MAP2K3,RPS27A,RPS6KA1,SUZ12,TNIK,TNRC6B	chr17:21303128:C/T:1,chr17:31973320:T/G:1,chr1:26571817:C/A:1,chr1:35850806:C/A:1,chr20:31605444:G/T:1,chr22:40049003:G/T:1,chr2:111863902:T/A:1,chr2:55234745:A/T:1,chr3:171373477:C/A:1,chr4:25418042:G/T:1,chr6:26156427:G/C:1
R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	Cellular responses to external stimuli	1.000000	HIST1H1E	chr6:26156427:G/C:1
R-HSA-2559585	Oncogene Induced Senescence	Cellular responses to external stimuli	0.135542	AGO4,ID1,RPS27A,TNRC6B	chr1:35850806:C/A:1,chr20:31605444:G/T:1,chr22:40049003:G/T:1,chr2:55234745:A/T:1
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	Cellular responses to external stimuli	0.090445	HIST1H1E	chr6:26156427:G/C:1
R-HSA-2562578	TRIF-mediated programmed cell death	Immune System	0.409840	CD14	chr5:140633030:C/A:1
R-HSA-2564830	Cytosolic iron-sulfur cluster assembly	Metabolism	0.166735	MMS19,RTEL1	chr10:97477794:A/G:1,chr20:63667624:C/A:1
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	Cell Cycle	0.637691	AKAP9,CEP78,PCNT,PPP1R12A,PPP2R1A,RPS27A	chr12:79822198:G/T:1,chr19:52215622:C/T:1,chr21:46351357:C/A:1,chr2:55234745:A/T:1,chr7:91974127:C/A:1,chr7:92040995:G/T:1,chr9:78246838:C/A:1
R-HSA-2586552	Signaling by Leptin	Signal Transduction	0.126518	IRS1,PTPN11	chr12:112489105:A/T:1,chr2:226796751:A/G:1
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	Disease	0.001443	FBXW7,HDAC11,HDAC3,HDAC5,HDAC8,HEY1,KAT2B,NCSTN,RBX1,RPS27A	chr17:44079338:G/T:1,chr1:160353563:A/G:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1,chr3:13496579:C/G:1,chr3:20072202:A/T:1,chr4:152350128:T/A:1,chr5:141629409:G/A:1,chr8:79766933:C/A:1,chrX:72572139:G/A:1
R-HSA-2644603	Signaling by NOTCH1 in Cancer	Disease	0.001443	FBXW7,HDAC11,HDAC3,HDAC5,HDAC8,HEY1,KAT2B,NCSTN,RBX1,RPS27A	chr17:44079338:G/T:1,chr1:160353563:A/G:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1,chr3:13496579:C/G:1,chr3:20072202:A/T:1,chr4:152350128:T/A:1,chr5:141629409:G/A:1,chr8:79766933:C/A:1,chrX:72572139:G/A:1
R-HSA-2644605	FBXW7 Mutants and NOTCH1 in Cancer	Disease	0.028804	FBXW7,RBX1	chr22:40963988:A/T:1,chr4:152350128:T/A:1
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	Disease	0.001443	FBXW7,HDAC11,HDAC3,HDAC5,HDAC8,HEY1,KAT2B,NCSTN,RBX1,RPS27A	chr17:44079338:G/T:1,chr1:160353563:A/G:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1,chr3:13496579:C/G:1,chr3:20072202:A/T:1,chr4:152350128:T/A:1,chr5:141629409:G/A:1,chr8:79766933:C/A:1,chrX:72572139:G/A:1
R-HSA-2644607	Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	Disease	0.028804	FBXW7,RBX1	chr22:40963988:A/T:1,chr4:152350128:T/A:1
R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle	Neuronal System	0.068709	CHAT,PPFIA4,TSPOAP1	chr10:49662454:G/A:1,chr17:58320561:C/A:1,chr1:203048066:G/T:1
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	Programmed Cell Death	0.505026	GSN	chr9:121312182:C/T:1
R-HSA-2672351	Stimuli-sensing channels	Transport of small molecules	0.002650	ANO3,ASIC2,RPS27A,RYR1,RYR2,RYR3,SLC9C1,TPCN1,TRPM7,TRPM8,TRPV3,TRPV4,UNC80,WNK2	chr11:26561226:C/A:1,chr12:109796329:G/T:1,chr12:113277113:G/C:1,chr15:33432668:T/G:1,chr15:33653029:T/A:1,chr15:50663094:T/A:1,chr17:34011650:C/A:1,chr17:3527683:A/G:1,chr19:38464585:G/T:1,chr1:237756505:G/T:1,chr1:237792382:C/T:1,chr2:209809377:C/A:1,chr2:233945718:C/A:1,chr2:55234745:A/T:1,chr3:112168997:G/T:1,chr9:93229811:A/T:1
R-HSA-2682334	EPH-Ephrin signaling	Developmental Biology	0.040242	AP2B1,ARPC1B,EPHB1,EPHB2,EPHB6,KALRN,LIMK2,MYH9,NCSTN,TIAM1	chr17:35682607:A/G:1,chr1:160353563:A/G:1,chr1:22893268:A/C:1,chr21:31135807:A/G:1,chr22:31260099:C/A:1,chr22:36320146:C/A:1,chr3:124138871:G/T:1,chr3:124477465:C/A:1,chr3:134932373:A/G:1,chr7:142863808:C/A:1,chr7:99394321:C/T:1
R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	Disease	0.584880	RPS27A	chr2:55234745:A/T:1
R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	Disease	0.584880	RPS27A	chr2:55234745:A/T:1
R-HSA-2730905	Role of LAT2/NTAL/LAB on calcium mobilization	Immune System	0.189816	PIK3CB	chr3:138778223:G/A:1
R-HSA-2855086	Ficolins bind to repetitive carbohydrate structures on the target cell surface	Immune System	0.253920	FCN1	chr9:134914627:C/T:1
R-HSA-2871796	FCERI mediated MAPK activation	Immune System	0.063211	GRAP2	chr22:39964624:C/A:1
R-HSA-2871809	FCERI mediated Ca+2 mobilization	Immune System	0.488090	GRAP2,ITPR2,ITPR3	chr12:26600531:C/A:1,chr22:39964624:C/A:1,chr6:33676739:C/A:1
R-HSA-2871837	FCERI mediated NF-kB activation	Immune System	0.193521	CARD11,NFKBIA,PSMF1,RPS27A	chr14:35403479:G/T:1,chr20:1117130:G/T:1,chr2:55234745:A/T:1,chr7:2924035:T/C:1
R-HSA-2892247	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	Developmental Biology	0.533217	SALL1	chr16:51137759:C/T:1
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	Disease	0.001443	FBXW7,HDAC11,HDAC3,HDAC5,HDAC8,HEY1,KAT2B,NCSTN,RBX1,RPS27A	chr17:44079338:G/T:1,chr1:160353563:A/G:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1,chr3:13496579:C/G:1,chr3:20072202:A/T:1,chr4:152350128:T/A:1,chr5:141629409:G/A:1,chr8:79766933:C/A:1,chrX:72572139:G/A:1
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	Disease	0.001443	FBXW7,HDAC11,HDAC3,HDAC5,HDAC8,HEY1,KAT2B,NCSTN,RBX1,RPS27A	chr17:44079338:G/T:1,chr1:160353563:A/G:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1,chr3:13496579:C/G:1,chr3:20072202:A/T:1,chr4:152350128:T/A:1,chr5:141629409:G/A:1,chr8:79766933:C/A:1,chrX:72572139:G/A:1
R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	Signal Transduction	0.358602	NCSTN,RPS27A	chr1:160353563:A/G:1,chr2:55234745:A/T:1
R-HSA-2980736	Peptide hormone metabolism	Metabolism of proteins	0.818989	ANPEP,CES1,GNAT3,TCF7L2	chr10:112964742:G/A:1,chr15:89801121:T/C:1,chr16:55830823:C/A:1,chr7:80474080:T/G:1
R-HSA-2980766	Nuclear Envelope Breakdown	Cell Cycle	0.226377	LPIN1,LPIN3,NUP214,PRKCB,VRK2	chr16:23867049:C/T:1,chr20:41345676:A/G:1,chr2:11819407:C/G:1,chr2:58084877:A/T:1,chr9:131215059:A/G:1
R-HSA-2990846	SUMOylation	Metabolism of proteins	0.424899	BRCA1,DNMT1,IKBKE,NFKBIA,NR1H3,NSMCE4A,NUP214,RORA,RPA1,SIN3A,SMC1A,STAG2,SUZ12	chr10:121961581:G/C:1,chr11:47259936:C/A:1,chr14:35403479:G/T:1,chr15:60556760:G/T:1,chr15:75409706:G/A:1,chr17:1853255:C/A:1,chr17:31973320:T/G:1,chr17:43049287:C/G:1,chr19:10173083:G/A:1,chr1:206479188:C/A:1,chr9:131215059:A/G:1,chrX:124057978:G/A:1,chrX:124422202:A/T:1,chrX:53380790:T/C:1
R-HSA-2995383	Initiation of Nuclear Envelope (NE) Reformation	Cell Cycle	0.294775	PPP2R1A,VRK2	chr19:52215622:C/T:1,chr2:58084877:A/T:1
R-HSA-2995410	Nuclear Envelope (NE) Reassembly	Cell Cycle	0.621173	PPP2R1A,RCC1,TUBB2A,TUBB8,VRK2	chr10:73757:T/G:1,chr19:52215622:C/T:1,chr1:28508571:C/A:1,chr2:58084877:A/T:1,chr6:3154999:A/G:1
R-HSA-3000157	Laminin interactions	Extracellular matrix organization	0.088131	COL4A6,HSPG2,LAMB3,LAMC2	chr1:183228170:A/G:1,chr1:209618498:C/T:1,chr1:21839609:G/T:1,chr1:21850169:G/T:1,chrX:108187727:G/A:1
R-HSA-3000170	Syndecan interactions	Extracellular matrix organization	0.196494	COL1A1,COL5A1,COL5A2	chr17:50195100:C/A:1,chr2:189098495:C/A:1,chr9:134782781:A/G:1
R-HSA-3000171	Non-integrin membrane-ECM interactions	Extracellular matrix organization	0.000424	COL11A1,COL11A2,COL1A1,COL2A1,COL4A6,COL5A1,COL5A2,HSPG2,LAMB3,LAMC2,NRXN1	chr12:47982418:C/T:1,chr17:50195100:C/A:1,chr1:102962717:G/T:1,chr1:183228170:A/G:1,chr1:209618498:C/T:1,chr1:21839609:G/T:1,chr1:21850169:G/T:1,chr2:189098495:C/A:1,chr2:51201665:C/A:1,chr6:33171551:C/T:1,chr9:134782781:A/G:1,chrX:108187727:G/A:1
R-HSA-3000178	ECM proteoglycans	Extracellular matrix organization	0.003617	BCAN,COL1A1,COL2A1,COL4A6,COL5A1,COL5A2,HSPG2,NCAM1,TGFB2,TNR,TNXB	chr11:113207596:G/T:1,chr12:47982418:C/T:1,chr17:50195100:C/A:1,chr1:156650224:G/T:1,chr1:156652083:T/G:1,chr1:175403542:C/T:1,chr1:21839609:G/T:1,chr1:218405442:G/T:1,chr1:21850169:G/T:1,chr2:189098495:C/A:1,chr6:32043581:A/G:1,chr6:32067650:T/C:1,chr6:32067826:C/T:1,chr6:32073565:C/A:1,chr6:32081732:G/T:1,chr9:134782781:A/G:1,chrX:108187727:G/A:1
R-HSA-3000471	Scavenging by Class B Receptors	Vesicle-mediated transport	0.296385	CD36	chr7:80474080:T/G:1
R-HSA-3000480	Scavenging by Class A Receptors	Vesicle-mediated transport	1.000000	COL1A1	chr17:50195100:C/A:1
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	Metabolism of proteins	0.451405	BRCA1,NSMCE4A,NUP214,RPA1,SMC1A,STAG2	chr10:121961581:G/C:1,chr17:1853255:C/A:1,chr17:43049287:C/G:1,chr9:131215059:A/G:1,chrX:124057978:G/A:1,chrX:124422202:A/T:1,chrX:53380790:T/C:1
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	Metabolism of proteins	0.334409	BRCA1,DNMT1,IKBKE,NFKBIA,NR1H3,NSMCE4A,NUP214,RORA,RPA1,SIN3A,SMC1A,STAG2,SUZ12	chr10:121961581:G/C:1,chr11:47259936:C/A:1,chr14:35403479:G/T:1,chr15:60556760:G/T:1,chr15:75409706:G/A:1,chr17:1853255:C/A:1,chr17:31973320:T/G:1,chr17:43049287:C/G:1,chr19:10173083:G/A:1,chr1:206479188:C/A:1,chr9:131215059:A/G:1,chrX:124057978:G/A:1,chrX:124422202:A/T:1,chrX:53380790:T/C:1
R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA	Immune System	0.584880	RPS27A	chr2:55234745:A/T:1
R-HSA-3214815	HDACs deacetylate histones	Chromatin organization	0.176044	HDAC3,HDAC8	chr5:141629409:G/A:1,chrX:72572139:G/A:1
R-HSA-3214841	PKMTs methylate histone lysines	Chromatin organization	0.287831	DOT1L,KMT2B,NSD1,SMYD3,SUZ12,WDR5	chr17:31973320:T/G:1,chr19:2185764:G/A:1,chr19:35731956:C/T:1,chr1:246034686:C/T:1,chr5:177209627:A/T:1,chr9:134155272:C/G:1
R-HSA-3214842	HDMs demethylate histones	Chromatin organization	1.000000	KDM4C,KDM5C	chr9:6893015:A/T:1,chrX:53196509:A/T:1
R-HSA-3214847	HATs acetylate histones	Chromatin organization	0.195189	KAT2B,MCRS1,MORF4L1,WDR5	chr12:49557449:T/C:1,chr12:49558885:G/A:1,chr15:78886316:G/C:1,chr3:20072202:A/T:1,chr9:134155272:C/G:1
R-HSA-3214858	RMTs methylate histone arginines	Chromatin organization	0.802324	ARID1B,SMARCA4,WDR5	chr19:11025539:C/G:1,chr6:156829096:A/G:1,chr6:157039620:T/A:1,chr9:134155272:C/G:1
R-HSA-3229121	Glycogen storage diseases	Disease	0.584880	RPS27A	chr2:55234745:A/T:1
R-HSA-3232142	SUMOylation of ubiquitinylation proteins	Metabolism of proteins	0.724963	NUP214	chr9:131215059:A/G:1
R-HSA-3238698	WNT ligand biogenesis and trafficking	Signal Transduction	1.000000	WNT7A	chr3:13816735:G/A:1,chr3:13816744:T/C:1
R-HSA-3247509	Chromatin modifying enzymes	Chromatin organization	0.505821	ARID1B,DOT1L,HDAC3,HDAC8,KAT2B,KDM4C,KDM5C,KMT2B,MCRS1,MORF4L1,NSD1,PADI2,PADI3,PADI6,SMARCA4,SMYD3,SUZ12,WDR5	chr12:49557449:T/C:1,chr12:49558885:G/A:1,chr15:78886316:G/C:1,chr17:31973320:T/G:1,chr19:11025539:C/G:1,chr19:2185764:G/A:1,chr19:35731956:C/T:1,chr1:17070003:T/C:1,chr1:17259359:A/C:1,chr1:17401141:T/G:1,chr1:246034686:C/T:1,chr3:20072202:A/T:1,chr5:141629409:G/A:1,chr5:177209627:A/T:1,chr6:156829096:A/G:1,chr6:157039620:T/A:1,chr9:134155272:C/G:1,chr9:6893015:A/T:1,chrX:53196509:A/T:1,chrX:72572139:G/A:1
R-HSA-3249367	STAT6-mediated induction of chemokines	Immune System	0.161161	STAT6	chr12:57102572:A/C:1
R-HSA-3270619	IRF3-mediated induction of type I IFN	Immune System	0.533217	IFI16	chr1:159000259:G/T:1
R-HSA-3295583	TRP channels	Transport of small molecules	0.071873	TRPM7,TRPM8,TRPV3,TRPV4	chr12:109796329:G/T:1,chr15:50663094:T/A:1,chr17:3527683:A/G:1,chr2:233945718:C/A:1
R-HSA-3296469	Defects in cobalamin (B12) metabolism	Disease	0.187575	ABCD4,MUT	chr14:74292598:G/T:1,chr14:74292774:C/T:1,chr6:49444826:C/A:1
R-HSA-3296482	Defects in vitamin and cofactor metabolism	Disease	0.126639	ABCD4,MUT,PCCA	chr13:100469233:C/A:1,chr14:74292598:G/T:1,chr14:74292774:C/T:1,chr6:49444826:C/A:1
R-HSA-3299685	Detoxification of Reactive Oxygen Species	Cellular responses to external stimuli	1.000000	CAT,SOD2	chr11:34471141:A/C:1,chr6:159684794:A/T:1
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	Cell Cycle	0.721233	NUP214	chr9:131215059:A/G:1
R-HSA-3322077	Glycogen synthesis	Metabolism	0.608530	RPS27A	chr2:55234745:A/T:1
R-HSA-3323169	Defects in biotin (Btn) metabolism	Disease	0.374212	PCCA	chr13:100469233:C/A:1
R-HSA-3359475	Defective MMAA causes methylmalonic aciduria type cblA	Disease	0.110550	MUT	chr6:49444826:C/A:1
R-HSA-3359478	Defective MUT causes methylmalonic aciduria mut type	Disease	0.110550	MUT	chr6:49444826:C/A:1
R-HSA-3371378	Regulation by c-FLIP	Programmed Cell Death	0.475135	TNFRSF10A	chr8:23202515:G/T:1
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	Cellular responses to external stimuli	0.470371	CCAR2,COL4A6,HSPA13,NUP214,RPA1,RPA2	chr17:1853255:C/A:1,chr1:27914481:C/T:1,chr21:14373552:G/T:1,chr8:22615430:G/T:1,chr9:131215059:A/G:1,chrX:108187727:G/A:1
R-HSA-3371497	HSP90 chaperone cycle for steroid hormone receptors (SHR)	Cellular responses to external stimuli	0.771548	TUBB2A,TUBB8	chr10:73757:T/G:1,chr6:3154999:A/G:1
R-HSA-3371511	HSF1 activation	Cellular responses to external stimuli	0.242029	COL4A6,RPA1,RPA2	chr17:1853255:C/A:1,chr1:27914481:C/T:1,chrX:108187727:G/A:1
R-HSA-3371556	Cellular response to heat stress	Cellular responses to external stimuli	0.517490	CCAR2,COL4A6,HSPA13,NUP214,RPA1,RPA2,RPTOR	chr17:1853255:C/A:1,chr17:80664395:C/A:1,chr1:27914481:C/T:1,chr21:14373552:G/T:1,chr8:22615430:G/T:1,chr9:131215059:A/G:1,chrX:108187727:G/A:1
R-HSA-3371568	Attenuation phase	Cellular responses to external stimuli	1.000000	COL4A6	chrX:108187727:G/A:1
R-HSA-3371571	HSF1-dependent transactivation	Cellular responses to external stimuli	1.000000	COL4A6,RPTOR	chr17:80664395:C/A:1,chrX:108187727:G/A:1
R-HSA-3371599	Defective HLCS causes multiple carboxylase deficiency	Disease	0.336437	PCCA	chr13:100469233:C/A:1
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	Cell Cycle	1.000000	COP1,PSMF1,RPS27A	chr1:176136414:C/A:1,chr20:1117130:G/T:1,chr2:55234745:A/T:1
R-HSA-350054	Notch-HLH transcription pathway	Gene expression (Transcription)	0.019384	HDAC11,HDAC3,HDAC5,HDAC8,KAT2B	chr17:44079338:G/T:1,chr3:13496579:C/G:1,chr3:20072202:A/T:1,chr5:141629409:G/A:1,chrX:72572139:G/A:1
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	Metabolism	0.367526	PSMF1	chr20:1117130:G/T:1
R-HSA-351202	Metabolism of polyamines	Metabolism	0.774251	PSMF1,SMS	chr20:1117130:G/T:1,chrX:21985061:A/T:1
R-HSA-351906	Apoptotic cleavage of cell adhesion  proteins	Programmed Cell Death	0.021449	CDH1,PKP1,TJP2	chr16:68779429:G/T:1,chr1:201324373:G/T:1,chr9:69250885:T/G:1
R-HSA-352230	Amino acid transport across the plasma membrane	Transport of small molecules	0.711848	SLC6A12,SLC7A7	chr12:197114:C/T:1,chr14:22780250:C/A:1
R-HSA-354192	Integrin signaling	Signal Transduction;Hemostasis	0.196494	CSK,PTPN1,TLN1	chr15:74802540:C/T:1,chr20:50526505:C/A:1,chr9:35697963:G/T:1
R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins 	Signal Transduction;Hemostasis	0.584880	TLN1	chr9:35697963:G/T:1
R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	Disease	0.293034	BCAN,CSPG4,EXT2,HSPG2	chr11:44236478:G/T:1,chr15:75675473:A/G:1,chr1:156650224:G/T:1,chr1:156652083:T/G:1,chr1:21839609:G/T:1,chr1:21850169:G/T:1
R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	Disease	0.101752	BCAN,CSPG4,HSPG2	chr15:75675473:A/G:1,chr1:156650224:G/T:1,chr1:156652083:T/G:1,chr1:21839609:G/T:1,chr1:21850169:G/T:1
R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	Disease	0.101752	BCAN,CSPG4,HSPG2	chr15:75675473:A/G:1,chr1:156650224:G/T:1,chr1:156652083:T/G:1,chr1:21839609:G/T:1,chr1:21850169:G/T:1
R-HSA-3595172	Defective CHST3 causes SEDCJD	Disease	0.072010	BCAN,CSPG4	chr15:75675473:A/G:1,chr1:156650224:G/T:1,chr1:156652083:T/G:1
R-HSA-3595174	Defective CHST14 causes EDS, musculocontractural type	Disease	0.072010	BCAN,CSPG4	chr15:75675473:A/G:1,chr1:156650224:G/T:1,chr1:156652083:T/G:1
R-HSA-3595177	Defective CHSY1 causes TPBS	Disease	0.072010	BCAN,CSPG4	chr15:75675473:A/G:1,chr1:156650224:G/T:1,chr1:156652083:T/G:1
R-HSA-3656237	Defective EXT2 causes exostoses 2	Disease	0.187575	EXT2,HSPG2	chr11:44236478:G/T:1,chr1:21839609:G/T:1,chr1:21850169:G/T:1
R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	Disease	0.187575	EXT2,HSPG2	chr11:44236478:G/T:1,chr1:21839609:G/T:1,chr1:21850169:G/T:1
R-HSA-3700989	Transcriptional Regulation by TP53	Gene expression (Transcription)	0.205573	AGO4,APAF1,BRCA1,CASP2,CHEK1,CNOT9,DDIT4,FANCI,GTF2F1,JMY,LRPPRC,PIN1,PLK2,POU4F1,PPP2R1A,PPP2R5C,PRKAA2,PRKAB2,RPA1,RPA2,RPS27A,RPTOR,TAF5,TIGAR,TNFRSF10A,TNRC6B	chr10:103387074:A/C:1,chr10:72275283:T/A:1,chr11:125637382:T/C:1,chr12:4321404:C/A:1,chr12:98648251:A/T:1,chr13:78601815:G/T:1,chr14:101883867:G/T:1,chr15:89263297:C/A:1,chr15:89304999:T/C:1,chr17:1853255:C/A:1,chr17:43049287:C/G:1,chr17:80664395:C/A:1,chr19:52215622:C/T:1,chr19:6380036:G/T:1,chr19:9849326:C/A:1,chr1:147172001:G/A:1,chr1:27914481:C/T:1,chr1:35850806:C/A:1,chr1:56706008:C/A:1,chr22:40049003:G/T:1,chr2:218582908:A/T:1,chr2:43944068:C/A:1,chr2:55234745:A/T:1,chr5:58454762:G/T:1,chr5:79300647:C/A:1,chr7:143292189:T/C:1,chr8:23202515:G/T:1
R-HSA-372708	p130Cas linkage to MAPK signaling for integrins	Signal Transduction;Hemostasis	0.584880	TLN1	chr9:35697963:G/T:1
R-HSA-372790	Signaling by GPCR	Signal Transduction	0.006253	ABCA4,ADGRE5,ARHGEF19,ARHGEF4,AVPR1A,BCO1,C5,CCL3L1,CRHR1,CXCL11,DAGLA,DGKI,GLP1R,GNA12,GNAQ,GNAT3,HSPG2,ITPR2,ITPR3,KALRN,KISS1,LHCGR,MCF2L,MYO7A,NPY,OBSCN,OR13C5,OR2F1,OR4C11,OR4N2,OXTR,PDE11A,PDE1C,PDE4D,PIK3R6,PLB1,PLCB4,PLXNB1,PPP2R1A,PRKCB,PRKCD,RGS9,RGSL1,RPS6KA1,TIAM1,VIPR2,WNT7A	chr11:55603498:C/A:1,chr11:61743387:T/A:1,chr11:77157326:T/C:1,chr11:77160849:G/T:1,chr11:77205582:C/A:1,chr12:26600531:C/A:1,chr12:63149800:A/T:1,chr13:113046521:T/G:1,chr14:19760050:G/T:1,chr16:23867049:C/T:1,chr16:81245335:G/T:1,chr17:36195375:A/G:1,chr17:45831011:G/T:1,chr17:45833036:G/C:1,chr17:65217991:G/T:1,chr17:8822843:A/G:1,chr19:14404629:C/A:1,chr19:52215622:C/T:1,chr1:16199915:C/A:1,chr1:182550726:A/G:1,chr1:204195297:C/T:1,chr1:21839609:G/T:1,chr1:21850169:G/T:1,chr1:228306995:G/A:1,chr1:26571817:C/A:1,chr1:94036566:G/A:1,chr20:9437223:T/G:1,chr21:31135807:A/G:1,chr2:130920920:C/A:1,chr2:177709965:T/C:1,chr2:28516675:G/T:1,chr2:48708797:C/G:1,chr3:124138871:G/T:1,chr3:124477465:C/A:1,chr3:13816735:G/A:1,chr3:13816744:T/C:1,chr3:48421052:G/A:1,chr3:53192052:T/G:1,chr3:8767870:G/A:1,chr4:76036090:T/C:1,chr5:59002058:C/A:1,chr6:33676739:C/A:1,chr6:39086149:G/A:1,chr7:137665038:C/A:1,chr7:143985449:C/T:1,chr7:159142629:C/A:1,chr7:24285140:T/G:1,chr7:2762539:T/C:1,chr7:32163293:C/T:1,chr7:80474080:T/G:1,chr9:104598758:G/A:1,chr9:120961515:C/A:1,chr9:77797745:T/A:1
R-HSA-373076	Class A/1 (Rhodopsin-like receptors)	Signal Transduction	0.007357	AVPR1A,C5,CCL3L1,CXCL11,KISS1,LHCGR,NPY,OXTR	chr12:63149800:A/T:1,chr17:36195375:A/G:1,chr1:204195297:C/T:1,chr2:48708797:C/G:1,chr3:8767870:G/A:1,chr4:76036090:T/C:1,chr7:24285140:T/G:1,chr9:120961515:C/A:1
R-HSA-373080	Class B/2 (Secretin family receptors)	Signal Transduction	1.000000	ADGRE5,CRHR1,GLP1R,VIPR2,WNT7A	chr17:45831011:G/T:1,chr17:45833036:G/C:1,chr19:14404629:C/A:1,chr3:13816735:G/A:1,chr3:13816744:T/C:1,chr6:39086149:G/A:1,chr7:159142629:C/A:1
R-HSA-373752	Netrin-1 signaling	Developmental Biology	0.530816	DOCK1,PITPNA,PTPN11,UNC5B	chr10:127257347:G/T:1,chr10:71291226:C/T:1,chr12:112489105:A/T:1,chr17:1520665:A/G:1
R-HSA-373753	Nephrin family interactions	Cell-Cell communication	0.008383	CD2AP,IQGAP1,KIRREL2,NPHS1,PIK3CB	chr15:90390695:A/G:1,chr15:90485816:T/C:1,chr19:35849297:C/T:1,chr19:35861057:C/T:1,chr3:138778223:G/A:1,chr6:47503412:G/T:1,chr6:47573971:A/T:1
R-HSA-373755	Semaphorin interactions	Developmental Biology	0.178594	LIMK2,MYH9,PIP5K1C,PLXNB1,PLXND1,TLN1	chr19:3643094:C/A:1,chr22:31260099:C/A:1,chr22:36320146:C/A:1,chr3:129575694:T/G:1,chr3:48421052:G/A:1,chr9:35697963:G/T:1
R-HSA-373760	L1CAM interactions	Developmental Biology	0.002142	ANK1,ANK3,AP2B1,EPHB2,ITGA10,KCNQ2,KCNQ3,L1CAM,NCAM1,NRCAM,RPS6KA1,SCN1A,SCN1B,SPTBN4,TUBB2A,TUBB8	chr10:60685310:G/A:1,chr10:73757:T/G:1,chr11:113207596:G/T:1,chr17:35682607:A/G:1,chr19:35033920:T/C:1,chr19:40569803:G/A:1,chr1:145895756:C/T:1,chr1:145909820:C/A:1,chr1:22893268:A/C:1,chr1:26571817:C/A:1,chr20:63439613:G/A:1,chr2:166047534:C/T:1,chr2:166047536:A/T:1,chr6:3154999:A/G:1,chr7:108168322:C/T:1,chr8:132175698:G/C:1,chr8:132192533:C/A:1,chr8:132421533:G/T:1,chr8:41808044:G/T:1,chrX:153863598:G/T:1
R-HSA-375165	NCAM signaling for neurite out-growth	Developmental Biology	0.002739	CACNA1G,CACNA1I,CACNB2,COL2A1,COL5A1,COL5A2,NCAM1,PTPRA,SPTBN4,ST8SIA2	chr10:18448206:G/A:1,chr11:113207596:G/T:1,chr12:47982418:C/T:1,chr15:92412994:G/T:1,chr17:50578132:A/G:1,chr17:50600626:G/T:1,chr19:40569803:G/A:1,chr20:2975202:A/T:1,chr20:2988197:T/A:1,chr22:39647807:A/G:1,chr2:189098495:C/A:1,chr9:134782781:A/G:1
R-HSA-375276	Peptide ligand-binding receptors	Signal Transduction	0.273850	AVPR1A,C5,CCL3L1,CXCL11,KISS1,NPY,OXTR	chr12:63149800:A/T:1,chr17:36195375:A/G:1,chr1:204195297:C/T:1,chr3:8767870:G/A:1,chr4:76036090:T/C:1,chr7:24285140:T/G:1,chr9:120961515:C/A:1
R-HSA-375281	Hormone ligand-binding receptors	Signal Transduction	0.505026	LHCGR	chr2:48708797:C/G:1
R-HSA-376176	Signaling by ROBO receptors	Developmental Biology	0.768916	ABL2,CLASP2,EVL,NCBP1,PSMF1,RBX1,ROBO3,RPL10,RPL23,RPL31,RPS27A,RPS6,RPS9	chr11:124874968:C/A:1,chr14:100141166:C/A:1,chr17:38850552:C/A:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr1:179221566:G/A:1,chr20:1117130:G/T:1,chr22:40963988:A/T:1,chr2:101018980:G/T:1,chr2:55234745:A/T:1,chr3:33602979:G/T:1,chr9:19376102:T/C:1,chr9:97664178:C/A:1,chrX:154405329:C/A:1
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	Signal Transduction	0.088208	MEN1,PYGO1,RPS27A,TCF7L2,TLE4	chr10:112964742:G/A:1,chr11:64807481:C/T:1,chr15:55588703:G/T:1,chr2:55234745:A/T:1,chr9:79693752:C/G:1
R-HSA-3781860	Diseases associated with N-glycosylation of proteins	Disease	1.000000	ALG12	chr22:49903355:G/T:1
R-HSA-3781865	Diseases of glycosylation	Disease	0.198451	ADAMTS1,ADAMTS13,ALG12,BCAN,CSPG4,EXT2,GALE,HSPG2,MUC15,MUC17,MUC3A,MUC4	chr11:26561226:C/A:1,chr11:44236478:G/T:1,chr15:75675473:A/G:1,chr1:156650224:G/T:1,chr1:156652083:T/G:1,chr1:21839609:G/T:1,chr1:21850169:G/T:1,chr1:23798309:A/C:1,chr21:26843749:G/A:1,chr22:49903355:G/T:1,chr3:195752618:A/G:1,chr3:195752619:G/C:1,chr7:100958263:A/G:1,chr7:101035696:G/T:1,chr9:133439628:C/T:1
R-HSA-3785653	Myoclonic epilepsy of Lafora	Disease	0.409840	RPS27A	chr2:55234745:A/T:1
R-HSA-379716	Cytosolic tRNA aminoacylation	Metabolism of proteins	1.000000	IARS	chr9:92274385:C/A:1
R-HSA-379724	tRNA Aminoacylation	Metabolism of proteins	0.731943	IARS	chr9:92274385:C/A:1
R-HSA-380108	Chemokine receptors bind chemokines	Signal Transduction	0.771548	CCL3L1,CXCL11	chr17:36195375:A/G:1,chr4:76036090:T/C:1
R-HSA-380259	Loss of Nlp from mitotic centrosomes	Cell Cycle	0.797578	AKAP9,CEP78,PCNT,PPP2R1A	chr19:52215622:C/T:1,chr21:46351357:C/A:1,chr7:91974127:C/A:1,chr7:92040995:G/T:1,chr9:78246838:C/A:1
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	Cell Cycle	1.000000	AKAP9,CEP78,PCNT,PPP2R1A	chr19:52215622:C/T:1,chr21:46351357:C/A:1,chr7:91974127:C/A:1,chr7:92040995:G/T:1,chr9:78246838:C/A:1
R-HSA-380284	Loss of proteins required for interphase microtubule organization from the centrosome	Cell Cycle	0.797578	AKAP9,CEP78,PCNT,PPP2R1A	chr19:52215622:C/T:1,chr21:46351357:C/A:1,chr7:91974127:C/A:1,chr7:92040995:G/T:1,chr9:78246838:C/A:1
R-HSA-380287	Centrosome maturation	Cell Cycle	1.000000	AKAP9,CEP78,PCNT,PPP2R1A	chr19:52215622:C/T:1,chr21:46351357:C/A:1,chr7:91974127:C/A:1,chr7:92040995:G/T:1,chr9:78246838:C/A:1
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	Cell Cycle	0.660190	AKAP9,CEP78,PCNT,PPP2R1A,TUBB2A,TUBB8	chr10:73757:T/G:1,chr19:52215622:C/T:1,chr21:46351357:C/A:1,chr6:3154999:A/G:1,chr7:91974127:C/A:1,chr7:92040995:G/T:1,chr9:78246838:C/A:1
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	Signal Transduction	0.226639	PRKAA2,PRKAB2,RPTOR	chr17:80664395:C/A:1,chr1:147172001:G/A:1,chr1:56706008:C/A:1
R-HSA-381038	XBP1(S) activates chaperone genes	Metabolism of proteins	0.752960	DDX11,SEC31A,TLN1	chr12:31087758:C/A:1,chr4:82855072:T/A:1,chr9:35697963:G/T:1
R-HSA-381070	IRE1alpha activates chaperones	Metabolism of proteins	0.761410	DDX11,SEC31A,TLN1	chr12:31087758:C/A:1,chr4:82855072:T/A:1,chr9:35697963:G/T:1
R-HSA-381119	Unfolded Protein Response (UPR)	Metabolism of proteins	0.492899	DDX11,SEC31A,TLN1	chr12:31087758:C/A:1,chr4:82855072:T/A:1,chr9:35697963:G/T:1
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	Developmental Biology	0.147974	CD36,CHD9,HDAC3,MED13L,MED14,MED25,THRAP3,ZNF638	chr12:115986913:T/C:1,chr16:53255530:C/A:1,chr19:49830773:C/A:1,chr1:36301559:C/T:1,chr2:71424636:A/T:1,chr5:141629409:G/A:1,chr7:80474080:T/G:1,chrX:40703435:G/C:1
R-HSA-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	Metabolism of proteins	0.326550	AFP,FBN1,MEN1,PNPLA2	chr11:64807481:C/T:1,chr11:822271:G/T:1,chr15:48472836:A/C:1,chr4:73447436:C/A:1
R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	Metabolism	0.299954	GLP1R,IQGAP1,ITPR2,ITPR3	chr12:26600531:C/A:1,chr15:90390695:A/G:1,chr15:90485816:T/C:1,chr6:33676739:C/A:1,chr6:39086149:G/A:1
R-HSA-381753	Olfactory Signaling Pathway	Signal Transduction	0.000001	OR13C5,OR2F1,OR4C11,OR4N2	chr11:55603498:C/A:1,chr14:19760050:G/T:1,chr7:143985449:C/T:1,chr9:104598758:G/A:1
R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	Metabolism of proteins	0.316221	GNAT3,TCF7L2	chr10:112964742:G/A:1,chr7:80474080:T/G:1
R-HSA-382551	Transport of small molecules	Transport of small molecules	0.115256	ABCA3,ABCA4,ABCC6,ABCG1,ANO3,AP2B1,ASIC2,ATP11C,ATP7B,BMP1,CFTR,DERL3,LPA,NR1H3,PSMF1,RPS27A,RYR1,RYR2,RYR3,SEL1L,SLC12A3,SLC13A3,SLC15A2,SLC17A6,SLC1A1,SLC27A1,SLC27A4,SLC28A3,SLC2A11,SLC2A6,SLC2A9,SLC47A2,SLC4A4,SLC6A11,SLC6A12,SLC6A2,SLC7A7,SLC8A1,SLC8A2,SLC8A3,SLC9A7,SLC9C1,TPCN1,TRPM7,TRPM8,TRPV3,TRPV4,UNC80,VLDLR,WNK2,YME1L1	chr10:27112141:C/T:1,chr11:22341861:T/C:1,chr11:26561226:C/A:1,chr11:47259936:C/A:1,chr12:109796329:G/T:1,chr12:113277113:G/C:1,chr12:197114:C/T:1,chr13:51941000:A/T:1,chr14:22780250:C/A:1,chr14:70060534:G/T:1,chr14:81490564:A/C:1,chr15:33432668:T/G:1,chr15:33653029:T/A:1,chr15:50663094:T/A:1,chr16:16203671:G/A:1,chr16:2287934:C/A:1,chr16:55656513:C/T:1,chr16:56879526:C/A:1,chr17:19713790:G/C:1,chr17:34011650:C/A:1,chr17:3527683:A/G:1,chr17:35682607:A/G:1,chr19:17487596:C/T:1,chr19:38464585:G/T:1,chr19:47437640:G/T:1,chr1:237756505:G/T:1,chr1:237792382:C/T:1,chr1:94036566:G/A:1,chr20:1117130:G/T:1,chr20:46606931:C/T:1,chr21:42291695:T/G:1,chr22:23838266:G/T:1,chr22:23875020:A/T:1,chr2:209809377:C/A:1,chr2:233945718:C/A:1,chr2:40160677:G/T:1,chr2:55234745:A/T:1,chr3:10820021:T/A:1,chr3:10933011:G/T:1,chr3:112168997:G/T:1,chr3:121939207:T/C:1,chr4:10005462:C/T:1,chr4:71544404:G/T:1,chr6:160535531:T/C:1,chr7:117542008:A/T:1,chr8:22196292:A/C:1,chr9:128360555:C/A:1,chr9:133472046:G/A:1,chr9:2644144:G/T:1,chr9:4576050:G/A:1,chr9:84279882:C/A:1,chr9:93229811:A/T:1,chrX:139798205:A/T:1,chrX:46643177:G/T:1
R-HSA-382556	ABC-family proteins mediated transport	Transport of small molecules	0.193635	ABCA3,ABCA4,ABCC6,ABCG1,CFTR,DERL3,PSMF1,RPS27A,SEL1L	chr14:81490564:A/C:1,chr16:16203671:G/A:1,chr16:2287934:C/A:1,chr1:94036566:G/A:1,chr20:1117130:G/T:1,chr21:42291695:T/G:1,chr22:23838266:G/T:1,chr2:55234745:A/T:1,chr7:117542008:A/T:1
R-HSA-383280	Nuclear Receptor transcription pathway	Gene expression (Transcription)	1.000000	NR1H3,PPARD,RORA	chr11:47259936:C/A:1,chr15:60556760:G/T:1,chr6:35396106:C/T:1
R-HSA-3858494	Beta-catenin independent WNT signaling	Signal Transduction	0.203361	AGO4,AP2B1,ITPR2,ITPR3,PRKCB,PSMF1,ROR2,RPS27A,SCRIB,SMURF1,TCF7L2,TNRC6B	chr10:112964742:G/A:1,chr12:26600531:C/A:1,chr16:23867049:C/T:1,chr17:35682607:A/G:1,chr1:35850806:C/A:1,chr20:1117130:G/T:1,chr22:40049003:G/T:1,chr2:55234745:A/T:1,chr6:33676739:C/A:1,chr7:99061975:G/T:1,chr8:143793785:G/A:1,chr9:91724340:G/A:1
R-HSA-388396	GPCR downstream signalling	Signal Transduction	0.007547	ABCA4,ARHGEF19,ARHGEF4,AVPR1A,BCO1,C5,CRHR1,CXCL11,DAGLA,DGKI,GLP1R,GNA12,GNAQ,GNAT3,HSPG2,ITPR2,ITPR3,KALRN,KISS1,LHCGR,MCF2L,MYO7A,NPY,OBSCN,OR13C5,OR2F1,OR4C11,OR4N2,OXTR,PDE11A,PDE1C,PDE4D,PIK3R6,PLB1,PLCB4,PLXNB1,PPP2R1A,PRKCB,PRKCD,RGS9,RGSL1,RPS6KA1,TIAM1,VIPR2	chr11:55603498:C/A:1,chr11:61743387:T/A:1,chr11:77157326:T/C:1,chr11:77160849:G/T:1,chr11:77205582:C/A:1,chr12:26600531:C/A:1,chr12:63149800:A/T:1,chr13:113046521:T/G:1,chr14:19760050:G/T:1,chr16:23867049:C/T:1,chr16:81245335:G/T:1,chr17:45831011:G/T:1,chr17:45833036:G/C:1,chr17:65217991:G/T:1,chr17:8822843:A/G:1,chr19:52215622:C/T:1,chr1:16199915:C/A:1,chr1:182550726:A/G:1,chr1:204195297:C/T:1,chr1:21839609:G/T:1,chr1:21850169:G/T:1,chr1:228306995:G/A:1,chr1:26571817:C/A:1,chr1:94036566:G/A:1,chr20:9437223:T/G:1,chr21:31135807:A/G:1,chr2:130920920:C/A:1,chr2:177709965:T/C:1,chr2:28516675:G/T:1,chr2:48708797:C/G:1,chr3:124138871:G/T:1,chr3:124477465:C/A:1,chr3:48421052:G/A:1,chr3:53192052:T/G:1,chr3:8767870:G/A:1,chr4:76036090:T/C:1,chr5:59002058:C/A:1,chr6:33676739:C/A:1,chr6:39086149:G/A:1,chr7:137665038:C/A:1,chr7:143985449:C/T:1,chr7:159142629:C/A:1,chr7:24285140:T/G:1,chr7:2762539:T/C:1,chr7:32163293:C/T:1,chr7:80474080:T/G:1,chr9:104598758:G/A:1,chr9:120961515:C/A:1,chr9:77797745:T/A:1
R-HSA-388479	Vasopressin-like receptors	Signal Transduction	0.041596	AVPR1A,OXTR	chr12:63149800:A/T:1,chr3:8767870:G/A:1
R-HSA-388841	Costimulation by the CD28 family	Immune System	0.018723	CD274,CSK,GRAP2,HLA-DRB1,HLA-DRB5,PPP2R1A,PPP2R5C,PTPN11,PTPN6	chr12:112489105:A/T:1,chr12:6960084:C/T:1,chr14:101883867:G/T:1,chr15:74802540:C/T:1,chr19:52215622:C/T:1,chr22:39964624:C/A:1,chr6:32530260:C/G:1,chr6:32584008:G/C:1,chr9:5456056:A/T:1
R-HSA-388844	Receptor-type tyrosine-protein phosphatases	Neuronal System	0.024251	IL1RAPL2,PPFIA4,PTPRD,PTPRF	chr1:203048066:G/T:1,chr1:43591997:G/T:1,chr1:43617848:G/A:1,chr1:43619068:C/T:1,chr1:43620409:T/C:1,chr9:9208846:C/T:1,chrX:105219858:C/A:1
R-HSA-389356	CD28 co-stimulation	Immune System	1.000000	GRAP2	chr22:39964624:C/A:1
R-HSA-389513	CTLA4 inhibitory signaling	Immune System	0.113936	PPP2R1A,PPP2R5C,PTPN11	chr12:112489105:A/T:1,chr14:101883867:G/T:1,chr19:52215622:C/T:1
R-HSA-389661	Glyoxylate metabolism and glycine degradation	Metabolism	0.257582	AGXT,ALDH4A1,PDHA1	chr1:18874401:C/T:1,chr2:240869136:A/G:1,chrX:19355267:G/T:1
R-HSA-389887	Beta-oxidation of pristanoyl-CoA	Metabolism	0.409840	CRAT	chr9:129110977:A/C:1
R-HSA-3899300	SUMOylation of transcription cofactors	Metabolism of proteins	0.516149	SIN3A	chr15:75409706:G/A:1
R-HSA-389948	PD-1 signaling	Immune System	0.002311	CD274,CSK,HLA-DRB1,HLA-DRB5,PTPN11,PTPN6	chr12:112489105:A/T:1,chr12:6960084:C/T:1,chr15:74802540:C/T:1,chr6:32530260:C/G:1,chr6:32584008:G/C:1,chr9:5456056:A/T:1
R-HSA-389957	Prefoldin mediated transfer of substrate  to CCT/TriC	Metabolism of proteins	0.672201	PFDN1,TUBB2A	chr5:140300313:G/T:1,chr6:3154999:A/G:1
R-HSA-389958	Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	Metabolism of proteins	0.711848	PFDN1,TUBB2A	chr5:140300313:G/T:1,chr6:3154999:A/G:1
R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC	Metabolism of proteins	1.000000	TUBB2A	chr6:3154999:A/G:1
R-HSA-389977	Post-chaperonin tubulin folding pathway	Metabolism of proteins	1.000000	TUBB2A	chr6:3154999:A/G:1
R-HSA-390466	Chaperonin-mediated protein folding	Metabolism of proteins	0.501531	FBXW7,GNAT3,HDAC3,KIFC3,PFDN1,RGS9,TUBB2A	chr16:57760705:G/A:1,chr17:65217991:G/T:1,chr4:152350128:T/A:1,chr5:140300313:G/T:1,chr5:141629409:G/A:1,chr6:3154999:A/G:1,chr7:80474080:T/G:1
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	Metabolism of proteins	0.485476	FBXW7,HDAC3,KIFC3	chr16:57760705:G/A:1,chr4:152350128:T/A:1,chr5:141629409:G/A:1
R-HSA-390522	Striated Muscle Contraction	Muscle contraction	0.146062	MYH3,NEB,TMOD2,TTN	chr15:51762681:T/C:1,chr17:10638623:C/A:1,chr2:151519554:G/T:1,chr2:151541809:G/T:1,chr2:151562679:G/T:1,chr2:178529881:A/T:1
R-HSA-3906995	Diseases associated with O-glycosylation of proteins	Disease	0.283338	ADAMTS1,ADAMTS13,MUC15,MUC17,MUC3A,MUC4	chr11:26561226:C/A:1,chr21:26843749:G/A:1,chr3:195752618:A/G:1,chr3:195752619:G/C:1,chr7:100958263:A/G:1,chr7:101035696:G/T:1,chr9:133439628:C/T:1
R-HSA-390918	Peroxisomal lipid metabolism	Metabolism	1.000000	CRAT	chr9:129110977:A/C:1
R-HSA-391160	Signal regulatory protein family interactions	Cell-Cell communication	0.058990	PTPN11,PTPN6,SFTPD	chr10:79946379:C/A:1,chr12:112489105:A/T:1,chr12:6960084:C/T:1
R-HSA-391251	Protein folding	Metabolism of proteins	0.525258	FBXW7,GNAT3,HDAC3,KIFC3,PFDN1,RGS9,TUBB2A	chr16:57760705:G/A:1,chr17:65217991:G/T:1,chr4:152350128:T/A:1,chr5:140300313:G/T:1,chr5:141629409:G/A:1,chr6:3154999:A/G:1,chr7:80474080:T/G:1
R-HSA-392154	Nitric oxide stimulates guanylate cyclase	Hemostasis	0.126639	GUCY1A2,NOS3,PDE11A	chr11:106824788:A/T:1,chr2:177709965:T/C:1,chr7:151010230:G/T:1
R-HSA-392170	ADP signalling through P2Y purinoceptor 12	Hemostasis	1.000000	GNAT3	chr7:80474080:T/G:1
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	Signal Transduction	1.000000	PIK3R6	chr17:8822843:A/G:1
R-HSA-392499	Metabolism of proteins	Metabolism of proteins	0.710182	ABCA3,ABRAXAS1,ADAMTS1,ADAMTS13,AFP,AGBL4,ALG12,ANK1,ANK3,ANPEP,ARSA,ART3,ASB3,ASGR2,B3GNTL1,BABAM2,BRCA1,CES1,CFTR,CNTN3,CNTN5,COMMD5,COMMD6,COP1,DDX11,DNMT1,FBN1,FBXO21,FBXW7,GALNT10,GALNT14,GALNT17,GGA2,GNAT3,GSN,HDAC3,HLTF,HSPG2,IARS,IKBKE,KAT2B,KIFC3,LSAMP,LY6G6C,MBD5,MCRS1,MDGA1,MEN1,MRPL2,MRPL28,MRPL4,MRPS18C,MRPS22,MUC15,MUC17,MUC3A,MUC4,NCSTN,NFKBIA,NOD2,NR1H3,NSMCE4A,NTM,NUP214,OPCML,PEX5,PFDN1,PIGB,PIGG,PIGO,PIGS,PNPLA2,POLB,PPP6C,PRKN,PSMF1,PTCD3,RAB10,RAB24,RAB3D,RAB4A,RAB6B,RBX1,RENBP,RGS9,RNF152,RORA,RPA1,RPL10,RPL23,RPL31,RPS27A,RPS6,RPS9,SEC16B,SEC23A,SEC24D,SEC31A,SEL1L,SFTPD,SIN3A,SMC1A,SPTBN4,SRP72,ST8SIA2,STAG2,STAM,STAMBPL1,SUZ12,TCF7L2,TLN1,TNKS,TUBB2A,TUBB8,USP42,USP8,WDR5,WDTC1,ZBTB16	chr10:112964742:G/A:1,chr10:121961581:G/C:1,chr10:17660650:A/C:1,chr10:60685310:G/A:1,chr10:73757:T/G:1,chr10:79946379:C/A:1,chr10:88947447:C/A:1,chr11:100308186:C/A:1,chr11:114087490:T/C:1,chr11:132146101:C/T:1,chr11:133140763:C/A:1,chr11:26561226:C/A:1,chr11:47259936:C/A:1,chr11:64807481:C/T:1,chr11:822271:G/T:1,chr12:117174552:T/C:1,chr12:31087758:C/A:1,chr12:49557449:T/C:1,chr12:49558885:G/A:1,chr12:7190218:T/G:1,chr13:75528022:C/T:1,chr14:35403479:G/T:1,chr14:39040609:C/A:1,chr14:81490564:A/C:1,chr15:48472836:A/C:1,chr15:50441258:C/A:1,chr15:55340803:G/A:1,chr15:60556760:G/T:1,chr15:75409706:G/A:1,chr15:89801121:T/C:1,chr15:92412994:G/T:1,chr16:2287934:C/A:1,chr16:23469223:G/T:1,chr16:368429:A/G:1,chr16:50711288:C/T:1,chr16:55830823:C/A:1,chr16:57760705:G/A:1,chr17:1853255:C/A:1,chr17:28564087:A/G:1,chr17:31973320:T/G:1,chr17:38850552:C/A:1,chr17:43049287:C/G:1,chr17:65217991:G/T:1,chr17:7114005:G/T:1,chr17:83048634:G/T:1,chr18:61844221:A/G:1,chr18:61844223:G/A:1,chr19:10173083:G/A:1,chr19:10259814:T/A:1,chr19:11343264:G/A:1,chr19:40569803:G/A:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr1:160353563:A/G:1,chr1:176136414:C/A:1,chr1:177936177:G/T:1,chr1:206479188:C/A:1,chr1:21839609:G/T:1,chr1:21850169:G/T:1,chr1:229288550:C/A:1,chr1:27299455:G/T:1,chr1:48560934:C/A:1,chr1:49844523:C/A:1,chr20:1117130:G/T:1,chr21:26843749:G/A:1,chr22:40963988:A/T:1,chr22:49903355:G/T:1,chr22:50625611:G/C:1,chr2:101018980:G/T:1,chr2:148510030:A/T:1,chr2:26109711:A/T:1,chr2:28274140:C/A:1,chr2:30924922:C/T:1,chr2:30945103:G/T:1,chr2:53728873:T/A:1,chr2:55234745:A/T:1,chr2:86111006:G/T:1,chr3:116602824:C/A:1,chr3:133841152:G/A:1,chr3:139130214:G/T:1,chr3:149055599:C/T:1,chr3:195752618:A/G:1,chr3:195752619:G/C:1,chr3:20072202:A/T:1,chr3:74521082:G/T:1,chr4:118833895:C/A:1,chr4:152350128:T/A:1,chr4:500224:G/A:1,chr4:56478721:C/G:1,chr4:56502018:T/G:1,chr4:73447436:C/A:1,chr4:76036090:T/C:1,chr4:82855072:T/A:1,chr4:83460892:G/T:1,chr5:140300313:G/T:1,chr5:141629409:G/A:1,chr5:154416093:G/C:1,chr5:177301877:T/C:1,chr6:161549199:T/A:1,chr6:3154999:A/G:1,chr6:31720741:T/A:1,chr6:37650494:G/C:1,chr6:43055804:A/T:1,chr7:100958263:A/G:1,chr7:101035696:G/T:1,chr7:117542008:A/T:1,chr7:6150119:C/T:1,chr7:6150149:T/C:1,chr7:71571591:C/A:1,chr7:80474080:T/G:1,chr8:144851440:T/C:1,chr8:41808044:G/T:1,chr8:42369772:A/T:1,chr8:9776590:C/A:1,chr9:121312182:C/T:1,chr9:125171223:T/A:1,chr9:131215059:A/G:1,chr9:133439628:C/T:1,chr9:134155272:C/G:1,chr9:19376102:T/C:1,chr9:35093530:T/C:1,chr9:35697963:G/T:1,chr9:92274385:C/A:1,chrX:124057978:G/A:1,chrX:124422202:A/T:1,chrX:153943642:G/T:1,chrX:154405329:C/A:1,chrX:53380790:T/C:1
R-HSA-392518	Signal amplification	Hemostasis	0.711848	GNAQ,GNAT3	chr7:80474080:T/G:1,chr9:77797745:T/A:1
R-HSA-3928662	EPHB-mediated forward signaling	Developmental Biology	0.008826	ARPC1B,EPHB1,EPHB2,EPHB6,KALRN,LIMK2,TIAM1	chr1:22893268:A/C:1,chr21:31135807:A/G:1,chr22:31260099:C/A:1,chr3:124138871:G/T:1,chr3:124477465:C/A:1,chr3:134932373:A/G:1,chr7:142863808:C/A:1,chr7:99394321:C/T:1
R-HSA-3928663	EPHA-mediated growth cone collapse	Developmental Biology	1.000000	MYH9	chr22:36320146:C/A:1
R-HSA-3928664	Ephrin signaling	Developmental Biology	0.090127	EPHB1,EPHB2,EPHB6	chr1:22893268:A/C:1,chr3:134932373:A/G:1,chr7:142863808:C/A:1
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	Developmental Biology	0.068041	AP2B1,EPHB1,EPHB2,EPHB6,NCSTN,TIAM1	chr17:35682607:A/G:1,chr1:160353563:A/G:1,chr1:22893268:A/C:1,chr21:31135807:A/G:1,chr3:134932373:A/G:1,chr7:142863808:C/A:1
R-HSA-397014	Muscle contraction	Muscle contraction	0.000043	ACTA2,AKAP9,CACNA1F,CACNA2D3,CACNB2,CAV3,GUCY1A2,ITPR2,ITPR3,KAT2B,KCNIP1,KCNIP4,KCNK1,KCNK16,MYH3,NEB,RYR1,RYR2,RYR3,SCN1A,SCN1B,SLC8A1,SLC8A2,SLC8A3,TLN1,TMOD2,TTN	chr10:18448206:G/A:1,chr10:88947447:C/A:1,chr11:106824788:A/T:1,chr12:26600531:C/A:1,chr14:70060534:G/T:1,chr15:33432668:T/G:1,chr15:33653029:T/A:1,chr15:51762681:T/C:1,chr17:10638623:C/A:1,chr19:35033920:T/C:1,chr19:38464585:G/T:1,chr19:47437640:G/T:1,chr1:233647414:G/T:1,chr1:237756505:G/T:1,chr1:237792382:C/T:1,chr2:151519554:G/T:1,chr2:151541809:G/T:1,chr2:151562679:G/T:1,chr2:166047534:C/T:1,chr2:166047536:A/T:1,chr2:178529881:A/T:1,chr2:40160677:G/T:1,chr3:20072202:A/T:1,chr3:54918338:T/C:1,chr3:8767870:G/A:1,chr4:21512091:G/A:1,chr5:170693194:C/A:1,chr6:33676739:C/A:1,chr6:39314972:G/A:1,chr7:91974127:C/A:1,chr7:92040995:G/T:1,chr9:35697963:G/T:1,chrX:49228469:G/T:1
R-HSA-397795	G-protein beta:gamma signalling	Signal Transduction	1.000000	PIK3R6	chr17:8822843:A/G:1
R-HSA-399719	Trafficking of AMPA receptors	Neuronal System	0.695622	AP2B1,PRKCB	chr16:23867049:C/T:1,chr17:35682607:A/G:1
R-HSA-399721	Glutamate binding, activation of AMPA receptors and synaptic plasticity	Neuronal System	0.695622	AP2B1,PRKCB	chr16:23867049:C/T:1,chr17:35682607:A/G:1
R-HSA-399955	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	Developmental Biology	0.187575	PIP5K1C,TLN1	chr19:3643094:C/A:1,chr9:35697963:G/T:1
R-HSA-399997	Acetylcholine regulates insulin secretion	Metabolism	0.443443	GNAQ	chr9:77797745:T/A:1
R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion	Metabolism	1.000000	CACNB2	chr10:18448206:G/A:1
R-HSA-400206	Regulation of lipid metabolism by PPARalpha	Metabolism	0.043775	CD36,CHD9,HDAC3,MED13L,MED14,MED25,NR1H3,PPARGC1B,RORA,SIN3A,SLC27A1,THRAP3	chr11:47259936:C/A:1,chr12:115986913:T/C:1,chr15:60556760:G/T:1,chr15:75409706:G/A:1,chr16:53255530:C/A:1,chr19:17487596:C/T:1,chr19:49830773:C/A:1,chr1:36301559:C/T:1,chr5:141629409:G/A:1,chr5:149834580:G/T:1,chr7:80474080:T/G:1,chrX:40703435:G/C:1
R-HSA-400253	Circadian Clock	Circadian Clock	1.000000	CHD9,HDAC3,RORA,RPS27A	chr15:60556760:G/T:1,chr16:53255530:C/A:1,chr2:55234745:A/T:1,chr5:141629409:G/A:1
R-HSA-400451	Free fatty acids regulate insulin secretion	Metabolism	0.126518	CD36,GNAQ	chr7:80474080:T/G:1,chr9:77797745:T/A:1
R-HSA-400508	Incretin synthesis, secretion, and inactivation	Metabolism of proteins	0.379439	GNAT3,TCF7L2	chr10:112964742:G/A:1,chr7:80474080:T/G:1
R-HSA-400685	Sema4D in semaphorin signaling	Developmental Biology	0.153436	LIMK2,MYH9,PLXNB1	chr22:31260099:C/A:1,chr22:36320146:C/A:1,chr3:48421052:G/A:1
R-HSA-4085001	Sialic acid metabolism	Metabolism of proteins	1.000000	ST8SIA2	chr15:92412994:G/T:1
R-HSA-4085377	SUMOylation of SUMOylation proteins	Metabolism of proteins	0.720838	NUP214	chr9:131215059:A/G:1
R-HSA-4086398	Ca2+ pathway	Signal Transduction	0.401444	AGO4,ITPR2,ITPR3,TCF7L2,TNRC6B	chr10:112964742:G/A:1,chr12:26600531:C/A:1,chr1:35850806:C/A:1,chr22:40049003:G/T:1,chr6:33676739:C/A:1
R-HSA-4086400	PCP/CE pathway	Signal Transduction	0.367214	AP2B1,PRKCB,PSMF1,ROR2,RPS27A,SCRIB,SMURF1	chr16:23867049:C/T:1,chr17:35682607:A/G:1,chr20:1117130:G/T:1,chr2:55234745:A/T:1,chr7:99061975:G/T:1,chr8:143793785:G/A:1,chr9:91724340:G/A:1
R-HSA-4090294	SUMOylation of intracellular receptors	Metabolism of proteins	0.687650	NR1H3,RORA	chr11:47259936:C/A:1,chr15:60556760:G/T:1
R-HSA-416476	G alpha (q) signalling events	Signal Transduction	0.766928	AVPR1A,DAGLA,DGKI,GNAQ,ITPR2,ITPR3,KALRN,KISS1,OXTR,PLCB4,PRKCD,RGSL1,RPS6KA1	chr11:61743387:T/A:1,chr12:26600531:C/A:1,chr12:63149800:A/T:1,chr1:182550726:A/G:1,chr1:204195297:C/T:1,chr1:26571817:C/A:1,chr20:9437223:T/G:1,chr3:124138871:G/T:1,chr3:124477465:C/A:1,chr3:53192052:T/G:1,chr3:8767870:G/A:1,chr6:33676739:C/A:1,chr7:137665038:C/A:1,chr9:77797745:T/A:1
R-HSA-416482	G alpha (12/13) signalling events	Signal Transduction	0.137141	ARHGEF19,ARHGEF4,GNA12,KALRN,MCF2L,OBSCN,PLXNB1,TIAM1	chr13:113046521:T/G:1,chr1:16199915:C/A:1,chr1:228306995:G/A:1,chr21:31135807:A/G:1,chr2:130920920:C/A:1,chr3:124138871:G/T:1,chr3:124477465:C/A:1,chr3:48421052:G/A:1,chr7:2762539:T/C:1
R-HSA-416550	Sema4D mediated inhibition of cell attachment and migration	Developmental Biology	0.374212	PLXNB1	chr3:48421052:G/A:1
R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	Developmental Biology	0.101752	LIMK2,MYH9,PLXNB1	chr22:31260099:C/A:1,chr22:36320146:C/A:1,chr3:48421052:G/A:1
R-HSA-416700	Other semaphorin interactions	Developmental Biology	1.000000	PLXND1	chr3:129575694:T/G:1
R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	Neuronal System	0.251662	AP2B1,PRKCB	chr16:23867049:C/T:1,chr17:35682607:A/G:1
R-HSA-418346	Platelet homeostasis	Hemostasis	0.001078	GUCY1A2,ITPR2,ITPR3,NOS3,PAFAH2,PDE11A,PPP2R1A,PPP2R5C,PTPN11,PTPN6,SLC8A1,SLC8A2,SLC8A3	chr11:106824788:A/T:1,chr12:112489105:A/T:1,chr12:26600531:C/A:1,chr12:6960084:C/T:1,chr14:101883867:G/T:1,chr14:70060534:G/T:1,chr19:47437640:G/T:1,chr19:52215622:C/T:1,chr1:25990859:G/T:1,chr2:177709965:T/C:1,chr2:40160677:G/T:1,chr6:33676739:C/A:1,chr7:151010230:G/T:1
R-HSA-418359	Reduction of cytosolic Ca++ levels	Hemostasis	0.027413	SLC8A1,SLC8A2,SLC8A3	chr14:70060534:G/T:1,chr19:47437640:G/T:1,chr2:40160677:G/T:1
R-HSA-418360	Platelet calcium homeostasis	Hemostasis	0.019384	ITPR2,ITPR3,SLC8A1,SLC8A2,SLC8A3	chr12:26600531:C/A:1,chr14:70060534:G/T:1,chr19:47437640:G/T:1,chr2:40160677:G/T:1,chr6:33676739:C/A:1
R-HSA-418457	cGMP effects	Hemostasis	0.608530	PDE11A	chr2:177709965:T/C:1
R-HSA-418555	G alpha (s) signalling events	Signal Transduction	0.000035	CRHR1,GLP1R,GNAT3,LHCGR,OR13C5,OR2F1,OR4C11,OR4N2,PDE11A,PDE4D,VIPR2	chr11:55603498:C/A:1,chr14:19760050:G/T:1,chr17:45831011:G/T:1,chr17:45833036:G/C:1,chr2:177709965:T/C:1,chr2:48708797:C/G:1,chr5:59002058:C/A:1,chr6:39086149:G/A:1,chr7:143985449:C/T:1,chr7:159142629:C/A:1,chr7:80474080:T/G:1,chr9:104598758:G/A:1
R-HSA-418592	ADP signalling through P2Y purinoceptor 1	Hemostasis	1.000000	GNAQ	chr9:77797745:T/A:1
R-HSA-418594	G alpha (i) signalling events	Signal Transduction	0.324039	ABCA4,BCO1,C5,CXCL11,GNAT3,HSPG2,ITPR2,ITPR3,MYO7A,NPY,PDE1C,PDE4D,PLB1,PLCB4,PPP2R1A,PRKCD,RGS9,RGSL1	chr11:77157326:T/C:1,chr11:77160849:G/T:1,chr11:77205582:C/A:1,chr12:26600531:C/A:1,chr16:81245335:G/T:1,chr17:65217991:G/T:1,chr19:52215622:C/T:1,chr1:182550726:A/G:1,chr1:21839609:G/T:1,chr1:21850169:G/T:1,chr1:94036566:G/A:1,chr20:9437223:T/G:1,chr2:28516675:G/T:1,chr3:53192052:T/G:1,chr4:76036090:T/C:1,chr5:59002058:C/A:1,chr6:33676739:C/A:1,chr7:24285140:T/G:1,chr7:32163293:C/T:1,chr7:80474080:T/G:1,chr9:120961515:C/A:1
R-HSA-418597	G alpha (z) signalling events	Signal Transduction	0.350430	GNAT3,PRKCB,PRKCD,RGSL1	chr16:23867049:C/T:1,chr1:182550726:A/G:1,chr3:53192052:T/G:1,chr7:80474080:T/G:1
R-HSA-418885	DCC mediated attractive signaling	Developmental Biology	0.559805	DOCK1	chr10:127257347:G/T:1
R-HSA-418886	Netrin mediated repulsion signals	Developmental Biology	0.072010	PTPN11,UNC5B	chr10:71291226:C/T:1,chr12:112489105:A/T:1
R-HSA-418889	Caspase activation via Dependence Receptors in the absence of ligand	Programmed Cell Death	0.107415	DAPK1,UNC5B	chr10:71291226:C/T:1,chr9:87640616:C/T:1
R-HSA-418890	Role of second messengers in netrin-1 signaling	Developmental Biology	0.443443	PITPNA	chr17:1520665:A/G:1
R-HSA-418990	Adherens junctions interactions	Cell-Cell communication	1.000000	CDH1	chr16:68779429:G/T:1
R-HSA-419037	NCAM1 interactions	Developmental Biology	0.002214	CACNA1G,CACNA1I,CACNB2,COL2A1,COL5A1,COL5A2,NCAM1,ST8SIA2	chr10:18448206:G/A:1,chr11:113207596:G/T:1,chr12:47982418:C/T:1,chr15:92412994:G/T:1,chr17:50578132:A/G:1,chr17:50600626:G/T:1,chr22:39647807:A/G:1,chr2:189098495:C/A:1,chr9:134782781:A/G:1
R-HSA-420092	Glucagon-type ligand receptors	Signal Transduction	0.711848	GLP1R,VIPR2	chr6:39086149:G/A:1,chr7:159142629:C/A:1
R-HSA-421270	Cell-cell junction organization	Cell-Cell communication	0.183632	CDH1	chr16:68779429:G/T:1
R-HSA-422356	Regulation of insulin secretion	Metabolism	0.212996	CACNB2,CD36,GLP1R,GNAQ,IQGAP1,ITPR2,ITPR3	chr10:18448206:G/A:1,chr12:26600531:C/A:1,chr15:90390695:A/G:1,chr15:90485816:T/C:1,chr6:33676739:C/A:1,chr6:39086149:G/A:1,chr7:80474080:T/G:1,chr9:77797745:T/A:1
R-HSA-422475	Axon guidance	Developmental Biology	0.000044	ABL2,ANK1,ANK3,AP2B1,ARPC1B,CACNA1G,CACNA1I,CACNB2,CLASP2,COL2A1,COL5A1,COL5A2,DOCK1,EPHB1,EPHB2,EPHB6,EVL,ITGA10,KALRN,KCNQ2,KCNQ3,L1CAM,LIMK2,MYH9,NCAM1,NCBP1,NCSTN,NRCAM,PIK3CB,PIP5K1C,PITPNA,PLXNB1,PLXND1,PSMF1,PTPN11,PTPRA,RBX1,ROBO3,RPL10,RPL23,RPL31,RPS27A,RPS6,RPS6KA1,RPS9,SCN1A,SCN1B,SPTBN4,ST8SIA2,TIAM1,TLN1,TUBB2A,TUBB8,UNC5B,VLDLR	chr10:127257347:G/T:1,chr10:18448206:G/A:1,chr10:60685310:G/A:1,chr10:71291226:C/T:1,chr10:73757:T/G:1,chr11:113207596:G/T:1,chr11:124874968:C/A:1,chr12:112489105:A/T:1,chr12:47982418:C/T:1,chr14:100141166:C/A:1,chr15:92412994:G/T:1,chr17:1520665:A/G:1,chr17:35682607:A/G:1,chr17:38850552:C/A:1,chr17:50578132:A/G:1,chr17:50600626:G/T:1,chr19:35033920:T/C:1,chr19:3643094:C/A:1,chr19:40569803:G/A:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr1:145895756:C/T:1,chr1:145909820:C/A:1,chr1:160353563:A/G:1,chr1:179221566:G/A:1,chr1:22893268:A/C:1,chr1:26571817:C/A:1,chr20:1117130:G/T:1,chr20:2975202:A/T:1,chr20:2988197:T/A:1,chr20:63439613:G/A:1,chr21:31135807:A/G:1,chr22:31260099:C/A:1,chr22:36320146:C/A:1,chr22:39647807:A/G:1,chr22:40963988:A/T:1,chr2:101018980:G/T:1,chr2:166047534:C/T:1,chr2:166047536:A/T:1,chr2:189098495:C/A:1,chr2:55234745:A/T:1,chr3:124138871:G/T:1,chr3:124477465:C/A:1,chr3:129575694:T/G:1,chr3:134932373:A/G:1,chr3:138778223:G/A:1,chr3:33602979:G/T:1,chr3:48421052:G/A:1,chr6:3154999:A/G:1,chr7:108168322:C/T:1,chr7:142863808:C/A:1,chr7:99394321:C/T:1,chr8:132175698:G/C:1,chr8:132192533:C/A:1,chr8:132421533:G/T:1,chr8:41808044:G/T:1,chr9:134782781:A/G:1,chr9:19376102:T/C:1,chr9:2644144:G/T:1,chr9:35697963:G/T:1,chr9:97664178:C/A:1,chrX:153863598:G/T:1,chrX:154405329:C/A:1
R-HSA-425366	Transport of bile salts and organic acids, metal ions and amine compounds	Transport of small molecules	0.817000	SLC13A3,SLC47A2,SLC6A11,SLC6A12,SLC6A2	chr12:197114:C/T:1,chr16:55656513:C/T:1,chr17:19713790:G/C:1,chr20:46606931:C/T:1,chr3:10820021:T/A:1,chr3:10933011:G/T:1
R-HSA-425381	Bicarbonate transporters	Transport of small molecules	0.443443	SLC4A4	chr4:71544404:G/T:1
R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	Transport of small molecules	0.052843	SLC12A3,SLC15A2,SLC17A6,SLC1A1,SLC4A4,SLC6A12,SLC7A7,SLC8A1,SLC8A2,SLC8A3,SLC9A7	chr11:22341861:T/C:1,chr12:197114:C/T:1,chr14:22780250:C/A:1,chr14:70060534:G/T:1,chr16:56879526:C/A:1,chr19:47437640:G/T:1,chr2:40160677:G/T:1,chr3:121939207:T/C:1,chr4:71544404:G/T:1,chr9:4576050:G/A:1,chrX:46643177:G/T:1
R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	Transport of small molecules	0.738060	SLC27A1,SLC27A4,SLC28A3	chr19:17487596:C/T:1,chr9:128360555:C/A:1,chr9:84279882:C/A:1
R-HSA-425407	SLC-mediated transmembrane transport	Transport of small molecules	0.070942	SLC12A3,SLC13A3,SLC15A2,SLC17A6,SLC1A1,SLC27A1,SLC27A4,SLC28A3,SLC2A11,SLC2A6,SLC2A9,SLC47A2,SLC4A4,SLC6A11,SLC6A12,SLC6A2,SLC7A7,SLC8A1,SLC8A2,SLC8A3,SLC9A7	chr11:22341861:T/C:1,chr12:197114:C/T:1,chr14:22780250:C/A:1,chr14:70060534:G/T:1,chr16:55656513:C/T:1,chr16:56879526:C/A:1,chr17:19713790:G/C:1,chr19:17487596:C/T:1,chr19:47437640:G/T:1,chr20:46606931:C/T:1,chr22:23875020:A/T:1,chr2:40160677:G/T:1,chr3:10820021:T/A:1,chr3:10933011:G/T:1,chr3:121939207:T/C:1,chr4:10005462:C/T:1,chr4:71544404:G/T:1,chr9:128360555:C/A:1,chr9:133472046:G/A:1,chr9:4576050:G/A:1,chr9:84279882:C/A:1,chrX:46643177:G/T:1
R-HSA-425561	Sodium/Calcium exchangers	Transport of small molecules	0.021449	SLC8A1,SLC8A2,SLC8A3	chr14:70060534:G/T:1,chr19:47437640:G/T:1,chr2:40160677:G/T:1
R-HSA-425986	Sodium/Proton exchangers	Transport of small molecules	0.409840	SLC9A7	chrX:46643177:G/T:1
R-HSA-426048	Arachidonate production from DAG	Signal Transduction;Hemostasis	0.253920	DAGLA	chr11:61743387:T/A:1
R-HSA-426117	Cation-coupled Chloride cotransporters	Transport of small molecules	0.336437	SLC12A3	chr16:56879526:C/A:1
R-HSA-426486	Small interfering RNA (siRNA) biogenesis	Gene expression (Transcription)	0.409840	AGO4	chr1:35850806:C/A:1
R-HSA-426496	Post-transcriptional silencing by small RNAs	Gene expression (Transcription)	0.056075	AGO4,TNRC6B	chr1:35850806:C/A:1,chr22:40049003:G/T:1
R-HSA-427413	NoRC negatively regulates rRNA expression	Gene expression (Transcription)	0.131070	DNMT1,SIN3A	chr15:75409706:G/A:1,chr19:10173083:G/A:1
R-HSA-427975	Proton/oligopeptide cotransporters	Transport of small molecules	0.208897	SLC15A2	chr3:121939207:T/C:1
R-HSA-428157	Sphingolipid metabolism	Metabolism	0.489191	ARSA,CERS3,SMPD4	chr15:100472812:G/T:1,chr22:50625611:G/C:1,chr2:130153274:G/A:1
R-HSA-428542	Regulation of commissural axon pathfinding by SLIT and ROBO	Developmental Biology	0.443443	ROBO3	chr11:124874968:C/A:1
R-HSA-428643	Organic anion transporters	Transport of small molecules	0.443443	SLC17A6	chr11:22341861:T/C:1
R-HSA-428890	Role of ABL in ROBO-SLIT signaling	Developmental Biology	0.072010	ABL2,CLASP2	chr1:179221566:G/A:1,chr3:33602979:G/T:1
R-HSA-428930	Thromboxane signalling through TP receptor	Hemostasis	1.000000	GNAQ	chr9:77797745:T/A:1
R-HSA-429914	Deadenylation-dependent mRNA decay	Metabolism of RNA	0.376108	CNOT9	chr2:218582908:A/T:1
R-HSA-429947	Deadenylation of mRNA	Metabolism of RNA	1.000000	CNOT9	chr2:218582908:A/T:1
R-HSA-430116	GP1b-IX-V activation signalling	Hemostasis	0.505026	COL1A1	chr17:50195100:C/A:1
R-HSA-432142	Platelet sensitization by LDL	Hemostasis	0.013632	PPP2R1A,PPP2R5C,PTPN11,PTPN6	chr12:112489105:A/T:1,chr12:6960084:C/T:1,chr14:101883867:G/T:1,chr19:52215622:C/T:1
R-HSA-432720	Lysosome Vesicle Biogenesis	Vesicle-mediated transport	0.720838	GNS	chr12:64722884:C/A:1
R-HSA-432722	Golgi Associated Vesicle Biogenesis	Vesicle-mediated transport	0.376108	CPD	chr17:30461111:A/T:1
R-HSA-433137	Sodium-coupled sulphate, di- and tri-carboxylate transporters	Transport of small molecules	0.253920	SLC13A3	chr20:46606931:C/T:1
R-HSA-434313	Intracellular metabolism of fatty acids regulates insulin secretion	Metabolism	0.161161	CD36	chr7:80474080:T/G:1
R-HSA-434316	Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion	Metabolism	0.374212	GNAQ	chr9:77797745:T/A:1
R-HSA-437239	Recycling pathway of L1	Developmental Biology	0.200665	AP2B1,L1CAM,RPS6KA1,TUBB2A,TUBB8	chr10:73757:T/G:1,chr17:35682607:A/G:1,chr1:26571817:C/A:1,chr6:3154999:A/G:1,chrX:153863598:G/T:1
R-HSA-438064	Post NMDA receptor activation events	Neuronal System	0.466045	ERBB4,PRKAA2,PRKAB2,RPS6KA1,TUBB2A,TUBB8	chr10:73757:T/G:1,chr1:147172001:G/A:1,chr1:26571817:C/A:1,chr1:56706008:C/A:1,chr2:211630704:C/G:1,chr6:3154999:A/G:1
R-HSA-4411364	Binding of TCF/LEF:CTNNB1 to target gene promoters	Signal Transduction	0.374212	TCF7L2	chr10:112964742:G/A:1
R-HSA-4419969	Depolymerisation of the Nuclear Lamina	Cell Cycle	0.049974	LPIN1,LPIN3,PRKCB	chr16:23867049:C/T:1,chr20:41345676:A/G:1,chr2:11819407:C/G:1
R-HSA-4420097	VEGFA-VEGFR2 Pathway	Signal Transduction	0.266594	DOCK1,ITPR2,ITPR3,NOS3,PIK3CB,PRKCB,PRKCD,WASF2	chr10:127257347:G/T:1,chr12:26600531:C/A:1,chr16:23867049:C/T:1,chr1:27412951:A/T:1,chr3:138778223:G/A:1,chr3:53192052:T/G:1,chr6:33676739:C/A:1,chr7:151010230:G/T:1
R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	Disease	0.101752	BCAN,CSPG4,HSPG2	chr15:75675473:A/G:1,chr1:156650224:G/T:1,chr1:156652083:T/G:1,chr1:21839609:G/T:1,chr1:21850169:G/T:1
R-HSA-442660	Na+/Cl- dependent neurotransmitter transporters	Transport of small molecules	0.090127	SLC6A11,SLC6A12,SLC6A2	chr12:197114:C/T:1,chr16:55656513:C/T:1,chr3:10820021:T/A:1,chr3:10933011:G/T:1
R-HSA-442742	CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling	Neuronal System	1.000000	RPS6KA1	chr1:26571817:C/A:1
R-HSA-442755	Activation of NMDA receptors and postsynaptic events	Neuronal System	0.656822	ERBB4,PRKAA2,PRKAB2,RPS6KA1,TUBB2A,TUBB8	chr10:73757:T/G:1,chr1:147172001:G/A:1,chr1:26571817:C/A:1,chr1:56706008:C/A:1,chr2:211630704:C/G:1,chr6:3154999:A/G:1
R-HSA-444257	RSK activation	Neuronal System	0.336437	RPS6KA1	chr1:26571817:C/A:1
R-HSA-445095	Interaction between L1 and Ankyrins	Developmental Biology	0.000038	ANK1,ANK3,KCNQ2,KCNQ3,L1CAM,NRCAM,SCN1A,SCN1B,SPTBN4	chr10:60685310:G/A:1,chr19:35033920:T/C:1,chr19:40569803:G/A:1,chr20:63439613:G/A:1,chr2:166047534:C/T:1,chr2:166047536:A/T:1,chr7:108168322:C/T:1,chr8:132175698:G/C:1,chr8:132192533:C/A:1,chr8:132421533:G/T:1,chr8:41808044:G/T:1,chrX:153863598:G/T:1
R-HSA-445144	Signal transduction by L1	Developmental Biology	0.337515	L1CAM,NCAM1	chr11:113207596:G/T:1,chrX:153863598:G/T:1
R-HSA-445355	Smooth Muscle Contraction	Muscle contraction	0.167999	ACTA2,CAV3,GUCY1A2,TLN1	chr10:88947447:C/A:1,chr11:106824788:A/T:1,chr3:8767870:G/A:1,chr9:35697963:G/T:1
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	Immune System	0.426293	NFKBIA,NOD2,RPS27A	chr14:35403479:G/T:1,chr16:50711288:C/T:1,chr2:55234745:A/T:1
R-HSA-446107	Type I hemidesmosome assembly	Cell-Cell communication	0.126518	LAMB3,LAMC2	chr1:183228170:A/G:1,chr1:209618498:C/T:1
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	Metabolism of proteins	0.627954	ALG12,RENBP,ST8SIA2	chr15:92412994:G/T:1,chr22:49903355:G/T:1,chrX:153943642:G/T:1
R-HSA-446203	Asparagine N-linked glycosylation	Metabolism of proteins	0.899904	ALG12,ANK1,ANK3,ASGR2,PPP6C,RENBP,RPS27A,SEC16B,SEC23A,SEC24D,SEC31A,SEL1L,SPTBN4,ST8SIA2,TUBB2A,TUBB8	chr10:60685310:G/A:1,chr10:73757:T/G:1,chr14:39040609:C/A:1,chr14:81490564:A/C:1,chr15:92412994:G/T:1,chr17:7114005:G/T:1,chr19:40569803:G/A:1,chr1:177936177:G/T:1,chr22:49903355:G/T:1,chr2:55234745:A/T:1,chr4:118833895:C/A:1,chr4:82855072:T/A:1,chr6:3154999:A/G:1,chr8:41808044:G/T:1,chr9:125171223:T/A:1,chrX:153943642:G/T:1
R-HSA-446210	Synthesis of UDP-N-acetyl-glucosamine	Metabolism of proteins	0.374212	RENBP	chrX:153943642:G/T:1
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	Metabolism of proteins	0.584327	RENBP,ST8SIA2	chr15:92412994:G/T:1,chrX:153943642:G/T:1
R-HSA-446353	Cell-extracellular matrix interactions	Cell-Cell communication	0.273233	FLNC,LIMS2	chr2:127640046:C/A:1,chr7:128850499:T/C:1
R-HSA-446652	Interleukin-1 family signaling	Immune System	1.000000	NFKBIA,NOD2,PSMF1,PTPN11,PTPN6,RBX1,RPS27A	chr12:112489105:A/T:1,chr12:6960084:C/T:1,chr14:35403479:G/T:1,chr16:50711288:C/T:1,chr20:1117130:G/T:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1
R-HSA-446728	Cell junction organization	Cell-Cell communication	1.000000	CDH1,FLNC,LAMB3,LAMC2,LIMS2	chr16:68779429:G/T:1,chr1:183228170:A/G:1,chr1:209618498:C/T:1,chr2:127640046:C/A:1,chr7:128850499:T/C:1
R-HSA-447038	NrCAM interactions	Developmental Biology	0.056075	ANK1,NRCAM	chr7:108168322:C/T:1,chr8:41808044:G/T:1
R-HSA-447041	CHL1 interactions	Developmental Biology	0.089187	ANK1,ITGA10	chr1:145895756:C/T:1,chr1:145909820:C/A:1,chr8:41808044:G/T:1
R-HSA-447043	Neurofascin interactions	Developmental Biology	0.056075	ANK1,NRCAM	chr7:108168322:C/T:1,chr8:41808044:G/T:1
R-HSA-447115	Interleukin-12 family signaling	Immune System	1.000000	PITPNA,SNRPA1,SOD2	chr15:101281621:G/T:1,chr17:1520665:A/G:1,chr6:159684794:A/T:1
R-HSA-448424	Interleukin-17 signaling	Immune System	0.601913	MAP2K3,NOD2,PPP2R1A,RPS27A,RPS6KA1	chr16:50711288:C/T:1,chr17:21303128:C/T:1,chr19:52215622:C/T:1,chr1:26571817:C/A:1,chr2:55234745:A/T:1
R-HSA-449147	Signaling by Interleukins	Immune System	0.150077	BLNK,CCL3L1,CD36,CNTFR,F13A1,FCER2,HCK,IGHG1,IGHG4,IL16,IL2RB,IRS1,ITGAM,LIFR,MAP2K3,NFKBIA,NOD2,PIK3CB,PITPNA,PPP2R1A,PSMF1,PTPN11,PTPN6,RAPGEF1,RBX1,RORA,RPS27A,RPS6KA1,SMARCA4,SNRPA1,SOD2,STAT6,TNFRSF1B	chr10:96227700:G/C:1,chr12:112489105:A/T:1,chr12:57102572:A/C:1,chr12:6960084:C/T:1,chr14:105624404:C/G:1,chr14:105741468:G/C:1,chr14:105741485:A/G:1,chr14:35403479:G/T:1,chr15:101281621:G/T:1,chr15:60556760:G/T:1,chr15:81169619:C/A:1,chr16:31299762:C/T:1,chr16:50711288:C/T:1,chr17:1520665:A/G:1,chr17:21303128:C/T:1,chr17:36195375:A/G:1,chr19:11025539:C/G:1,chr19:52215622:C/T:1,chr19:7699499:C/T:1,chr1:12188701:A/G:1,chr1:12203460:C/A:1,chr1:26571817:C/A:1,chr20:1117130:G/T:1,chr20:32098788:C/A:1,chr22:37132322:T/G:1,chr22:37142288:T/C:1,chr22:40963988:A/T:1,chr2:226796751:A/G:1,chr2:55234745:A/T:1,chr3:138778223:G/A:1,chr5:38482482:C/A:1,chr6:159684794:A/T:1,chr6:6224619:A/T:1,chr7:80474080:T/G:1,chr9:131592242:G/T:1,chr9:34582938:G/T:1
R-HSA-449836	Other interleukin signaling	Immune System	1.000000	IL16	chr15:81169619:C/A:1
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	Immune System	0.695622	PPP2R1A,RPS6KA1	chr19:52215622:C/T:1,chr1:26571817:C/A:1
R-HSA-450294	MAP kinase activation	Immune System	0.406965	MAP2K3,NOD2,PPP2R1A,RPS27A,RPS6KA1	chr16:50711288:C/T:1,chr17:21303128:C/T:1,chr19:52215622:C/T:1,chr1:26571817:C/A:1,chr2:55234745:A/T:1
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	Immune System	0.139819	MAP2K3,NOD2,RPS27A	chr16:50711288:C/T:1,chr17:21303128:C/T:1,chr2:55234745:A/T:1
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	Immune System	0.358602	NOD2,RPS27A	chr16:50711288:C/T:1,chr2:55234745:A/T:1
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	Metabolism of RNA	0.769701	PSMF1,RPS27A	chr20:1117130:G/T:1,chr2:55234745:A/T:1
R-HSA-450520	HuR (ELAVL1) binds and stabilizes mRNA	Metabolism of RNA	0.072010	NUP214,PRKCD	chr3:53192052:T/G:1,chr9:131215059:A/G:1
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	Metabolism of RNA	0.818582	NUP214,PRKCD,PSMF1,RPS27A	chr20:1117130:G/T:1,chr2:55234745:A/T:1,chr3:53192052:T/G:1,chr9:131215059:A/G:1
R-HSA-451306	Ionotropic activity of kainate receptors	Neuronal System	0.443443	GRIK4	chr11:120591708:G/A:1,chr11:120607427:G/T:1
R-HSA-451308	Activation of Ca-permeable Kainate Receptor	Neuronal System	0.443443	GRIK4	chr11:120591708:G/A:1,chr11:120607427:G/T:1
R-HSA-451326	Activation of kainate receptors upon glutamate binding	Neuronal System	1.000000	GRIK4	chr11:120591708:G/A:1,chr11:120607427:G/T:1
R-HSA-451927	Interleukin-2 family signaling	Immune System	0.738060	IL2RB,PIK3CB,PTPN6	chr12:6960084:C/T:1,chr22:37132322:T/G:1,chr22:37142288:T/C:1,chr3:138778223:G/A:1
R-HSA-452723	Transcriptional regulation of pluripotent stem cells	Developmental Biology	1.000000	SALL1	chr16:51137759:C/T:1
R-HSA-453274	Mitotic G2-G2/M phases	Cell Cycle	0.876928	AKAP9,CEP78,PCNT,PPP1R12A,PPP2R1A,PSMF1,RBX1,RPS27A,TUBB2A,TUBB8	chr10:73757:T/G:1,chr12:79822198:G/T:1,chr19:52215622:C/T:1,chr20:1117130:G/T:1,chr21:46351357:C/A:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1,chr6:3154999:A/G:1,chr7:91974127:C/A:1,chr7:92040995:G/T:1,chr9:78246838:C/A:1
R-HSA-453276	Regulation of mitotic cell cycle	Cell Cycle	1.000000	ANAPC1,ANAPC4,PSMF1,RPS27A	chr20:1117130:G/T:1,chr2:111863902:T/A:1,chr2:55234745:A/T:1,chr4:25418042:G/T:1
R-HSA-453279	Mitotic G1 phase and G1/S transition	Cell Cycle	0.476891	POLE,PPP2R1A,PSMF1,RPA1,RPA2,RPS27A	chr12:132643245:T/C:1,chr17:1853255:C/A:1,chr19:52215622:C/T:1,chr1:27914481:C/T:1,chr20:1117130:G/T:1,chr2:55234745:A/T:1
R-HSA-4551638	SUMOylation of chromatin organization proteins	Metabolism of proteins	0.438864	NUP214,SUZ12	chr17:31973320:T/G:1,chr9:131215059:A/G:1
R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	Hemostasis	0.703700	GNA12,GNAQ	chr7:2762539:T/C:1,chr9:77797745:T/A:1
R-HSA-4570464	SUMOylation of RNA binding proteins	Metabolism of proteins	0.521556	NUP214	chr9:131215059:A/G:1
R-HSA-4608870	Asymmetric localization of PCP proteins	Signal Transduction	0.784180	PSMF1,RPS27A,SCRIB,SMURF1	chr20:1117130:G/T:1,chr2:55234745:A/T:1,chr7:99061975:G/T:1,chr8:143793785:G/A:1
R-HSA-4615885	SUMOylation of DNA replication proteins	Metabolism of proteins	0.519406	NUP214	chr9:131215059:A/G:1
R-HSA-4641257	Degradation of AXIN	Signal Transduction	1.000000	PSMF1,RPS27A,TNKS	chr20:1117130:G/T:1,chr2:55234745:A/T:1,chr8:9776590:C/A:1
R-HSA-4641258	Degradation of DVL	Signal Transduction	1.000000	PSMF1,RBX1,RPS27A	chr20:1117130:G/T:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	Signal Transduction	0.695622	PPP2R1A,PPP2R5C	chr14:101883867:G/T:1,chr19:52215622:C/T:1
R-HSA-4641263	Regulation of FZD by ubiquitination	Signal Transduction	0.028647	LGR5,RPS27A,RSPO1,USP8	chr12:71578101:A/C:1,chr15:50441258:C/A:1,chr1:37625400:G/T:1,chr2:55234745:A/T:1
R-HSA-4641265	Repression of WNT target genes	Signal Transduction	0.187575	TCF7L2,TLE4	chr10:112964742:G/A:1,chr9:79693752:C/G:1
R-HSA-4655427	SUMOylation of DNA methylation proteins	Metabolism of proteins	0.608530	DNMT1	chr19:10173083:G/A:1
R-HSA-4720489	Defective ALG12 causes ALG12-CDG (CDG-1g)	Disease	0.056891	ALG12	chr22:49903355:G/T:1
R-HSA-4755510	SUMOylation of immune response proteins	Metabolism of proteins	0.126518	IKBKE,NFKBIA	chr14:35403479:G/T:1,chr1:206479188:C/A:1
R-HSA-4791275	Signaling by WNT in cancer	Disease	0.125346	PPP2R1A,PPP2R5C,TCF7L2,TNKS	chr10:112964742:G/A:1,chr14:101883867:G/T:1,chr19:52215622:C/T:1,chr8:9776590:C/A:1
R-HSA-4839726	Chromatin organization	Chromatin organization	0.505821	ARID1B,DOT1L,HDAC3,HDAC8,KAT2B,KDM4C,KDM5C,KMT2B,MCRS1,MORF4L1,NSD1,PADI2,PADI3,PADI6,SMARCA4,SMYD3,SUZ12,WDR5	chr12:49557449:T/C:1,chr12:49558885:G/A:1,chr15:78886316:G/C:1,chr17:31973320:T/G:1,chr19:11025539:C/G:1,chr19:2185764:G/A:1,chr19:35731956:C/T:1,chr1:17070003:T/C:1,chr1:17259359:A/C:1,chr1:17401141:T/G:1,chr1:246034686:C/T:1,chr3:20072202:A/T:1,chr5:141629409:G/A:1,chr5:177209627:A/T:1,chr6:156829096:A/G:1,chr6:157039620:T/A:1,chr9:134155272:C/G:1,chr9:6893015:A/T:1,chrX:53196509:A/T:1,chrX:72572139:G/A:1
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	Disease	0.187575	PPP2R1A,PPP2R5C	chr14:101883867:G/T:1,chr19:52215622:C/T:1
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	Disease	0.208745	PPP2R1A,PPP2R5C	chr14:101883867:G/T:1,chr19:52215622:C/T:1
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	Disease	0.187575	PPP2R1A,PPP2R5C	chr14:101883867:G/T:1,chr19:52215622:C/T:1
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	Disease	0.187575	PPP2R1A,PPP2R5C	chr14:101883867:G/T:1,chr19:52215622:C/T:1
R-HSA-499943	Interconversion of nucleotide di- and triphosphates	Metabolism	1.000000	AK2	chr1:33024644:G/C:1
R-HSA-500792	GPCR ligand binding	Signal Transduction	0.003955	ADGRE5,AVPR1A,C5,CCL3L1,CRHR1,CXCL11,GLP1R,KISS1,LHCGR,NPY,OXTR,VIPR2,WNT7A	chr12:63149800:A/T:1,chr17:36195375:A/G:1,chr17:45831011:G/T:1,chr17:45833036:G/C:1,chr19:14404629:C/A:1,chr1:204195297:C/T:1,chr2:48708797:C/G:1,chr3:13816735:G/A:1,chr3:13816744:T/C:1,chr3:8767870:G/A:1,chr4:76036090:T/C:1,chr6:39086149:G/A:1,chr7:159142629:C/A:1,chr7:24285140:T/G:1,chr9:120961515:C/A:1
R-HSA-5083625	Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)	Disease	0.010906	MUC15,MUC17,MUC3A,MUC4	chr11:26561226:C/A:1,chr3:195752618:A/G:1,chr3:195752619:G/C:1,chr7:100958263:A/G:1,chr7:101035696:G/T:1
R-HSA-5083632	Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)	Disease	0.013632	MUC15,MUC17,MUC3A,MUC4	chr11:26561226:C/A:1,chr3:195752618:A/G:1,chr3:195752619:G/C:1,chr7:100958263:A/G:1,chr7:101035696:G/T:1
R-HSA-5083635	Defective B3GALTL causes Peters-plus syndrome (PpS)	Disease	1.000000	ADAMTS1,ADAMTS13	chr21:26843749:G/A:1,chr9:133439628:C/T:1
R-HSA-5083636	Defective GALNT12 causes colorectal cancer 1 (CRCS1)	Disease	0.010906	MUC15,MUC17,MUC3A,MUC4	chr11:26561226:C/A:1,chr3:195752618:A/G:1,chr3:195752619:G/C:1,chr7:100958263:A/G:1,chr7:101035696:G/T:1
R-HSA-5099900	WNT5A-dependent internalization of FZD4	Signal Transduction	0.208745	AP2B1,PRKCB	chr16:23867049:C/T:1,chr17:35682607:A/G:1
R-HSA-512988	Interleukin-3, Interleukin-5 and GM-CSF signaling	Immune System	0.005246	BLNK,HCK,IL2RB,PIK3CB,PTPN11,PTPN6,RAPGEF1,RPS27A	chr10:96227700:G/C:1,chr12:112489105:A/T:1,chr12:6960084:C/T:1,chr20:32098788:C/A:1,chr22:37132322:T/G:1,chr22:37142288:T/C:1,chr2:55234745:A/T:1,chr3:138778223:G/A:1,chr9:131592242:G/T:1
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	Signal Transduction	0.166735	AP2B1,ROR2	chr17:35682607:A/G:1,chr9:91724340:G/A:1
R-HSA-5173105	O-linked glycosylation	Metabolism of proteins	0.144037	ADAMTS1,ADAMTS13,B3GNTL1,GALNT10,GALNT14,GALNT17,MUC15,MUC17,MUC3A,MUC4	chr11:26561226:C/A:1,chr17:83048634:G/T:1,chr21:26843749:G/A:1,chr2:30924922:C/T:1,chr2:30945103:G/T:1,chr3:195752618:A/G:1,chr3:195752619:G/C:1,chr5:154416093:G/C:1,chr7:100958263:A/G:1,chr7:101035696:G/T:1,chr7:71571591:C/A:1,chr9:133439628:C/T:1
R-HSA-5173214	O-glycosylation of TSR domain-containing proteins	Metabolism of proteins	1.000000	ADAMTS1,ADAMTS13	chr21:26843749:G/A:1,chr9:133439628:C/T:1
R-HSA-5205647	Mitophagy	Autophagy	0.679827	PRKN,RPS27A	chr2:55234745:A/T:1,chr6:161549199:T/A:1
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	Autophagy	0.358602	PRKN,RPS27A	chr2:55234745:A/T:1,chr6:161549199:T/A:1
R-HSA-5210891	Uptake and function of anthrax toxins	Disease	0.475135	MAP2K3	chr17:21303128:C/T:1
R-HSA-5213460	RIPK1-mediated regulated necrosis	Programmed Cell Death	0.316221	RPS27A,TNFRSF10A	chr2:55234745:A/T:1,chr8:23202515:G/T:1
R-HSA-5218859	Regulated Necrosis	Programmed Cell Death	0.316221	RPS27A,TNFRSF10A	chr2:55234745:A/T:1,chr8:23202515:G/T:1
R-HSA-5218900	CASP8 activity is inhibited	Programmed Cell Death	0.475135	TNFRSF10A	chr8:23202515:G/T:1
R-HSA-5218920	VEGFR2 mediated vascular permeability	Signal Transduction	1.000000	NOS3	chr7:151010230:G/T:1
R-HSA-5218921	VEGFR2 mediated cell proliferation	Signal Transduction	0.020291	ITPR2,ITPR3,PRKCB,PRKCD	chr12:26600531:C/A:1,chr16:23867049:C/T:1,chr3:53192052:T/G:1,chr6:33676739:C/A:1
R-HSA-5250913	Positive epigenetic regulation of rRNA expression	Gene expression (Transcription)	0.131070	KAT2B,MYBBP1A	chr17:4545528:G/A:1,chr3:20072202:A/T:1
R-HSA-5250924	B-WICH complex positively regulates rRNA expression	Gene expression (Transcription)	0.244306	KAT2B,MYBBP1A	chr17:4545528:G/A:1,chr3:20072202:A/T:1
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	Gene expression (Transcription)	0.093074	DNMT1,SIN3A	chr15:75409706:G/A:1,chr19:10173083:G/A:1
R-HSA-525793	Myogenesis	Developmental Biology	1.000000	MYOD1	chr11:17721453:C/G:1
R-HSA-5260271	Diseases of Immune System	Disease	0.153436	CD14,CD36,NFKBIA	chr14:35403479:G/T:1,chr5:140633030:C/A:1,chr7:80474080:T/G:1
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	Metabolism of proteins	1.000000	RPS27A,SEL1L	chr14:81490564:A/C:1,chr2:55234745:A/T:1
R-HSA-5334118	DNA methylation	Gene expression (Transcription)	0.266463	DNMT1	chr19:10173083:G/A:1
R-HSA-5339562	Uptake and actions of bacterial toxins	Disease	1.000000	MAP2K3	chr17:21303128:C/T:1
R-HSA-5339700	TCF7L2 mutants don't bind CTBP	Disease	0.161161	TCF7L2	chr10:112964742:G/A:1
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	Disease	0.208745	PPP2R1A,PPP2R5C	chr14:101883867:G/T:1,chr19:52215622:C/T:1
R-HSA-5357769	Caspase activation via extrinsic apoptotic signalling pathway	Programmed Cell Death	0.057309	CD14,DAPK1,TNFRSF10A,UNC5B	chr10:71291226:C/T:1,chr5:140633030:C/A:1,chr8:23202515:G/T:1,chr9:87640616:C/T:1
R-HSA-5357801	Programmed Cell Death	Programmed Cell Death	0.073421	APAF1,ARHGAP10,CD14,CDH1,DAPK1,GSN,HIST1H1E,PKP1,PRKCD,PSMF1,RPS27A,STK26,TJP2,TNFRSF10A,UACA,UNC5B	chr10:71291226:C/T:1,chr12:98648251:A/T:1,chr15:70694991:A/T:1,chr16:68779429:G/T:1,chr1:201324373:G/T:1,chr20:1117130:G/T:1,chr2:55234745:A/T:1,chr3:53192052:T/G:1,chr4:147964990:A/T:1,chr4:147975614:C/A:1,chr5:140633030:C/A:1,chr6:26156427:G/C:1,chr8:23202515:G/T:1,chr9:121312182:C/T:1,chr9:69250885:T/G:1,chr9:87640616:C/T:1,chrX:132069471:A/T:1
R-HSA-5357905	Regulation of TNFR1 signaling	Signal Transduction	0.711848	RPS27A,TAX1BP1	chr2:55234745:A/T:1,chr7:27841060:C/A:1
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	Signal Transduction	1.000000	RPS27A	chr2:55234745:A/T:1
R-HSA-5358346	Hedgehog ligand biogenesis	Signal Transduction	1.000000	PSMF1,RPS27A,SEL1L	chr14:81490564:A/C:1,chr20:1117130:G/T:1,chr2:55234745:A/T:1
R-HSA-5358351	Signaling by Hedgehog	Signal Transduction	0.723146	IQCE,PSMF1,RBX1,RPS27A,SEL1L,SMURF1,TUBB2A	chr14:81490564:A/C:1,chr20:1117130:G/T:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1,chr6:3154999:A/G:1,chr7:2607089:A/G:1,chr7:99061975:G/T:1
R-HSA-5358508	Mismatch Repair	DNA Repair	0.208745	RPA1,RPA2	chr17:1853255:C/A:1,chr1:27914481:C/T:1
R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	DNA Repair	0.187575	RPA1,RPA2	chr17:1853255:C/A:1,chr1:27914481:C/T:1
R-HSA-5358606	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	DNA Repair	0.187575	RPA1,RPA2	chr17:1853255:C/A:1,chr1:27914481:C/T:1
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	Disease	0.208745	PPP2R1A,PPP2R5C	chr14:101883867:G/T:1,chr19:52215622:C/T:1
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	Disease	0.208745	PPP2R1A,PPP2R5C	chr14:101883867:G/T:1,chr19:52215622:C/T:1
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	Disease	0.208745	PPP2R1A,PPP2R5C	chr14:101883867:G/T:1,chr19:52215622:C/T:1
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	Disease	0.208745	PPP2R1A,PPP2R5C	chr14:101883867:G/T:1,chr19:52215622:C/T:1
R-HSA-5362517	Signaling by Retinoic Acid	Signal Transduction	1.000000	PDHA1,PPARD	chr6:35396106:C/T:1,chrX:19355267:G/T:1
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	Disease	1.000000	PSMF1,RPS27A,SEL1L	chr14:81490564:A/C:1,chr20:1117130:G/T:1,chr2:55234745:A/T:1
R-HSA-5368286	Mitochondrial translation initiation	Metabolism of proteins	0.637691	MRPL2,MRPL28,MRPL4,MRPS18C,MRPS22,PTCD3	chr16:368429:A/G:1,chr19:10259814:T/A:1,chr2:86111006:G/T:1,chr3:139130214:G/T:1,chr4:83460892:G/T:1,chr6:43055804:A/T:1
R-HSA-5368287	Mitochondrial translation	Metabolism of proteins	0.653595	MRPL2,MRPL28,MRPL4,MRPS18C,MRPS22,PTCD3	chr16:368429:A/G:1,chr19:10259814:T/A:1,chr2:86111006:G/T:1,chr3:139130214:G/T:1,chr4:83460892:G/T:1,chr6:43055804:A/T:1
R-HSA-5387390	Hh mutants abrogate ligand secretion	Disease	1.000000	PSMF1,RPS27A,SEL1L	chr14:81490564:A/C:1,chr20:1117130:G/T:1,chr2:55234745:A/T:1
R-HSA-5389840	Mitochondrial translation elongation	Metabolism of proteins	0.637691	MRPL2,MRPL28,MRPL4,MRPS18C,MRPS22,PTCD3	chr16:368429:A/G:1,chr19:10259814:T/A:1,chr2:86111006:G/T:1,chr3:139130214:G/T:1,chr4:83460892:G/T:1,chr6:43055804:A/T:1
R-HSA-5419276	Mitochondrial translation termination	Metabolism of proteins	0.637691	MRPL2,MRPL28,MRPL4,MRPS18C,MRPS22,PTCD3	chr16:368429:A/G:1,chr19:10259814:T/A:1,chr2:86111006:G/T:1,chr3:139130214:G/T:1,chr4:83460892:G/T:1,chr6:43055804:A/T:1
R-HSA-5423646	Aflatoxin activation and detoxification	Metabolism	1.000000	MGST1	chr12:16605069:T/G:1
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	Disease	0.187575	PPP2R1A,PPP2R5C	chr14:101883867:G/T:1,chr19:52215622:C/T:1
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	Disease	0.187575	PPP2R1A,PPP2R5C	chr14:101883867:G/T:1,chr19:52215622:C/T:1
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	Disease	0.187575	PPP2R1A,PPP2R5C	chr14:101883867:G/T:1,chr19:52215622:C/T:1
R-HSA-5545619	XAV939 inhibits tankyrase, stabilizing AXIN	Disease	0.110550	TNKS	chr8:9776590:C/A:1
R-HSA-556833	Metabolism of lipids	Metabolism	0.322780	ACSBG2,ACSM3,ARSA,CD36,CERS3,CHAT,CHD9,CRAT,CYP11A1,CYP2D6,GNPAT,GPAT2,HDAC3,LPCAT1,LPCAT2,LPIN1,LPIN3,LSS,MED13L,MED14,MED25,MUT,NR1H3,PCCA,PIK3CB,PIK3R6,PIP5K1C,PLA2R1,PLB1,PNPLA2,PPARD,PPARGC1B,PPT1,PRKAA2,PRKAB2,PTGR1,RAB4A,RORA,SBF1,SEC23A,SEC24D,SIN3A,SLC27A1,SMPD4,STARD3,TBXAS1,THRAP3,TSPOAP1	chr10:49662454:G/A:1,chr11:47259936:C/A:1,chr11:822271:G/T:1,chr12:115986913:T/C:1,chr13:100469233:C/A:1,chr14:39040609:C/A:1,chr15:100472812:G/T:1,chr15:60556760:G/T:1,chr15:74348128:C/T:1,chr15:75409706:G/A:1,chr16:20621896:G/T:1,chr16:53255530:C/A:1,chr16:55566632:C/A:1,chr17:39660742:G/T:1,chr17:58320561:C/A:1,chr17:8822843:A/G:1,chr19:17487596:C/T:1,chr19:3643094:C/A:1,chr19:49830773:C/A:1,chr19:6161586:G/A:1,chr1:147172001:G/A:1,chr1:229288550:C/A:1,chr1:231267458:C/A:1,chr1:36301559:C/T:1,chr1:40085102:C/T:1,chr1:56706008:C/A:1,chr20:41345676:A/G:1,chr21:46213081:T/C:1,chr22:42126548:G/A:1,chr22:50461719:C/T:1,chr22:50625611:G/C:1,chr2:11819407:C/G:1,chr2:130153274:G/A:1,chr2:160032712:C/A:1,chr2:28516675:G/T:1,chr2:96023639:T/A:1,chr3:138778223:G/A:1,chr4:118833895:C/A:1,chr5:141629409:G/A:1,chr5:149834580:G/T:1,chr5:1501675:T/C:1,chr6:35396106:C/T:1,chr6:49444826:C/A:1,chr7:139865711:G/A:1,chr7:80474080:T/G:1,chr9:111594402:T/A:1,chr9:129110977:A/C:1,chrX:40703435:G/C:1
R-HSA-5576886	Phase 4 - resting membrane potential	Muscle contraction	0.294775	KCNK1,KCNK16	chr1:233647414:G/T:1,chr6:39314972:G/A:1
R-HSA-5576890	Phase 3 - rapid repolarisation	Muscle contraction	0.374212	AKAP9	chr7:91974127:C/A:1,chr7:92040995:G/T:1
R-HSA-5576891	Cardiac conduction	Muscle contraction	0.000267	AKAP9,CACNA1F,CACNA2D3,CACNB2,ITPR2,ITPR3,KAT2B,KCNIP1,KCNIP4,KCNK1,KCNK16,RYR1,RYR2,RYR3,SCN1A,SCN1B,SLC8A1,SLC8A2,SLC8A3	chr10:18448206:G/A:1,chr12:26600531:C/A:1,chr14:70060534:G/T:1,chr15:33432668:T/G:1,chr15:33653029:T/A:1,chr19:35033920:T/C:1,chr19:38464585:G/T:1,chr19:47437640:G/T:1,chr1:233647414:G/T:1,chr1:237756505:G/T:1,chr1:237792382:C/T:1,chr2:166047534:C/T:1,chr2:166047536:A/T:1,chr2:40160677:G/T:1,chr3:20072202:A/T:1,chr3:54918338:T/C:1,chr4:21512091:G/A:1,chr5:170693194:C/A:1,chr6:33676739:C/A:1,chr6:39314972:G/A:1,chr7:91974127:C/A:1,chr7:92040995:G/T:1,chrX:49228469:G/T:1
R-HSA-5576892	Phase 0 - rapid depolarisation	Muscle contraction	0.088208	CACNA1F,CACNA2D3,CACNB2,SCN1A,SCN1B	chr10:18448206:G/A:1,chr19:35033920:T/C:1,chr2:166047534:C/T:1,chr2:166047536:A/T:1,chr3:54918338:T/C:1,chrX:49228469:G/T:1
R-HSA-5576893	Phase 2 - plateau phase	Muscle contraction	0.050683	AKAP9,CACNA1F,CACNA2D3,CACNB2	chr10:18448206:G/A:1,chr3:54918338:T/C:1,chr7:91974127:C/A:1,chr7:92040995:G/T:1,chrX:49228469:G/T:1
R-HSA-5576894	Phase 1 - inactivation of fast Na+ channels	Muscle contraction	0.056075	KCNIP1,KCNIP4	chr4:21512091:G/A:1,chr5:170693194:C/A:1
R-HSA-5578749	Transcriptional regulation by small RNAs	Gene expression (Transcription)	0.031215	NUP214	chr9:131215059:A/G:1
R-HSA-5578768	Physiological factors	Muscle contraction	0.505026	KAT2B	chr3:20072202:A/T:1
R-HSA-5578775	Ion homeostasis	Muscle contraction	0.010739	ITPR2,ITPR3,RYR1,RYR2,RYR3,SLC8A1,SLC8A2,SLC8A3	chr12:26600531:C/A:1,chr14:70060534:G/T:1,chr15:33432668:T/G:1,chr15:33653029:T/A:1,chr19:38464585:G/T:1,chr19:47437640:G/T:1,chr1:237756505:G/T:1,chr1:237792382:C/T:1,chr2:40160677:G/T:1,chr6:33676739:C/A:1
R-HSA-5579024	Defective MAT1A causes Methionine adenosyltransferase deficiency (MATD)	Disease	0.056891	MAT1A	chr10:80283820:G/A:1
R-HSA-5579026	Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)	Disease	0.208897	CYP11A1	chr15:74348128:C/T:1
R-HSA-5579029	Metabolic disorders of biological oxidation enzymes	Disease	0.457614	CYP11A1,MAT1A,TBXAS1	chr10:80283820:G/A:1,chr15:74348128:C/T:1,chr7:139865711:G/A:1
R-HSA-5579032	Defective TBXAS1 causes Ghosal hematodiaphyseal dysplasia (GHDD)	Disease	0.056891	TBXAS1	chr7:139865711:G/A:1
R-HSA-5602358	Diseases associated with the TLR signaling cascade	Disease	0.153436	CD14,CD36,NFKBIA	chr14:35403479:G/T:1,chr5:140633030:C/A:1,chr7:80474080:T/G:1
R-HSA-5602498	MyD88 deficiency (TLR2/4)	Disease	0.107415	CD14,CD36	chr5:140633030:C/A:1,chr7:80474080:T/G:1
R-HSA-5603029	IkBA variant leads to EDA-ID	Disease	0.336437	NFKBIA	chr14:35403479:G/T:1
R-HSA-5603041	IRAK4 deficiency (TLR2/4)	Disease	0.126518	CD14,CD36	chr5:140633030:C/A:1,chr7:80474080:T/G:1
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	Immune System	0.583563	PSMF1,RPS27A	chr20:1117130:G/T:1,chr2:55234745:A/T:1
R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	Immune System	0.126518	ITPR2,ITPR3	chr12:26600531:C/A:1,chr6:33676739:C/A:1
R-HSA-5607764	CLEC7A (Dectin-1) signaling	Immune System	0.513885	CARD11,ITPR2,ITPR3,NFKBIA,PRKCD,PSMF1,RPS27A	chr12:26600531:C/A:1,chr14:35403479:G/T:1,chr20:1117130:G/T:1,chr2:55234745:A/T:1,chr3:53192052:T/G:1,chr6:33676739:C/A:1,chr7:2924035:T/C:1
R-HSA-5609975	Diseases associated with glycosylation precursor biosynthesis	Disease	1.000000	GALE	chr1:23798309:A/C:1
R-HSA-5609977	Defective GALE can cause Epimerase-deficiency galactosemia (EDG)	Disease	0.056891	GALE	chr1:23798309:A/C:1
R-HSA-5610780	Degradation of GLI1 by the proteasome	Signal Transduction	1.000000	PSMF1,RBX1,RPS27A	chr20:1117130:G/T:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1
R-HSA-5610783	Degradation of GLI2 by the proteasome	Signal Transduction	1.000000	PSMF1,RBX1,RPS27A	chr20:1117130:G/T:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	Signal Transduction	1.000000	PSMF1,RBX1,RPS27A	chr20:1117130:G/T:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1
R-HSA-5610787	Hedgehog 'off' state	Signal Transduction	0.415692	PSMF1,RBX1,RPS27A,TUBB2A	chr20:1117130:G/T:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1,chr6:3154999:A/G:1
R-HSA-5617472	Activation of anterior HOX genes in hindbrain development during early embryogenesis	Developmental Biology	0.324771	CNOT9,HDAC3,SUZ12,WDR5	chr17:31973320:T/G:1,chr2:218582908:A/T:1,chr5:141629409:G/A:1,chr9:134155272:C/G:1
R-HSA-5617833	Cilium Assembly	Organelle biogenesis and maintenance	0.759865	AKAP9,B9D1,CEP78,FBF1,MARK4,NPHP1,PCNT,PPP2R1A,TUBB2A,TUBB8	chr10:73757:T/G:1,chr17:19343762:G/A:1,chr17:75926749:C/A:1,chr19:45103617:C/A:1,chr19:52215622:C/T:1,chr21:46351357:C/A:1,chr2:110144454:A/T:1,chr6:3154999:A/G:1,chr7:91974127:C/A:1,chr7:92040995:G/T:1,chr9:78246838:C/A:1
R-HSA-5619047	Defective SLC2A9 causes hypouricemia renal 2 (RHUC2)	Disease	0.056891	SLC2A9	chr4:10005462:C/T:1
R-HSA-5619054	Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA)	Disease	0.056891	SLC4A4	chr4:71544404:G/T:1
R-HSA-5619067	Defective SLC1A1 is implicated in schizophrenia 18 (SCZD18) and dicarboxylic aminoaciduria (DCBXA)	Disease	0.056891	SLC1A1	chr9:4576050:G/A:1
R-HSA-5619084	ABC transporter disorders	Disease	0.081288	ABCA3,ABCC6,ABCD4,CFTR,DERL3,PSMF1,RPS27A,SEL1L	chr14:74292598:G/T:1,chr14:74292774:C/T:1,chr14:81490564:A/C:1,chr16:16203671:G/A:1,chr16:2287934:C/A:1,chr20:1117130:G/T:1,chr22:23838266:G/T:1,chr2:55234745:A/T:1,chr7:117542008:A/T:1
R-HSA-5619087	Defective SLC12A3 causes Gitelman syndrome (GS)	Disease	0.056891	SLC12A3	chr16:56879526:C/A:1
R-HSA-5619099	Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI)	Disease	0.161161	AVPR1A	chr12:63149800:A/T:1
R-HSA-5619102	SLC transporter disorders	Disease	0.183651	AVPR1A,NUP214,SLC12A3,SLC1A1,SLC27A4,SLC2A9,SLC4A4,SLC6A2,SLC7A7	chr12:63149800:A/T:1,chr14:22780250:C/A:1,chr16:55656513:C/T:1,chr16:56879526:C/A:1,chr4:10005462:C/T:1,chr4:71544404:G/T:1,chr9:128360555:C/A:1,chr9:131215059:A/G:1,chr9:4576050:G/A:1
R-HSA-5619107	Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)	Disease	1.000000	NUP214	chr9:131215059:A/G:1
R-HSA-5619108	Defective SLC27A4 causes ichthyosis prematurity syndrome (IPS)	Disease	0.056891	SLC27A4	chr9:128360555:C/A:1
R-HSA-5619109	Defective SLC6A2 causes orthostatic intolerance (OI)	Disease	0.056891	SLC6A2	chr16:55656513:C/T:1
R-HSA-5619115	Disorders of transmembrane transporters	Disease	0.031045	ABCA3,ABCC6,ABCD4,AVPR1A,CFTR,DERL3,NUP214,PSMF1,RPS27A,SEL1L,SLC12A3,SLC1A1,SLC27A4,SLC2A9,SLC4A4,SLC6A2,SLC7A7	chr12:63149800:A/T:1,chr14:22780250:C/A:1,chr14:74292598:G/T:1,chr14:74292774:C/T:1,chr14:81490564:A/C:1,chr16:16203671:G/A:1,chr16:2287934:C/A:1,chr16:55656513:C/T:1,chr16:56879526:C/A:1,chr20:1117130:G/T:1,chr22:23838266:G/T:1,chr2:55234745:A/T:1,chr4:10005462:C/T:1,chr4:71544404:G/T:1,chr7:117542008:A/T:1,chr9:128360555:C/A:1,chr9:131215059:A/G:1,chr9:4576050:G/A:1
R-HSA-5619507	Activation of HOX genes during differentiation	Developmental Biology	0.324771	CNOT9,HDAC3,SUZ12,WDR5	chr17:31973320:T/G:1,chr2:218582908:A/T:1,chr5:141629409:G/A:1,chr9:134155272:C/G:1
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	Organelle biogenesis and maintenance	0.266594	AKAP9,B9D1,CEP78,FBF1,MARK4,NPHP1,PCNT,PPP2R1A	chr17:19343762:G/A:1,chr17:75926749:C/A:1,chr19:45103617:C/A:1,chr19:52215622:C/T:1,chr21:46351357:C/A:1,chr2:110144454:A/T:1,chr7:91974127:C/A:1,chr7:92040995:G/T:1,chr9:78246838:C/A:1
R-HSA-5620924	Intraflagellar transport	Organelle biogenesis and maintenance	0.371138	TUBB2A	chr6:3154999:A/G:1
R-HSA-5621480	Dectin-2 family	Immune System	0.014241	CLEC4D,MUC15,MUC17,MUC3A,MUC4	chr11:26561226:C/A:1,chr12:8512275:G/T:1,chr3:195752618:A/G:1,chr3:195752619:G/C:1,chr7:100958263:A/G:1,chr7:101035696:G/T:1
R-HSA-5621481	C-type lectin receptors (CLRs)	Immune System	0.140025	CARD11,CLEC4D,ITPR2,ITPR3,MUC15,MUC17,MUC3A,MUC4,NFKBIA,PRKCD,PSMF1,RPS27A	chr11:26561226:C/A:1,chr12:26600531:C/A:1,chr12:8512275:G/T:1,chr14:35403479:G/T:1,chr20:1117130:G/T:1,chr2:55234745:A/T:1,chr3:195752618:A/G:1,chr3:195752619:G/C:1,chr3:53192052:T/G:1,chr6:33676739:C/A:1,chr7:100958263:A/G:1,chr7:101035696:G/T:1,chr7:2924035:T/C:1
R-HSA-5625740	RHO GTPases activate PKNs	Signal Transduction	0.492899	KDM4C,MYH9,PPP1R12A	chr12:79822198:G/T:1,chr22:36320146:C/A:1,chr9:6893015:A/T:1
R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	Signal Transduction	0.183632	KDM4C	chr9:6893015:A/T:1
R-HSA-5625900	RHO GTPases activate CIT	Signal Transduction	0.090127	CIT,MYH9,PPP1R12A	chr12:119796589:G/T:1,chr12:79822198:G/T:1,chr22:36320146:C/A:1
R-HSA-5625970	RHO GTPases activate KTN1	Signal Transduction	0.126518	KLC2,KLC4	chr11:66264919:G/A:1,chr6:43055804:A/T:1
R-HSA-5626467	RHO GTPases activate IQGAPs	Signal Transduction	0.001801	CDH1,CLIP1,IQGAP1,IQGAP2,MEN1,TUBB2A,TUBB8	chr10:73757:T/G:1,chr11:64807481:C/T:1,chr12:122341757:C/T:1,chr15:90390695:A/G:1,chr15:90485816:T/C:1,chr16:68779429:G/T:1,chr5:76654711:T/C:1,chr6:3154999:A/G:1
R-HSA-5627083	RHO GTPases regulate CFTR trafficking	Signal Transduction	0.161161	CFTR	chr7:117542008:A/T:1
R-HSA-5627117	RHO GTPases Activate ROCKs	Signal Transduction	0.090127	LIMK2,MYH9,PPP1R12A	chr12:79822198:G/T:1,chr22:31260099:C/A:1,chr22:36320146:C/A:1
R-HSA-5627123	RHO GTPases activate PAKs	Signal Transduction	0.113936	CTTN,MYH9,PPP1R12A	chr11:70431006:C/A:1,chr12:79822198:G/T:1,chr22:36320146:C/A:1
R-HSA-5628897	TP53 Regulates Metabolic Genes	Gene expression (Transcription)	0.147974	AGO4,DDIT4,LRPPRC,PRKAA2,PRKAB2,RPTOR,TIGAR,TNRC6B	chr10:72275283:T/A:1,chr12:4321404:C/A:1,chr17:80664395:C/A:1,chr1:147172001:G/A:1,chr1:35850806:C/A:1,chr1:56706008:C/A:1,chr22:40049003:G/T:1,chr2:43944068:C/A:1
R-HSA-5632684	Hedgehog 'on' state	Signal Transduction	0.817000	IQCE,PSMF1,RBX1,RPS27A,SMURF1	chr20:1117130:G/T:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1,chr7:2607089:A/G:1,chr7:99061975:G/T:1
R-HSA-5633007	Regulation of TP53 Activity	Gene expression (Transcription)	0.169577	BRCA1,CHEK1,JMY,PIN1,POU4F1,PPP2R1A,PPP2R5C,PRKAA2,PRKAB2,RPA1,RPA2,RPS27A,TAF5	chr10:103387074:A/C:1,chr11:125637382:T/C:1,chr13:78601815:G/T:1,chr14:101883867:G/T:1,chr17:1853255:C/A:1,chr17:43049287:C/G:1,chr19:52215622:C/T:1,chr19:9849326:C/A:1,chr1:147172001:G/A:1,chr1:27914481:C/T:1,chr1:56706008:C/A:1,chr2:55234745:A/T:1,chr5:79300647:C/A:1
R-HSA-5633008	TP53 Regulates Transcription of Cell Death Genes	Gene expression (Transcription)	0.738060	APAF1,CASP2,TNFRSF10A	chr12:98648251:A/T:1,chr7:143292189:T/C:1,chr8:23202515:G/T:1
R-HSA-5635838	Activation of SMO	Signal Transduction	1.000000	IQCE	chr7:2607089:A/G:1
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	Disease	1.000000	RPS27A	chr2:55234745:A/T:1
R-HSA-5649702	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway	DNA Repair	0.056075	NEIL1,POLB	chr15:75355845:G/C:1,chr8:42369772:A/T:1
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	DNA Repair	0.028647	POLB,POLE,RPA1,RPA2	chr12:132643245:T/C:1,chr17:1853255:C/A:1,chr1:27914481:C/T:1,chr8:42369772:A/T:1
R-HSA-5653656	Vesicle-mediated transport	Vesicle-mediated transport	0.319371	ALPP,ALS2,ANK1,ANK3,AP2B1,BIN1,CD36,CFTR,COL1A1,CPD,CTTN,DENND3,EPS15,FCHO1,FCHO2,GABARAP,GGA2,GNS,GOLGA1,HPS4,ITSN2,KIF11,KIF25,KLC2,KLC4,MYH9,NBAS,PIP5K1C,PPP6C,PRKAA2,PRKAB2,RAB10,RAB3GAP1,RAB4A,RAB6B,RPS27A,SBF1,SCOC,SEC16B,SEC23A,SEC24D,SEC31A,SPTBN4,STAM,TBC1D14,TUBB2A,TUBB8	chr10:17660650:A/C:1,chr10:60685310:G/A:1,chr10:73757:T/G:1,chr10:92639648:G/T:1,chr11:66264919:G/A:1,chr11:70431006:C/A:1,chr12:64722884:C/A:1,chr14:39040609:C/A:1,chr16:23469223:G/T:1,chr17:30461111:A/T:1,chr17:35682607:A/G:1,chr17:50195100:C/A:1,chr17:7240852:C/A:1,chr19:17774499:G/A:1,chr19:17787746:T/C:1,chr19:3643094:C/A:1,chr19:40569803:G/A:1,chr1:147172001:G/A:1,chr1:177936177:G/T:1,chr1:229288550:C/A:1,chr1:51465474:T/A:1,chr1:56706008:C/A:1,chr22:26465716:C/T:1,chr22:36320146:C/A:1,chr22:50461719:C/T:1,chr2:127060445:C/T:1,chr2:135113016:C/T:1,chr2:15421926:C/A:1,chr2:201728707:T/A:1,chr2:232379271:A/T:1,chr2:24209639:T/G:1,chr2:26109711:A/T:1,chr2:55234745:A/T:1,chr3:133841152:G/A:1,chr4:118833895:C/A:1,chr4:140287063:A/C:1,chr4:7030472:G/C:1,chr4:82855072:T/A:1,chr5:73087969:C/A:1,chr6:168040119:C/A:1,chr6:3154999:A/G:1,chr6:43055804:A/T:1,chr7:117542008:A/T:1,chr7:80474080:T/G:1,chr8:141176474:A/G:1,chr8:41808044:G/T:1,chr9:124921607:C/T:1,chr9:125171223:T/A:1
R-HSA-5654687	Downstream signaling of activated FGFR1	Signal Transduction	1.000000	PTPN11	chr12:112489105:A/T:1
R-HSA-5654689	PI-3K cascade:FGFR1	Signal Transduction	1.000000	PTPN11	chr12:112489105:A/T:1
R-HSA-5654693	FRS-mediated FGFR1 signaling	Signal Transduction	1.000000	PTPN11	chr12:112489105:A/T:1
R-HSA-5654695	PI-3K cascade:FGFR2	Signal Transduction	1.000000	PTPN11	chr12:112489105:A/T:1
R-HSA-5654696	Downstream signaling of activated FGFR2	Signal Transduction	1.000000	PTPN11	chr12:112489105:A/T:1
R-HSA-5654700	FRS-mediated FGFR2 signaling	Signal Transduction	1.000000	PTPN11	chr12:112489105:A/T:1
R-HSA-5654706	FRS-mediated FGFR3 signaling	Signal Transduction	1.000000	PTPN11	chr12:112489105:A/T:1
R-HSA-5654708	Downstream signaling of activated FGFR3	Signal Transduction	1.000000	PTPN11	chr12:112489105:A/T:1
R-HSA-5654710	PI-3K cascade:FGFR3	Signal Transduction	1.000000	PTPN11	chr12:112489105:A/T:1
R-HSA-5654712	FRS-mediated FGFR4 signaling	Signal Transduction	1.000000	PTPN11	chr12:112489105:A/T:1
R-HSA-5654716	Downstream signaling of activated FGFR4	Signal Transduction	1.000000	PTPN11	chr12:112489105:A/T:1
R-HSA-5654720	PI-3K cascade:FGFR4	Signal Transduction	1.000000	PTPN11	chr12:112489105:A/T:1
R-HSA-5654726	Negative regulation of FGFR1 signaling	Signal Transduction	0.433338	PPP2R1A,PTPN11,RPS27A	chr12:112489105:A/T:1,chr19:52215622:C/T:1,chr2:55234745:A/T:1
R-HSA-5654727	Negative regulation of FGFR2 signaling	Signal Transduction	0.440945	PPP2R1A,PTPN11,RPS27A	chr12:112489105:A/T:1,chr19:52215622:C/T:1,chr2:55234745:A/T:1
R-HSA-5654732	Negative regulation of FGFR3 signaling	Signal Transduction	0.226639	PPP2R1A,PTPN11,RPS27A	chr12:112489105:A/T:1,chr19:52215622:C/T:1,chr2:55234745:A/T:1
R-HSA-5654733	Negative regulation of FGFR4 signaling	Signal Transduction	0.257582	PPP2R1A,PTPN11,RPS27A	chr12:112489105:A/T:1,chr19:52215622:C/T:1,chr2:55234745:A/T:1
R-HSA-5654736	Signaling by FGFR1	Signal Transduction	0.761410	PPP2R1A,PTPN11,RPS27A	chr12:112489105:A/T:1,chr19:52215622:C/T:1,chr2:55234745:A/T:1
R-HSA-5654738	Signaling by FGFR2	Signal Transduction	0.309032	GTF2F1,NCBP1,PPP2R1A,PTBP1,PTPN11,RPS27A	chr12:112489105:A/T:1,chr19:52215622:C/T:1,chr19:6380036:G/T:1,chr19:804704:T/A:1,chr2:55234745:A/T:1,chr9:97664178:C/A:1
R-HSA-5654741	Signaling by FGFR3	Signal Transduction	0.495338	PPP2R1A,PTPN11,RPS27A	chr12:112489105:A/T:1,chr19:52215622:C/T:1,chr2:55234745:A/T:1
R-HSA-5654743	Signaling by FGFR4	Signal Transduction	0.505418	PPP2R1A,PTPN11,RPS27A	chr12:112489105:A/T:1,chr19:52215622:C/T:1,chr2:55234745:A/T:1
R-HSA-5655253	Signaling by FGFR2 in disease	Disease	1.000000	GTF2F1,NCBP1	chr19:6380036:G/T:1,chr9:97664178:C/A:1
R-HSA-5655302	Signaling by FGFR1 in disease	Disease	0.723323	MYO18A	chr17:29097561:C/T:1
R-HSA-5655862	Translesion synthesis by POLK	DNA Repair	0.068709	RPA1,RPA2,RPS27A	chr17:1853255:C/A:1,chr1:27914481:C/T:1,chr2:55234745:A/T:1
R-HSA-5656121	Translesion synthesis by POLI	DNA Repair	0.068709	RPA1,RPA2,RPS27A	chr17:1853255:C/A:1,chr1:27914481:C/T:1,chr2:55234745:A/T:1
R-HSA-5656169	Termination of translesion DNA synthesis	DNA Repair	0.105992	POLE,RPA1,RPA2,RPS27A	chr12:132643245:T/C:1,chr17:1853255:C/A:1,chr1:27914481:C/T:1,chr2:55234745:A/T:1
R-HSA-5658442	Regulation of RAS by GAPs	Signal Transduction;Immune System	0.109059	DAB2IP,PSMF1,RASAL1,RASAL2,RBX1,RPS27A,SPRED3	chr12:113100514:A/G:1,chr12:113118892:G/T:1,chr19:38392374:C/T:1,chr19:38394161:T/G:1,chr1:178470804:T/C:1,chr20:1117130:G/T:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1,chr9:121578321:C/A:1
R-HSA-5660862	Defective SLC7A7 causes lysinuric protein intolerance (LPI)	Disease	0.110550	SLC7A7	chr14:22780250:C/A:1
R-HSA-5663084	Diseases of carbohydrate metabolism	Disease	0.433338	GALNS,GNS,RPS27A	chr12:64722884:C/A:1,chr16:88837557:G/T:1,chr2:55234745:A/T:1
R-HSA-5663202	Diseases of signal transduction by growth factor receptors and second messengers	Disease	0.039643	AKAP9,BIN2,CSK,ERBB4,FBXW7,GTF2F1,HDAC11,HDAC3,HDAC5,HDAC8,HEY1,IQGAP1,IRS1,KAT2B,KITLG,MYO18A,NCBP1,NCSTN,NRG3,PIK3CB,PPP2R1A,PPP2R5C,PSMF1,PTPN11,RBX1,RPS27A,SEL1L,SPRED3,TCF7L2,TLN1,TNKS	chr10:112964742:G/A:1,chr10:82985678:T/A:1,chr12:112489105:A/T:1,chr12:51297095:C/A:1,chr12:88516155:G/T:1,chr14:101883867:G/T:1,chr14:81490564:A/C:1,chr15:74802540:C/T:1,chr15:90390695:A/G:1,chr15:90485816:T/C:1,chr17:29097561:C/T:1,chr17:44079338:G/T:1,chr19:38392374:C/T:1,chr19:38394161:T/G:1,chr19:52215622:C/T:1,chr19:6380036:G/T:1,chr1:160353563:A/G:1,chr20:1117130:G/T:1,chr22:40963988:A/T:1,chr2:211630704:C/G:1,chr2:226796751:A/G:1,chr2:55234745:A/T:1,chr3:13496579:C/G:1,chr3:138778223:G/A:1,chr3:20072202:A/T:1,chr4:152350128:T/A:1,chr5:141629409:G/A:1,chr7:91974127:C/A:1,chr7:92040995:G/T:1,chr8:79766933:C/A:1,chr8:9776590:C/A:1,chr9:35697963:G/T:1,chr9:97664178:C/A:1,chrX:72572139:G/A:1
R-HSA-5663205	Infectious disease	Disease	0.341204	AP2B1,ARPC1B,CDH1,CRHR1,DOCK1,EPS15,GLP1R,GNAT3,GTF2F1,HCK,HDAC3,IGHG1,IGHG2,IGHG4,ITPR2,ITPR3,LHCGR,MAP2K3,MYH9,NCBP1,NUP214,PLK2,PSMF1,RBX1,RCC1,RPL10,RPL23,RPL31,RPS27A,RPS6,RPS9,STAM,SUZ12,TAF5,TUBB2A,TUBB8,VIPR2,VPS33B,WASF2	chr10:103387074:A/C:1,chr10:127257347:G/T:1,chr10:17660650:A/C:1,chr10:73757:T/G:1,chr12:26600531:C/A:1,chr14:105624404:C/G:1,chr14:105641644:C/T:1,chr14:105741468:G/C:1,chr14:105741485:A/G:1,chr15:91014129:G/T:1,chr16:68779429:G/T:1,chr17:21303128:C/T:1,chr17:31973320:T/G:1,chr17:35682607:A/G:1,chr17:38850552:C/A:1,chr17:45831011:G/T:1,chr17:45833036:G/C:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr19:6380036:G/T:1,chr1:27412951:A/T:1,chr1:28508571:C/A:1,chr1:51465474:T/A:1,chr20:1117130:G/T:1,chr20:32098788:C/A:1,chr22:36320146:C/A:1,chr22:40963988:A/T:1,chr2:101018980:G/T:1,chr2:48708797:C/G:1,chr2:55234745:A/T:1,chr5:141629409:G/A:1,chr5:58454762:G/T:1,chr6:3154999:A/G:1,chr6:33676739:C/A:1,chr6:39086149:G/A:1,chr7:159142629:C/A:1,chr7:80474080:T/G:1,chr7:99394321:C/T:1,chr9:131215059:A/G:1,chr9:19376102:T/C:1,chr9:97664178:C/A:1,chrX:154405329:C/A:1
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	Signal Transduction	1.000000	ARPC1B,WASF2	chr1:27412951:A/T:1,chr7:99394321:C/T:1
R-HSA-5663220	RHO GTPases Activate Formins	Signal Transduction	0.711275	CLASP2,CLIP1,EVL,KNL1,PPP2R1A,PPP2R5C,RCC2,TUBB2A,TUBB8	chr10:73757:T/G:1,chr12:122341757:C/T:1,chr14:100141166:C/A:1,chr14:101883867:G/T:1,chr15:40651961:A/T:1,chr19:52215622:C/T:1,chr1:17413265:G/T:1,chr3:33602979:G/T:1,chr6:3154999:A/G:1
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	Immune System	0.382124	PSMF1,RPS27A,TNFRSF1B	chr1:12188701:A/G:1,chr1:12203460:C/A:1,chr20:1117130:G/T:1,chr2:55234745:A/T:1
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	Signal Transduction	0.153436	PIN1,PRKCB,PRKCD	chr16:23867049:C/T:1,chr19:9849326:C/A:1,chr3:53192052:T/G:1
R-HSA-5668914	Diseases of metabolism	Disease	0.016892	ABCA3,ABCD4,ADAMTS1,ADAMTS13,ALG12,BCAN,CSPG4,CYP11A1,EXT2,GALE,GALNS,GNS,HSPG2,MAT1A,MUC15,MUC17,MUC3A,MUC4,MUT,PCCA,RPS27A,SFTPD,TBXAS1	chr10:79946379:C/A:1,chr10:80283820:G/A:1,chr11:26561226:C/A:1,chr11:44236478:G/T:1,chr12:64722884:C/A:1,chr13:100469233:C/A:1,chr14:74292598:G/T:1,chr14:74292774:C/T:1,chr15:74348128:C/T:1,chr15:75675473:A/G:1,chr16:2287934:C/A:1,chr16:88837557:G/T:1,chr1:156650224:G/T:1,chr1:156652083:T/G:1,chr1:21839609:G/T:1,chr1:21850169:G/T:1,chr1:23798309:A/C:1,chr21:26843749:G/A:1,chr22:49903355:G/T:1,chr2:55234745:A/T:1,chr3:195752618:A/G:1,chr3:195752619:G/C:1,chr6:49444826:C/A:1,chr7:100958263:A/G:1,chr7:101035696:G/T:1,chr7:139865711:G/A:1,chr9:133439628:C/T:1
R-HSA-5669034	TNFs bind their physiological receptors	Immune System	1.000000	TNFRSF1B	chr1:12188701:A/G:1,chr1:12203460:C/A:1
R-HSA-5673000	RAF activation	Signal Transduction;Immune System	0.687650	PPP2R1A,PPP2R5C	chr14:101883867:G/T:1,chr19:52215622:C/T:1
R-HSA-5673001	RAF/MAP kinase cascade	Signal Transduction;Immune System	0.123719	CSK,DAB2IP,ERBB4,IL2RB,IQGAP1,IRS1,KITLG,NCAM1,NRG3,PPP2R1A,PPP2R5C,PSMF1,PTPRA,RASAL1,RASAL2,RBX1,RPS27A,SPRED3,SPTBN4,TLN1	chr10:82985678:T/A:1,chr11:113207596:G/T:1,chr12:113100514:A/G:1,chr12:113118892:G/T:1,chr12:88516155:G/T:1,chr14:101883867:G/T:1,chr15:74802540:C/T:1,chr15:90390695:A/G:1,chr15:90485816:T/C:1,chr19:38392374:C/T:1,chr19:38394161:T/G:1,chr19:40569803:G/A:1,chr19:52215622:C/T:1,chr1:178470804:T/C:1,chr20:1117130:G/T:1,chr20:2975202:A/T:1,chr20:2988197:T/A:1,chr22:37132322:T/G:1,chr22:37142288:T/C:1,chr22:40963988:A/T:1,chr2:211630704:C/G:1,chr2:226796751:A/G:1,chr2:55234745:A/T:1,chr9:121578321:C/A:1,chr9:35697963:G/T:1
R-HSA-5674135	MAP2K and MAPK activation	Signal Transduction;Immune System	0.495338	CSK,IQGAP1,TLN1	chr15:74802540:C/T:1,chr15:90390695:A/G:1,chr15:90485816:T/C:1,chr9:35697963:G/T:1
R-HSA-5675221	Negative regulation of MAPK pathway	Signal Transduction;Immune System	0.495338	PPP2R1A,PPP2R5C,RPS27A	chr14:101883867:G/T:1,chr19:52215622:C/T:1,chr2:55234745:A/T:1
R-HSA-5675482	Regulation of necroptotic cell death	Programmed Cell Death	0.273233	RPS27A,TNFRSF10A	chr2:55234745:A/T:1,chr8:23202515:G/T:1
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	Immune System	0.774251	PSMF1,RPS27A	chr20:1117130:G/T:1,chr2:55234745:A/T:1
R-HSA-5678895	Defective CFTR causes cystic fibrosis	Disease	0.396260	CFTR,DERL3,PSMF1,RPS27A,SEL1L	chr14:81490564:A/C:1,chr20:1117130:G/T:1,chr22:23838266:G/T:1,chr2:55234745:A/T:1,chr7:117542008:A/T:1
R-HSA-5683057	MAPK family signaling cascades	Signal Transduction	0.074204	AGO4,CSK,DAB2IP,ERBB4,IL2RB,IQGAP1,IRS1,KALRN,KITLG,NCAM1,NRG3,PPP2R1A,PPP2R5C,PSMF1,PTPN11,PTPRA,RASAL1,RASAL2,RBX1,RPS27A,SPRED3,SPTBN4,TLN1,TNRC6B	chr10:82985678:T/A:1,chr11:113207596:G/T:1,chr12:112489105:A/T:1,chr12:113100514:A/G:1,chr12:113118892:G/T:1,chr12:88516155:G/T:1,chr14:101883867:G/T:1,chr15:74802540:C/T:1,chr15:90390695:A/G:1,chr15:90485816:T/C:1,chr19:38392374:C/T:1,chr19:38394161:T/G:1,chr19:40569803:G/A:1,chr19:52215622:C/T:1,chr1:178470804:T/C:1,chr1:35850806:C/A:1,chr20:1117130:G/T:1,chr20:2975202:A/T:1,chr20:2988197:T/A:1,chr22:37132322:T/G:1,chr22:37142288:T/C:1,chr22:40049003:G/T:1,chr22:40963988:A/T:1,chr2:211630704:C/G:1,chr2:226796751:A/G:1,chr2:55234745:A/T:1,chr3:124138871:G/T:1,chr3:124477465:C/A:1,chr9:121578321:C/A:1,chr9:35697963:G/T:1
R-HSA-5683329	Defective ABCD4 causes methylmalonic aciduria and homocystinuria, cblj type (MAHCJ)	Disease	0.056891	ABCD4	chr14:74292598:G/T:1,chr14:74292774:C/T:1
R-HSA-5683678	Defective ABCA3 causes pulmonary surfactant metabolism dysfunction type 3 (SMDP3)	Disease	0.056891	ABCA3	chr16:2287934:C/A:1
R-HSA-5683826	Surfactant metabolism	Metabolism of proteins	0.687650	ABCA3,SFTPD	chr10:79946379:C/A:1,chr16:2287934:C/A:1
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	Immune System	0.608530	RPS27A	chr2:55234745:A/T:1
R-HSA-5684996	MAPK1/MAPK3 signaling	Signal Transduction	0.073878	CSK,DAB2IP,ERBB4,IL2RB,IQGAP1,IRS1,KITLG,NCAM1,NRG3,PPP2R1A,PPP2R5C,PSMF1,PTPN11,PTPRA,RASAL1,RASAL2,RBX1,RPS27A,SPRED3,SPTBN4,TLN1	chr10:82985678:T/A:1,chr11:113207596:G/T:1,chr12:112489105:A/T:1,chr12:113100514:A/G:1,chr12:113118892:G/T:1,chr12:88516155:G/T:1,chr14:101883867:G/T:1,chr15:74802540:C/T:1,chr15:90390695:A/G:1,chr15:90485816:T/C:1,chr19:38392374:C/T:1,chr19:38394161:T/G:1,chr19:40569803:G/A:1,chr19:52215622:C/T:1,chr1:178470804:T/C:1,chr20:1117130:G/T:1,chr20:2975202:A/T:1,chr20:2988197:T/A:1,chr22:37132322:T/G:1,chr22:37142288:T/C:1,chr22:40963988:A/T:1,chr2:211630704:C/G:1,chr2:226796751:A/G:1,chr2:55234745:A/T:1,chr9:121578321:C/A:1,chr9:35697963:G/T:1
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	DNA Repair	0.466570	BRCA1,RPA1,RPA2	chr17:1853255:C/A:1,chr17:43049287:C/G:1,chr1:27914481:C/T:1
R-HSA-5685942	HDR through Homologous Recombination (HRR)	DNA Repair	0.055021	BRCA1,CHEK1,POLE,RPA1,RPA2,RPS27A,RTEL1,SPIDR	chr11:125637382:T/C:1,chr12:132643245:T/C:1,chr17:1853255:C/A:1,chr17:43049287:C/G:1,chr1:27914481:C/T:1,chr20:63667624:C/A:1,chr2:55234745:A/T:1,chr8:47592011:C/A:1
R-HSA-5686938	Regulation of TLR by endogenous ligand	Immune System	0.090127	CD14,CD36,SFTPD	chr10:79946379:C/A:1,chr5:140633030:C/A:1,chr7:80474080:T/G:1
R-HSA-5687128	MAPK6/MAPK4 signaling	Signal Transduction	1.000000	AGO4,KALRN,PSMF1,RPS27A,TNRC6B	chr1:35850806:C/A:1,chr20:1117130:G/T:1,chr22:40049003:G/T:1,chr2:55234745:A/T:1,chr3:124138871:G/T:1,chr3:124477465:C/A:1
R-HSA-5687613	Diseases associated with surfactant metabolism	Disease	0.107415	ABCA3,SFTPD	chr10:79946379:C/A:1,chr16:2287934:C/A:1
R-HSA-5688399	Defective ABCA3 causes pulmonary surfactant metabolism dysfunction 3 (SMDP3)	Disease	0.056891	ABCA3	chr16:2287934:C/A:1
R-HSA-5688426	Deubiquitination	Metabolism of proteins	0.799498	ABRAXAS1,BABAM2,BRCA1,CFTR,KAT2B,MBD5,MCRS1,NFKBIA,NOD2,POLB,PRKN,PSMF1,RPS27A,STAM,STAMBPL1,TNKS,USP42,USP8	chr10:17660650:A/C:1,chr10:88947447:C/A:1,chr12:49557449:T/C:1,chr12:49558885:G/A:1,chr14:35403479:G/T:1,chr15:50441258:C/A:1,chr16:50711288:C/T:1,chr17:43049287:C/G:1,chr20:1117130:G/T:1,chr2:148510030:A/T:1,chr2:28274140:C/A:1,chr2:55234745:A/T:1,chr3:20072202:A/T:1,chr4:83460892:G/T:1,chr6:161549199:T/A:1,chr7:117542008:A/T:1,chr7:6150119:C/T:1,chr7:6150149:T/C:1,chr8:42369772:A/T:1,chr8:9776590:C/A:1
R-HSA-5688849	Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)	Disease	0.374212	SFTPD	chr10:79946379:C/A:1
R-HSA-5688890	Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)	Disease	0.374212	SFTPD	chr10:79946379:C/A:1
R-HSA-5689603	UCH proteinases	Metabolism of proteins	0.664442	MBD5,MCRS1,PSMF1,RPS27A	chr12:49557449:T/C:1,chr12:49558885:G/A:1,chr20:1117130:G/T:1,chr2:148510030:A/T:1,chr2:55234745:A/T:1
R-HSA-5689877	Josephin domain DUBs	Metabolism of proteins	0.146339	PRKN,RPS27A	chr2:55234745:A/T:1,chr6:161549199:T/A:1
R-HSA-5689880	Ub-specific processing proteases	Metabolism of proteins	0.238654	CFTR,NFKBIA,POLB,PSMF1,RPS27A,TNKS,USP42,USP8	chr14:35403479:G/T:1,chr15:50441258:C/A:1,chr20:1117130:G/T:1,chr2:55234745:A/T:1,chr7:117542008:A/T:1,chr7:6150119:C/T:1,chr7:6150149:T/C:1,chr8:42369772:A/T:1,chr8:9776590:C/A:1
R-HSA-5689896	Ovarian tumor domain proteases	Metabolism of proteins	1.000000	NOD2,RPS27A	chr16:50711288:C/T:1,chr2:55234745:A/T:1
R-HSA-5689901	Metalloprotease DUBs	Metabolism of proteins	0.004305	ABRAXAS1,BABAM2,BRCA1,KAT2B,RPS27A,STAM,STAMBPL1	chr10:17660650:A/C:1,chr10:88947447:C/A:1,chr17:43049287:C/G:1,chr2:28274140:C/A:1,chr2:55234745:A/T:1,chr3:20072202:A/T:1,chr4:83460892:G/T:1
R-HSA-5690338	Defective ABCC6 causes pseudoxanthoma elasticum (PXE)	Disease	0.056891	ABCC6	chr16:16203671:G/A:1
R-HSA-5690714	CD22 mediated BCR regulation	Immune System	0.262601	PTPN6	chr12:6960084:C/T:1
R-HSA-5693532	DNA Double-Strand Break Repair	DNA Repair	0.610073	ABRAXAS1,BABAM2,BRCA1,CHEK1,POLE,RPA1,RPA2,RPS27A,RTEL1,SPIDR,TDP1	chr11:125637382:T/C:1,chr12:132643245:T/C:1,chr14:89966308:A/G:1,chr14:89985137:A/T:1,chr17:1853255:C/A:1,chr17:43049287:C/G:1,chr1:27914481:C/T:1,chr20:63667624:C/A:1,chr2:28274140:C/A:1,chr2:55234745:A/T:1,chr4:83460892:G/T:1,chr8:47592011:C/A:1
R-HSA-5693537	Resolution of D-Loop Structures	DNA Repair	0.440945	BRCA1,RTEL1,SPIDR	chr17:43049287:C/G:1,chr20:63667624:C/A:1,chr8:47592011:C/A:1
R-HSA-5693538	Homology Directed Repair	DNA Repair	0.455384	ABRAXAS1,BABAM2,BRCA1,CHEK1,POLE,RPA1,RPA2,RPS27A,RTEL1,SPIDR	chr11:125637382:T/C:1,chr12:132643245:T/C:1,chr17:1853255:C/A:1,chr17:43049287:C/G:1,chr1:27914481:C/T:1,chr20:63667624:C/A:1,chr2:28274140:C/A:1,chr2:55234745:A/T:1,chr4:83460892:G/T:1,chr8:47592011:C/A:1
R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	DNA Repair	0.657751	BRCA1,RTEL1	chr17:43049287:C/G:1,chr20:63667624:C/A:1
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	DNA Repair	1.000000	ABRAXAS1,BABAM2,BRCA1,RPS27A	chr17:43049287:C/G:1,chr2:28274140:C/A:1,chr2:55234745:A/T:1,chr4:83460892:G/T:1
R-HSA-5693567	HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)	DNA Repair	0.340949	ABRAXAS1,BABAM2,BRCA1,CHEK1,POLE,RPA1,RPA2,RPS27A,RTEL1,SPIDR	chr11:125637382:T/C:1,chr12:132643245:T/C:1,chr17:1853255:C/A:1,chr17:43049287:C/G:1,chr1:27914481:C/T:1,chr20:63667624:C/A:1,chr2:28274140:C/A:1,chr2:55234745:A/T:1,chr4:83460892:G/T:1,chr8:47592011:C/A:1
R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	DNA Repair	0.711848	BRCA1,SPIDR	chr17:43049287:C/G:1,chr8:47592011:C/A:1
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	DNA Repair	0.797578	ABRAXAS1,BABAM2,BRCA1,TDP1	chr14:89966308:A/G:1,chr14:89985137:A/T:1,chr17:43049287:C/G:1,chr2:28274140:C/A:1,chr4:83460892:G/T:1
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	DNA Repair	0.299954	BRCA1,CHEK1,RPA1,RPA2	chr11:125637382:T/C:1,chr17:1853255:C/A:1,chr17:43049287:C/G:1,chr1:27914481:C/T:1
R-HSA-5693606	DNA Double Strand Break Response	DNA Repair	1.000000	ABRAXAS1,BABAM2,BRCA1,RPS27A	chr17:43049287:C/G:1,chr2:28274140:C/A:1,chr2:55234745:A/T:1,chr4:83460892:G/T:1
R-HSA-5693607	Processing of DNA double-strand break ends	DNA Repair	0.507277	ABRAXAS1,BABAM2,BRCA1,CHEK1,RPA1,RPA2,RPS27A	chr11:125637382:T/C:1,chr17:1853255:C/A:1,chr17:43049287:C/G:1,chr1:27914481:C/T:1,chr2:28274140:C/A:1,chr2:55234745:A/T:1,chr4:83460892:G/T:1
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	DNA Repair	0.280796	BRCA1,CHEK1,RPA1,RPA2	chr11:125637382:T/C:1,chr17:1853255:C/A:1,chr17:43049287:C/G:1,chr1:27914481:C/T:1
R-HSA-5694530	Cargo concentration in the ER	Metabolism of proteins;Vesicle-mediated transport	0.711848	SEC23A,SEC24D	chr14:39040609:C/A:1,chr4:118833895:C/A:1
R-HSA-5696394	DNA Damage Recognition in GG-NER	DNA Repair	0.475872	MCRS1,RBX1,RPS27A	chr12:49557449:T/C:1,chr12:49558885:G/A:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1
R-HSA-5696395	Formation of Incision Complex in GG-NER	DNA Repair	0.095399	CHD1L,RBX1,RPA1,RPA2,RPS27A	chr17:1853255:C/A:1,chr1:147271053:C/A:1,chr1:27914481:C/T:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	DNA Repair	0.050683	POLE,RPA1,RPA2,RPS27A	chr12:132643245:T/C:1,chr17:1853255:C/A:1,chr1:27914481:C/T:1,chr2:55234745:A/T:1
R-HSA-5696398	Nucleotide Excision Repair	DNA Repair	0.678937	CHD1L,MCRS1,POLE,RBX1,RPA1,RPA2,RPS27A	chr12:132643245:T/C:1,chr12:49557449:T/C:1,chr12:49558885:G/A:1,chr17:1853255:C/A:1,chr1:147271053:C/A:1,chr1:27914481:C/T:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	DNA Repair	0.336293	CHD1L,MCRS1,POLE,RBX1,RPA1,RPA2,RPS27A	chr12:132643245:T/C:1,chr12:49557449:T/C:1,chr12:49558885:G/A:1,chr17:1853255:C/A:1,chr1:147271053:C/A:1,chr1:27914481:C/T:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1
R-HSA-5696400	Dual Incision in GG-NER	DNA Repair	0.027212	CHD1L,POLE,RBX1,RPA1,RPA2,RPS27A	chr12:132643245:T/C:1,chr17:1853255:C/A:1,chr1:147271053:C/A:1,chr1:27914481:C/T:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1
R-HSA-597592	Post-translational protein modification	Metabolism of proteins	0.297395	ABRAXAS1,ADAMTS1,ADAMTS13,AFP,AGBL4,ALG12,ANK1,ANK3,ARSA,ART3,ASB3,ASGR2,B3GNTL1,BABAM2,BRCA1,CFTR,CNTN3,CNTN5,COMMD5,COMMD6,COP1,DNMT1,FBN1,FBXO21,FBXW7,GALNT10,GALNT14,GALNT17,HLTF,IKBKE,KAT2B,LSAMP,LY6G6C,MBD5,MCRS1,MDGA1,MEN1,MUC15,MUC17,MUC3A,MUC4,NFKBIA,NOD2,NR1H3,NSMCE4A,NTM,NUP214,OPCML,PEX5,PIGB,PIGG,PIGO,PIGS,PNPLA2,POLB,PPP6C,PRKN,PSMF1,RAB10,RAB24,RAB3D,RAB4A,RAB6B,RBX1,RENBP,RNF152,RORA,RPA1,RPS27A,SEC16B,SEC23A,SEC24D,SEC31A,SEL1L,SIN3A,SMC1A,SPTBN4,ST8SIA2,STAG2,STAM,STAMBPL1,SUZ12,TNKS,TUBB2A,TUBB8,USP42,USP8,WDR5,WDTC1,ZBTB16	chr10:121961581:G/C:1,chr10:17660650:A/C:1,chr10:60685310:G/A:1,chr10:73757:T/G:1,chr10:88947447:C/A:1,chr11:100308186:C/A:1,chr11:114087490:T/C:1,chr11:132146101:C/T:1,chr11:133140763:C/A:1,chr11:26561226:C/A:1,chr11:47259936:C/A:1,chr11:64807481:C/T:1,chr11:822271:G/T:1,chr12:117174552:T/C:1,chr12:49557449:T/C:1,chr12:49558885:G/A:1,chr12:7190218:T/G:1,chr13:75528022:C/T:1,chr14:35403479:G/T:1,chr14:39040609:C/A:1,chr14:81490564:A/C:1,chr15:48472836:A/C:1,chr15:50441258:C/A:1,chr15:55340803:G/A:1,chr15:60556760:G/T:1,chr15:75409706:G/A:1,chr15:92412994:G/T:1,chr16:50711288:C/T:1,chr17:1853255:C/A:1,chr17:28564087:A/G:1,chr17:31973320:T/G:1,chr17:43049287:C/G:1,chr17:7114005:G/T:1,chr17:83048634:G/T:1,chr18:61844221:A/G:1,chr18:61844223:G/A:1,chr19:10173083:G/A:1,chr19:11343264:G/A:1,chr19:40569803:G/A:1,chr1:176136414:C/A:1,chr1:177936177:G/T:1,chr1:206479188:C/A:1,chr1:229288550:C/A:1,chr1:27299455:G/T:1,chr1:48560934:C/A:1,chr1:49844523:C/A:1,chr20:1117130:G/T:1,chr21:26843749:G/A:1,chr22:40963988:A/T:1,chr22:49903355:G/T:1,chr22:50625611:G/C:1,chr2:148510030:A/T:1,chr2:26109711:A/T:1,chr2:28274140:C/A:1,chr2:30924922:C/T:1,chr2:30945103:G/T:1,chr2:53728873:T/A:1,chr2:55234745:A/T:1,chr3:116602824:C/A:1,chr3:133841152:G/A:1,chr3:149055599:C/T:1,chr3:195752618:A/G:1,chr3:195752619:G/C:1,chr3:20072202:A/T:1,chr3:74521082:G/T:1,chr4:118833895:C/A:1,chr4:152350128:T/A:1,chr4:500224:G/A:1,chr4:73447436:C/A:1,chr4:76036090:T/C:1,chr4:82855072:T/A:1,chr4:83460892:G/T:1,chr5:154416093:G/C:1,chr5:177301877:T/C:1,chr6:161549199:T/A:1,chr6:3154999:A/G:1,chr6:31720741:T/A:1,chr6:37650494:G/C:1,chr7:100958263:A/G:1,chr7:101035696:G/T:1,chr7:117542008:A/T:1,chr7:6150119:C/T:1,chr7:6150149:T/C:1,chr7:71571591:C/A:1,chr8:144851440:T/C:1,chr8:41808044:G/T:1,chr8:42369772:A/T:1,chr8:9776590:C/A:1,chr9:125171223:T/A:1,chr9:131215059:A/G:1,chr9:133439628:C/T:1,chr9:134155272:C/G:1,chr9:35093530:T/C:1,chrX:124057978:G/A:1,chrX:124422202:A/T:1,chrX:153943642:G/T:1,chrX:53380790:T/C:1
R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	Cell Cycle	0.441652	KNL1,OIP5	chr15:40651961:A/T:1,chr15:41319933:G/T:1
R-HSA-611105	Respiratory electron transport	Metabolism	1.000000	ACAD9,ETFA,LRPPRC,NDUFA10,NDUFB2	chr15:76261301:A/T:1,chr2:239969825:G/A:1,chr2:43944068:C/A:1,chr3:128908910:T/C:1,chr7:140705050:A/G:1
R-HSA-674695	RNA Polymerase II Pre-transcription Events	Gene expression (Transcription)	0.632340	GTF2F1,NCBP1,TAF5	chr10:103387074:A/C:1,chr19:6380036:G/T:1,chr9:97664178:C/A:1
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	DNA Repair	0.768800	RBX1,RPS27A	chr22:40963988:A/T:1,chr2:55234745:A/T:1
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	DNA Repair	0.803501	POLE,RBX1,RPA1,RPA2,RPS27A	chr12:132643245:T/C:1,chr17:1853255:C/A:1,chr1:27914481:C/T:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1
R-HSA-6782135	Dual incision in TC-NER	DNA Repair	0.418932	POLE,RBX1,RPA1,RPA2,RPS27A	chr12:132643245:T/C:1,chr17:1853255:C/A:1,chr1:27914481:C/T:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	DNA Repair	0.412801	POLE,RBX1,RPA1,RPA2,RPS27A	chr12:132643245:T/C:1,chr17:1853255:C/A:1,chr1:27914481:C/T:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1
R-HSA-6782315	tRNA modification in the nucleus and cytosol	Metabolism of RNA	0.734871	QTRT2,TYW1,WDR4	chr21:42859689:C/A:1,chr3:114068202:G/T:1,chr7:67238132:G/C:1
R-HSA-6782861	Synthesis of wybutosine at G37 of tRNA(Phe)	Metabolism of RNA	0.296385	TYW1	chr7:67238132:G/C:1
R-HSA-6783310	Fanconi Anemia Pathway	DNA Repair	0.280796	FANCI,RPA1,RPA2,RPS27A	chr15:89263297:C/A:1,chr15:89304999:T/C:1,chr17:1853255:C/A:1,chr1:27914481:C/T:1,chr2:55234745:A/T:1
R-HSA-6783589	Interleukin-6 family signaling	Immune System	0.153436	CNTFR,LIFR,PTPN11	chr12:112489105:A/T:1,chr5:38482482:C/A:1,chr9:34582938:G/T:1
R-HSA-6783783	Interleukin-10 signaling	Immune System	0.741484	CCL3L1,FCER2,TNFRSF1B	chr17:36195375:A/G:1,chr19:7699499:C/T:1,chr1:12188701:A/G:1,chr1:12203460:C/A:1
R-HSA-6784531	tRNA processing in the nucleus	Metabolism of RNA	0.260565	NUP214	chr9:131215059:A/G:1
R-HSA-6785631	ERBB2 Regulates Cell Motility	Signal Transduction	0.208745	ERBB4,NRG3	chr10:82985678:T/A:1,chr2:211630704:C/G:1
R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	Immune System	0.296902	CD36,F13A1,FCER2,IGHG1,IGHG4,ITGAM,RORA,STAT6,TNFRSF1B	chr12:57102572:A/C:1,chr14:105624404:C/G:1,chr14:105741468:G/C:1,chr14:105741485:A/G:1,chr15:60556760:G/T:1,chr16:31299762:C/T:1,chr19:7699499:C/T:1,chr1:12188701:A/G:1,chr1:12203460:C/A:1,chr6:6224619:A/T:1,chr7:80474080:T/G:1
R-HSA-6788467	IL-6-type cytokine receptor ligand interactions	Immune System	0.251662	CNTFR,LIFR	chr5:38482482:C/A:1,chr9:34582938:G/T:1
R-HSA-6790901	rRNA modification in the nucleus and cytosol	Metabolism of RNA	0.154058	NAT10,NOP14,RPS6,RPS9,UTP20,WDR75	chr11:34132001:A/T:1,chr12:101281201:G/T:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr2:189465352:G/A:1,chr4:2939691:G/A:1,chr9:19376102:T/C:1
R-HSA-6791226	Major pathway of rRNA processing in the nucleolus and cytosol	Metabolism of RNA	0.871408	NOP14,RPL10,RPL23,RPL31,RPS27A,RPS6,RPS9,UTP20,WDR75	chr12:101281201:G/T:1,chr17:38850552:C/A:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr2:101018980:G/T:1,chr2:189465352:G/A:1,chr2:55234745:A/T:1,chr4:2939691:G/A:1,chr9:19376102:T/C:1,chrX:154405329:C/A:1
R-HSA-6791312	TP53 Regulates Transcription of Cell Cycle Genes	Gene expression (Transcription)	1.000000	CNOT9,PLK2	chr2:218582908:A/T:1,chr5:58454762:G/T:1
R-HSA-6794361	Neurexins and neuroligins	Neuronal System	1.000000	EPB41L5,NRXN1,NRXN3	chr14:78220607:G/T:1,chr2:120161150:T/C:1,chr2:51201665:C/A:1
R-HSA-6794362	Protein-protein interactions at synapses	Neuronal System	0.158797	EPB41L5,IL1RAPL2,LRFN3,NRXN1,NRXN3,PPFIA4,PTPRD,PTPRF	chr14:78220607:G/T:1,chr19:35939983:C/A:1,chr19:35944781:C/T:1,chr1:203048066:G/T:1,chr1:43591997:G/T:1,chr1:43617848:G/A:1,chr1:43619068:C/T:1,chr1:43620409:T/C:1,chr2:120161150:T/C:1,chr2:51201665:C/A:1,chr9:9208846:C/T:1,chrX:105219858:C/A:1
R-HSA-6796648	TP53 Regulates Transcription of DNA Repair Genes	Gene expression (Transcription)	0.786623	BRCA1,CHEK1,FANCI,GTF2F1	chr11:125637382:T/C:1,chr15:89263297:C/A:1,chr15:89304999:T/C:1,chr17:43049287:C/G:1,chr19:6380036:G/T:1
R-HSA-6798163	Choline catabolism	Metabolism	0.003219	ALDH7A1,CHDH,SARDH	chr3:53819484:G/T:1,chr5:126559182:C/A:1,chr9:133730014:G/T:1
R-HSA-6798695	Neutrophil degranulation	Immune System	0.033638	ADGRE5,ANPEP,APAF1,ARSA,BIN2,CAMP,CAT,CD14,CD36,CLEC4D,CRACR2A,CTSB,DDX3X,DNASE1L1,FCN1,FRMPD3,GALNS,GNS,GSN,HLA-B,IQGAP1,IQGAP2,ITGAL,ITGAM,LILRB3,LPCAT1,MGAM,MGST1,NCSTN,PADI2,PDAP1,PKP1,PRKCD,PTPN6,RAB10,RAB24,RAB3D,TNFRSF1B	chr11:34471141:A/C:1,chr12:16605069:T/G:1,chr12:3658138:G/T:1,chr12:51297095:C/A:1,chr12:64722884:C/A:1,chr12:6960084:C/T:1,chr12:8512275:G/T:1,chr12:98648251:A/T:1,chr15:89801121:T/C:1,chr15:90390695:A/G:1,chr15:90485816:T/C:1,chr16:30494137:C/A:1,chr16:31299762:C/T:1,chr16:88837557:G/T:1,chr19:11343264:G/A:1,chr19:14404629:C/A:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr1:12188701:A/G:1,chr1:12203460:C/A:1,chr1:160353563:A/G:1,chr1:17070003:T/C:1,chr1:201324373:G/T:1,chr22:50625611:G/C:1,chr2:26109711:A/T:1,chr3:48225051:G/T:1,chr3:53192052:T/G:1,chr5:140633030:C/A:1,chr5:1501675:T/C:1,chr5:177301877:T/C:1,chr5:76654711:T/C:1,chr6:31356312:G/A:1,chr7:142093478:C/A:1,chr7:80474080:T/G:1,chr7:99394321:C/T:1,chr8:11847933:G/T:1,chr9:121312182:C/T:1,chr9:134914627:C/T:1,chrX:107602813:C/A:1,chrX:154405329:C/A:1,chrX:41343158:A/T:1
R-HSA-6799198	Complex I biogenesis	Metabolism	0.757118	ACAD9,NDUFA10,NDUFB2	chr2:239969825:G/A:1,chr3:128908910:T/C:1,chr7:140705050:A/G:1
R-HSA-6799990	Metal sequestration by antimicrobial proteins	Immune System	0.296385	S100A7A	chr1:153419515:C/A:1
R-HSA-6802946	Signaling by moderate kinase activity BRAF mutants	Disease	0.741484	CSK,IQGAP1,TLN1	chr15:74802540:C/T:1,chr15:90390695:A/G:1,chr15:90485816:T/C:1,chr9:35697963:G/T:1
R-HSA-6802948	Signaling by high-kinase activity BRAF mutants	Disease	0.457614	CSK,IQGAP1,TLN1	chr15:74802540:C/T:1,chr15:90390695:A/G:1,chr15:90485816:T/C:1,chr9:35697963:G/T:1
R-HSA-6802949	Signaling by RAS mutants	Disease	0.741484	CSK,IQGAP1,TLN1	chr15:74802540:C/T:1,chr15:90390695:A/G:1,chr15:90485816:T/C:1,chr9:35697963:G/T:1
R-HSA-6802952	Signaling by BRAF and RAF fusions	Disease	0.786623	AKAP9,CSK,IQGAP1,TLN1	chr15:74802540:C/T:1,chr15:90390695:A/G:1,chr15:90485816:T/C:1,chr7:91974127:C/A:1,chr7:92040995:G/T:1,chr9:35697963:G/T:1
R-HSA-6802953	RAS signaling downstream of NF1 loss-of-function variants	Disease	0.336437	SPRED3	chr19:38392374:C/T:1,chr19:38394161:T/G:1
R-HSA-6802955	Paradoxical activation of RAF signaling by kinase inactive BRAF	Disease	0.741484	CSK,IQGAP1,TLN1	chr15:74802540:C/T:1,chr15:90390695:A/G:1,chr15:90485816:T/C:1,chr9:35697963:G/T:1
R-HSA-6802957	Oncogenic MAPK signaling	Disease	0.605338	AKAP9,CSK,IQGAP1,SPRED3,TLN1	chr15:74802540:C/T:1,chr15:90390695:A/G:1,chr15:90485816:T/C:1,chr19:38392374:C/T:1,chr19:38394161:T/G:1,chr7:91974127:C/A:1,chr7:92040995:G/T:1,chr9:35697963:G/T:1
R-HSA-6803157	Antimicrobial peptides	Immune System	0.376566	BPIFA1,CAMP,S100A7A	chr1:153419515:C/A:1,chr20:33237991:G/A:1,chr3:48225051:G/T:1
R-HSA-6803207	TP53 Regulates Transcription of Caspase Activators and Caspases	Gene expression (Transcription)	0.146339	APAF1,CASP2	chr12:98648251:A/T:1,chr7:143292189:T/C:1
R-HSA-6803211	TP53 Regulates Transcription of Death Receptors and Ligands	Gene expression (Transcription)	0.505026	TNFRSF10A	chr8:23202515:G/T:1
R-HSA-6803529	FGFR2 alternative splicing	Signal Transduction	0.196494	GTF2F1,NCBP1,PTBP1	chr19:6380036:G/T:1,chr19:804704:T/A:1,chr9:97664178:C/A:1
R-HSA-6804115	TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain	Gene expression (Transcription)	0.337515	CNOT9,PLK2	chr2:218582908:A/T:1,chr5:58454762:G/T:1
R-HSA-6804756	Regulation of TP53 Activity through Phosphorylation	Gene expression (Transcription)	0.106975	BRCA1,CHEK1,PIN1,PRKAA2,PRKAB2,RPA1,RPA2,RPS27A,TAF5	chr10:103387074:A/C:1,chr11:125637382:T/C:1,chr17:1853255:C/A:1,chr17:43049287:C/G:1,chr19:9849326:C/A:1,chr1:147172001:G/A:1,chr1:27914481:C/T:1,chr1:56706008:C/A:1,chr2:55234745:A/T:1
R-HSA-6804757	Regulation of TP53 Degradation	Gene expression (Transcription)	0.457614	PPP2R1A,PPP2R5C,RPS27A	chr14:101883867:G/T:1,chr19:52215622:C/T:1,chr2:55234745:A/T:1
R-HSA-6804758	Regulation of TP53 Activity through Acetylation	Gene expression (Transcription)	1.000000	PIN1	chr19:9849326:C/A:1
R-HSA-6804759	Regulation of TP53 Activity through Association with Co-factors	Gene expression (Transcription)	0.559805	POU4F1	chr13:78601815:G/T:1
R-HSA-6804760	Regulation of TP53 Activity through Methylation	Gene expression (Transcription)	0.294775	JMY,RPS27A	chr2:55234745:A/T:1,chr5:79300647:C/A:1
R-HSA-6805567	Keratinization	Developmental Biology	0.136414	KRT3,KRT6A,KRT75,KRT9,KRTAP10-4,PKP1,SPINK5	chr12:52424307:T/C:1,chr12:52492434:T/C:1,chr12:52790990:A/G:1,chr17:41571796:C/A:1,chr1:201324373:G/T:1,chr21:44585730:C/A:1,chr5:148118167:C/T:1
R-HSA-6806003	Regulation of TP53 Expression and Degradation	Gene expression (Transcription)	0.466570	PPP2R1A,PPP2R5C,RPS27A	chr14:101883867:G/T:1,chr19:52215622:C/T:1,chr2:55234745:A/T:1
R-HSA-6806667	Metabolism of fat-soluble vitamins	Metabolism	0.752960	BCO1,HSPG2,PLB1	chr16:81245335:G/T:1,chr1:21839609:G/T:1,chr1:21850169:G/T:1,chr2:28516675:G/T:1
R-HSA-6806834	Signaling by MET	Signal Transduction	0.000007	COL11A1,COL11A2,COL1A1,COL2A1,COL5A1,COL5A2,EPS15,LAMB3,LAMC2,PTPN1,PTPN11,RAB4A,RAPGEF1,RPS27A,STAM,USP8	chr10:17660650:A/C:1,chr12:112489105:A/T:1,chr12:47982418:C/T:1,chr15:50441258:C/A:1,chr17:50195100:C/A:1,chr1:102962717:G/T:1,chr1:183228170:A/G:1,chr1:209618498:C/T:1,chr1:229288550:C/A:1,chr1:51465474:T/A:1,chr20:50526505:C/A:1,chr2:189098495:C/A:1,chr2:55234745:A/T:1,chr6:33171551:C/T:1,chr9:131592242:G/T:1,chr9:134782781:A/G:1
R-HSA-6807004	Negative regulation of MET activity	Signal Transduction	0.005570	EPS15,PTPN1,RPS27A,STAM,USP8	chr10:17660650:A/C:1,chr15:50441258:C/A:1,chr1:51465474:T/A:1,chr20:50526505:C/A:1,chr2:55234745:A/T:1
R-HSA-6807070	PTEN Regulation	Signal Transduction	0.710250	AGO4,HDAC3,HDAC5,PSMF1,RPS27A,RPTOR,SUZ12,TNKS,TNRC6B	chr17:31973320:T/G:1,chr17:44079338:G/T:1,chr17:80664395:C/A:1,chr1:35850806:C/A:1,chr20:1117130:G/T:1,chr22:40049003:G/T:1,chr2:55234745:A/T:1,chr5:141629409:G/A:1,chr8:9776590:C/A:1
R-HSA-6807505	RNA polymerase II transcribes snRNA genes	Gene expression (Transcription)	0.807771	GTF2F1,INTS3,NCBP1,SNAPC1,TAF5	chr10:103387074:A/C:1,chr14:61776044:A/T:1,chr19:6380036:G/T:1,chr1:153763739:C/A:1,chr1:153770813:C/G:1,chr9:97664178:C/A:1
R-HSA-6807878	COPI-mediated anterograde transport	Metabolism of proteins;Vesicle-mediated transport	1.000000	ANK1,ANK3,SPTBN4,TUBB2A,TUBB8	chr10:60685310:G/A:1,chr10:73757:T/G:1,chr19:40569803:G/A:1,chr6:3154999:A/G:1,chr8:41808044:G/T:1
R-HSA-6809371	Formation of the cornified envelope	Developmental Biology	0.846781	KRT3,KRT6A,KRT75,KRT9,PKP1,SPINK5	chr12:52424307:T/C:1,chr12:52492434:T/C:1,chr12:52790990:A/G:1,chr17:41571796:C/A:1,chr1:201324373:G/T:1,chr5:148118167:C/T:1
R-HSA-6811434	COPI-dependent Golgi-to-ER retrograde traffic	Vesicle-mediated transport	0.513885	KIF11,KIF25,KLC2,KLC4,NBAS,TUBB2A,TUBB8	chr10:73757:T/G:1,chr10:92639648:G/T:1,chr11:66264919:G/A:1,chr2:15421926:C/A:1,chr6:168040119:C/A:1,chr6:3154999:A/G:1,chr6:43055804:A/T:1
R-HSA-6811436	COPI-independent Golgi-to-ER retrograde traffic	Vesicle-mediated transport	0.543720	RAB3GAP1,RAB6B,TUBB2A,TUBB8	chr10:73757:T/G:1,chr2:135113016:C/T:1,chr3:133841152:G/A:1,chr6:3154999:A/G:1
R-HSA-6811438	Intra-Golgi traffic	Vesicle-mediated transport	0.516674	ALPP	chr2:232379271:A/T:1
R-HSA-6811440	Retrograde transport at the Trans-Golgi-Network	Vesicle-mediated transport	0.757118	GOLGA1,RAB6B,SCOC	chr3:133841152:G/A:1,chr4:140287063:A/C:1,chr9:124921607:C/T:1
R-HSA-6811442	Intra-Golgi and retrograde Golgi-to-ER traffic	Vesicle-mediated transport	0.877893	ALPP,GOLGA1,KIF11,KIF25,KLC2,KLC4,NBAS,RAB3GAP1,RAB6B,SCOC,TUBB2A,TUBB8	chr10:73757:T/G:1,chr10:92639648:G/T:1,chr11:66264919:G/A:1,chr2:135113016:C/T:1,chr2:15421926:C/A:1,chr2:232379271:A/T:1,chr3:133841152:G/A:1,chr4:140287063:A/C:1,chr6:168040119:C/A:1,chr6:3154999:A/G:1,chr6:43055804:A/T:1,chr9:124921607:C/T:1
R-HSA-6811555	PI5P Regulates TP53 Acetylation	Gene expression (Transcription)	0.409840	PIN1	chr19:9849326:C/A:1
R-HSA-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	Signal Transduction	0.193635	ERBB4,IRS1,KITLG,NRG3,PIK3CB,PIP5K1C,PPP2R1A,PPP2R5C,PTPN11	chr10:82985678:T/A:1,chr12:112489105:A/T:1,chr12:88516155:G/T:1,chr14:101883867:G/T:1,chr19:3643094:C/A:1,chr19:52215622:C/T:1,chr2:211630704:C/G:1,chr2:226796751:A/G:1,chr3:138778223:G/A:1
R-HSA-6814122	Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding	Metabolism of proteins	1.000000	GNAT3,RGS9	chr17:65217991:G/T:1,chr7:80474080:T/G:1
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	DNA Replication	0.774251	PSMF1,RPS27A	chr20:1117130:G/T:1,chr2:55234745:A/T:1
R-HSA-68867	Assembly of the pre-replicative complex	DNA Replication	0.437564	PSMF1,RPS27A	chr20:1117130:G/T:1,chr2:55234745:A/T:1
R-HSA-68875	Mitotic Prophase	Cell Cycle	0.583462	LPIN1,LPIN3,NUP214,PPP2R1A,PRKCB,VRK2	chr16:23867049:C/T:1,chr19:52215622:C/T:1,chr20:41345676:A/G:1,chr2:11819407:C/G:1,chr2:58084877:A/T:1,chr9:131215059:A/G:1
R-HSA-68877	Mitotic Prometaphase	Cell Cycle	0.282799	AKAP9,CDCA5,CEP78,CLASP2,CLIP1,HDAC8,KNL1,PCNT,PPP2R1A,PPP2R5C,RCC2,SMC1A,STAG2,TUBB2A,TUBB8	chr10:73757:T/G:1,chr11:65083833:C/T:1,chr12:122341757:C/T:1,chr14:101883867:G/T:1,chr15:40651961:A/T:1,chr19:52215622:C/T:1,chr1:17413265:G/T:1,chr21:46351357:C/A:1,chr3:33602979:G/T:1,chr6:3154999:A/G:1,chr7:91974127:C/A:1,chr7:92040995:G/T:1,chr9:78246838:C/A:1,chrX:124057978:G/A:1,chrX:124422202:A/T:1,chrX:53380790:T/C:1,chrX:72572139:G/A:1
R-HSA-68882	Mitotic Anaphase	Cell Cycle	0.196419	ANAPC1,ANAPC4,CDCA5,CLASP2,CLIP1,HDAC8,KNL1,PPP2R1A,PPP2R5C,PSMF1,RCC1,RCC2,RPS27A,SMC1A,STAG2,TUBB2A,TUBB8,VRK2	chr10:73757:T/G:1,chr11:65083833:C/T:1,chr12:122341757:C/T:1,chr14:101883867:G/T:1,chr15:40651961:A/T:1,chr19:52215622:C/T:1,chr1:17413265:G/T:1,chr1:28508571:C/A:1,chr20:1117130:G/T:1,chr2:111863902:T/A:1,chr2:55234745:A/T:1,chr2:58084877:A/T:1,chr3:33602979:G/T:1,chr4:25418042:G/T:1,chr6:3154999:A/G:1,chrX:124057978:G/A:1,chrX:124422202:A/T:1,chrX:53380790:T/C:1,chrX:72572139:G/A:1
R-HSA-68884	Mitotic Telophase/Cytokinesis	Cell Cycle	0.166735	SMC1A,STAG2	chrX:124057978:G/A:1,chrX:124422202:A/T:1,chrX:53380790:T/C:1
R-HSA-68886	M Phase	Cell Cycle	0.745066	AKAP9,ANAPC1,ANAPC4,CDCA5,CEP78,CLASP2,CLIP1,HDAC8,KNL1,LPIN1,LPIN3,NUP214,PCNT,PPP2R1A,PPP2R5C,PRKCB,PSMF1,RCC1,RCC2,RPS27A,SMC1A,STAG2,TUBB2A,TUBB8,VRK2	chr10:73757:T/G:1,chr11:65083833:C/T:1,chr12:122341757:C/T:1,chr14:101883867:G/T:1,chr15:40651961:A/T:1,chr16:23867049:C/T:1,chr19:52215622:C/T:1,chr1:17413265:G/T:1,chr1:28508571:C/A:1,chr20:1117130:G/T:1,chr20:41345676:A/G:1,chr21:46351357:C/A:1,chr2:111863902:T/A:1,chr2:11819407:C/G:1,chr2:55234745:A/T:1,chr2:58084877:A/T:1,chr3:33602979:G/T:1,chr4:25418042:G/T:1,chr6:3154999:A/G:1,chr7:91974127:C/A:1,chr7:92040995:G/T:1,chr9:131215059:A/G:1,chr9:78246838:C/A:1,chrX:124057978:G/A:1,chrX:124422202:A/T:1,chrX:53380790:T/C:1,chrX:72572139:G/A:1
R-HSA-68949	Orc1 removal from chromatin	DNA Replication;Cell Cycle	0.798282	PSMF1,RBX1,RPS27A	chr20:1117130:G/T:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1
R-HSA-68952	DNA replication initiation	DNA Replication;Cell Cycle	0.374212	POLE	chr12:132643245:T/C:1
R-HSA-68962	Activation of the pre-replicative complex	DNA Replication;Cell Cycle	0.433338	POLE,RPA1,RPA2	chr12:132643245:T/C:1,chr17:1853255:C/A:1,chr1:27914481:C/T:1
R-HSA-69002	DNA Replication Pre-Initiation	DNA Replication	0.814970	POLE,PSMF1,RPA1,RPA2,RPS27A	chr12:132643245:T/C:1,chr17:1853255:C/A:1,chr1:27914481:C/T:1,chr20:1117130:G/T:1,chr2:55234745:A/T:1
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	DNA Replication;Cell Cycle	1.000000	ANAPC1,ANAPC4,PSMF1,RPS27A	chr20:1117130:G/T:1,chr2:111863902:T/A:1,chr2:55234745:A/T:1,chr4:25418042:G/T:1
R-HSA-69052	Switching of origins to a post-replicative state	DNA Replication;Cell Cycle	1.000000	ANAPC1,ANAPC4,PSMF1,RBX1,RPS27A	chr20:1117130:G/T:1,chr22:40963988:A/T:1,chr2:111863902:T/A:1,chr2:55234745:A/T:1,chr4:25418042:G/T:1
R-HSA-69166	Removal of the Flap Intermediate	DNA Replication;Cell Cycle	0.187575	RPA1,RPA2	chr17:1853255:C/A:1,chr1:27914481:C/T:1
R-HSA-69183	Processive synthesis on the lagging strand	DNA Replication;Cell Cycle	0.208745	RPA1,RPA2	chr17:1853255:C/A:1,chr1:27914481:C/T:1
R-HSA-69186	Lagging Strand Synthesis	DNA Replication;Cell Cycle	0.316221	RPA1,RPA2	chr17:1853255:C/A:1,chr1:27914481:C/T:1
R-HSA-69190	DNA strand elongation	DNA Replication;Cell Cycle	0.703700	RPA1,RPA2	chr17:1853255:C/A:1,chr1:27914481:C/T:1
R-HSA-69202	Cyclin E associated events during G1/S transition 	Cell Cycle	0.333727	PSMF1,RPS27A	chr20:1117130:G/T:1,chr2:55234745:A/T:1
R-HSA-69206	G1/S Transition	Cell Cycle	0.706303	POLE,PPP2R1A,PSMF1,RPA1,RPA2,RPS27A	chr12:132643245:T/C:1,chr17:1853255:C/A:1,chr19:52215622:C/T:1,chr1:27914481:C/T:1,chr20:1117130:G/T:1,chr2:55234745:A/T:1
R-HSA-69231	Cyclin D associated events in G1	Cell Cycle	1.000000	PPP2R1A,RPS27A	chr19:52215622:C/T:1,chr2:55234745:A/T:1
R-HSA-69236	G1 Phase	Cell Cycle	1.000000	PPP2R1A,RPS27A	chr19:52215622:C/T:1,chr2:55234745:A/T:1
R-HSA-69239	Synthesis of DNA	DNA Replication;Cell Cycle	0.551161	ANAPC1,ANAPC4,POLE,PSMF1,RBX1,RPA1,RPA2,RPS27A	chr12:132643245:T/C:1,chr17:1853255:C/A:1,chr1:27914481:C/T:1,chr20:1117130:G/T:1,chr22:40963988:A/T:1,chr2:111863902:T/A:1,chr2:55234745:A/T:1,chr4:25418042:G/T:1
R-HSA-69242	S Phase	Cell Cycle	0.491863	ANAPC1,ANAPC4,CDCA5,POLE,PSMF1,RBX1,RPA1,RPA2,RPS27A,SMC1A,STAG2	chr11:65083833:C/T:1,chr12:132643245:T/C:1,chr17:1853255:C/A:1,chr1:27914481:C/T:1,chr20:1117130:G/T:1,chr22:40963988:A/T:1,chr2:111863902:T/A:1,chr2:55234745:A/T:1,chr4:25418042:G/T:1,chrX:124057978:G/A:1,chrX:124422202:A/T:1,chrX:53380790:T/C:1
R-HSA-69273	Cyclin A/B1/B2 associated events during G2/M transition	Cell Cycle	1.000000	PPP2R1A	chr19:52215622:C/T:1
R-HSA-69275	G2/M Transition	Cell Cycle	0.876463	AKAP9,CEP78,PCNT,PPP1R12A,PPP2R1A,PSMF1,RBX1,RPS27A,TUBB2A,TUBB8	chr10:73757:T/G:1,chr12:79822198:G/T:1,chr19:52215622:C/T:1,chr20:1117130:G/T:1,chr21:46351357:C/A:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1,chr6:3154999:A/G:1,chr7:91974127:C/A:1,chr7:92040995:G/T:1,chr9:78246838:C/A:1
R-HSA-69278	Cell Cycle, Mitotic	Cell Cycle	0.850944	AKAP9,ANAPC1,ANAPC4,CDCA5,CEP78,CLASP2,CLIP1,HDAC8,KNL1,LPIN1,LPIN3,NUP214,PCNT,POLE,PPP1R12A,PPP2R1A,PPP2R5C,PRKCB,PSMF1,RBX1,RCC1,RCC2,RPA1,RPA2,RPS27A,SMC1A,STAG2,TUBB2A,TUBB8,VRK2	chr10:73757:T/G:1,chr11:65083833:C/T:1,chr12:122341757:C/T:1,chr12:132643245:T/C:1,chr12:79822198:G/T:1,chr14:101883867:G/T:1,chr15:40651961:A/T:1,chr16:23867049:C/T:1,chr17:1853255:C/A:1,chr19:52215622:C/T:1,chr1:17413265:G/T:1,chr1:27914481:C/T:1,chr1:28508571:C/A:1,chr20:1117130:G/T:1,chr20:41345676:A/G:1,chr21:46351357:C/A:1,chr22:40963988:A/T:1,chr2:111863902:T/A:1,chr2:11819407:C/G:1,chr2:55234745:A/T:1,chr2:58084877:A/T:1,chr3:33602979:G/T:1,chr4:25418042:G/T:1,chr6:3154999:A/G:1,chr7:91974127:C/A:1,chr7:92040995:G/T:1,chr9:131215059:A/G:1,chr9:78246838:C/A:1,chrX:124057978:G/A:1,chrX:124422202:A/T:1,chrX:53380790:T/C:1,chrX:72572139:G/A:1
R-HSA-69306	DNA Replication	DNA Replication	0.699432	ANAPC1,ANAPC4,POLE,PSMF1,RBX1,RPA1,RPA2,RPS27A	chr12:132643245:T/C:1,chr17:1853255:C/A:1,chr1:27914481:C/T:1,chr20:1117130:G/T:1,chr22:40963988:A/T:1,chr2:111863902:T/A:1,chr2:55234745:A/T:1,chr4:25418042:G/T:1
R-HSA-69416	Dimerization of procaspase-8	Programmed Cell Death	0.475135	TNFRSF10A	chr8:23202515:G/T:1
R-HSA-69473	G2/M DNA damage checkpoint	Cell Cycle	0.660190	ABRAXAS1,BABAM2,BRCA1,CHEK1,RPA1,RPA2	chr11:125637382:T/C:1,chr17:1853255:C/A:1,chr17:43049287:C/G:1,chr1:27914481:C/T:1,chr2:28274140:C/A:1,chr4:83460892:G/T:1
R-HSA-69481	G2/M Checkpoints	Cell Cycle	0.737315	ABRAXAS1,BABAM2,BRCA1,CHEK1,PSMF1,RPA1,RPA2,RPS27A	chr11:125637382:T/C:1,chr17:1853255:C/A:1,chr17:43049287:C/G:1,chr1:27914481:C/T:1,chr20:1117130:G/T:1,chr2:28274140:C/A:1,chr2:55234745:A/T:1,chr4:83460892:G/T:1
R-HSA-69541	Stabilization of p53	Cell Cycle	1.000000	COP1,PSMF1,RPS27A	chr1:176136414:C/A:1,chr20:1117130:G/T:1,chr2:55234745:A/T:1
R-HSA-69563	p53-Dependent G1 DNA Damage Response	Cell Cycle	1.000000	COP1,PSMF1,RPS27A	chr1:176136414:C/A:1,chr20:1117130:G/T:1,chr2:55234745:A/T:1
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	Cell Cycle	1.000000	COP1,PSMF1,RPS27A	chr1:176136414:C/A:1,chr20:1117130:G/T:1,chr2:55234745:A/T:1
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	Cell Cycle	1.000000	CHEK1,PSMF1,RPS27A	chr11:125637382:T/C:1,chr20:1117130:G/T:1,chr2:55234745:A/T:1
R-HSA-69610	p53-Independent DNA Damage Response	Cell Cycle	1.000000	CHEK1,PSMF1,RPS27A	chr11:125637382:T/C:1,chr20:1117130:G/T:1,chr2:55234745:A/T:1
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	Cell Cycle	1.000000	CHEK1,PSMF1,RPS27A	chr11:125637382:T/C:1,chr20:1117130:G/T:1,chr2:55234745:A/T:1
R-HSA-69615	G1/S DNA Damage Checkpoints	Cell Cycle	0.794681	CHEK1,COP1,PSMF1,RPS27A	chr11:125637382:T/C:1,chr1:176136414:C/A:1,chr20:1117130:G/T:1,chr2:55234745:A/T:1
R-HSA-69618	Mitotic Spindle Checkpoint	Cell Cycle	0.409437	ANAPC1,ANAPC4,CLASP2,CLIP1,KNL1,PPP2R1A,PPP2R5C,RCC2	chr12:122341757:C/T:1,chr14:101883867:G/T:1,chr15:40651961:A/T:1,chr19:52215622:C/T:1,chr1:17413265:G/T:1,chr2:111863902:T/A:1,chr3:33602979:G/T:1,chr4:25418042:G/T:1
R-HSA-69620	Cell Cycle Checkpoints	Cell Cycle	0.897632	ABRAXAS1,ANAPC1,ANAPC4,BABAM2,BRCA1,CHEK1,CLASP2,CLIP1,COP1,KNL1,PPP2R1A,PPP2R5C,PSMF1,RCC2,RPA1,RPA2,RPS27A	chr11:125637382:T/C:1,chr12:122341757:C/T:1,chr14:101883867:G/T:1,chr15:40651961:A/T:1,chr17:1853255:C/A:1,chr17:43049287:C/G:1,chr19:52215622:C/T:1,chr1:17413265:G/T:1,chr1:176136414:C/A:1,chr1:27914481:C/T:1,chr20:1117130:G/T:1,chr2:111863902:T/A:1,chr2:28274140:C/A:1,chr2:55234745:A/T:1,chr3:33602979:G/T:1,chr4:25418042:G/T:1,chr4:83460892:G/T:1
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	Cell Cycle	0.240280	PSMF1,RPS27A	chr20:1117130:G/T:1,chr2:55234745:A/T:1
R-HSA-70171	Glycolysis	Metabolism	0.440074	NUP214,PPP2R1A	chr19:52215622:C/T:1,chr9:131215059:A/G:1
R-HSA-70221	Glycogen breakdown (glycogenolysis)	Metabolism	0.584880	PHKA2	chrX:18910786:G/T:1
R-HSA-70263	Gluconeogenesis	Metabolism	1.000000	SLC37A2	chr11:125085266:C/T:1
R-HSA-70268	Pyruvate metabolism	Metabolism	0.695622	PDHA1,PPARD	chr6:35396106:C/T:1,chrX:19355267:G/T:1
R-HSA-70326	Glucose metabolism	Metabolism	0.491386	NUP214,PPP2R1A,SLC37A2	chr11:125085266:C/T:1,chr19:52215622:C/T:1,chr9:131215059:A/G:1
R-HSA-70370	Galactose catabolism	Metabolism	0.253920	GALE	chr1:23798309:A/C:1
R-HSA-70688	Proline catabolism	Metabolism	0.161161	ALDH4A1	chr1:18874401:C/T:1
R-HSA-70895	Branched-chain amino acid catabolism	Metabolism	1.000000	PPM1K	chr4:88265238:T/C:1
R-HSA-70921	Histidine catabolism	Metabolism	0.374212	HAL	chr12:95976434:G/T:1
R-HSA-71032	Propionyl-CoA catabolism	Metabolism	0.028804	MUT,PCCA	chr13:100469233:C/A:1,chr6:49444826:C/A:1
R-HSA-71064	Lysine catabolism	Metabolism	0.505026	ALDH7A1	chr5:126559182:C/A:1
R-HSA-71262	Carnitine synthesis	Metabolism	0.208897	ALDH9A1	chr1:165676357:A/G:1
R-HSA-71288	Creatine metabolism	Metabolism	0.126518	SLC6A11,SLC6A12	chr12:197114:C/T:1,chr3:10820021:T/A:1,chr3:10933011:G/T:1
R-HSA-71291	Metabolism of amino acids and derivatives	Metabolism	0.649908	AGXT,ALDH4A1,ALDH7A1,ALDH9A1,ASMT,CHDH,HAL,IARS,MAT1A,PDHA1,PHGDH,PPM1K,PSMF1,RPL10,RPL23,RPL31,RPS27A,RPS6,RPS9,SARDH,SLC6A11,SLC6A12,SMS	chr10:80283820:G/A:1,chr12:197114:C/T:1,chr12:95976434:G/T:1,chr17:38850552:C/A:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr1:119721477:C/G:1,chr1:165676357:A/G:1,chr1:18874401:C/T:1,chr20:1117130:G/T:1,chr2:101018980:G/T:1,chr2:240869136:A/G:1,chr2:55234745:A/T:1,chr3:10820021:T/A:1,chr3:10933011:G/T:1,chr3:53819484:G/T:1,chr4:88265238:T/C:1,chr5:126559182:C/A:1,chr9:133730014:G/T:1,chr9:19376102:T/C:1,chr9:92274385:C/A:1,chrX:154405329:C/A:1,chrX:1624068:G/T:1,chrX:19355267:G/T:1,chrX:21985061:A/T:1
R-HSA-71387	Metabolism of carbohydrates	Metabolism	0.608009	B3GALT5,BCAN,CSPG4,EXT2,GALE,GALNS,GNS,HSPG2,MAN2C1,NUP214,PHKA2,PPP2R1A,RPS27A,SLC37A2	chr11:125085266:C/T:1,chr11:44236478:G/T:1,chr12:64722884:C/A:1,chr15:75355845:G/C:1,chr15:75675473:A/G:1,chr16:88837557:G/T:1,chr19:52215622:C/T:1,chr1:156650224:G/T:1,chr1:156652083:T/G:1,chr1:21839609:G/T:1,chr1:21850169:G/T:1,chr1:23798309:A/C:1,chr21:39664662:C/T:1,chr2:55234745:A/T:1,chr9:131215059:A/G:1,chrX:18910786:G/T:1
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	Metabolism	0.769701	PDHA1,PPARD	chr6:35396106:C/T:1,chrX:19355267:G/T:1
R-HSA-72086	mRNA Capping	Metabolism of RNA	0.679827	GTF2F1,NCBP1	chr19:6380036:G/T:1,chr9:97664178:C/A:1
R-HSA-72163	mRNA Splicing - Major Pathway	Metabolism of RNA	0.624739	GTF2F1,NCBP1,PLRG1,PTBP1,RBM5,SNRPA1,SNRPE,SRSF11	chr15:101281621:G/T:1,chr19:6380036:G/T:1,chr19:804704:T/A:1,chr1:203869988:C/G:1,chr1:70228405:A/T:1,chr3:50092208:G/T:1,chr3:50115335:C/A:1,chr4:154546952:G/C:1,chr9:97664178:C/A:1
R-HSA-72165	mRNA Splicing - Minor Pathway	Metabolism of RNA	1.000000	GTF2F1,NCBP1,SNRPE	chr19:6380036:G/T:1,chr1:203869988:C/G:1,chr9:97664178:C/A:1
R-HSA-72172	mRNA Splicing	Metabolism of RNA	0.523331	GTF2F1,NCBP1,PLRG1,PTBP1,RBM5,SNRPA1,SNRPE,SRSF11	chr15:101281621:G/T:1,chr19:6380036:G/T:1,chr19:804704:T/A:1,chr1:203869988:C/G:1,chr1:70228405:A/T:1,chr3:50092208:G/T:1,chr3:50115335:C/A:1,chr4:154546952:G/C:1,chr9:97664178:C/A:1
R-HSA-72187	mRNA 3'-end processing	Metabolism of RNA	0.565401	DDX39B,NCBP1,SRSF11,THOC5	chr1:70228405:A/T:1,chr22:29527997:G/T:1,chr6:31536198:G/C:1,chr9:97664178:C/A:1
R-HSA-72200	mRNA Editing: C to U Conversion	Metabolism of RNA	0.374212	APOBEC3A	chr22:38962236:C/T:1
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	Metabolism of RNA	0.479734	DDX39B,NCBP1,NUP214,NXF1,SRSF11,THOC5	chr11:62795754:C/G:1,chr1:70228405:A/T:1,chr22:29527997:G/T:1,chr6:31536198:G/C:1,chr9:131215059:A/G:1,chr9:97664178:C/A:1
R-HSA-72203	Processing of Capped Intron-Containing Pre-mRNA	Metabolism of RNA	0.778204	DDX39B,GTF2F1,NCBP1,NUP214,NXF1,PLRG1,PTBP1,RBM5,SNRPA1,SNRPE,SRSF11,THOC5	chr11:62795754:C/G:1,chr15:101281621:G/T:1,chr19:6380036:G/T:1,chr19:804704:T/A:1,chr1:203869988:C/G:1,chr1:70228405:A/T:1,chr22:29527997:G/T:1,chr3:50092208:G/T:1,chr3:50115335:C/A:1,chr4:154546952:G/C:1,chr6:31536198:G/C:1,chr9:131215059:A/G:1,chr9:97664178:C/A:1
R-HSA-72306	tRNA processing	Metabolism of RNA	0.529713	NUP214,QTRT2,TYW1,WDR4	chr21:42859689:C/A:1,chr3:114068202:G/T:1,chr7:67238132:G/C:1,chr9:131215059:A/G:1
R-HSA-72312	rRNA processing	Metabolism of RNA	0.759937	NAT10,NOP14,RPL10,RPL23,RPL31,RPS27A,RPS6,RPS9,UTP20,WDR75	chr11:34132001:A/T:1,chr12:101281201:G/T:1,chr17:38850552:C/A:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr2:101018980:G/T:1,chr2:189465352:G/A:1,chr2:55234745:A/T:1,chr4:2939691:G/A:1,chr9:19376102:T/C:1,chrX:154405329:C/A:1
R-HSA-72613	Eukaryotic Translation Initiation	Metabolism of proteins	1.000000	RPL10,RPL23,RPL31,RPS27A,RPS6,RPS9	chr17:38850552:C/A:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr2:101018980:G/T:1,chr2:55234745:A/T:1,chr9:19376102:T/C:1,chrX:154405329:C/A:1
R-HSA-72649	Translation initiation complex formation	Metabolism of proteins	1.000000	RPS27A,RPS6,RPS9	chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr2:55234745:A/T:1,chr9:19376102:T/C:1
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	Metabolism of proteins	1.000000	RPS27A,RPS6,RPS9	chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr2:55234745:A/T:1,chr9:19376102:T/C:1
R-HSA-72689	Formation of a pool of free 40S subunits	Metabolism of proteins	0.830225	RPL10,RPL23,RPL31,RPS27A,RPS6,RPS9	chr17:38850552:C/A:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr2:101018980:G/T:1,chr2:55234745:A/T:1,chr9:19376102:T/C:1,chrX:154405329:C/A:1
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	Metabolism of proteins	1.000000	RPS27A,RPS6,RPS9	chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr2:55234745:A/T:1,chr9:19376102:T/C:1
R-HSA-72702	Ribosomal scanning and start codon recognition	Metabolism of proteins	1.000000	RPS27A,RPS6,RPS9	chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr2:55234745:A/T:1,chr9:19376102:T/C:1
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	Metabolism of proteins	1.000000	RPL10,RPL23,RPL31,RPS27A,RPS6,RPS9	chr17:38850552:C/A:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr2:101018980:G/T:1,chr2:55234745:A/T:1,chr9:19376102:T/C:1,chrX:154405329:C/A:1
R-HSA-72737	Cap-dependent Translation Initiation	Metabolism of proteins	1.000000	RPL10,RPL23,RPL31,RPS27A,RPS6,RPS9	chr17:38850552:C/A:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr2:101018980:G/T:1,chr2:55234745:A/T:1,chr9:19376102:T/C:1,chrX:154405329:C/A:1
R-HSA-72764	Eukaryotic Translation Termination	Metabolism of proteins	0.656822	RPL10,RPL23,RPL31,RPS27A,RPS6,RPS9	chr17:38850552:C/A:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr2:101018980:G/T:1,chr2:55234745:A/T:1,chr9:19376102:T/C:1,chrX:154405329:C/A:1
R-HSA-72766	Translation	Metabolism of proteins	0.608009	IARS,MRPL2,MRPL28,MRPL4,MRPS18C,MRPS22,PTCD3,RPL10,RPL23,RPL31,RPS27A,RPS6,RPS9,SRP72	chr16:368429:A/G:1,chr17:38850552:C/A:1,chr19:10259814:T/A:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr2:101018980:G/T:1,chr2:55234745:A/T:1,chr2:86111006:G/T:1,chr3:139130214:G/T:1,chr4:56478721:C/G:1,chr4:56502018:T/G:1,chr4:83460892:G/T:1,chr6:43055804:A/T:1,chr9:19376102:T/C:1,chr9:92274385:C/A:1,chrX:154405329:C/A:1
R-HSA-73762	RNA Polymerase I Transcription Initiation	Gene expression (Transcription)	0.521556	KAT2B	chr3:20072202:A/T:1
R-HSA-73776	RNA Polymerase II Promoter Escape	Gene expression (Transcription)	1.000000	GTF2F1,TAF5	chr10:103387074:A/C:1,chr19:6380036:G/T:1
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	Gene expression (Transcription)	1.000000	GTF2F1,TAF5	chr10:103387074:A/C:1,chr19:6380036:G/T:1
R-HSA-73854	RNA Polymerase I Promoter Clearance	Gene expression (Transcription)	0.032644	KAT2B	chr3:20072202:A/T:1
R-HSA-73856	RNA Polymerase II Transcription Termination	Gene expression (Transcription)	0.425340	DDX39B,NCBP1,SNRPE,SRSF11,THOC5	chr1:203869988:C/G:1,chr1:70228405:A/T:1,chr22:29527997:G/T:1,chr6:31536198:G/C:1,chr9:97664178:C/A:1
R-HSA-73857	RNA Polymerase II Transcription	Gene expression (Transcription)	0.900659	AGO4,ANAPC1,ANAPC4,APAF1,ARID1B,BRCA1,CASP2,CAT,CHEK1,CNOT9,COL1A1,DDIT4,DDX39B,FANCI,FBXW7,GTF2F1,HDAC11,HDAC3,HDAC5,HDAC8,HEY1,INTS3,ITGAL,JMY,KAT2B,KMT2B,LIFR,LRPPRC,MED14,MED25,MEN1,NCBP1,NPY,NR1H3,PIN1,PLK2,POU4F1,PPARD,PPARGC1B,PPP2R1A,PPP2R5C,PRKAA2,PRKAB2,PRKCB,PSMF1,PTPN1,PTPN11,RBFOX1,RBX1,RORA,RPA1,RPA2,RPS27A,RPTOR,SIN3A,SMARCA4,SMURF1,SNAPC1,SNRPE,SOD2,SRSF11,SUZ12,TAF5,TCF7L2,THOC5,TIGAR,TNFRSF10A,TNRC6B,WDR5,ZNF135,ZNF154,ZNF267,ZNF551,ZNF552,ZNF555,ZNF586,ZNF595,ZNF699,ZNF717	chr10:103387074:A/C:1,chr10:112964742:G/A:1,chr10:72275283:T/A:1,chr11:125637382:T/C:1,chr11:34471141:A/C:1,chr11:47259936:C/A:1,chr11:64807481:C/T:1,chr12:112489105:A/T:1,chr12:4321404:C/A:1,chr12:98648251:A/T:1,chr13:78601815:G/T:1,chr14:101883867:G/T:1,chr14:61776044:A/T:1,chr15:60556760:G/T:1,chr15:75409706:G/A:1,chr15:89263297:C/A:1,chr15:89304999:T/C:1,chr16:23867049:C/T:1,chr16:30494137:C/A:1,chr16:31895162:G/A:1,chr16:5366001:C/A:1,chr17:1853255:C/A:1,chr17:31973320:T/G:1,chr17:43049287:C/G:1,chr17:44079338:G/T:1,chr17:50195100:C/A:1,chr17:80664395:C/A:1,chr19:11025539:C/G:1,chr19:2852284:A/C:1,chr19:35731956:C/T:1,chr19:49830773:C/A:1,chr19:52215622:C/T:1,chr19:57704603:C/A:1,chr19:57814755:G/T:1,chr19:58063587:G/T:1,chr19:6380036:G/T:1,chr19:9305000:G/T:1,chr19:9849326:C/A:1,chr1:147172001:G/A:1,chr1:153763739:C/A:1,chr1:153770813:C/G:1,chr1:203869988:C/G:1,chr1:27914481:C/T:1,chr1:35850806:C/A:1,chr1:56706008:C/A:1,chr1:70228405:A/T:1,chr20:1117130:G/T:1,chr20:50526505:C/A:1,chr22:29527997:G/T:1,chr22:40049003:G/T:1,chr22:40963988:A/T:1,chr2:111863902:T/A:1,chr2:218582908:A/T:1,chr2:43944068:C/A:1,chr2:55234745:A/T:1,chr3:13496579:C/G:1,chr3:20072202:A/T:1,chr3:75741893:A/G:1,chr4:152350128:T/A:1,chr4:25418042:G/T:1,chr4:54908:G/A:1,chr5:141629409:G/A:1,chr5:149834580:G/T:1,chr5:38482482:C/A:1,chr5:58454762:G/T:1,chr5:79300647:C/A:1,chr6:156829096:A/G:1,chr6:157039620:T/A:1,chr6:159684794:A/T:1,chr6:31536198:G/C:1,chr6:35396106:C/T:1,chr7:143292189:T/C:1,chr7:24285140:T/G:1,chr7:99061975:G/T:1,chr8:23202515:G/T:1,chr8:79766933:C/A:1,chr9:134155272:C/G:1,chr9:97664178:C/A:1,chrX:40703435:G/C:1,chrX:72572139:G/A:1
R-HSA-73864	RNA Polymerase I Transcription	Gene expression (Transcription)	0.021280	KAT2B	chr3:20072202:A/T:1
R-HSA-73884	Base Excision Repair	DNA Repair	1.000000	NEIL1,POLB,POLE,RPA1,RPA2	chr12:132643245:T/C:1,chr15:75355845:G/C:1,chr17:1853255:C/A:1,chr1:27914481:C/T:1,chr8:42369772:A/T:1
R-HSA-73886	Chromosome Maintenance	Cell Cycle	0.687003	KNL1,OIP5,RPA1,RPA2,RTEL1	chr15:40651961:A/T:1,chr15:41319933:G/T:1,chr17:1853255:C/A:1,chr1:27914481:C/T:1,chr20:63667624:C/A:1
R-HSA-73887	Death Receptor Signalling	Signal Transduction	0.094876	ARHGEF19,ARHGEF4,CASP2,HDAC3,KALRN,MCF2L,NCSTN,NFKBIA,OBSCN,RPS27A,TAX1BP1,TIAM1,TNFRSF10A	chr13:113046521:T/G:1,chr14:35403479:G/T:1,chr1:160353563:A/G:1,chr1:16199915:C/A:1,chr1:228306995:G/A:1,chr21:31135807:A/G:1,chr2:130920920:C/A:1,chr2:55234745:A/T:1,chr3:124138871:G/T:1,chr3:124477465:C/A:1,chr5:141629409:G/A:1,chr7:143292189:T/C:1,chr7:27841060:C/A:1,chr8:23202515:G/T:1
R-HSA-73893	DNA Damage Bypass	DNA Repair	0.195270	POLE,RBX1,RPA1,RPA2,RPS27A	chr12:132643245:T/C:1,chr17:1853255:C/A:1,chr1:27914481:C/T:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1
R-HSA-73894	DNA Repair	DNA Repair	0.809003	ABRAXAS1,BABAM2,BRCA1,CHD1L,CHEK1,FANCI,MCRS1,NEIL1,POLB,POLE,RBX1,RPA1,RPA2,RPS27A,RTEL1,SPIDR,TDP1	chr11:125637382:T/C:1,chr12:132643245:T/C:1,chr12:49557449:T/C:1,chr12:49558885:G/A:1,chr14:89966308:A/G:1,chr14:89985137:A/T:1,chr15:75355845:G/C:1,chr15:89263297:C/A:1,chr15:89304999:T/C:1,chr17:1853255:C/A:1,chr17:43049287:C/G:1,chr1:147271053:C/A:1,chr1:27914481:C/T:1,chr20:63667624:C/A:1,chr22:40963988:A/T:1,chr2:28274140:C/A:1,chr2:55234745:A/T:1,chr4:83460892:G/T:1,chr8:42369772:A/T:1,chr8:47592011:C/A:1
R-HSA-73928	Depyrimidination	DNA Repair	0.262601	NEIL1	chr15:75355845:G/C:1
R-HSA-73929	Base-Excision Repair, AP Site Formation	DNA Repair	0.266463	NEIL1	chr15:75355845:G/C:1
R-HSA-73930	Abasic sugar-phosphate removal via the single-nucleotide replacement pathway	DNA Repair	0.110550	POLB	chr8:42369772:A/T:1
R-HSA-73933	Resolution of Abasic Sites (AP sites)	DNA Repair	0.062432	NEIL1,POLB,POLE,RPA1,RPA2	chr12:132643245:T/C:1,chr15:75355845:G/C:1,chr17:1853255:C/A:1,chr1:27914481:C/T:1,chr8:42369772:A/T:1
R-HSA-73980	RNA Polymerase III Transcription Termination	Gene expression (Transcription)	1.000000	NFIA	chr1:61088112:A/T:1
R-HSA-74158	RNA Polymerase III Transcription	Gene expression (Transcription)	0.505418	BDP1,NFIA,SNAPC1	chr14:61776044:A/T:1,chr1:61088112:A/T:1,chr5:71462094:C/T:1
R-HSA-74160	Gene expression (Transcription)	Gene expression (Transcription)	0.857498	AGO4,ANAPC1,ANAPC4,APAF1,ARID1B,BDP1,BRCA1,CASP2,CAT,CHEK1,CNOT9,COL1A1,DDIT4,DDX39B,DNMT1,FANCI,FBXW7,GTF2F1,HDAC11,HDAC3,HDAC5,HDAC8,HEY1,INTS3,ITGAL,JMY,KAT2B,KMT2B,LIFR,LRPPRC,MED14,MED25,MEN1,MYBBP1A,NCBP1,NFIA,NPY,NR1H3,NUP214,PIN1,PLK2,POU4F1,PPARD,PPARGC1B,PPP2R1A,PPP2R5C,PRKAA2,PRKAB2,PRKCB,PSMF1,PTPN1,PTPN11,RBFOX1,RBX1,RORA,RPA1,RPA2,RPS27A,RPTOR,SIN3A,SMARCA4,SMURF1,SNAPC1,SNRPE,SOD2,SRSF11,SUZ12,TAF5,TCF7L2,THOC5,TIGAR,TNFRSF10A,TNRC6B,WDR5,ZNF135,ZNF154,ZNF267,ZNF551,ZNF552,ZNF555,ZNF586,ZNF595,ZNF699,ZNF717	chr10:103387074:A/C:1,chr10:112964742:G/A:1,chr10:72275283:T/A:1,chr11:125637382:T/C:1,chr11:34471141:A/C:1,chr11:47259936:C/A:1,chr11:64807481:C/T:1,chr12:112489105:A/T:1,chr12:4321404:C/A:1,chr12:98648251:A/T:1,chr13:78601815:G/T:1,chr14:101883867:G/T:1,chr14:61776044:A/T:1,chr15:60556760:G/T:1,chr15:75409706:G/A:1,chr15:89263297:C/A:1,chr15:89304999:T/C:1,chr16:23867049:C/T:1,chr16:30494137:C/A:1,chr16:31895162:G/A:1,chr16:5366001:C/A:1,chr17:1853255:C/A:1,chr17:31973320:T/G:1,chr17:43049287:C/G:1,chr17:44079338:G/T:1,chr17:4545528:G/A:1,chr17:50195100:C/A:1,chr17:80664395:C/A:1,chr19:10173083:G/A:1,chr19:11025539:C/G:1,chr19:2852284:A/C:1,chr19:35731956:C/T:1,chr19:49830773:C/A:1,chr19:52215622:C/T:1,chr19:57704603:C/A:1,chr19:57814755:G/T:1,chr19:58063587:G/T:1,chr19:6380036:G/T:1,chr19:9305000:G/T:1,chr19:9849326:C/A:1,chr1:147172001:G/A:1,chr1:153763739:C/A:1,chr1:153770813:C/G:1,chr1:203869988:C/G:1,chr1:27914481:C/T:1,chr1:35850806:C/A:1,chr1:56706008:C/A:1,chr1:61088112:A/T:1,chr1:70228405:A/T:1,chr20:1117130:G/T:1,chr20:50526505:C/A:1,chr22:29527997:G/T:1,chr22:40049003:G/T:1,chr22:40963988:A/T:1,chr2:111863902:T/A:1,chr2:218582908:A/T:1,chr2:43944068:C/A:1,chr2:55234745:A/T:1,chr3:13496579:C/G:1,chr3:20072202:A/T:1,chr3:75741893:A/G:1,chr4:152350128:T/A:1,chr4:25418042:G/T:1,chr4:54908:G/A:1,chr5:141629409:G/A:1,chr5:149834580:G/T:1,chr5:38482482:C/A:1,chr5:58454762:G/T:1,chr5:71462094:C/T:1,chr5:79300647:C/A:1,chr6:156829096:A/G:1,chr6:157039620:T/A:1,chr6:159684794:A/T:1,chr6:31536198:G/C:1,chr6:35396106:C/T:1,chr7:143292189:T/C:1,chr7:24285140:T/G:1,chr7:99061975:G/T:1,chr8:23202515:G/T:1,chr8:79766933:C/A:1,chr9:131215059:A/G:1,chr9:134155272:C/G:1,chr9:97664178:C/A:1,chrX:40703435:G/C:1,chrX:72572139:G/A:1
R-HSA-74713	IRS activation	Signal Transduction	0.253920	IRS1	chr2:226796751:A/G:1
R-HSA-74749	Signal attenuation	Signal Transduction	0.443443	IRS1	chr2:226796751:A/G:1
R-HSA-74751	Insulin receptor signalling cascade	Signal Transduction	1.000000	IRS1,PIK3CB,PTPN11	chr12:112489105:A/T:1,chr2:226796751:A/G:1,chr3:138778223:G/A:1
R-HSA-74752	Signaling by Insulin receptor	Signal Transduction	0.627954	IRS1,PIK3CB,PTPN11	chr12:112489105:A/T:1,chr2:226796751:A/G:1,chr3:138778223:G/A:1
R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	Gene expression (Transcription)	0.505418	BDP1,NFIA,SNAPC1	chr14:61776044:A/T:1,chr1:61088112:A/T:1,chr5:71462094:C/T:1
R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	Cell Cycle	0.533217	CHEK1	chr11:125637382:T/C:1
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	Metabolism of RNA	0.672201	NCBP1,SNRPE	chr1:203869988:C/G:1,chr9:97664178:C/A:1
R-HSA-75072	mRNA Editing	Metabolism of RNA	0.443443	APOBEC3A	chr22:38962236:C/T:1
R-HSA-75094	Formation of the Editosome	Metabolism of RNA	0.374212	APOBEC3A	chr22:38962236:C/T:1
R-HSA-75105	Fatty acyl-CoA biosynthesis	Metabolism	1.000000	ACSBG2,PPT1	chr19:6161586:G/A:1,chr1:40085102:C/T:1
R-HSA-75109	Triglyceride biosynthesis	Metabolism	0.041691	GPAT2,LPIN1,LPIN3	chr20:41345676:A/G:1,chr2:11819407:C/G:1,chr2:96023639:T/A:1
R-HSA-75153	Apoptotic execution phase	Programmed Cell Death	0.026909	CDH1,GSN,HIST1H1E,PKP1,PRKCD,STK26,TJP2	chr16:68779429:G/T:1,chr1:201324373:G/T:1,chr3:53192052:T/G:1,chr6:26156427:G/C:1,chr9:121312182:C/T:1,chr9:69250885:T/G:1,chrX:132069471:A/T:1
R-HSA-75158	TRAIL  signaling	Signal Transduction	0.374212	TNFRSF10A	chr8:23202515:G/T:1
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	Cell Cycle	0.768730	PSMF1,RPS27A	chr20:1117130:G/T:1,chr2:55234745:A/T:1
R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs	Metabolism	1.000000	ACSBG2	chr19:6161586:G/A:1
R-HSA-75892	Platelet Adhesion to exposed collagen	Hemostasis	0.208745	COL1A1,ITGA10	chr17:50195100:C/A:1,chr1:145895756:C/T:1,chr1:145909820:C/A:1
R-HSA-75893	TNF signaling	Signal Transduction	1.000000	RPS27A,TAX1BP1	chr2:55234745:A/T:1,chr7:27841060:C/A:1
R-HSA-75896	Plasmalogen biosynthesis	Metabolism	0.161161	GNPAT	chr1:231267458:C/A:1
R-HSA-75953	RNA Polymerase II Transcription Initiation	Gene expression (Transcription)	1.000000	GTF2F1,TAF5	chr10:103387074:A/C:1,chr19:6380036:G/T:1
R-HSA-75955	RNA Polymerase II Transcription Elongation	Gene expression (Transcription)	0.583162	GTF2F1,NCBP1	chr19:6380036:G/T:1,chr9:97664178:C/A:1
R-HSA-76002	Platelet activation, signaling and aggregation	Hemostasis	0.002561	CD36,COL1A1,CSK,DAGLA,DGKI,F13A1,GNA12,GNAQ,GNAT3,ITIH4,ITPR2,ITPR3,LHFPL2,MPIG6B,PHACTR2,PIK3CB,PIK3R6,PLEK,PRKCB,PRKCD,PTPN1,PTPN11,PTPN6,TGFB2,TIMP3,TLN1,TTN	chr11:61743387:T/A:1,chr12:112489105:A/T:1,chr12:26600531:C/A:1,chr12:6960084:C/T:1,chr15:74802540:C/T:1,chr16:23867049:C/T:1,chr17:50195100:C/A:1,chr17:8822843:A/G:1,chr1:218405442:G/T:1,chr20:50526505:C/A:1,chr22:32803374:G/T:1,chr2:178529881:A/T:1,chr2:68391550:T/C:1,chr3:138778223:G/A:1,chr3:52819352:G/A:1,chr3:53192052:T/G:1,chr5:78708953:G/A:1,chr6:143777479:C/A:1,chr6:31720741:T/A:1,chr6:33676739:C/A:1,chr6:6224619:A/T:1,chr7:137665038:C/A:1,chr7:2762539:T/C:1,chr7:80474080:T/G:1,chr9:35697963:G/T:1,chr9:77797745:T/A:1
R-HSA-76005	Response to elevated platelet cytosolic Ca2+	Hemostasis	0.183698	CD36,F13A1,ITIH4,LHFPL2,PHACTR2,PLEK,PRKCB,TGFB2,TIMP3,TLN1,TTN	chr16:23867049:C/T:1,chr1:218405442:G/T:1,chr22:32803374:G/T:1,chr2:178529881:A/T:1,chr2:68391550:T/C:1,chr3:52819352:G/A:1,chr5:78708953:G/A:1,chr6:143777479:C/A:1,chr6:6224619:A/T:1,chr7:80474080:T/G:1,chr9:35697963:G/T:1
R-HSA-76009	Platelet Aggregation (Plug Formation)	Hemostasis	0.280796	COL1A1,CSK,PTPN1,TLN1	chr15:74802540:C/T:1,chr17:50195100:C/A:1,chr20:50526505:C/A:1,chr9:35697963:G/T:1
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	Gene expression (Transcription)	1.000000	GTF2F1,TAF5	chr10:103387074:A/C:1,chr19:6380036:G/T:1
R-HSA-76046	RNA Polymerase III Transcription Initiation	Gene expression (Transcription)	1.000000	BDP1,SNAPC1	chr14:61776044:A/T:1,chr5:71462094:C/T:1
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	Gene expression (Transcription)	1.000000	BDP1	chr5:71462094:C/T:1
R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	Gene expression (Transcription)	1.000000	BDP1	chr5:71462094:C/T:1
R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	Gene expression (Transcription)	0.672201	BDP1,SNAPC1	chr14:61776044:A/T:1,chr5:71462094:C/T:1
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	Gene expression (Transcription)	1.000000	GTF2F1	chr19:6380036:G/T:1
R-HSA-77286	mitochondrial fatty acid beta-oxidation of saturated fatty acids	Metabolism	0.475135	ACSM3	chr16:20621896:G/T:1
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	Metabolism	0.466570	ACSM3,MUT,PCCA	chr13:100469233:C/A:1,chr16:20621896:G/T:1,chr6:49444826:C/A:1
R-HSA-77352	Beta oxidation of butanoyl-CoA to acetyl-CoA	Metabolism	0.253920	ACSM3	chr16:20621896:G/T:1
R-HSA-774815	Nucleosome assembly	Cell Cycle	0.441652	KNL1,OIP5	chr15:40651961:A/T:1,chr15:41319933:G/T:1
R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	Metabolism of RNA	0.126518	NCBP1,SNRPE	chr1:203869988:C/G:1,chr9:97664178:C/A:1
R-HSA-77595	Processing of Intronless Pre-mRNAs	Metabolism of RNA	1.000000	NCBP1	chr9:97664178:C/A:1
R-HSA-804914	Transport of fatty acids	Transport of small molecules	0.072010	SLC27A1,SLC27A4	chr19:17487596:C/T:1,chr9:128360555:C/A:1
R-HSA-83936	Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane	Transport of small molecules	0.505026	SLC28A3	chr9:84279882:C/A:1
R-HSA-877300	Interferon gamma signaling	Immune System	0.248186	HLA-B,HLA-DRB1,HLA-DRB5,NCAM1,PRKCD,PTPN1,PTPN11,PTPN6	chr11:113207596:G/T:1,chr12:112489105:A/T:1,chr12:6960084:C/T:1,chr20:50526505:C/A:1,chr3:53192052:T/G:1,chr6:31356312:G/A:1,chr6:32530260:C/G:1,chr6:32584008:G/C:1
R-HSA-877312	Regulation of IFNG signaling	Immune System	0.041691	PTPN1,PTPN11,PTPN6	chr12:112489105:A/T:1,chr12:6960084:C/T:1,chr20:50526505:C/A:1
R-HSA-881907	Gastrin-CREB signalling pathway via PKC and MAPK	Signal Transduction	1.000000	RPS6KA1	chr1:26571817:C/A:1
R-HSA-8847993	ERBB2 Activates PTK6 Signaling	Signal Transduction	0.166735	ERBB4,NRG3	chr10:82985678:T/A:1,chr2:211630704:C/G:1
R-HSA-8848021	Signaling by PTK6	Signal Transduction	0.233734	DOCK1,ERBB4,NRG3,PTPN1,RPS27A	chr10:127257347:G/T:1,chr10:82985678:T/A:1,chr20:50526505:C/A:1,chr2:211630704:C/G:1,chr2:55234745:A/T:1
R-HSA-8848584	Wax and plasmalogen biosynthesis	Metabolism	0.336437	GNPAT	chr1:231267458:C/A:1
R-HSA-8849469	PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1	Signal Transduction	0.409840	RPS27A	chr2:55234745:A/T:1
R-HSA-8849471	PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases	Signal Transduction	0.559805	DOCK1	chr10:127257347:G/T:1
R-HSA-8849472	PTK6 Down-Regulation	Signal Transduction	0.161161	PTPN1	chr20:50526505:C/A:1
R-HSA-8849932	Synaptic adhesion-like molecules	Neuronal System	0.113936	LRFN3,PTPRD,PTPRF	chr19:35939983:C/A:1,chr19:35944781:C/T:1,chr1:43591997:G/T:1,chr1:43617848:G/A:1,chr1:43619068:C/T:1,chr1:43620409:T/C:1,chr9:9208846:C/T:1
R-HSA-8851708	Signaling by FGFR2 IIIa TM	Disease	0.294775	GTF2F1,NCBP1	chr19:6380036:G/T:1,chr9:97664178:C/A:1
R-HSA-8852135	Protein ubiquitination	Metabolism of proteins	1.000000	HLTF,PEX5,RNF152,RPS27A	chr12:7190218:T/G:1,chr18:61844221:A/G:1,chr18:61844223:G/A:1,chr2:55234745:A/T:1,chr3:149055599:C/T:1
R-HSA-8852276	The role of GTSE1 in G2/M progression after G2 checkpoint	Cell Cycle	1.000000	PSMF1,RPS27A,TUBB2A,TUBB8	chr10:73757:T/G:1,chr20:1117130:G/T:1,chr2:55234745:A/T:1,chr6:3154999:A/G:1
R-HSA-8853383	Lysosomal oligosaccharide catabolism	Metabolism	0.208897	MAN2C1	chr15:75355845:G/C:1
R-HSA-8853659	RET signaling	Developmental Biology	1.000000	PIK3CB,PTPN11	chr12:112489105:A/T:1,chr3:138778223:G/A:1
R-HSA-8853884	Transcriptional Regulation by VENTX	Gene expression (Transcription)	0.074714	AGO4,ANAPC1,ANAPC4,TCF7L2,TNRC6B	chr10:112964742:G/A:1,chr1:35850806:C/A:1,chr22:40049003:G/T:1,chr2:111863902:T/A:1,chr4:25418042:G/T:1
R-HSA-8854050	FBXL7 down-regulates AURKA during mitotic entry and in early mitosis	Cell Cycle	1.000000	PSMF1,RBX1,RPS27A	chr20:1117130:G/T:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1
R-HSA-8854214	TBC/RABGAPs	Vesicle-mediated transport	0.102878	GABARAP,GGA2,RAB4A,RAB6B,TBC1D14	chr16:23469223:G/T:1,chr17:7240852:C/A:1,chr1:229288550:C/A:1,chr3:133841152:G/A:1,chr4:7030472:G/C:1
R-HSA-8854518	AURKA Activation by TPX2	Cell Cycle	1.000000	AKAP9,CEP78,PCNT,PPP2R1A	chr19:52215622:C/T:1,chr21:46351357:C/A:1,chr7:91974127:C/A:1,chr7:92040995:G/T:1,chr9:78246838:C/A:1
R-HSA-8854691	Interleukin-20 family signaling	Immune System	1.000000	PTPN11	chr12:112489105:A/T:1
R-HSA-8856688	Golgi-to-ER retrograde transport	Vesicle-mediated transport	0.571540	KIF11,KIF25,KLC2,KLC4,NBAS,RAB3GAP1,RAB6B,TUBB2A,TUBB8	chr10:73757:T/G:1,chr10:92639648:G/T:1,chr11:66264919:G/A:1,chr2:135113016:C/T:1,chr2:15421926:C/A:1,chr3:133841152:G/A:1,chr6:168040119:C/A:1,chr6:3154999:A/G:1,chr6:43055804:A/T:1
R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	Vesicle-mediated transport	0.391930	AP2B1,CFTR,EPS15,FCHO1,FCHO2,ITSN2,RPS27A,STAM	chr10:17660650:A/C:1,chr17:35682607:A/G:1,chr19:17774499:G/A:1,chr19:17787746:T/C:1,chr1:51465474:T/A:1,chr2:24209639:T/G:1,chr2:55234745:A/T:1,chr5:73087969:C/A:1,chr7:117542008:A/T:1
R-HSA-8856828	Clathrin-mediated endocytosis	Vesicle-mediated transport	0.281490	AP2B1,BIN1,CFTR,CTTN,EPS15,FCHO1,FCHO2,ITSN2,PIP5K1C,RPS27A,STAM	chr10:17660650:A/C:1,chr11:70431006:C/A:1,chr17:35682607:A/G:1,chr19:17774499:G/A:1,chr19:17787746:T/C:1,chr19:3643094:C/A:1,chr1:51465474:T/A:1,chr2:127060445:C/T:1,chr2:24209639:T/G:1,chr2:55234745:A/T:1,chr5:73087969:C/A:1,chr7:117542008:A/T:1
R-HSA-8862803	Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models	Disease	1.000000	SOD2	chr6:159684794:A/T:1
R-HSA-8863678	Neurodegenerative Diseases	Disease	1.000000	SOD2	chr6:159684794:A/T:1
R-HSA-8863795	Downregulation of ERBB2 signaling	Signal Transduction	0.079795	ERBB4,NRG3,RPS27A,USP8	chr10:82985678:T/A:1,chr15:50441258:C/A:1,chr2:211630704:C/G:1,chr2:55234745:A/T:1
R-HSA-8865999	MET activates PTPN11	Signal Transduction	0.253920	PTPN11	chr12:112489105:A/T:1
R-HSA-8866376	Reelin signalling pathway	Developmental Biology	0.253920	VLDLR	chr9:2644144:G/T:1
R-HSA-8866427	VLDLR internalisation and degradation	Transport of small molecules	0.027413	AP2B1,NR1H3,VLDLR	chr11:47259936:C/A:1,chr17:35682607:A/G:1,chr9:2644144:G/T:1
R-HSA-8866652	Synthesis of active ubiquitin: roles of E1 and E2 enzymes	Metabolism of proteins	1.000000	RPS27A	chr2:55234745:A/T:1
R-HSA-8866654	E3 ubiquitin ligases ubiquitinate target proteins	Metabolism of proteins	0.577730	HLTF,PEX5,RNF152,RPS27A	chr12:7190218:T/G:1,chr18:61844221:A/G:1,chr18:61844223:G/A:1,chr2:55234745:A/T:1,chr3:149055599:C/T:1
R-HSA-8868773	rRNA processing in the nucleus and cytosol	Metabolism of RNA	0.875955	NAT10,NOP14,RPL10,RPL23,RPL31,RPS27A,RPS6,RPS9,UTP20,WDR75	chr11:34132001:A/T:1,chr12:101281201:G/T:1,chr17:38850552:C/A:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr2:101018980:G/T:1,chr2:189465352:G/A:1,chr2:55234745:A/T:1,chr4:2939691:G/A:1,chr9:19376102:T/C:1,chrX:154405329:C/A:1
R-HSA-8873719	RAB geranylgeranylation	Metabolism of proteins	0.418932	RAB10,RAB24,RAB3D,RAB4A,RAB6B	chr19:11343264:G/A:1,chr1:229288550:C/A:1,chr2:26109711:A/T:1,chr3:133841152:G/A:1,chr5:177301877:T/C:1
R-HSA-8874081	MET activates PTK2 signaling	Signal Transduction	0.000201	COL11A1,COL11A2,COL1A1,COL2A1,COL5A1,COL5A2,LAMB3,LAMC2	chr12:47982418:C/T:1,chr17:50195100:C/A:1,chr1:102962717:G/T:1,chr1:183228170:A/G:1,chr1:209618498:C/T:1,chr2:189098495:C/A:1,chr6:33171551:C/T:1,chr9:134782781:A/G:1
R-HSA-8875360	InlB-mediated entry of Listeria monocytogenes into host cell	Disease	0.049974	EPS15,RPS27A,STAM	chr10:17660650:A/C:1,chr1:51465474:T/A:1,chr2:55234745:A/T:1
R-HSA-8875555	MET activates RAP1 and RAC1	Signal Transduction	0.475135	RAPGEF1	chr9:131592242:G/T:1
R-HSA-8875656	MET receptor recycling	Signal Transduction	0.443443	RAB4A	chr1:229288550:C/A:1
R-HSA-8875878	MET promotes cell motility	Signal Transduction	0.000399	COL11A1,COL11A2,COL1A1,COL2A1,COL5A1,COL5A2,LAMB3,LAMC2,RAPGEF1	chr12:47982418:C/T:1,chr17:50195100:C/A:1,chr1:102962717:G/T:1,chr1:183228170:A/G:1,chr1:209618498:C/T:1,chr2:189098495:C/A:1,chr6:33171551:C/T:1,chr9:131592242:G/T:1,chr9:134782781:A/G:1
R-HSA-8876198	RAB GEFs exchange GTP for GDP on RABs	Vesicle-mediated transport	0.357900	ALS2,DENND3,HPS4,RAB10,RAB3GAP1,RAB6B,SBF1	chr22:26465716:C/T:1,chr22:50461719:C/T:1,chr2:135113016:C/T:1,chr2:201728707:T/A:1,chr2:26109711:A/T:1,chr3:133841152:G/A:1,chr8:141176474:A/G:1
R-HSA-8876384	Listeria monocytogenes entry into host cells	Disease	0.024251	CDH1,EPS15,RPS27A,STAM	chr10:17660650:A/C:1,chr16:68779429:G/T:1,chr1:51465474:T/A:1,chr2:55234745:A/T:1
R-HSA-8876493	InlA-mediated entry of Listeria monocytogenes into host cells	Disease	0.089187	CDH1,RPS27A	chr16:68779429:G/T:1,chr2:55234745:A/T:1
R-HSA-8878159	Transcriptional regulation by RUNX3	Gene expression (Transcription)	0.822879	ITGAL,KAT2B,PSMF1,RPS27A,SMURF1,TCF7L2	chr10:112964742:G/A:1,chr16:30494137:C/A:1,chr20:1117130:G/T:1,chr2:55234745:A/T:1,chr3:20072202:A/T:1,chr7:99061975:G/T:1
R-HSA-8878166	Transcriptional regulation by RUNX2	Gene expression (Transcription)	0.423063	COL1A1,FBXW7,HDAC3,HEY1,PPARGC1B,PSMF1,RBX1,RPS27A,SMURF1	chr17:50195100:C/A:1,chr20:1117130:G/T:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1,chr4:152350128:T/A:1,chr5:141629409:G/A:1,chr5:149834580:G/T:1,chr7:99061975:G/T:1,chr8:79766933:C/A:1
R-HSA-8878171	Transcriptional regulation by RUNX1	Gene expression (Transcription)	1.000000	AGO4,ARID1B,KAT2B,KMT2B,LIFR,PRKCB,PSMF1,PTPN11,RPS27A,SIN3A,SMARCA4,TNRC6B,WDR5	chr12:112489105:A/T:1,chr15:75409706:G/A:1,chr16:23867049:C/T:1,chr19:11025539:C/G:1,chr19:35731956:C/T:1,chr1:35850806:C/A:1,chr20:1117130:G/T:1,chr22:40049003:G/T:1,chr2:55234745:A/T:1,chr3:20072202:A/T:1,chr5:38482482:C/A:1,chr6:156829096:A/G:1,chr6:157039620:T/A:1,chr9:134155272:C/G:1
R-HSA-888590	GABA synthesis, release, reuptake and degradation	Neuronal System	0.294775	SLC6A11,SLC6A12	chr12:197114:C/T:1,chr3:10820021:T/A:1,chr3:10933011:G/T:1
R-HSA-888593	Reuptake of GABA	Neuronal System	0.017954	SLC6A11,SLC6A12	chr12:197114:C/T:1,chr3:10820021:T/A:1,chr3:10933011:G/T:1
R-HSA-8934593	Regulation of RUNX1 Expression and Activity	Gene expression (Transcription)	0.068709	AGO4,PTPN11,TNRC6B	chr12:112489105:A/T:1,chr1:35850806:C/A:1,chr22:40049003:G/T:1
R-HSA-8935690	Digestion	Digestion and absorption	1.000000	MGAM	chr7:142093478:C/A:1
R-HSA-8936459	RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function	Gene expression (Transcription)	0.822879	AGO4,KAT2B,KMT2B,SIN3A,TNRC6B,WDR5	chr15:75409706:G/A:1,chr19:35731956:C/T:1,chr1:35850806:C/A:1,chr22:40049003:G/T:1,chr3:20072202:A/T:1,chr9:134155272:C/G:1
R-HSA-8939211	ESR-mediated signaling	Signal Transduction	0.556528	AGO4,ERBB4,GNAT3,GTF2F1,KAT2B,NOS3,SMC1A,STAG2,TNRC6B,USF2	chr19:35270616:A/G:1,chr19:6380036:G/T:1,chr1:35850806:C/A:1,chr22:40049003:G/T:1,chr2:211630704:C/G:1,chr3:20072202:A/T:1,chr7:151010230:G/T:1,chr7:80474080:T/G:1,chrX:124057978:G/A:1,chrX:124422202:A/T:1,chrX:53380790:T/C:1
R-HSA-8939236	RUNX1 regulates transcription of genes involved in differentiation of HSCs	Gene expression (Transcription)	0.034634	PSMF1,RPS27A	chr20:1117130:G/T:1,chr2:55234745:A/T:1
R-HSA-8939243	RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known	Gene expression (Transcription)	1.000000	ARID1B,SMARCA4	chr19:11025539:C/G:1,chr6:156829096:A/G:1,chr6:157039620:T/A:1
R-HSA-8939246	RUNX1 regulates transcription of genes involved in differentiation of myeloid cells	Gene expression (Transcription)	0.336437	PRKCB	chr16:23867049:C/T:1
R-HSA-8939247	RUNX1 regulates transcription of genes involved in interleukin signaling	Gene expression (Transcription)	0.253920	LIFR	chr5:38482482:C/A:1
R-HSA-8939902	Regulation of RUNX2 expression and activity	Gene expression (Transcription)	0.309032	FBXW7,PPARGC1B,PSMF1,RBX1,RPS27A,SMURF1	chr20:1117130:G/T:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1,chr4:152350128:T/A:1,chr5:149834580:G/T:1,chr7:99061975:G/T:1
R-HSA-8940973	RUNX2 regulates osteoblast differentiation	Gene expression (Transcription)	0.153436	COL1A1,HDAC3,HEY1	chr17:50195100:C/A:1,chr5:141629409:G/A:1,chr8:79766933:C/A:1
R-HSA-8941237	Invadopodia formation	Extracellular matrix organization	0.208897	SH3PXD2A	chr10:103661168:C/A:1
R-HSA-8941326	RUNX2 regulates bone development	Gene expression (Transcription)	0.257582	COL1A1,HDAC3,HEY1	chr17:50195100:C/A:1,chr5:141629409:G/A:1,chr8:79766933:C/A:1
R-HSA-8941856	RUNX3 regulates NOTCH signaling	Gene expression (Transcription)	0.559805	KAT2B	chr3:20072202:A/T:1
R-HSA-8941858	Regulation of RUNX3 expression and activity	Gene expression (Transcription)	1.000000	PSMF1,RPS27A,SMURF1	chr20:1117130:G/T:1,chr2:55234745:A/T:1,chr7:99061975:G/T:1
R-HSA-8943723	Regulation of PTEN mRNA translation	Signal Transduction	0.089187	AGO4,TNRC6B	chr1:35850806:C/A:1,chr22:40049003:G/T:1
R-HSA-8943724	Regulation of PTEN gene transcription	Signal Transduction	0.777723	HDAC3,HDAC5,RPTOR,SUZ12	chr17:31973320:T/G:1,chr17:44079338:G/T:1,chr17:80664395:C/A:1,chr5:141629409:G/A:1
R-HSA-8948216	Collagen chain trimerization	Extracellular matrix organization	0.000141	COL11A1,COL11A2,COL12A1,COL13A1,COL1A1,COL22A1,COL2A1,COL4A6,COL5A1,COL5A2	chr10:69827305:G/T:1,chr12:47982418:C/T:1,chr17:50195100:C/A:1,chr1:102962717:G/T:1,chr2:189098495:C/A:1,chr6:33171551:C/T:1,chr6:75151273:C/A:1,chr8:138852265:G/T:1,chr8:138870935:G/A:1,chr9:134782781:A/G:1,chrX:108187727:G/A:1
R-HSA-8948700	Competing endogenous RNAs (ceRNAs) regulate PTEN translation	Signal Transduction	0.072010	AGO4,TNRC6B	chr1:35850806:C/A:1,chr22:40049003:G/T:1
R-HSA-8948747	Regulation of PTEN localization	Signal Transduction	0.409840	RPS27A	chr2:55234745:A/T:1
R-HSA-8948751	Regulation of PTEN stability and activity	Signal Transduction	1.000000	PSMF1,RPS27A,TNKS	chr20:1117130:G/T:1,chr2:55234745:A/T:1,chr8:9776590:C/A:1
R-HSA-8949215	Mitochondrial calcium ion transport	Transport of small molecules	0.379439	SLC8A3,YME1L1	chr10:27112141:C/T:1,chr14:70060534:G/T:1
R-HSA-8949275	RUNX3 Regulates Immune Response and Cell Migration	Gene expression (Transcription)	0.296385	ITGAL	chr16:30494137:C/A:1
R-HSA-8949664	Processing of SMDT1	Transport of small molecules	0.608530	YME1L1	chr10:27112141:C/T:1
R-HSA-8950505	Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation	Immune System	0.475872	PITPNA,SNRPA1,SOD2	chr15:101281621:G/T:1,chr17:1520665:A/G:1,chr6:159684794:A/T:1
R-HSA-8951430	RUNX3 regulates WNT signaling	Gene expression (Transcription)	0.374212	TCF7L2	chr10:112964742:G/A:1
R-HSA-8951664	Neddylation	Metabolism of proteins	0.886112	ASB3,COMMD5,COMMD6,COP1,FBXO21,FBXW7,PSMF1,RBX1,RPS27A,WDR5,WDTC1,ZBTB16	chr11:114087490:T/C:1,chr12:117174552:T/C:1,chr13:75528022:C/T:1,chr1:176136414:C/A:1,chr1:27299455:G/T:1,chr20:1117130:G/T:1,chr22:40963988:A/T:1,chr2:53728873:T/A:1,chr2:55234745:A/T:1,chr4:152350128:T/A:1,chr8:144851440:T/C:1,chr9:134155272:C/G:1
R-HSA-8953750	Transcriptional Regulation by E2F6	Gene expression (Transcription)	0.125346	APAF1,BRCA1,CHEK1,SUZ12	chr11:125637382:T/C:1,chr12:98648251:A/T:1,chr17:31973320:T/G:1,chr17:43049287:C/G:1
R-HSA-8953854	Metabolism of RNA	Metabolism of RNA	0.195558	APOBEC3A,CNOT9,DDX39B,GTF2F1,NAT10,NCBP1,NOP14,NUP214,NXF1,PLRG1,PPP2R1A,PRKCD,PSMF1,PTBP1,QTRT2,RBM5,RPL10,RPL23,RPL31,RPS27A,RPS6,RPS9,SNRPA1,SNRPE,SRSF11,THOC5,TYW1,UTP20,WDR4,WDR75	chr11:34132001:A/T:1,chr11:62795754:C/G:1,chr12:101281201:G/T:1,chr15:101281621:G/T:1,chr17:38850552:C/A:1,chr19:52215622:C/T:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr19:6380036:G/T:1,chr19:804704:T/A:1,chr1:203869988:C/G:1,chr1:70228405:A/T:1,chr20:1117130:G/T:1,chr21:42859689:C/A:1,chr22:29527997:G/T:1,chr22:38962236:C/T:1,chr2:101018980:G/T:1,chr2:189465352:G/A:1,chr2:218582908:A/T:1,chr2:55234745:A/T:1,chr3:114068202:G/T:1,chr3:50092208:G/T:1,chr3:50115335:C/A:1,chr3:53192052:T/G:1,chr4:154546952:G/C:1,chr4:2939691:G/A:1,chr6:31536198:G/C:1,chr7:67238132:G/C:1,chr9:131215059:A/G:1,chr9:19376102:T/C:1,chr9:97664178:C/A:1,chrX:154405329:C/A:1
R-HSA-8953897	Cellular responses to external stimuli	Cellular responses to external stimuli	0.718630	AGO4,ANAPC1,ANAPC4,C12orf66,CAT,CCAR2,COL4A6,HIST1H1E,HSPA13,ID1,LIMD1,MAP2K3,NUP214,PSMF1,RBX1,RPA1,RPA2,RPL10,RPL23,RPL31,RPS27A,RPS6,RPS6KA1,RPS9,RPTOR,SOD2,SUZ12,SZT2,TNIK,TNRC6B,TUBB2A,TUBB8	chr10:73757:T/G:1,chr11:34471141:A/C:1,chr12:64216016:T/A:1,chr17:1853255:C/A:1,chr17:21303128:C/T:1,chr17:31973320:T/G:1,chr17:38850552:C/A:1,chr17:80664395:C/A:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr1:26571817:C/A:1,chr1:27914481:C/T:1,chr1:35850806:C/A:1,chr1:43426518:G/A:1,chr20:1117130:G/T:1,chr20:31605444:G/T:1,chr21:14373552:G/T:1,chr22:40049003:G/T:1,chr22:40963988:A/T:1,chr2:101018980:G/T:1,chr2:111863902:T/A:1,chr2:55234745:A/T:1,chr3:171373477:C/A:1,chr3:45595947:T/C:1,chr3:45665554:A/T:1,chr4:25418042:G/T:1,chr6:159684794:A/T:1,chr6:26156427:G/C:1,chr6:3154999:A/G:1,chr8:22615430:G/T:1,chr9:131215059:A/G:1,chr9:19376102:T/C:1,chrX:108187727:G/A:1,chrX:154405329:C/A:1
R-HSA-8955332	Carboxyterminal post-translational modifications of tubulin	Metabolism of proteins	0.734871	AGBL4,TUBB2A,TUBB8	chr10:73757:T/G:1,chr1:48560934:C/A:1,chr1:49844523:C/A:1,chr6:3154999:A/G:1
R-HSA-8957275	Post-translational protein phosphorylation	Metabolism of proteins	0.527867	AFP,FBN1,MEN1,PNPLA2	chr11:64807481:C/T:1,chr11:822271:G/T:1,chr15:48472836:A/C:1,chr4:73447436:C/A:1
R-HSA-8957322	Metabolism of steroids	Metabolism	0.723343	CHD9,CYP11A1,LSS,SEC23A,SEC24D,STARD3,TSPOAP1	chr14:39040609:C/A:1,chr15:74348128:C/T:1,chr16:53255530:C/A:1,chr17:39660742:G/T:1,chr17:58320561:C/A:1,chr21:46213081:T/C:1,chr4:118833895:C/A:1
R-HSA-8963743	Digestion and absorption	Digestion and absorption	1.000000	MGAM	chr7:142093478:C/A:1
R-HSA-8963896	HDL assembly	Transport of small molecules	0.374212	BMP1	chr8:22196292:A/C:1
R-HSA-8963898	Plasma lipoprotein assembly	Transport of small molecules	1.000000	BMP1	chr8:22196292:A/C:1
R-HSA-8963899	Plasma lipoprotein remodeling	Transport of small molecules	0.703700	ABCG1,LPA	chr21:42291695:T/G:1,chr6:160535531:T/C:1
R-HSA-8964038	LDL clearance	Transport of small molecules	1.000000	AP2B1	chr17:35682607:A/G:1
R-HSA-8964041	LDL remodeling	Transport of small molecules	0.208897	LPA	chr6:160535531:T/C:1
R-HSA-8964043	Plasma lipoprotein clearance	Transport of small molecules	0.433338	AP2B1,NR1H3,VLDLR	chr11:47259936:C/A:1,chr17:35682607:A/G:1,chr9:2644144:G/T:1
R-HSA-8964046	VLDL clearance	Transport of small molecules	0.296385	VLDLR	chr9:2644144:G/T:1
R-HSA-8964058	HDL remodeling	Transport of small molecules	0.443443	ABCG1	chr21:42291695:T/G:1
R-HSA-8978868	Fatty acid metabolism	Metabolism	0.742292	ACSBG2,ACSM3,CRAT,MUT,PCCA,PPARD,PPT1,PRKAA2,PRKAB2,PTGR1,TBXAS1	chr13:100469233:C/A:1,chr16:20621896:G/T:1,chr19:6161586:G/A:1,chr1:147172001:G/A:1,chr1:40085102:C/T:1,chr1:56706008:C/A:1,chr6:35396106:C/T:1,chr6:49444826:C/A:1,chr7:139865711:G/A:1,chr9:111594402:T/A:1,chr9:129110977:A/C:1
R-HSA-8978934	Metabolism of cofactors	Metabolism	0.294775	COQ3,NOS3	chr6:99394018:G/T:1,chr7:151010230:G/T:1
R-HSA-8979227	Triglyceride metabolism	Metabolism	0.475872	GPAT2,LPIN1,LPIN3	chr20:41345676:A/G:1,chr2:11819407:C/G:1,chr2:96023639:T/A:1
R-HSA-8982491	Glycogen metabolism	Metabolism	0.664823	PHKA2,RPS27A	chr2:55234745:A/T:1,chrX:18910786:G/T:1
R-HSA-8983432	Interleukin-15 signaling	Immune System	0.559805	IL2RB	chr22:37132322:T/G:1,chr22:37142288:T/C:1
R-HSA-8986944	Transcriptional Regulation by MECP2	Gene expression (Transcription)	0.172033	AGO4,HDAC3,PTPN1,RBFOX1,SIN3A,TNRC6B	chr15:75409706:G/A:1,chr16:5366001:C/A:1,chr1:35850806:C/A:1,chr20:50526505:C/A:1,chr22:40049003:G/T:1,chr5:141629409:G/A:1
R-HSA-9005891	Loss of function of MECP2 in Rett syndrome	Disease	0.166735	HDAC3,SIN3A	chr15:75409706:G/A:1,chr5:141629409:G/A:1
R-HSA-9005895	Pervasive developmental disorders	Disease	0.166735	HDAC3,SIN3A	chr15:75409706:G/A:1,chr5:141629409:G/A:1
R-HSA-9006115	Signaling by NTRK2 (TRKB)	Signal Transduction	0.651048	PTPN11,TIAM1	chr12:112489105:A/T:1,chr21:31135807:A/G:1
R-HSA-9006335	Signaling by Erythropoietin	Signal Transduction	0.651048	PIK3CB,RAPGEF1	chr3:138778223:G/A:1,chr9:131592242:G/T:1
R-HSA-9006925	Intracellular signaling by second messengers	Signal Transduction	0.256200	AGO4,ERBB4,HDAC3,HDAC5,IRS1,ITPR2,ITPR3,KITLG,NRG3,PDE1C,PIK3CB,PIP5K1C,PPP2R1A,PPP2R5C,PRKCD,PSMF1,PTPN11,RPS27A,RPTOR,SUZ12,TNKS,TNRC6B	chr10:82985678:T/A:1,chr12:112489105:A/T:1,chr12:26600531:C/A:1,chr12:88516155:G/T:1,chr14:101883867:G/T:1,chr17:31973320:T/G:1,chr17:44079338:G/T:1,chr17:80664395:C/A:1,chr19:3643094:C/A:1,chr19:52215622:C/T:1,chr1:35850806:C/A:1,chr20:1117130:G/T:1,chr22:40049003:G/T:1,chr2:211630704:C/G:1,chr2:226796751:A/G:1,chr2:55234745:A/T:1,chr3:138778223:G/A:1,chr3:53192052:T/G:1,chr5:141629409:G/A:1,chr6:33676739:C/A:1,chr7:32163293:C/T:1,chr8:9776590:C/A:1
R-HSA-9006927	Signaling by Non-Receptor Tyrosine Kinases	Signal Transduction	0.233734	DOCK1,ERBB4,NRG3,PTPN1,RPS27A	chr10:127257347:G/T:1,chr10:82985678:T/A:1,chr20:50526505:C/A:1,chr2:211630704:C/G:1,chr2:55234745:A/T:1
R-HSA-9006931	Signaling by Nuclear Receptors	Signal Transduction	0.798251	ABCG1,AGO4,ERBB4,GNAT3,GTF2F1,HDAC3,KAT2B,NOS3,NR1H3,PDHA1,PPARD,SMC1A,STAG2,TNRC6B,USF2	chr11:47259936:C/A:1,chr19:35270616:A/G:1,chr19:6380036:G/T:1,chr1:35850806:C/A:1,chr21:42291695:T/G:1,chr22:40049003:G/T:1,chr2:211630704:C/G:1,chr3:20072202:A/T:1,chr5:141629409:G/A:1,chr6:35396106:C/T:1,chr7:151010230:G/T:1,chr7:80474080:T/G:1,chrX:124057978:G/A:1,chrX:124422202:A/T:1,chrX:19355267:G/T:1,chrX:53380790:T/C:1
R-HSA-9006934	Signaling by Receptor Tyrosine Kinases	Signal Transduction	0.007515	AP2B1,CHEK1,COL11A1,COL11A2,COL1A1,COL2A1,COL5A1,COL5A2,CSK,DOCK1,EPS15,ERBB4,GRAP2,GTF2F1,ID1,IRS1,ITPR2,ITPR3,KITLG,LAMB3,LAMC2,NAB1,NCBP1,NCSTN,NOS3,NRG3,PIK3CB,PPP2R1A,PRKCB,PRKCD,PTBP1,PTPN1,PTPN11,PTPN6,RAB4A,RAPGEF1,RPS27A,RPS6KA1,STAM,STAT6,TIAM1,USP8,WASF2	chr10:127257347:G/T:1,chr10:17660650:A/C:1,chr10:82985678:T/A:1,chr11:125637382:T/C:1,chr12:112489105:A/T:1,chr12:26600531:C/A:1,chr12:47982418:C/T:1,chr12:57102572:A/C:1,chr12:6960084:C/T:1,chr12:88516155:G/T:1,chr15:50441258:C/A:1,chr15:74802540:C/T:1,chr16:23867049:C/T:1,chr17:35682607:A/G:1,chr17:50195100:C/A:1,chr19:52215622:C/T:1,chr19:6380036:G/T:1,chr19:804704:T/A:1,chr1:102962717:G/T:1,chr1:160353563:A/G:1,chr1:183228170:A/G:1,chr1:209618498:C/T:1,chr1:229288550:C/A:1,chr1:26571817:C/A:1,chr1:27412951:A/T:1,chr1:51465474:T/A:1,chr20:31605444:G/T:1,chr20:50526505:C/A:1,chr21:31135807:A/G:1,chr22:39964624:C/A:1,chr2:189098495:C/A:1,chr2:190687195:C/T:1,chr2:190687196:A/T:1,chr2:211630704:C/G:1,chr2:226796751:A/G:1,chr2:55234745:A/T:1,chr3:138778223:G/A:1,chr3:53192052:T/G:1,chr6:33171551:C/T:1,chr6:33676739:C/A:1,chr7:151010230:G/T:1,chr9:131592242:G/T:1,chr9:134782781:A/G:1,chr9:97664178:C/A:1
R-HSA-9006936	Signaling by TGF-beta family members	Signal Transduction	0.286208	MEN1,RPS27A,SMURF1	chr11:64807481:C/T:1,chr2:55234745:A/T:1,chr7:99061975:G/T:1
R-HSA-9007101	Rab regulation of trafficking	Vesicle-mediated transport	0.114108	ALS2,DENND3,GABARAP,GGA2,HPS4,RAB10,RAB3GAP1,RAB4A,RAB6B,SBF1,TBC1D14	chr16:23469223:G/T:1,chr17:7240852:C/A:1,chr1:229288550:C/A:1,chr22:26465716:C/T:1,chr22:50461719:C/T:1,chr2:135113016:C/T:1,chr2:201728707:T/A:1,chr2:26109711:A/T:1,chr3:133841152:G/A:1,chr4:7030472:G/C:1,chr8:141176474:A/G:1
R-HSA-9008059	Interleukin-37 signaling	Immune System	0.337515	PTPN11,PTPN6	chr12:112489105:A/T:1,chr12:6960084:C/T:1
R-HSA-9009391	Extra-nuclear estrogen signaling	Signal Transduction	0.445867	GNAT3,NOS3	chr7:151010230:G/T:1,chr7:80474080:T/G:1
R-HSA-901032	ER Quality Control Compartment (ERQC)	Metabolism of proteins	0.337515	RPS27A,SEL1L	chr14:81490564:A/C:1,chr2:55234745:A/T:1
R-HSA-901042	Calnexin/calreticulin cycle	Metabolism of proteins	0.657751	RPS27A,SEL1L	chr14:81490564:A/C:1,chr2:55234745:A/T:1
R-HSA-9010553	Regulation of expression of SLITs and ROBOs	Developmental Biology	0.868316	NCBP1,PSMF1,RBX1,ROBO3,RPL10,RPL23,RPL31,RPS27A,RPS6,RPS9	chr11:124874968:C/A:1,chr17:38850552:C/A:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr20:1117130:G/T:1,chr22:40963988:A/T:1,chr2:101018980:G/T:1,chr2:55234745:A/T:1,chr9:19376102:T/C:1,chr9:97664178:C/A:1,chrX:154405329:C/A:1
R-HSA-9010642	ROBO receptors bind AKAP5	Developmental Biology	0.409840	ROBO3	chr11:124874968:C/A:1
R-HSA-9012852	Signaling by NOTCH3	Signal Transduction	0.058018	HEY1,KAT2B,NCSTN,PLXND1,RPS27A,WWC1	chr1:160353563:A/G:1,chr2:55234745:A/T:1,chr3:129575694:T/G:1,chr3:20072202:A/T:1,chr5:168402535:G/T:1,chr8:79766933:C/A:1
R-HSA-9013507	NOTCH3 Activation and Transmission of Signal to the Nucleus	Signal Transduction	0.651048	NCSTN,RPS27A	chr1:160353563:A/G:1,chr2:55234745:A/T:1
R-HSA-9013508	NOTCH3 Intracellular Domain Regulates Transcription	Signal Transduction	0.050683	HEY1,KAT2B,PLXND1,WWC1	chr3:129575694:T/G:1,chr3:20072202:A/T:1,chr5:168402535:G/T:1,chr8:79766933:C/A:1
R-HSA-9013694	Signaling by NOTCH4	Signal Transduction	0.142025	ACTA2,FBXW7,HEY1,KAT2B,NCSTN,PSMF1,RBX1,RPS27A	chr10:88947447:C/A:1,chr1:160353563:A/G:1,chr20:1117130:G/T:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1,chr3:20072202:A/T:1,chr4:152350128:T/A:1,chr8:79766933:C/A:1
R-HSA-9013695	NOTCH4 Intracellular Domain Regulates Transcription	Signal Transduction	0.101752	ACTA2,HEY1,KAT2B	chr10:88947447:C/A:1,chr3:20072202:A/T:1,chr8:79766933:C/A:1
R-HSA-9013700	NOTCH4 Activation and Transmission of Signal to the Nucleus	Signal Transduction	0.475135	NCSTN	chr1:160353563:A/G:1
R-HSA-9013973	TICAM1-dependent activation of IRF3/IRF7	Immune System	0.146339	IKBKE,RPS27A	chr1:206479188:C/A:1,chr2:55234745:A/T:1
R-HSA-9014325	TICAM1,TRAF6-dependent induction of TAK1 complex	Immune System	0.475135	RPS27A	chr2:55234745:A/T:1
R-HSA-9017802	Noncanonical activation of NOTCH3	Signal Transduction	0.374212	NCSTN	chr1:160353563:A/G:1
R-HSA-9018519	Estrogen-dependent gene expression	Signal Transduction	1.000000	AGO4,ERBB4,GTF2F1,KAT2B,SMC1A,STAG2,TNRC6B,USF2	chr19:35270616:A/G:1,chr19:6380036:G/T:1,chr1:35850806:C/A:1,chr22:40049003:G/T:1,chr2:211630704:C/G:1,chr3:20072202:A/T:1,chrX:124057978:G/A:1,chrX:124422202:A/T:1,chrX:53380790:T/C:1
R-HSA-9018677	Biosynthesis of DHA-derived SPMs	Metabolism	1.000000	CYP2D6	chr22:42126548:G/A:1
R-HSA-9018678	Biosynthesis of specialized proresolving mediators (SPMs)	Metabolism	0.294775	CYP2D6,PTGR1	chr22:42126548:G/A:1,chr9:111594402:T/A:1
R-HSA-9018682	Biosynthesis of maresins	Metabolism	0.374212	CYP2D6	chr22:42126548:G/A:1
R-HSA-9020558	Interleukin-2 signaling	Immune System	0.505026	IL2RB	chr22:37132322:T/G:1,chr22:37142288:T/C:1
R-HSA-9020591	Interleukin-12 signaling	Immune System	0.748955	PITPNA,SNRPA1,SOD2	chr15:101281621:G/T:1,chr17:1520665:A/G:1,chr6:159684794:A/T:1
R-HSA-9020702	Interleukin-1 signaling	Immune System	1.000000	NFKBIA,NOD2,PSMF1,RBX1,RPS27A	chr14:35403479:G/T:1,chr16:50711288:C/T:1,chr20:1117130:G/T:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1
R-HSA-9022537	Loss of MECP2 binding ability to the NCoR/SMRT complex	Disease	0.336437	HDAC3	chr5:141629409:G/A:1
R-HSA-9022538	Loss of MECP2 binding ability to 5mC-DNA	Disease	0.208897	SIN3A	chr15:75409706:G/A:1
R-HSA-9022692	Regulation of MECP2 expression and activity	Gene expression (Transcription)	0.105992	AGO4,HDAC3,SIN3A,TNRC6B	chr15:75409706:G/A:1,chr1:35850806:C/A:1,chr22:40049003:G/T:1,chr5:141629409:G/A:1
R-HSA-9022699	MECP2 regulates neuronal receptors and channels	Gene expression (Transcription)	0.273233	PTPN1,SIN3A	chr15:75409706:G/A:1,chr20:50526505:C/A:1
R-HSA-9022702	MECP2 regulates transcription of neuronal ligands	Gene expression (Transcription)	0.374212	SIN3A	chr15:75409706:G/A:1
R-HSA-9022707	MECP2 regulates transcription factors	Gene expression (Transcription)	0.253920	RBFOX1	chr16:5366001:C/A:1
R-HSA-9024446	NR1H2 and NR1H3-mediated signaling	Signal Transduction	0.190330	ABCG1,AGO4,HDAC3,NR1H3,TNRC6B	chr11:47259936:C/A:1,chr1:35850806:C/A:1,chr21:42291695:T/G:1,chr22:40049003:G/T:1,chr5:141629409:G/A:1
R-HSA-9027276	Erythropoietin activates Phosphoinositide-3-kinase (PI3K)	Signal Transduction	0.505026	PIK3CB	chr3:138778223:G/A:1
R-HSA-9027284	Erythropoietin activates RAS	Signal Transduction	0.559805	RAPGEF1	chr9:131592242:G/T:1
R-HSA-9027307	Biosynthesis of maresin-like SPMs	Metabolism	0.296385	CYP2D6	chr22:42126548:G/A:1
R-HSA-9028731	Activated NTRK2 signals through FRS2 and FRS3	Signal Transduction	0.475135	PTPN11	chr12:112489105:A/T:1
R-HSA-9029558	NR1H2 & NR1H3 regulate gene expression linked to lipogenesis	Signal Transduction	0.409840	NR1H3	chr11:47259936:C/A:1
R-HSA-9029569	NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux	Signal Transduction	0.056753	ABCG1,AGO4,HDAC3,NR1H3,TNRC6B	chr11:47259936:C/A:1,chr1:35850806:C/A:1,chr21:42291695:T/G:1,chr22:40049003:G/T:1,chr5:141629409:G/A:1
R-HSA-9031525	NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake 	Signal Transduction	0.253920	NR1H3	chr11:47259936:C/A:1
R-HSA-9031528	NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose	Signal Transduction	0.253920	NR1H3	chr11:47259936:C/A:1
R-HSA-9031628	NGF-stimulated transcription	Signal Transduction	1.000000	ID1,NAB1	chr20:31605444:G/T:1,chr2:190687195:C/T:1,chr2:190687196:A/T:1
R-HSA-9032845	Activated NTRK2 signals through CDK5	Signal Transduction	0.296385	TIAM1	chr21:31135807:A/G:1
R-HSA-9033241	Peroxisomal protein import	Protein localization	0.090313	AGXT,CAT,CRAT,GNPAT,PEX5,PEX7,RPS27A	chr11:34471141:A/C:1,chr12:7190218:T/G:1,chr1:231267458:C/A:1,chr2:240869136:A/G:1,chr2:55234745:A/T:1,chr6:136900399:T/G:1,chr9:129110977:A/C:1
R-HSA-9033658	Blood group systems biosynthesis	Metabolism	1.000000	B3GALT5	chr21:39664662:C/T:1
R-HSA-9034015	Signaling by NTRK3 (TRKC)	Signal Transduction	1.000000	IRS1	chr2:226796751:A/G:1
R-HSA-9037629	Lewis blood group biosynthesis	Metabolism	1.000000	B3GALT5	chr21:39664662:C/T:1
R-HSA-909733	Interferon alpha/beta signaling	Immune System	0.598728	HLA-B,IFI6,PTPN1,PTPN11,PTPN6	chr12:112489105:A/T:1,chr12:6960084:C/T:1,chr1:27668390:G/T:1,chr20:50526505:C/A:1,chr6:31356312:G/A:1
R-HSA-912446	Meiotic recombination	Reproduction;Cell Cycle	1.000000	BRCA1,MSH5,RPA1,RPA2	chr17:1853255:C/A:1,chr17:43049287:C/G:1,chr1:27914481:C/T:1,chr6:31747193:C/A:1
R-HSA-912526	Interleukin receptor SHC signaling	Immune System	0.196494	IL2RB,PIK3CB,PTPN6	chr12:6960084:C/T:1,chr22:37132322:T/G:1,chr22:37142288:T/C:1,chr3:138778223:G/A:1
R-HSA-912631	Regulation of signaling by CBL	Immune System	0.006876	BLNK,HCK,PIK3CB,RAPGEF1,RPS27A	chr10:96227700:G/C:1,chr20:32098788:C/A:1,chr2:55234745:A/T:1,chr3:138778223:G/A:1,chr9:131592242:G/T:1
R-HSA-912694	Regulation of IFNA signaling	Immune System	0.181814	PTPN1,PTPN11,PTPN6	chr12:112489105:A/T:1,chr12:6960084:C/T:1,chr20:50526505:C/A:1
R-HSA-913531	Interferon Signaling	Immune System	0.759085	HLA-B,HLA-DRB1,HLA-DRB5,IFI6,NCAM1,NUP214,PIN1,PRKCD,PTPN1,PTPN11,PTPN6,RPS27A	chr11:113207596:G/T:1,chr12:112489105:A/T:1,chr12:6960084:C/T:1,chr19:9849326:C/A:1,chr1:27668390:G/T:1,chr20:50526505:C/A:1,chr2:55234745:A/T:1,chr3:53192052:T/G:1,chr6:31356312:G/A:1,chr6:32530260:C/G:1,chr6:32584008:G/C:1,chr9:131215059:A/G:1
R-HSA-913709	O-linked glycosylation of mucins	Metabolism of proteins	0.023519	B3GNTL1,GALNT10,GALNT14,GALNT17,MUC15,MUC17,MUC3A,MUC4	chr11:26561226:C/A:1,chr17:83048634:G/T:1,chr2:30924922:C/T:1,chr2:30945103:G/T:1,chr3:195752618:A/G:1,chr3:195752619:G/C:1,chr5:154416093:G/C:1,chr7:100958263:A/G:1,chr7:101035696:G/T:1,chr7:71571591:C/A:1
R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	Vesicle-mediated transport	0.695622	RPS27A,STAM	chr10:17660650:A/C:1,chr2:55234745:A/T:1
R-HSA-917937	Iron uptake and transport	Transport of small molecules	0.260268	RPS27A	chr2:55234745:A/T:1
R-HSA-918233	TRAF3-dependent IRF activation pathway	Immune System	0.559805	IKBKE	chr1:206479188:C/A:1
R-HSA-927802	Nonsense-Mediated Decay (NMD)	Metabolism of RNA	0.542776	NCBP1,PPP2R1A,RPL10,RPL23,RPL31,RPS27A,RPS6,RPS9	chr17:38850552:C/A:1,chr19:52215622:C/T:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr2:101018980:G/T:1,chr2:55234745:A/T:1,chr9:19376102:T/C:1,chr9:97664178:C/A:1,chrX:154405329:C/A:1
R-HSA-933541	TRAF6 mediated IRF7 activation	Immune System	1.000000	IKBKE	chr1:206479188:C/A:1
R-HSA-933542	TRAF6 mediated NF-kB activation	Immune System	1.000000	NFKBIA	chr14:35403479:G/T:1
R-HSA-936440	Negative regulators of DDX58/IFIH1 signaling	Immune System	0.125346	IKBKE,PIN1,RPS27A,TAX1BP1	chr19:9849326:C/A:1,chr1:206479188:C/A:1,chr2:55234745:A/T:1,chr7:27841060:C/A:1
R-HSA-936837	Ion transport by P-type ATPases	Transport of small molecules	0.769701	ATP11C,ATP7B	chr13:51941000:A/T:1,chrX:139798205:A/T:1
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	Immune System	0.013632	CD14,IKBKE,PTPN11,RPS27A	chr12:112489105:A/T:1,chr1:206479188:C/A:1,chr2:55234745:A/T:1,chr5:140633030:C/A:1
R-HSA-937039	IRAK1 recruits IKK complex	Immune System	0.559805	RPS27A	chr2:55234745:A/T:1
R-HSA-937041	IKK complex recruitment mediated by RIP1	Immune System	0.379439	CD14,RPS27A	chr2:55234745:A/T:1,chr5:140633030:C/A:1
R-HSA-937042	IRAK2 mediated activation of TAK1 complex	Immune System	0.443443	RPS27A	chr2:55234745:A/T:1
R-HSA-937061	TRIF(TICAM1)-mediated TLR4 signaling 	Immune System	0.122923	CD14,IKBKE,MAP2K3,NFKBIA,NOD2,PPP2R1A,PTPN11,RPS27A,RPS6KA1	chr12:112489105:A/T:1,chr14:35403479:G/T:1,chr16:50711288:C/T:1,chr17:21303128:C/T:1,chr19:52215622:C/T:1,chr1:206479188:C/A:1,chr1:26571817:C/A:1,chr2:55234745:A/T:1,chr5:140633030:C/A:1
R-HSA-937072	TRAF6-mediated induction of TAK1 complex within TLR4 complex	Immune System	0.230138	CD14,RPS27A	chr2:55234745:A/T:1,chr5:140633030:C/A:1
R-HSA-948021	Transport to the Golgi and subsequent modification	Metabolism of proteins	0.872579	ANK1,ANK3,PPP6C,SEC16B,SEC23A,SEC24D,SEC31A,SPTBN4,ST8SIA2,TUBB2A,TUBB8	chr10:60685310:G/A:1,chr10:73757:T/G:1,chr14:39040609:C/A:1,chr15:92412994:G/T:1,chr19:40569803:G/A:1,chr1:177936177:G/T:1,chr4:118833895:C/A:1,chr4:82855072:T/A:1,chr6:3154999:A/G:1,chr8:41808044:G/T:1,chr9:125171223:T/A:1
R-HSA-9603381	Activated NTRK3 signals through PI3K	Signal Transduction	0.296385	IRS1	chr2:226796751:A/G:1
R-HSA-9604323	Negative regulation of NOTCH4 signaling	Signal Transduction	0.548710	FBXW7,PSMF1,RBX1,RPS27A	chr20:1117130:G/T:1,chr22:40963988:A/T:1,chr2:55234745:A/T:1,chr4:152350128:T/A:1
R-HSA-9605308	Diseases of Base Excision Repair	Disease	0.253920	NEIL1	chr15:75355845:G/C:1
R-HSA-9607240	FLT3 Signaling	Immune System	0.042599	CSK,DAB2IP,ERBB4,HCK,IL2RB,IQGAP1,IRS1,KITLG,NCAM1,NRG3,PIK3CB,PPP2R1A,PPP2R5C,PSMF1,PTPN11,PTPRA,RASAL1,RASAL2,RBX1,RPS27A,SPRED3,SPTBN4,TLN1	chr10:82985678:T/A:1,chr11:113207596:G/T:1,chr12:112489105:A/T:1,chr12:113100514:A/G:1,chr12:113118892:G/T:1,chr12:88516155:G/T:1,chr14:101883867:G/T:1,chr15:74802540:C/T:1,chr15:90390695:A/G:1,chr15:90485816:T/C:1,chr19:38392374:C/T:1,chr19:38394161:T/G:1,chr19:40569803:G/A:1,chr19:52215622:C/T:1,chr1:178470804:T/C:1,chr20:1117130:G/T:1,chr20:2975202:A/T:1,chr20:2988197:T/A:1,chr20:32098788:C/A:1,chr22:37132322:T/G:1,chr22:37142288:T/C:1,chr22:40963988:A/T:1,chr2:211630704:C/G:1,chr2:226796751:A/G:1,chr2:55234745:A/T:1,chr3:138778223:G/A:1,chr9:121578321:C/A:1,chr9:35697963:G/T:1
R-HSA-9609507	Protein localization	Protein localization	0.607966	AGXT,CAT,CRAT,GNPAT,PEX5,PEX7,RPS27A	chr11:34471141:A/C:1,chr12:7190218:T/G:1,chr1:231267458:C/A:1,chr2:240869136:A/G:1,chr2:55234745:A/T:1,chr6:136900399:T/G:1,chr9:129110977:A/C:1
R-HSA-9609646	HCMV Infection	Disease	0.224758	HDAC3,NUP214,SUZ12,TUBB2A,TUBB8	chr10:73757:T/G:1,chr17:31973320:T/G:1,chr5:141629409:G/A:1,chr6:3154999:A/G:1,chr9:131215059:A/G:1
R-HSA-9609690	HCMV Early Events	Disease	0.452540	HDAC3,NUP214,SUZ12,TUBB2A,TUBB8	chr10:73757:T/G:1,chr17:31973320:T/G:1,chr5:141629409:G/A:1,chr6:3154999:A/G:1,chr9:131215059:A/G:1
R-HSA-9609736	Assembly and cell surface presentation of NMDA receptors	Neuronal System	1.000000	TUBB2A,TUBB8	chr10:73757:T/G:1,chr6:3154999:A/G:1
R-HSA-9610379	HCMV Late Events	Disease	0.022265	NUP214	chr9:131215059:A/G:1
R-HSA-9612973	Autophagy	Autophagy	0.152353	ATG14,ATG16L1,CFTR,GABARAP,PCNT,PEX5,PRKAA2,PRKAB2,PRKN,RPS27A,RPTOR,TUBB2A,TUBB8	chr10:73757:T/G:1,chr12:7190218:T/G:1,chr14:55385868:G/A:1,chr17:7240852:C/A:1,chr17:80664395:C/A:1,chr1:147172001:G/A:1,chr1:56706008:C/A:1,chr21:46351357:C/A:1,chr2:233274667:A/T:1,chr2:55234745:A/T:1,chr6:161549199:T/A:1,chr6:3154999:A/G:1,chr7:117542008:A/T:1
R-HSA-9613354	Lipophagy	Autophagy	0.089187	PRKAA2,PRKAB2	chr1:147172001:G/A:1,chr1:56706008:C/A:1
R-HSA-9613829	Chaperone Mediated Autophagy	Autophagy	0.126639	CFTR,PCNT,RPS27A	chr21:46351357:C/A:1,chr2:55234745:A/T:1,chr7:117542008:A/T:1
R-HSA-9614085	FOXO-mediated transcription	Gene expression (Transcription)	0.425340	CAT,KAT2B,NPY,SIN3A,SOD2	chr11:34471141:A/C:1,chr15:75409706:G/A:1,chr3:20072202:A/T:1,chr6:159684794:A/T:1,chr7:24285140:T/G:1
R-HSA-9615017	FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes	Gene expression (Transcription)	0.088131	CAT,NPY,SIN3A,SOD2	chr11:34471141:A/C:1,chr15:75409706:G/A:1,chr6:159684794:A/T:1,chr7:24285140:T/G:1
R-HSA-9615710	Late endosomal microautophagy	Autophagy	0.440945	CFTR,PCNT,RPS27A	chr21:46351357:C/A:1,chr2:55234745:A/T:1,chr7:117542008:A/T:1
R-HSA-9615933	Postmitotic nuclear pore complex (NPC) reformation	Cell Cycle	1.000000	RCC1	chr1:28508571:C/A:1
R-HSA-9616222	Transcriptional regulation of granulopoiesis	Developmental Biology	0.063258	FLI1	chr11:128784861:G/A:1
R-HSA-9616334	Defective Base Excision Repair Associated with NEIL1	Disease	0.056891	NEIL1	chr15:75355845:G/C:1
R-HSA-9617629	Regulation of FOXO transcriptional activity by acetylation	Gene expression (Transcription)	0.443443	KAT2B	chr3:20072202:A/T:1
R-HSA-9619483	Activation of AMPK downstream of NMDARs	Neuronal System	0.079795	PRKAA2,PRKAB2,TUBB2A,TUBB8	chr10:73757:T/G:1,chr1:147172001:G/A:1,chr1:56706008:C/A:1,chr6:3154999:A/G:1
R-HSA-9619665	EGR2 and SOX10-mediated initiation of Schwann cell myelination	Developmental Biology	0.679827	NAB1,SMARCA4	chr19:11025539:C/G:1,chr2:190687195:C/T:1,chr2:190687196:A/T:1
R-HSA-9620244	Long-term potentiation	Neuronal System	1.000000	ERBB4	chr2:211630704:C/G:1
R-HSA-9623433	NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis	Signal Transduction	0.409840	NR1H3	chr11:47259936:C/A:1
R-HSA-9627069	Regulation of the apoptosome activity	Programmed Cell Death	0.146339	APAF1,UACA	chr12:98648251:A/T:1,chr15:70694991:A/T:1
R-HSA-9632974	NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis 	Signal Transduction	0.253920	NR1H3	chr11:47259936:C/A:1
R-HSA-9633012	Response of EIF2AK4 (GCN2) to amino acid deficiency	Cellular responses to external stimuli	0.830225	RPL10,RPL23,RPL31,RPS27A,RPS6,RPS9	chr17:38850552:C/A:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr2:101018980:G/T:1,chr2:55234745:A/T:1,chr9:19376102:T/C:1,chrX:154405329:C/A:1
R-HSA-9634600	Regulation of glycolysis by fructose 2,6-bisphosphate metabolism	Metabolism	0.505026	PPP2R1A	chr19:52215622:C/T:1
R-HSA-9635486	Infection with Mycobacterium tuberculosis	Disease	0.664823	RPS27A,VPS33B	chr15:91014129:G/T:1,chr2:55234745:A/T:1
R-HSA-9636383	Prevention of phagosomal-lysosomal fusion	Disease	0.089187	RPS27A,VPS33B	chr15:91014129:G/T:1,chr2:55234745:A/T:1
R-HSA-9637628	Modulation by Mtb of host immune system	Disease	0.336437	RPS27A	chr2:55234745:A/T:1
R-HSA-9637687	Suppression of phagosomal maturation	Disease	0.166735	RPS27A,VPS33B	chr15:91014129:G/T:1,chr2:55234745:A/T:1
R-HSA-9637690	Response of Mtb to phagocytosis	Disease	0.379439	RPS27A,VPS33B	chr15:91014129:G/T:1,chr2:55234745:A/T:1
R-HSA-9639288	Amino acids regulate mTORC1	Cellular responses to external stimuli	1.000000	C12orf66,RPTOR,SZT2	chr12:64216016:T/A:1,chr17:80664395:C/A:1,chr1:43426518:G/A:1
R-HSA-9645135	STAT5 Activation	Immune System	0.336437	PTPN11	chr12:112489105:A/T:1
R-HSA-9645460	Alpha-protein kinase 1 signaling pathway	Immune System	0.475135	RPS27A	chr2:55234745:A/T:1
R-HSA-9645723	Diseases of programmed cell death	Disease	1.000000	SOD2	chr6:159684794:A/T:1
R-HSA-9646399	Aggrephagy	Autophagy	0.037062	CFTR,PCNT,PRKN,RPS27A,TUBB2A,TUBB8	chr10:73757:T/G:1,chr21:46351357:C/A:1,chr2:55234745:A/T:1,chr6:161549199:T/A:1,chr6:3154999:A/G:1,chr7:117542008:A/T:1
R-HSA-9648025	EML4 and NUDC in mitotic spindle formation	Cell Cycle	0.545402	CLASP2,CLIP1,KNL1,PPP2R1A,PPP2R5C,RCC2,TUBB2A,TUBB8	chr10:73757:T/G:1,chr12:122341757:C/T:1,chr14:101883867:G/T:1,chr15:40651961:A/T:1,chr19:52215622:C/T:1,chr1:17413265:G/T:1,chr3:33602979:G/T:1,chr6:3154999:A/G:1
R-HSA-9649948	Signaling downstream of RAS mutants	Disease	0.741484	CSK,IQGAP1,TLN1	chr15:74802540:C/T:1,chr15:90390695:A/G:1,chr15:90485816:T/C:1,chr9:35697963:G/T:1
R-HSA-9658195	Leishmania infection	Disease	0.900049	ARPC1B,CRHR1,DOCK1,GLP1R,GNAT3,HCK,IGHG1,IGHG2,IGHG4,ITPR2,ITPR3,LHCGR,MYH9,PLK2,VIPR2,WASF2	chr10:127257347:G/T:1,chr12:26600531:C/A:1,chr14:105624404:C/G:1,chr14:105641644:C/T:1,chr14:105741468:G/C:1,chr14:105741485:A/G:1,chr17:45831011:G/T:1,chr17:45833036:G/C:1,chr1:27412951:A/T:1,chr20:32098788:C/A:1,chr22:36320146:C/A:1,chr2:48708797:C/G:1,chr5:58454762:G/T:1,chr6:33676739:C/A:1,chr6:39086149:G/A:1,chr7:159142629:C/A:1,chr7:80474080:T/G:1,chr7:99394321:C/T:1
R-HSA-9660821	ADORA2B mediated anti-inflammatory cytokines production	Disease	0.449731	CRHR1,GLP1R,GNAT3,LHCGR,VIPR2	chr17:45831011:G/T:1,chr17:45833036:G/C:1,chr2:48708797:C/G:1,chr6:39086149:G/A:1,chr7:159142629:C/A:1,chr7:80474080:T/G:1
R-HSA-9662834	CD163 mediating an anti-inflammatory response	Disease	0.089187	MYH9,PLK2	chr22:36320146:C/A:1,chr5:58454762:G/T:1
R-HSA-9662851	Anti-inflammatory response favouring Leishmania parasite infection	Disease	0.883661	CRHR1,GLP1R,GNAT3,HCK,IGHG1,IGHG2,IGHG4,ITPR2,ITPR3,LHCGR,MYH9,PLK2,VIPR2	chr12:26600531:C/A:1,chr14:105624404:C/G:1,chr14:105641644:C/T:1,chr14:105741468:G/C:1,chr14:105741485:A/G:1,chr17:45831011:G/T:1,chr17:45833036:G/C:1,chr20:32098788:C/A:1,chr22:36320146:C/A:1,chr2:48708797:C/G:1,chr5:58454762:G/T:1,chr6:33676739:C/A:1,chr6:39086149:G/A:1,chr7:159142629:C/A:1,chr7:80474080:T/G:1
R-HSA-9663891	Selective autophagy	Autophagy	0.050768	CFTR,PCNT,PEX5,PRKAA2,PRKAB2,PRKN,RPS27A,TUBB2A,TUBB8	chr10:73757:T/G:1,chr12:7190218:T/G:1,chr1:147172001:G/A:1,chr1:56706008:C/A:1,chr21:46351357:C/A:1,chr2:55234745:A/T:1,chr6:161549199:T/A:1,chr6:3154999:A/G:1,chr7:117542008:A/T:1
R-HSA-9664323	FCGR3A-mediated IL10 synthesis	Disease	0.660190	HCK,IGHG1,IGHG2,IGHG4,ITPR2,ITPR3	chr12:26600531:C/A:1,chr14:105624404:C/G:1,chr14:105641644:C/T:1,chr14:105741468:G/C:1,chr14:105741485:A/G:1,chr20:32098788:C/A:1,chr6:33676739:C/A:1
R-HSA-9664407	Parasite infection	Disease	0.542776	ARPC1B,DOCK1,HCK,IGHG1,IGHG2,IGHG4,MYH9,WASF2	chr10:127257347:G/T:1,chr14:105624404:C/G:1,chr14:105641644:C/T:1,chr14:105741468:G/C:1,chr14:105741485:A/G:1,chr1:27412951:A/T:1,chr20:32098788:C/A:1,chr22:36320146:C/A:1,chr7:99394321:C/T:1
R-HSA-9664417	Leishmania phagocytosis	Disease	0.542776	ARPC1B,DOCK1,HCK,IGHG1,IGHG2,IGHG4,MYH9,WASF2	chr10:127257347:G/T:1,chr14:105624404:C/G:1,chr14:105641644:C/T:1,chr14:105741468:G/C:1,chr14:105741485:A/G:1,chr1:27412951:A/T:1,chr20:32098788:C/A:1,chr22:36320146:C/A:1,chr7:99394321:C/T:1
R-HSA-9664422	FCGR3A-mediated phagocytosis	Disease	0.542776	ARPC1B,DOCK1,HCK,IGHG1,IGHG2,IGHG4,MYH9,WASF2	chr10:127257347:G/T:1,chr14:105624404:C/G:1,chr14:105641644:C/T:1,chr14:105741468:G/C:1,chr14:105741485:A/G:1,chr1:27412951:A/T:1,chr20:32098788:C/A:1,chr22:36320146:C/A:1,chr7:99394321:C/T:1
R-HSA-9664433	Leishmania parasite growth and survival	Disease	0.883661	CRHR1,GLP1R,GNAT3,HCK,IGHG1,IGHG2,IGHG4,ITPR2,ITPR3,LHCGR,MYH9,PLK2,VIPR2	chr12:26600531:C/A:1,chr14:105624404:C/G:1,chr14:105641644:C/T:1,chr14:105741468:G/C:1,chr14:105741485:A/G:1,chr17:45831011:G/T:1,chr17:45833036:G/C:1,chr20:32098788:C/A:1,chr22:36320146:C/A:1,chr2:48708797:C/G:1,chr5:58454762:G/T:1,chr6:33676739:C/A:1,chr6:39086149:G/A:1,chr7:159142629:C/A:1,chr7:80474080:T/G:1
R-HSA-9664565	Signaling by ERBB2 KD Mutants	Disease	0.651048	ERBB4,NRG3	chr10:82985678:T/A:1,chr2:211630704:C/G:1
R-HSA-9664873	Pexophagy	Autophagy	0.126518	PEX5,RPS27A	chr12:7190218:T/G:1,chr2:55234745:A/T:1
R-HSA-9665686	Signaling by ERBB2 TMD/JMD mutants	Disease	0.358602	ERBB4,NRG3	chr10:82985678:T/A:1,chr2:211630704:C/G:1
R-HSA-9668328	Sealing of the nuclear envelope (NE) by ESCRT-III	Cell Cycle	0.703700	TUBB2A,TUBB8	chr10:73757:T/G:1,chr6:3154999:A/G:1
R-HSA-9671555	Signaling by PDGFR in disease	Disease	0.316221	BIN2,PIK3CB	chr12:51297095:C/A:1,chr3:138778223:G/A:1
R-HSA-9673767	Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants	Disease	0.505026	PIK3CB	chr3:138778223:G/A:1
R-HSA-9673768	Signaling by membrane-tethered fusions of PDGFRA or PDGFRB	Disease	0.253920	BIN2	chr12:51297095:C/A:1
R-HSA-9673770	Signaling by PDGFRA extracellular domain mutants	Disease	0.505026	PIK3CB	chr3:138778223:G/A:1
R-HSA-9675108	Nervous system development	Developmental Biology	0.000043	ABL2,ANK1,ANK3,AP2B1,ARPC1B,CACNA1G,CACNA1I,CACNB2,CLASP2,COL2A1,COL5A1,COL5A2,DOCK1,EPHB1,EPHB2,EPHB6,EVL,ITGA10,KALRN,KCNQ2,KCNQ3,L1CAM,LIMK2,MYH9,NAB1,NCAM1,NCBP1,NCSTN,NRCAM,PIK3CB,PIP5K1C,PITPNA,PLXNB1,PLXND1,PSMF1,PTPN11,PTPRA,RBX1,ROBO3,RPL10,RPL23,RPL31,RPS27A,RPS6,RPS6KA1,RPS9,SCN1A,SCN1B,SMARCA4,SPTBN4,ST8SIA2,TIAM1,TLN1,TUBB2A,TUBB8,UNC5B,VLDLR	chr10:127257347:G/T:1,chr10:18448206:G/A:1,chr10:60685310:G/A:1,chr10:71291226:C/T:1,chr10:73757:T/G:1,chr11:113207596:G/T:1,chr11:124874968:C/A:1,chr12:112489105:A/T:1,chr12:47982418:C/T:1,chr14:100141166:C/A:1,chr15:92412994:G/T:1,chr17:1520665:A/G:1,chr17:35682607:A/G:1,chr17:38850552:C/A:1,chr17:50578132:A/G:1,chr17:50600626:G/T:1,chr19:11025539:C/G:1,chr19:35033920:T/C:1,chr19:3643094:C/A:1,chr19:40569803:G/A:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr1:145895756:C/T:1,chr1:145909820:C/A:1,chr1:160353563:A/G:1,chr1:179221566:G/A:1,chr1:22893268:A/C:1,chr1:26571817:C/A:1,chr20:1117130:G/T:1,chr20:2975202:A/T:1,chr20:2988197:T/A:1,chr20:63439613:G/A:1,chr21:31135807:A/G:1,chr22:31260099:C/A:1,chr22:36320146:C/A:1,chr22:39647807:A/G:1,chr22:40963988:A/T:1,chr2:101018980:G/T:1,chr2:166047534:C/T:1,chr2:166047536:A/T:1,chr2:189098495:C/A:1,chr2:190687195:C/T:1,chr2:190687196:A/T:1,chr2:55234745:A/T:1,chr3:124138871:G/T:1,chr3:124477465:C/A:1,chr3:129575694:T/G:1,chr3:134932373:A/G:1,chr3:138778223:G/A:1,chr3:33602979:G/T:1,chr3:48421052:G/A:1,chr6:3154999:A/G:1,chr7:108168322:C/T:1,chr7:142863808:C/A:1,chr7:99394321:C/T:1,chr8:132175698:G/C:1,chr8:132192533:C/A:1,chr8:132421533:G/T:1,chr8:41808044:G/T:1,chr9:134782781:A/G:1,chr9:19376102:T/C:1,chr9:2644144:G/T:1,chr9:35697963:G/T:1,chr9:97664178:C/A:1,chrX:153863598:G/T:1,chrX:154405329:C/A:1
R-HSA-9675135	Diseases of DNA repair	Disease	0.443443	NEIL1	chr15:75355845:G/C:1
R-HSA-9675143	Diseases of the neuronal system	Disease	0.533217	ABCA4	chr1:94036566:G/A:1
R-HSA-9675151	Disorders of developmental biology	Disease	0.166735	HDAC3,SIN3A	chr15:75409706:G/A:1,chr5:141629409:G/A:1
R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	Immune System	0.559805	RPS27A	chr2:55234745:A/T:1
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	Immune System	0.357900	CD14,MAP2K3,NFKBIA,NOD2,PPP2R1A,RPS27A,RPS6KA1	chr14:35403479:G/T:1,chr16:50711288:C/T:1,chr17:21303128:C/T:1,chr19:52215622:C/T:1,chr1:26571817:C/A:1,chr2:55234745:A/T:1,chr5:140633030:C/A:1
R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	Immune System	0.559805	RPS27A	chr2:55234745:A/T:1
R-HSA-975155	MyD88 dependent cascade initiated on endosome	Immune System	0.362437	CD14,MAP2K3,NFKBIA,NOD2,PPP2R1A,RPS27A,RPS6KA1	chr14:35403479:G/T:1,chr16:50711288:C/T:1,chr17:21303128:C/T:1,chr19:52215622:C/T:1,chr1:26571817:C/A:1,chr2:55234745:A/T:1,chr5:140633030:C/A:1
R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	Immune System	0.208745	CD14,RPS27A	chr2:55234745:A/T:1,chr5:140633030:C/A:1
R-HSA-975576	N-glycan antennae elongation in the medial/trans-Golgi	Metabolism of proteins	1.000000	ST8SIA2	chr15:92412994:G/T:1
R-HSA-975577	N-Glycan antennae elongation	Metabolism of proteins	0.584880	ST8SIA2	chr15:92412994:G/T:1
R-HSA-975634	Retinoid metabolism and transport	Signal Transduction;Metabolism	0.738060	BCO1,HSPG2,PLB1	chr16:81245335:G/T:1,chr1:21839609:G/T:1,chr1:21850169:G/T:1,chr2:28516675:G/T:1
R-HSA-975871	MyD88 cascade initiated on plasma membrane	Immune System	0.479734	MAP2K3,NFKBIA,NOD2,PPP2R1A,RPS27A,RPS6KA1	chr14:35403479:G/T:1,chr16:50711288:C/T:1,chr17:21303128:C/T:1,chr19:52215622:C/T:1,chr1:26571817:C/A:1,chr2:55234745:A/T:1
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	Metabolism of RNA	0.501531	NCBP1,RPL10,RPL23,RPL31,RPS27A,RPS6,RPS9	chr17:38850552:C/A:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr2:101018980:G/T:1,chr2:55234745:A/T:1,chr9:19376102:T/C:1,chr9:97664178:C/A:1,chrX:154405329:C/A:1
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	Metabolism of RNA	0.542776	NCBP1,PPP2R1A,RPL10,RPL23,RPL31,RPS27A,RPS6,RPS9	chr17:38850552:C/A:1,chr19:52215622:C/T:1,chr19:54201442:G/T:1,chr19:54217221:A/G:1,chr19:54221926:G/T:1,chr19:54222987:C/T:1,chr2:101018980:G/T:1,chr2:55234745:A/T:1,chr9:19376102:T/C:1,chr9:97664178:C/A:1,chrX:154405329:C/A:1
R-HSA-977068	Termination of O-glycan biosynthesis	Metabolism of proteins	0.038769	MUC15,MUC17,MUC3A,MUC4	chr11:26561226:C/A:1,chr3:195752618:A/G:1,chr3:195752619:G/C:1,chr7:100958263:A/G:1,chr7:101035696:G/T:1
R-HSA-977225	Amyloid fiber formation	Metabolism of proteins	1.000000	GGA2,GSN,HSPG2,NCSTN,PRKN,RPS27A	chr16:23469223:G/T:1,chr1:160353563:A/G:1,chr1:21839609:G/T:1,chr1:21850169:G/T:1,chr2:55234745:A/T:1,chr6:161549199:T/A:1,chr9:121312182:C/T:1
R-HSA-977347	Serine biosynthesis	Metabolism	0.409840	PHGDH	chr1:119721477:C/G:1
R-HSA-977443	GABA receptor activation	Neuronal System	1.000000	GABRA5,GNAT3,KCNJ6	chr15:26939977:C/A:1,chr21:37714489:C/T:1,chr7:80474080:T/G:1
R-HSA-977444	GABA B receptor activation	Neuronal System	1.000000	GNAT3,KCNJ6	chr21:37714489:C/T:1,chr7:80474080:T/G:1
R-HSA-977606	Regulation of Complement cascade	Immune System	0.525258	C5,C7,C9,CPN2,IGHG1,IGHG2,IGHG4	chr14:105624404:C/G:1,chr14:105641644:C/T:1,chr14:105741468:G/C:1,chr14:105741485:A/G:1,chr3:194341790:C/T:1,chr5:39342273:C/A:1,chr5:40936518:G/A:1,chr9:120961515:C/A:1
R-HSA-982772	Growth hormone receptor signaling	Immune System	0.044502	CSH1,IRS1,PTPN1,PTPN6	chr12:6960084:C/T:1,chr17:63895212:T/C:1,chr20:50526505:C/A:1,chr2:226796751:A/G:1
R-HSA-983168	Antigen processing: Ubiquitination & Proteasome degradation	Immune System	0.210317	ANAPC1,ANAPC4,ASB3,FBXO21,FBXW7,HECW2,PRKN,PSMF1,RBX1,RPS27A,SMURF1,ZBTB16	chr11:114087490:T/C:1,chr12:117174552:T/C:1,chr20:1117130:G/T:1,chr22:40963988:A/T:1,chr2:111863902:T/A:1,chr2:196222438:A/C:1,chr2:53728873:T/A:1,chr2:55234745:A/T:1,chr4:152350128:T/A:1,chr4:25418042:G/T:1,chr6:161549199:T/A:1,chr7:99061975:G/T:1
R-HSA-983169	Class I MHC mediated antigen processing & presentation	Immune System	0.567928	ANAPC1,ANAPC4,ASB3,CD14,CD36,FBXO21,FBXW7,HECW2,HLA-B,PRKN,PSMF1,RBX1,RPS27A,SEC23A,SEC24D,SEC31A,SMURF1,ZBTB16	chr11:114087490:T/C:1,chr12:117174552:T/C:1,chr14:39040609:C/A:1,chr20:1117130:G/T:1,chr22:40963988:A/T:1,chr2:111863902:T/A:1,chr2:196222438:A/C:1,chr2:53728873:T/A:1,chr2:55234745:A/T:1,chr4:118833895:C/A:1,chr4:152350128:T/A:1,chr4:25418042:G/T:1,chr4:82855072:T/A:1,chr5:140633030:C/A:1,chr6:161549199:T/A:1,chr6:31356312:G/A:1,chr7:80474080:T/G:1,chr7:99061975:G/T:1
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	Immune System	0.050683	HLA-B,SEC23A,SEC24D,SEC31A	chr14:39040609:C/A:1,chr4:118833895:C/A:1,chr4:82855072:T/A:1,chr6:31356312:G/A:1
R-HSA-983189	Kinesins	Hemostasis	0.159754	KIF11,KIF25,KLC2,KLC4,TUBB2A,TUBB8	chr10:73757:T/G:1,chr10:92639648:G/T:1,chr11:66264919:G/A:1,chr6:168040119:C/A:1,chr6:3154999:A/G:1,chr6:43055804:A/T:1
R-HSA-983231	Factors involved in megakaryocyte development and platelet production	Hemostasis	0.612668	CARMIL1,DOCK1,DOCK4,JMJD1C,KIF11,KIF25,KLC2,KLC4,SIN3A,TUBB2A,TUBB8	chr10:127257347:G/T:1,chr10:63215138:A/G:1,chr10:73757:T/G:1,chr10:92639648:G/T:1,chr11:66264919:G/A:1,chr15:75409706:G/A:1,chr6:168040119:C/A:1,chr6:25442364:C/A:1,chr6:3154999:A/G:1,chr6:43055804:A/T:1,chr7:111808804:C/T:1
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	Immune System	1.000000	BLNK,ITPR2,ITPR3,PTPN6	chr10:96227700:G/C:1,chr12:26600531:C/A:1,chr12:6960084:C/T:1,chr6:33676739:C/A:1
R-HSA-983705	Signaling by the B Cell Receptor (BCR)	Immune System	1.000000	BLNK,CARD11,ITPR2,ITPR3,NFKBIA,PRKCB,PSMF1,PTPN6,RPS27A	chr10:96227700:G/C:1,chr12:26600531:C/A:1,chr12:6960084:C/T:1,chr14:35403479:G/T:1,chr16:23867049:C/T:1,chr20:1117130:G/T:1,chr2:55234745:A/T:1,chr6:33676739:C/A:1,chr7:2924035:T/C:1
R-HSA-983712	Ion channel transport	Transport of small molecules	0.076312	ANO3,ASIC2,ATP11C,ATP7B,RPS27A,RYR1,RYR2,RYR3,SLC9C1,TPCN1,TRPM7,TRPM8,TRPV3,TRPV4,UNC80,WNK2	chr11:26561226:C/A:1,chr12:109796329:G/T:1,chr12:113277113:G/C:1,chr13:51941000:A/T:1,chr15:33432668:T/G:1,chr15:33653029:T/A:1,chr15:50663094:T/A:1,chr17:34011650:C/A:1,chr17:3527683:A/G:1,chr19:38464585:G/T:1,chr1:237756505:G/T:1,chr1:237792382:C/T:1,chr2:209809377:C/A:1,chr2:233945718:C/A:1,chr2:55234745:A/T:1,chr3:112168997:G/T:1,chr9:93229811:A/T:1,chrX:139798205:A/T:1
R-HSA-991365	Activation of GABAB receptors	Neuronal System	1.000000	GNAT3,KCNJ6	chr21:37714489:C/T:1,chr7:80474080:T/G:1
R-HSA-997272	Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits	Neuronal System	1.000000	KCNJ6	chr21:37714489:C/T:1